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ABSTRACT
The purpose of these hospital and community-based case-control
studies was to investigate the association between cigarette smoking and
cervical cancer (in-situ and invasive).
A number of local and international studies have investigated the
association between cigarette smoking and cervical cancer. However few if
any have investigated this association in in-situ and invasive cervical cancer
using community and hospital controls at the same time.
The association between cigarette smoking and cervical cancer is
investigated in samples of 114 in-situ cervical cancer cases, 75 invasive
cervical cancer cases, 181 community controls and 331 hospital controls.
These cervical cancer cases and hospital controls were collected from Royal
Price Alfred hospital and Westmead hospital in Sydney, Australia during
1980 - 1983. Community control data were identified from the fIles of the
family doctor or from university affiliated general practices from the same
areas as the in-situ cases. The data for invasive cases and hospital controls
were collected as a part of a WHO Collaborative Study of Neoplasia and
Steroid Contraceptives in Australia (1980-1983). The data for in-situ cases
and community controls were collected as part of a case-control study on
dietary factors and risk of in-situ cervical cancer conducted by Brock and
others (1980-1983).
Number of sexual partners, induced abortion experience, practise of
11 safe period11 contraception, and cigarette smoking measured both by ever
smoked and number of cigarettes smoked per day are significantly associated
with increased risk of developing in-situ cervical cancer using community
controls. For in-situ cervical cancer cases using hospital controls number of
sexual partners, early age at first intercourse, spouses I duration of education,
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induced abortion experience, spirit drinking habit, use of oral contraceptives
and smoking status are identified as risk factors. Invasive cervical cancer
using hospital controls revealed a different pattern of risk factors. In this
study parous women, women who engaged in unskilled jobs, women who
drank beer and women who smoked are at an increased risk of developing
invasive cervical cancer. Thus in this study cigarette smoking is established as
one of risk factors for cervical cancer.
The increased risks of developing cervical cancer caused by cigarette
smoking are various. For in-situ cervical cancer using community and
hospital controls the risks are 2.3 and 1.8 respectively; for invasive cervical
cancer the risk is 1.8. A dose response relationship between number of
cigarettes smoked per day and increased risk of developing in-situ cervical
cancer was also observed in the study involving in-situ cervical cancer using
community controls.
The study on in-situ cervical cancer with different control groups
namely hospital and community controls revealed a different pattern with
regard to the risk factors. It is still uncertain whether this difference is a true
difference with regard to different exposure toward the hospital and
community populations or as the result of biases including selection bias,
admission bias, information bias and recall bias.
With regard to the smoking variables, the finding in this study is still
inconclusive since this study was not specifically designed to investigate the
association between cigarette smoking and cervical cancer and also this study
failed to control for another major risk factor for cervical cancer, namely
history of infection of Human Papilloma Virus. Thus in order to establish
cigarette smoking as a risk factor for cervical cancer it is still necessary to
further investigate the history of Human Papilloma Virus infection in this
study population.
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CHAPTER 1. INTRODUCTION.
A REVIEW OF CERVICAL CANCER, CIGARETTE
SMOKING AND OTHER IDENTIFIED RISK FACTORS FOR
CERVICAL CANCER
1.1. Introduction.
These are hospital and community based case-control studies on the
association between cigarette smoking and cervical cancer (invasive and in-situ
cervical cancer). The existence of which association has been debated since
1977 (Winkelstein, 1977; Winkelstein, 1981; Winkelstein 1981; MacDonald,
1983; Winkelstein, 1984; Zang, et.al. , 1989; Layde, 1989; Winkelstein,
1990; Brinton, 1990).
Issues of cancer and cancer causation, cervical cancer, the carcinogenic
effect of tobacco and established risk factors for cervical cancer will be
summarised in this chapter. The epidemiological and biological plausibility
studies relating cigarette smoking and cervical cancer will also be presented.
1.2. Cancer and cancer causation.
In modern industrialised countries, where starvation and infectious
diseases, are the things of the past, cancer has become the most feared of all
diseases. Although its frequency is still less than heart disease, it is usually a
progressive fatal condition for which little treatment has been discovered
(Cairns, 1978).
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Comparison of the data of cancer, collected world-wide, leads to a
hypothesis that cancer is a preventable disease (Doll and Peto, 1981;
Peto,1986; Peto, 1987). The evidence to support this is as follows:
a. There are differences in the incidence of particular types of cancer
between different parts of the world, between different areas of one
country and between different populations in one area.
b. The changes in the incidence of cancer in migrant groups (from
that in their former countries toward their new countries of
residences), provide good evidence of the importance of life-style
and another environment factors in the production of cancer.
c. Changes in the incidence of particular types of cancer with the
passage of time provide evidence that extrinsic factors affect those
types of cancer
d. Recently several environmental agents have been discovered as the
causes of several types of cancer (carcinogens). These agents can be
grouped into chemical and physical agents, including chemical,
radiation trauma and chronic irritation; biological agents, i.e. viral
and bacterial, agents (Doll and Peto, 1981; Ruddon, 1987); but also
the contribution of hereditary factors should not be forgotten.
Diagram 1.1 presents various stages of cancer progression as observed
histologically. It can be seen that cancer progresses through various stages
until the appearance of malignant cells.
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Diagram 1.1. The natural history of neoplasia.
(after Pitot, 1986)
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Diagram 1.2 schematically represents the development of cancer over
time with each stage and process. It can be seen that cancer causation develops
over a long period of time.
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Diagram 1.2. Development of cancer within time.
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In vitro studies clearly show that the nature of cancer development is
not single stage - single factorial, but that is multi stage - multi factorial,
such as the process of initiation and promotion (Basil, 1989)
Diagram 1.3 presents cancer as a multi stage process. In its simplest
form two stages are identified. An initiation phase, which is essential but as
its own can not produce a malignant tumour. Initiation process oftens happen
in early life and these cells can remain latent for a long period of time. A
second phase (sometimes multiple) is needed to progress these cells to become
malignant. This is called promotion.
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Diagram 1.3. Cancer as a multistage process.
(after Volder, et.al., 1988)
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During the initiation process, tumour initiating agents interact with
DNA, but this interaction alone will not produce a malignant tumour. Initiated
cells undergo several rounds of replicatio~ before they become cancerous.
Initi.ation can occur after a single, brief exposure to a potent initiating agent.
It is still a debate whether this process is reversible or irreversible (Ruddon,
1987; Volders, 1988; Basil, 1989). The initiation phase only requires a small
amount of time, and it must be heritable because the initiated cells convey the
malignant alteration to their daughter cells. This stage can be either inherited,
spontaneously induced or induced by environmental compounds.
The promotion phase is described as the growth of the initiated cells
into a pre-cancerous lesion (known as in-situ). This is usually a sloWl~adUal 'i
process and often requires a more prolonged exposure to the promoting agent.
Promotion occupies the greater part of the latent period of carcinogenesis.
This process is at least partially reversible during the early stages of
development and can be arrested by certain anticarcinogenic agents. Several
substances were detected as promoting agents in in vivo experimental systems
and these include hormones and immunosuppressors (Pitot, 1986; Ruddon,
1987).
The problem in the observation regarding causes of cancer is the fact
that cancer formation is a slow process with a long latency period, in some
cases 20 years or more between the initiating insult and the appearance of a
clinically detectable tumour; often promotion takes effect with multiple factors
over various times.
These subsequent steps are related to the combined interaction of
different environmental factors and life styles to which human being are
exposed during their lifetime (peto, 1987; Ruddon, 1987) (diagram 1.4).
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Diagram 1.4. Multiple factors model of cancer causation
(after Volders, et.al., 1988)
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Thus, the evidence for the causes of cancer are usually a combination
of biological (often cellular) evidence and human (population based) data.
1.3. Cervical cancer
Cervical cancer is regarded as the most typical example of cancerous
disease with a preclinical phase detectable for a long time (Hakama, 83). It
has a gradual, rather than explosive, onset and that the precursor may exist in
a reversible form that is followed by a stage of surface or in situ development
for some years.
Cervical cancer originates from the epithelial layer at the junction of
the portion squamous epithelium and the columnar mucous epithelium of the
endocervix. That border is known as squamo-collumnair junction, i.e. the
transition between squamous complex epithelial tissue of vagina and
collumnair epithelial tissue of corpus uteri (Brenner, 1982).
There are several steps in its development, usually starting as a
hyperplasia of the epithelial, followed by metaplasia, dysplasia, carcinoma in-
situ (CIS) and invasive carcinoma.
According to the origin of cells, the great majority of cervical cancer is
squamous cell type (90%), and the remainder (10%) includes adenomas and
sarcomas (Brinton and Fraumeni, 1986; Hakama, 1983).
Cervical cancer accounting for 15 % of all cancers diagnosed in women
(parkin et.al. , 1988). Of these cases, 20% occur in the developed countries
and 80% in the developing countries. Cervical cancer constitutes 5% - 20% of
all cases of cancer in females in the Western population and 20 % - 35 % of
cases in females in developing countries. The incidence varies from 5 to 60
per 100,000 women a year between different countries. This is the 5th most
common form of cancer in the USA and the 16th cause of mortality (1985)
(Smith, 1987). In Australia cervical cancer is the 6th most common form of
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cancer among women (1982). And in New South Wales, it is the 6th most
common cancer among women and it contributes 3% (8th) of cancer mortality
among women (1984) (AIR, 1989).
Early diagnosis of cervical cancer is attributed to the wide spread use
of cytologic screening developed by Papanicolaou (pap test) (van der Graaf,
et.al. , 1988). Overall, Pap test has a false-negative rate of 10% to 35%
(Skrabanek, 1989). It is recommended that sexually active women should have
two annual Pap tests between the age of 18 and 20 years, followed by Pap
tests every 3 years until the age of 35 and there after at 5 year intervals until
the age of 60 (Brenner, 1982; Brinton and Fraumeni, 1986).
The mortality rate of cervical cancer has been declining since the
1950's in Australia, Britain and the USA. But even though the mortality rates
of cervical cancer are decreasing, there is some recent evidence that the
morbidity rate of CIN, especially among young women (25- 29) in Australia
and U.K is increasing. Mitchell and Medley (1990) found that there is a
progressive lowering of the age group having the highest prevalence of
definite CIN, from women aged 40 - 49 years in 1970 - 1973 to women aged
25 - 29 years in 1982 - 1988. Walker (1985) found an increase in the mortality
rate in young women aged 15 - 34 years in New Zealand, Canada (Alberta)
and U.K, as well as in Australia (Rolman and Armstrong, 1987).
1.3.1. Carcinoma in situ (CIS).
The lesions in which the full thickness of the epithelium is composed of
undifferentiated neoplastic cells is called carcinoma in situ. The term dysplasia
is used for all other precancerous disorders of the epithelium, which are
subdivided into mild, moderate and severe grades. These early forms are also
called cervical intraepithelial neoplasia (CIN) and are divided into three
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categories, i.e. CIN grade 1 (mild dysplasia), CIN grade 2 (moderate
dysplasia) and CIN grade 3 (severe dysplasia and CIS) (DiSaia, 1990).
The incidence of dysplasia or CIN is thought to be highest during
period of greatest sexual activity (25-29 years old) and then falls in middle age
(Brinton and Fraumeni, 1986; Doll and Peto, 1981). Dysplasias may regress
and quite frequently do so when they occur under 40 years of age (Doll, 1983;
Brinton and Fraumeni, 1986), but there also is a tendency for the disease to
progress over time to a more advanced state; and it is well accepted that CIN
m or in-situ is a pre-cancerous condition (Brenner, 1982; Brinton and
Fraumeni, 1986).
1.3.2. Invasive carcinoma.
The ability to penetrate the basal layer of cervix uteri tissue and to
invade the stroma differentiates CIN grade 3 (CIS) from an invasive
carcinoma.
In its development, CIN can either regress or progress to invasive
carcinoma. The progression rate increases with increasing grade of CIN.
Richart (in DiSaia, 1990) found that it needs 85 months for CIN grade 1 to
become CIN grade 3, and 38 months for CIN grade 2. Also the progression
rate to invasive carcinoma are higher in CIN grade 3 (CIS) than in earlier
states.
For clinical purposes, FIGO classification of cervical cancer is widely
used in the world. According to its clinical staging, cervical cancer is
classified as stage 0 (i.e. carcinoma in situ), stage I, la, Ia1, Ia2, Ib, stage IT,
ITa,IIb, stage m, ma, IIIb, and stage IV, IVa, IVb (DiSaia, 1990).
Invasive carcinoma begins to occur soon after sexual activity begins.
The incidence increases rapidly and reaches its maximum at about 45-50 years
of age, and after that the incidence tends to remain static (Hakama, 1983).
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Thus, as a conclusion, the natural development of cancer provides a
possibility for preventive intervention, Le. by breaking the link either before
initiation happened or at least prohibiting the promotion process. With regard
to cervical cancer, this issue is important because cervical cancer is a
. preventable disease and especially recently while the morbidity and mortality
rates of cervical cancer is increasing among younger age group of women.
1.4. Carcinogenic effect of tobacco.
Smoking is associated with an increased risk of a variety of malignant
diseases. It has been estimated that almost 35 % of deaths from cancer are
related to smoking (Burton, 1983; Doll, 1988).
Cigarette smoking involves inhaling a complex mixture of chemicals.
The chemical content in tobacco has been partially identified. Some of these
chemical compounds, such as nitrosamine and nitrosopiperidine, have been
identified as carcinogenic (Yuspa and Harris, 1986).
Exposure to the constituents of tobacco smoke can occur through the
active intake of mainstream smoke, the passive intake of sidestream smoke, or
the transfer of tobacco smoke constituents by the maternal blood stream to the
fetus (Haley, et. al., 1986).
Exposure can be evaluated, either subjectively by self reporting, or
objectively by physiological or biochemical methods (Jarvis, et. al., 1987).
Nicotine is specific to tobacco; although limited by a short biological half-life
(30 minutes), but its metabolite, cotinine, has a long half-life (30 hours)
(Hellberg, et. al., 1988) and can be measured from blood, urine, saliva,
13
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exhaled air and cervical mucus lately (Haley, et.al. , 1986; Hellberg, et. al.,
1988; Rowel, 1983; Sasson, et.al., 1986).
Among tobacco carcinogens, the polyaromatic hydrocarbons in animal
experiments have been found to be carcinogenic to the cervix. Today, the
major interest is focused on tobacco specific nitrosamines, in which nicotine is
one of the exclusive source of the most potent carcinogen in within
nitrosamines group, i.e. 4~(methyl nitrosamino)-1-(3-pyridil)-1-butanone
(Hellberg, et. al., 1988; Rowel, 1983).
1.5. Identified risk factors for cervical cancer.
Although several risk factors for cervical cancer have been identified
trough epidemiologic research, many of the factors are highly correlated and
interrelationship have not been adequately explored. In addition, most studies
of invasive cancer were conducted in the 1950s and 1960s , when the disease
was more prevalent and it is unclear whether the same risk factors apply
today. Thus, a major challenge exists to disentangle and clarify the causes of
cervical cancer, utilizing a variety of epidemiologic approaches combined with
laboratory assays to define the agents and mechanisms that may be amenable
to preventive strategies (Brinton and Fraumeni, 1986).
A summary of the evidence supporting the role of various potential risk
factors for cervical cancer follows:
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1.5.1. Reproductive and sexual factors.
Doll (1987) stated that cervical cancer is related in some way to
sexual activity; thus, it appears to be a disease of venereal origin.
Some of the sexual factors that can be attributed to cervical
cancer are:
1. number of sexual partners (the strongest evidence)
2. age at 1st intercourse. Brinton and Fraumeni (1986) stated
that this may be due to confounding to number of sexual
partners)
3. parity (recently identified in South American population
(Brinton, et.al. , 1989)
4. spouse factors, Le. number of sexual partners of the spouse
and circumcision status of spouse (Buckley, et.al. , 1981;
Hellberg, et.al., 1983; Marshall, et.al., 1983; Reeves, et.al.,
1985; Slattery, et.al., 1989; Thomas, et.al., 1973; Tokuhata,
1967; Zunzunegui, et.al., 1986).
1.5.2. Education and sodo-economic status.
Most of the studies pointed out that the incidence of cervical
cancer is higher among low socio-economic and low educated groups
of females. As with most studies where low socio-economic status is a
risk factor, it is a question of what is the actual exposure factor.
There is some evidence that women of lower socio-economic status
get screened less often and thus have higher mortality (van der Graaf,
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et. al., 1988) but there are many other factors which could also be
considered, e.g. diet, conconominant infection.
1.5.3. History of sexually-transmitted disease.
The role of genital infection has been considered for a long
time; Trichomoniasis .(Tokuhata, 1967) and Chlamidia trachomatis
(Thomas, 1973) had once been considered as the cause of cervical
cancer. Later Herpes Simplex Virus (HSV) type 2 and 11 were
suspected as the cause of cervical cancer. From a cohort study, Vonka
et.al. (1986) found that there was no relationship between infection of
HSV type 2 and 11 with cervical cancer. R~cently, epidemiological
and biological evidence has implicated Human Papilloma Virus
(HPV) type 6, 11, 16, 18 and 31 as a suspected cause of cervical
cancer, although it still needs to be substantiated in human population
(Baird, 1988; Franscheschi, et. al, 1983; Munoz, Bosch and Kaldor,
1988; DiSaia, 1990).
1.5.4. Contraceptive methods.
Oral contraceptives have been considered as one of the potential
risk factors contributing to cervical cancer although many of these
studies have been criticized for lack of control for sexual activity.
Two recent well controlled case-control studies (Brinton, et. al. ,
1986; WHO Collaborative Study, 1985) have shown an increased risk
of crN for long-term pill users. The WHO Collaborative Study of
Neoplasia and Steroid Contraceptive (1985) gave evidence that the
pill is related to invasive cervical cancer (RR = 1.2 - 1.5). The risk
appears to be highest among users of pills" containing high estrogen
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doses. The barrier methods, Le. condom and diaphragm, (Celentano,
et.al. , 1987; Fasal, et.al., 1981; Hildesheim, et.al. , 1990; Herrero,
et.al. , 1990); rhythm method and tuballigation (Brock, et.al., 1989),
appear to give protection. More studies with HPV data need to be
conducted in order to resolve the question of whether this apparent
effect of the oral contraceptives is due to confounding by HPV
exposure or to the oral contraceptives itself. (Le. residual
confounding) .
1.5.5. Dietary factor.
Several studies indicate that beta-carotene and vitamin C give a
protective effects against cervical cancer. The role of beta-carotene as
a protective agent involves the trapping of free radical and a
prophylactic action against chromosal breakage (Ziegler, et.al., 1990;
Brock, et.al. , 1988; Thomas and Chu, 1986), while vitamin C is an
anti-oxidant, which may prevent malignant transformation by
inactivating free radicals (Grubb, 1987). Poor diet may be an
explanation for the socio- economic finding.
Thus, cervical cancer appears to have a multi causal etiology ranging
from exposure to a venereal agent, e.g. HPV (a possible initiator), to exposure
to environmental agents documented by socio-economic status, exposure to
oral contraceptives and dietary habits.
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1.6. Epidemiological studies in the association between cigarette smoking
and cervical cancer.
Evidence for the causal relationship between cigarette smoking and
cervical cancer has been collected since 1966 (Naguib, Lunden and Davis,
1966). These evidence from a screening study (Naguib, 1966), 2 case- control
studies (Thomas, 1973; Williams and Horm, 1977), 1 cohort study (Tokuhata,
1967) and geographical mortality observations (Winkelstein, et. al., 1977) led
Winkelstein in 1977 to publish explicitly a hypothesis on this topic.
Table 1.1 presents some of the evidence from which Winkelstein
(1977) made his hypothesis. None of these studies were designed specifically
to test the cigarette smoking and cervical cancer hypothesis.
Initially, Winkelstein' s hypothesis and the results of those studies were
rejected by others (Doll, 1985; Layde, 1989) on the ground that potential risk
of smoking with respect to cervical cancer from lack of control for
confounding by sexual behaviour. Until the present time, there is still dispute
over the role of cigarette smoking as one of the risk factors for cervical
cancer. Despite this controversy, evidence supporting the hypothesis has been
continue accumulating since 1977. A summary of this epidemiological
evidence is presented in Table 1.2.
Table 1.2 presents a summary of the epidemiological data in the
following format. First, the evidence from two cohort studies is presented in
chronological order. Second, the evidence from twenty nine case-control
studies is presented in chronological order for different geographical location
of studies. The data for all the studies are divided into year of studies,
geographical location, stage of cervical cancer studied, number of subjects
(cases and controls). Control for confounding in analysis is documented by
identifying the confounder adjusted for by variables as noted after Table 1.2.
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The strength of association is also documented by the relative risk (RR)
reported in each paper. In each case, the comparison group is non smokers.
Evidence for a dose- response relationship is presented and the type of control
selected is documented under the bias heading for case-control studies. As
many of these studies were multi risk factor studies of cervical cancer, extra
comments relating to smoking data are also included.
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Table 1.1. Epidemiological studies of Smoking and Cervical cancer published prior to 1977.
No Year Place Type Study Study size Confounding R.R. D.R. Bias Comments.
type
* **
95 1967 USA, Invasive Cohort 1729 none Cig. 1.19 No Mix Snuff/chewing tobacco
Memphis Other1.48 significant, husband's
smoking RR= 1.22-1.50,
selection (cases and controls)
bias.
94 1973 USA, CIS, displasia. Case- 626 5 1.33 (ns) No Hospital Selection bias
Maryland cervicitis, control
unknown
105 1977 USA, CIS, invasive Case- 626 7 1.13 (ns) No Communi Selection bias, 70.2 %of CIS
Maryland control -tv smokers (s)
20
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Table 1.2. Epidemiological studies on Smoking and Cervical Cancer published since 1977.
I COHORT STUDIES I
Ref. Year Place Type Study size Confoun- R.R. C.I. D.R. Bias Comments
din2 * **
100 1984 Prague All 10,683 AI, A2 - - Yes, smoke> - Association b/w CC and Smoking 23.6-
10 cigs/dav 37.4 (p<.01)
42 1985 U.K. All 17,032 B,D 2.0 - Yes - Heavy smokers have a 2 fold or greater
increase in risk (p < .001)
I CASE-CONTROL STUDIES I
19 1989 Sydney CIS 309 AI, A2, 4.5 2.2 - 9.1 Yes, no. of Com. Smoking < --- > immune < --- > viral
B,C,D, cigs. smoked infection
E currently/day
47 1983 Sweden CIN 420 AI, A2, - - not mentioned Hos. Highly significant for female smoking
B,D (p < .001)
6 1983 Sweden CIS 6699 B 2.2 - 3.1 - Yes, no. of Com. Cases: smoked earlier, more cigs.lday
cigs. /day
98 1986 Italy All 826 AI, A2, 1.69 -1.76 1.08 -2.65 Yes, no. of Hos. The RR of current smokers increased
B,C,D cigs.lday across strata of age, SES parity and no.
of Pap-smear
71 1988 GDR Invasi 660 AI, A2, B 1.21 0.8 - 1.7 Yes, years of Hos. Dose-response relationship was more
-ye smoking obvious in women with multiple
partners
46 1980 U.K. CIN 659 AI, A2, 3.00-4.32 - Yes, no. of Hos. Smoked> 20 cigs.day had 3-4x risk
B,D cigs.
smoked/day
4 1980 U.K. CIN 659 AI, A2, 2.12 -2.45 - Yes, no. of Hos. Current smokers had greatest risk
and B,D cigs.
Invasi smoked/day &
ve age started
77 1985 Panama CIN 37 AI, A2, 16 - not mentioned Hos. Multiple etiologies of cervical cancer
and B,C (smoking and HPV not synergised)
Invasi
ve
21
--------- - - - - - - _.- - - - -
76 1985 Panama CIN 452 AI, A2, No - - Corn. 52 % cases and control smoked max.
and B,C,D relation 1-2/cigs. day
Invasi
ve
78 1987 Panama Invasi 97 AI, A2, 2.88 - Not mentioned Corn. HPV Study design
ve B,C (p < .01) +
Hos.
104 1980 Canada, All 4320 - 1.33 - 3.8 - Yes, no. of. Hos. Dose-response especially in invasive
Alberta cigs. type.
smoked/day
25 1982 Canada, Invasi 1036 A1,A2,B 1.7-2.3 1.6-3.3 Yes, no. of. Corn. The occurrence of 2na primary tumours
Toronto ve cigs. of the lung among women with cervical
smoked/day cancer was 3x greater than expected
(Ontario Ca. Registry)
26 1985 Canada, Displ 750 AI, A2, 1.9 Not mentioned Corn. Cig. smoking depressed immune
Toronto ease B,D (p < .01) mechanism
16 1988 Canada, CIN 384 AI, A2, 1.9-3.5 1.2-3.7 Yes, no. of. Hos. Smoking <--> condyloma & CIN, the
Quebec C cigs. effect of smoking may vary according to
smoked/day tvpeofHPV
91 1980 USA,NY All 2057 B 1.2-1.3 - No relation Hos. Smoking wasn't associated at 5 % level
(os) (control both confounding
simultaneously), selection bias
63 1983 USA, NY All 1003 AI, A2, 1.14 (os) - No relation Hos. Effect of cigarette smoking either fairly
B,E weak or artefact of other variables;
study design (for diet)
61 1983 USA,Utah CIS 460 AI, A2, 3.5 2.3-5.2 Not mentioned Corn. Smoking association was strongest in
B, the youngest age and weaker in older
age
97 1983 USA, Displ 662 AI, A2, 2.4-3.6 1.6-6.2 Yes, pack Hos. The risk of smoking was greatest among
Atlanta ease B,D years smoked women who began to smoke in their
and early teenage years
CIS
64 1985 USA, SF All 527 AI, B, C, 1.27-2.94 1.33-6.45 Yes, amount Hos. No joint effect of viral infection and
D & duration of smoking
ciJ:~s. smoking
22
- - - - - - - - - - - - - - - - - - - - -
13 1986 USA 5 Invasi 1277 AI, A2, 1.4-2.4 2.2-9.1 Yes, no. of Corn. The older starting to smoke the higher
states ve B,C,D cigs. the risk
(Ala, smoked/day,
Mia, Phi, years of
Den, Chi) smoking
73 1986 USA, LA Invasi 400 AI, A2, 4.2 2.0-7.8 Not mentioned Corn. Specific for Latin and Non Latin
ve B, C,D
115 1986 USA, SF Invasi 78 AI, A2, 3.3 - Not mentioned Hos. Study of the risks from spouse
ve (couples) C
24 1987 USA, Invasi 306 AI, A2, 1.03 - Yes, years Hos. Study design
Maryland ve B,D smoked
88 1989 USA, CIS 750 AI, B 1.91-3.42 2.10-5.57 Yes, no. of Corn. Cigs. smoking is a more important risk
Utah and cigs. factor in women who haven't
Invasi smoked/day experienced other major risk factors
ve
15 1989 USA, Invasi 1324 - 1.7-3.9 2.7-5.6 Yes, amount Hos. Unadjusted for another potential
Missouri ve of cigs. confounders
smoked/day
94 1989 USA, Invasi 497 AI, A2, - - Not mentioned Corn. Smoking was a significant risk factor
Maryland ve C,D
101 1989 USA, Invasi 1324 AI, A2, 2.2-3.9 1.4-5.6 Yes, duration Corn. The age specific data suggested a strong
Missouri ve B,C,D of smoking relationship b/w smoking and invasive
cervical cancer
12 1990 USA 4 CIS 1094 AI, A2, 1.9
-
Not mentioned Corn.
states C,D
(Ala, Chi,
Mia, Den)
114 1989 4 Latin Invasi 2097 Al 1.2 0.8-1.3 Yes, No.of Hosp Smoking has a limited effect, possibly
America ve B, age cigarette + only to women with certain type of
countries Corn HPV infection
30 1990 London CIS 1330 AI, A2 1.52 - Yes, Pack Com p<O.ool
B, D, age years
*Confounding : - A = Reproductive and sexual behaviour
Al = No.of Sexual partner
A2 = Age at Ist intercourse
- B = Socio-economic factors
23
- C = History of sexually transmitted disease
- D = Use of oral contraceptives
- E = Dietary factor
** Bias: Corn = Community control
Hosp = Hospital control
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From the evidence for a causal relationship between cigarette smoking
and cervical cancer presented in the above tables, it can be seen there is
evidence for a causal relationship between cigarette smoking and cervical
cancer.
Thirty studies reported a positive association. The strength of the
association ranged from a relative risk (RR) of 1.2 to 16. Twenty nine studies
found this positive association to be statistically significant (see confidence
limit presented in the Table 1.2).
Twenty eight studies which found a positive association were adjusted
for reproductive and sexual risk factor. Thirteen studies were adjusted for
history of sexual transmitted disease risk factor. Two studies were also
adjusted for dietary factor and fourteen studies were adjusted for exposure to
oral contraceptives use. Twenty one studies were adjusted for socio-economic
risk factor.
Thus, the majority of studies show a positive association between
cigarette smoking and cervical cancer. Twenty studies showed a dose-response
relationship presented by either number of cigarette smoked per day, years of
smoking or pack years.
The studies presented encompass different times (from 1980 - 1990);
different "geographical location of studies, Le. Australia (Sydney), U.K,
Sweden, Prague, Italy, German Democratic Republic (GDR), Latin America
(different countries), Canada (different states) and the USA (different states as
well) and types of subjects also varies in ethnics, ages, occupation and
education.
A source of bias in case-control studies is the selection of control
subjects (Henneken, 1987; Rothmans, 1986), particularly when the exposure
of interest is an environmental exposure. It has been hypothesized that due to
the differences in the admission rates of exposed and unexposed cases and
controls (Berkson I s bias), hospital patients may have different smoking habits
24
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from controls in the community (Sackett, 1979). Fifteen of the studies
documented hospital patients as control subject and 12 of the studies had
community control. Thus, the stronger evidence is from studies using
community control.
It can thus be concluded that at present the evidence for a causal
relationship between cigarette smoking and cervical cancer is increasingly
positive. An interesting observation is that the majority of studies suggest that
the impact of cigarette smoking is in the current smokers and this suggest that
cigarette smoking probably a promoting factor. In fact one recent study
hypothesized that smoking is an effect modifier of HPV status and thus is a
strong promoting factor (Brinton, et. al.,1990).
1.7. Biological plausibility of the association between cigarette smoking
and cervical cancer.
Two major criticisms of the cigarette smoking and cervical cancer
hypothesis have been the lack of control of confounding factors and the lack of
biological mechanism to explain the phenomenon.
Recent laboratory studies found that nicotine and cotinine can be
detected in the cervical mucus of cigarette smokers (either active or passive
smokers) (Holly, 1986; Sasson, et.al., 1986). The cotinine level found in the
cervical mucus of cigarette smokers is similar to that found in serum; this is
also the case for nicotine. Since technology today still can not detect other
cigarette constituents in the body, it is thought that other cigarette constituents
may be detected in the cervical mucus in the future (Hellberg, et.al. , 1988;
Rowel, 1983).
Support for the role of cigarette smoking in developing cervical cancer
has also come from immunological studies (Gorelik and Herberman, 1986;
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Hersey, 1983; Hughes, 1985). It has been found that cigarette smoking is
associated with a number of alterations in the cellular immune system
(Tollerud, et.al. ,1989), including an elevated leucocytes count, increased
number of circulating lymphocytes (Hughes, 1985), decreased in Natural
Killer (NK) cells and Langerhans' cells concentration (Barton, et.al. , 1988;
Tollerud, et.al., 1989).
NK cells are a type of lymphocyte with a pre- existence ability to
destroy tumour cells in vivo without a need for immunization against tumour
cells. It is able to inhibit tumour growth and also able to eliminate
intravascular tumour cells. The similar decrease in NK cells has been noted in
patients with lung cancer and other malignancies (Gorelik and Herberman,
1986).
Langerhans I cells are epithelial dendritic cells that originates from bone
marrow and are important in presenting antigen to T-lymphocytes. These cells
are the most prominent type of antigen-presenting cell in normal cervical
epithelium (McArdle, 1986). In 1988, Barton et.al. published the important
immunological finding that ex-smokers tended to have cell counts between
those of smokers and non-smokers.
It is thought that reduction in the number of NK cells and Langerhans'
cells might influence the local cellular immunity and susceptibility. It seems
possible that cigarette smoking alters cervical cancer through its
immunosuppressive effects. Since most studies found that high risks are
especially associated with current smoking, smoking may act at a late stage
i.e. promotion stage of carcinogenesis (Berggren, 1983; Brinton, 1990; Brock,
et.al., 1989).
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1.8. Conclusion.
An understanding of cervical cancer etiology will require a better
identification of risk factors for precursor lesions as well as factors that
enhance their progression to invasive cancer (Brinton and Fraumeni, 1986).
Studies already discussed in this paper, support the hypothesis that
cigarette smoking plays a major role in the development of cervical cancer.
Although Human Papilloma Virus may be considered as the initiator of
cervical cancer, it is not the only factor involved as it needs a promotor to
develop the cancer cells (Grubb, 1987). Barton (1988) found that HPV is also
found in women with apparently normal cervices. It is reasonable to assume
that smoking is a possible promotor in the second stage of cancer
development. As noted that smoking possibly alters cervical cancer through its
immunosuppressive effect, further attention appears warranted regarding how
smoking-induced immunosuppression may be involved; especially with respect
to enhanced opportunity for genital infections (Brinton, 1990).
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CHAPTER 2.
STUDY DESIGN, SUBJECTS AND METHOD.
2.1. Introduction.
In this chapter, the hypotheses of this study will be stated in terms of
specific research questions that will lead to the identification of risk factors for
in-situ and invasive cervical cancer in this particular study population.
The study design, the origin of the data, criteria for subject selection,
sample size, ethical issues and statistical analytical technique will be discussed.
2.2. Research questions.
The main hypothesis investigated in this study was that cigarette
smoking increases the risk in women of acquiring either in-situ or invasive
cervical cancer. The research questions emerging from this hypothesis were :
1. What were the other risk factors associated with in-situ or invasive cervical
cancer in this particular study population ?
2. Were risk factors the same among in-situ and invasive cervical cancer in
this particular study population ?
3. How large was the association between cigarette smoking and in-situ and or
invasive cervical cancer in this particular study population after controlling
for other identified risk factors ?
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2.3. Study design.
The study design chosen to answer these research questions is a case-
control study. In a case-control study, individuals with a particular disease (the
cases) are selected for comparison with a series of individuals in whom the
disea.se is absent (the controls). Thus, a case-control study is a very suitable
study design for rare diseases or diseases with a long latency period. A case-
control study is also quick to mount and conduct, relatively inexpensive,
existing records can be used and does not give any risk to subjects (no ethical
consideration) (Schlesselman, 1982). Thus, regarding the characteristics of
cancer, a case-control study was chosen as the study design.
The case-control study is categorised cccording to the source of
control group as hospital-based case-control study and population-based or
community-based case-control study. In a hospital-based case-control study,
the control group comes from the same hospital or hospital network with the
cases. While a community-based case-control study identifies its control group
from within a defined geographic area from which the cases arose
(Schlesselman, 1982).
In this study, there were three data sets, i.e. invasive cervical cancer
with hospital controls, in-situ cervical cancer with hospital controls and in-situ
cervical cancer with community controls. These data sets provided a good
opportunity to explore the association between cigarette smoking and cervical
cancer (both in-situ and invasive cervical cancer) since one of the major
disagreements among epidemiologists on this issue is on the selection of
control groups hospital or community.
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2.4. Criterion of cases and controls.
The cases were selected from two major teaching hospitals in Sydney,
Royal Prince Alfred hospital and Westmead hospital.
Eligible cases were women aged 18 - 65 years, residing within the
Sydney metropolitan area with newly diagnosed, histologically confirmed
cervical cancer (in-situ and invasive cervical cancer) during the years 1980 to
1983. There were 114 in-situ cases of cervical cancer and 75 cases of invasive
cervical cancer collected from Royal Prince Alfred hospital and Westmead
hospital.
The hospital control group was selected from women admitted to other
than obstetric and gynaecological wards from the same hospitals within 24
hours of admission. There were 331 controls identified. These numbers
yielded roughly three controls for each case of in-situ cervical cancer and four
controls for each of invasive cervical cancer. The hospital control group was
not matched to specific cases, but the age distributions of the case and control
groups were kept similar by stratification. These hospital data were collected
as a part of a World Health Organisation (WHO) multicenter collaborative
study of steroid contraceptives and risk of neoplasia during the years 1980 to
1983. The details of the WHO multicenter collaborative study of steroid
contraceptives and risk of neoplasia has been reported elsewhere (WHO
Collaborative Study of Neoplasia and Steroid Contraceptives, 1985).
Community control data were collected for in-situ cervical cancer
cases. This control group was identified from the files of the family doctor or
from a university-affiliated general practices from the same residential areas as
the cases. The detail of community control selection was reported elsewhere
(Brock, et.al., 1989).
One hundred and eighty-one community controls were identified. This
roughly yields two controls for each case of in-situ cervical cancer. These data
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were collected as a part of a case-control study on dietary factors and risk of
in-situ cervical cancer conducted by Brock and others in 1980 - 1983 (Brock,
et. al. , 1989).
Women were excluded as a case or control if their records or
admissions showed conditions that might alter their contraceptive practices.
These conditions included circulatory and cardio-vascular diseases, diabetes
mellitus, chronic renal disease or renal transplant, benign breast disease,
previously diagnosed cancer and chronic liver disease. The details of control
selection have been reported elsewhere (Brock, et.al. , 1989; WHO
Collaborative Study, 1985).
In general hospital controls are easy to identify, readily accessible,
generally cooperative and by virtue of their illness tend to give a more detailed
medical and exposure history, thus hospital patients provide a convenient and
relatively economical source of controls particularly in a large study. While
community controls tend to be healthy and reflect the health status of the
area I s population. In the initial WHO study hospital controls were chosen in
relation with the detection of cases. Since cases in most developing countries
collaborated in this WHO study could be best identified from hospital
admissions thus it was decided to select controls among women in hospitals.
This attemp were made to control for selective factors that might render the
cases unrepresentative of all incident cases with regard to their contraceptive
practices (WHO, 1985). The initial study conducted by Brock and others was
to investigate the association between in-situ cervical cancer and dietary
factors. In a study of a dietary nature, it is necessary to employ community
control groups since it is belief that hospitalized controls may have alter their
dietary habits or perceptions (Brock, et.al., 1989).
31
I
I
I
I
I,
I
I
I
I
I
I
I
I
I
I
~I
I
,I
I,
I
I
2.5. The Questionnaire.
A detailed questionnaire developed by WHO was administered to the
cases and controls to obtain information on the known and suspected risk
factors for all the neoplasms included in the WHO Collaborative Study.
This questionnaire (appendices 1 and 2) included admission record,
demographic data, medical history, reproductive history, contraceptive
history, other hormones and medication ever administered, family history of
cancer, residential and socio-economic factors and gynaecological history data.
This questionnaire encompassed 362 variables.
2.6. Smoking variables.
The smoking variables incorporated smoking status (never smoked and
ever smoked) and number of cigarettes smoked. These variables were not part
of the original WHO questionnaire (appendices 1 and 2).
In the community control group, smoking data were collected as a part
of the study conducted by Brock, et.al. (1989). For the hospital data,
smoking variables were collected from the subject's medical records. One
hundred per cent of the smoking data of the hospital cases and controls were
collected.
2.7. Data collection.
2.7.1. Raw data.
Raw data originated from the data collected for the WHO
Collaborative Study of Neoplasia and Steroid Contraceptives. This study was
conducted in Sydney, Australia (as one of 11 centres in the world) in 1980 -
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1983. It was a hospital-based case-control study, conducted at Royal Prince
Alfred Hospital and Westmead Hospital.
The data, original questionnaire and computer recorded data, were then
kept at the School of Public Health, Sydney Univ~rsity. These data comprised
WHO subject number, subject's name and medical record number (as the
identifier unit), general and demographic data, certain medical history,
reproductive history, contraceptive history, any other hormones and
medication history, family history of cancer and certain diseases, residential
and socioeconomic factors and gynaecologic history, but not smoking history.
It was decided to use all the invasive and in-situ cervical cancer cases
available as two case groups to be analysed separately. As for the control
groups, community control data for in-situ cervical cancer cases and hospital
control data for in-situ and invasive cervical cancer cases were available.
The community control group originated from a case-control study on
dietary factors and risks for in-situ cervical cancer conducted on 1980 - 1983
by Brock and others. There were 181 community control subjects. The details
of this study has been reported elsewhere (Brock, et.al., 1989).
The hospital control subjects were selected randomly from all the
available WHO study control subjects. This control group was not matched on
any particular variable with the cases, but the age distributions of the case and
control groups were kept similar by stratification. Thus, there were four data
sets available Le. in-situ cervical cancer cases, invasive cervical cancer cases,
community controls for in-situ group and hospital controls for both cases.
The computer administrator of School of Public Health, Sydney
University, then identified all the in-situ and invasive cases through searching
the computer records that is kept in the School of Public Health J S
minicomputer. Seventy five cases of invasive cervical cancer were identified
and used as case subjects. Three hundred and seventy five control subjects
were also generated (all case and control subjects were from Royal Prince
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Alfred Hospital and Westmead Hospital). For various reason (see Cleaning
data below) only 331 control subjects were used in the analysis. There were
114 in-situ cases with 181 community controls.
From the computer printout of the WHO subject numbers, the name
and medical record number of each subject could be traced back to the original
questionnaire data. The printout of date of birth was also used to check and
match with the name and medical record number in the original questionnaire.
Requests were put to the Medical Record Department of Royal Prince Alfred
Hospital and Westmead Hospital (appendix 3). From the subjects' medical
records (cases and controls) the smoking data were collected. They include
smoking status (ever smoked and never smoke) and number of cigarettes
smoked per day.
The data from the computer administrator of the School of Public
Health, Sydney University and the data collected from medical record were
then assembled for further analysis.
2.7.2. Cleaning and identifying missing data
After all the data were collected, it was assembled as a single data file
in SAS (SAS Statistical Computer Package) format. A random printout of 20
subjects from the complete data set was executed in order to identify the
coding of the data that had already been done and checked this with the
standard WHO questionnaire coding (appendix 2) (for the computer program
see appendix 4). It was also found from the printout that some of the control
subjects were uneligible because they had already had a hysterectomy.
Following this attempts were made to exclude all subjects that had had
hysterectomy (see appendix 4 for the compl,lter program). This attempt
reduced the number of control subjects to 331 subjects. Recoding was also
carried out for certain variables (see appendix 4).
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Further analyses were conducted using SPIDA (Statistical Package for
Interactive Data Analysis, Lunn and McNeil, 1991) for purposes of interactive
data analysis. Even though random checking of data coding has been done
with SAS, cross-tabulations and frequency histograms were also generated
using SPIDA in order to check for missing values, ranges and consistency. To
avoid problems with different numbers of subject in variables fitted using a
multivariate model (Buyse, 1990), missing values were recoded prior to
analysis using indicator variables (see appendix on computer programs for the
precise treatment of missing values on each variable). Outliers were checked
with the possible answers provided in the questionnaire.
2.7.3. Generating SPIDA format data set.
A program in SAS was written to output the data from SAS format to
text file format so it could be read by SPIDA (appendix 4).
The variables that were put in the program were subject status (case or
control), age, place of birth, history of cancer (self and family members),
reproductive history, contraception history, alcohol drinking habit, housing,
area of living, race, religion, marital/sexual history, occupation (self and
spouse), Papanicolau smear-test (pap smears) and gynaecologic history. (see
appendix 4 for detail variables)
This program created a text file format data set which could be further
analysed using SPIDA.
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2.8. Sample size.
Sample size is one of the fundamental considerations in planning a
study. A study should have sufficiently many subjects to avoid two sources of
error (Schlesellman, 1982) :
1. type I errors, Le. claiming that the exposure is associated with the
disease when in fact it is not. The probability of making a type I error
is also called the level of significance (denoted by cr)
2. type II error, i.e. claiming that exposure is not associated with disease,
when in fact it is. The probability of making type II error is
represented by ~. The quantity of 1-~ is called the power of the study.
The power of the study is the probability of finding that the sample
estimate of the odds ratio or relative risk differs significantly from 1.
Basically, an answer to the question of how many subjects should be
selected for a case-control study depends on the specification of four values
(Schlesellman, 1982):
1. relative frequency of exposure among controls in the target population, Po.
2. a hypothesized odds ratio or relative risk associated with exposure, R.
3. the desired level of significance, cr.
4. the desired study power, 1-~.
Walter (1977) gave a formula to compute the desired sample size in
cohort and case-control studies. The formula for multiple controls per case in
a case-control study is as follows:
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where
pI = poRR/[1 + po(RR -1)]
p' =(PI +cpo)/(1 +c)
q' = 1- p'
n =(1 +1/c)pl q!(Za + Zf3)2 /(PI - pO)2
In this study, the samples sizes were already provided. There were
three sample data sets as follows:
1. One hundred and fourteen cases of in-situ cervical cancer with 181
community controls (n=295).
2. One hundred and fourteen cases of in-situ cervical cancer with 331 hospital
controls (n=445).
3. Seventy five cases of invasive cervical cancer with 331 hospital controls
(n=406).
Instead of computing the sample sizes, it was decided to compute the
power of the study.
In 1986, 28% of Australian females were smokers (Dwyer, et.al. ,
1986), then PO = 0.28. Table 2.1 below presents various study powers for
different levels of a. and the odds ratios. These computations were performed
on a program called NewSAM developed by DR. Paul Glasziou in the
National Health and Medical Research Council, Clinical Trials Centre,
Sydney, Australia.
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Data sets OR <X Power
tiJm&iliMllifMllliVittj 2.0 0.05 0.749
3.0 0.05 0.991
4.0 0.05 0.999
2.0 0.10 0.838
3.0 0.10 0.996
4.0 0.10 0.999
,H~i~,ii~n1t~:(':::::';::::::':':' 2.0 0.05 0.832
3.0 0.05 0.997
4.0 0.05 1.000
2.0 0.10 0.899
3.0 0.10 0.999
4.0 0.10 1.000
/In'V~~i~~'(H6s'Sitiiff'::G'8 2.0 0.05 0.686
3.0 0.05 0.981
4.0 0.05 0.999
2.0 0.10 0.788
3.0 0.10 0.991
4.0 0.10 0.999
Table 2.1. Power of study in different level of et. and different OR.
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As it can be seen from Table 2.1 with increase of numbers of control
more power were obtained. The power ranges from 0.75 to 1.0 which is quite
acceptable. It was then decided to use a. = 0.05.
2.9. Ethical considerations.
Even though most of the data needed in this study were already
collected, the smoking data were not available. Thus, permission was sought
to the Secretary of the Ethics Committees of Royal Prince Alfred and
Westmead hospitals.
Permission was granted to collect the smoking data from the medical
records of the necessary subjects (appendix 3).
2.10. Statistical analytical technique.
2.10.1. Univariate.
Exploratory data analysis was carried out using appropriate univariate
statistical techniques. The SPIDA statistical computer package was employed
to do cross-tabulation, frequency, various plots and descriptive statistics (Lunn
and McNeil, 1991).
2.10.2. Multivariate.
2.10.2.1 Multiple logistic regression.
In classical multiple linear regression the mean value of the dependent
variable is expressed as a linear function of a set of explanatory variables and
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D denotes the outcome event or "disease" and x is the value of an exposure E.
The functional form of the right hand side of Equation (2) ensures that its
values are always between 0 and 1, which is reasonable given that they are
probabilities.
If there are p predictor variables xl'x2'x3' ••.•.xp, the logistic
regression model takes the form
thus for an observed value of the dependent variable there is an error term.
This error term is independently and normally distributed with zero mean and
constant variance (Armitage and Berry, 1988). However this method is not
applicable when the dependent variable is qualitative (such as absence and
presence of disease). Thus, in order to fit the relationship using linear
regression it is necessary to apply a transformation which lead to the method
of logistic regression.
As it was mentioned before, the logistic regression model is similar to
the linear regression model. The main difference is that whereas in linear
regression we assume that the outcome variable is continous while logistic
regression model requires that the outcome variable be dichotomous, such as
the case of absence or presence of disease. Logistic regression model can also
handle quite general exposure variables not just dichotomous ones (Lunn and
McNeil, 1991).
For a single exposure variable E, the logistic model takes the form
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1Prob[D] =
1+ exp( -(X - f3x) (2)
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model 2 Ya = a + f31xl + f32x2 + ••• + f3kxk+ e
(without x3' df=df:0
model! Ya = a + f31xl + f32x2 + 133x3 + .••+ f3kxk+ e
(with x3' df=df1)
2.10.2.2. Hypothesis testing.
Hypothesis testing in logistic regression is computed by testing the
difference in deviance between two models (Kleinbaum, 1991). For example
consider of testing an independent variable named x3 in a model consisting of
k independent variables. This statement can also be translated as testing
hypothesis of Ho: 133 = O. Thus, in the computation we have two models
as follows;
(3)1 p
l+exp(-a- L13 j X j )
j=1
Prob[D] =
thus generalizing Equation (2) (Rosmer and Lemeshow, 1989).
Eventhough the logistic model was originally developed for the
analysis of prospective studies, it has been proved that the parameters (J3s) of
the logistic model are equivalent in cohort and case control studies (individual
risk and odds ratio) with the exception of the intercept term (a) (Kleinbaum,
1991). In cohort studies, this intercept term represent the effect of non-
exposure on disease while it has no direct interpretation in case-control studies
since we do not know the sampling fraction of the population. This
unconditional logistic regression can be performed in SPIDA using the lreg
command.
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(Xi maybe continous variables, indicator (dummy) variables for categorical
data or interaction terms.)
The differences between the deviance for model 2 and model 1 is an
approximate X2 statistic with degree of freedom equal to (df2 - df1). This test
is commonly known as likelihood ratio test.
There is also another way to carry out hypothesis testing in logistic
regression without using likelihood ratio test. This second method is called
Wald test. This test is usually done when there is a large numbers sample and
when there is only one parameter being tested (as in the example above). The
Wald statistic is computed by dividing the Pby its standard error. This statistic
has approximately a normal (0,1) distribution (Z distribution) on a large
sample. Thus Wald test is computed as
In testing hypothesis in logistic regression, Kleinbaum (1991) recommended
the use of the likelihood ratio test.
2.10.2.3. Dose-response test.
For ordinal independent variables of k greater than 2 categories a test
for dose-response relationship could be carried out where appropriate using a
method described by Berry (1980). This model assumes that the log-odds of
disease is a linear function of the exposure variable, thus this model forces the
relationship to be linear while in fact it may not be a linear relationship.
Based on this argument a dose response relationship of an independent
variable will be analyzed by examining the increase or decrease of ~s
coefficients on each category of the independent variable.
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2.10.2.4. Interaction terms.
Effect modification between exposure variable (L e. smoking) and other
independent variables or among independent variables may be included as
product terms. The process of assessing interaction may be conducted by using
"hierarchically well formulated" models as described by Kleinbaum (1991)
using the hierarchical backwards elimination approach.
Testing for interaction in this study is only conducted when there is an
a priori reason to believe that the association between disease and exposure
depends on a third factor.
2.10.2.5. Testing for the imal models.
In order to develop the final model for each data sets, it is necessary to
develop a "gold standard model" of each data set. Thus, odds ratio and
confidence interval from this model could then be compared with reduced
models. The hierarchical backward elimination method, as described by
Kleinbaum (1991), is employed to to arrive at the fmal model.
The decision whether to remove or retain a particular independent
variable (xV in the model may be described as follows; (Kleinbaum, 1991)
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Diagram 2.1. Flow chart in developing the final models.
(after Kleinbaum, 1991)
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
IAre ORs meaningfully different I
yes
~ no
Ido not need to control xi for confounding I
consider precision with and without
Xi by comparing confidence interval (Cl)
Icontrol xi for confounding I
Inarrower Cl -7 retain Xi I
"
Iwider Cl -7 drop Xi
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
2.10.3. Computing the odds ratio and confidence intervals.
In case-control studies the relative risk can not be computed
(Kleinbaum, Kupper and Morgenstem, 1982), so the odds ratio is an
approximate measurement of relative risk. Given a 2x2 table as follows
E E
Dab
D e d
the relative risk is computed as
a / e
RR = a+b e+d
The odds ratio is close to the relative risk where the disease is rare;
thus given the data table as above, the odds ratio is
OR=ad
be
Miettinen (1976) showed that the need for rare disease assumption need
not apply for the odds ratio to be equivalent to the ratio of incidence rates.
Since the data set in this study is an incidense density sampling, thus the
estimate of odds ratio is in essence equivalent ro relative risk.
Using the logistic model as described in Equations (2) and (3), it is a
straightforward matter to derive formulas for the various measures of
association (Lunn and MeNeil, 1991). Suppose that the exposure x has just
two possible values which may be taken to be 0 (unexposed) and 1(exposed),
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the risk of the outcome given the exposure is thus obtained by putting x=l in
and this reduce after cancellation simply to exp(a+ fi). Similarly, using
Equation 5, the odds of the outcome given no exposure is
The relative risk may now be computed as the ratio of these two
equations. However the equations for the odds and the odds ratio are much
simpler. The odds of the outcome given the exposure is, from Equation (4)
1
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(4)
(5)
= exp(a)
1Prob[DIE] =-----
1+ exp(-a- fi)
1Prob[DIE]=----
l+exp(-a)
1
Prob[DIE] = l+exp(-a)
1-Prob[DIE] 1- 1
l+exp(-a)
Prob[DIE] = Prob[DIE] = l+exp(-a-fi)
Prob[DIE] 1-Prob[DIE] 1- 1
1+ exp(-a - fi)
Equation (2), that is
whilst the risk of the outcome given no exposure (x=O) is
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The log odds ratio based on the logistic regression model is even
simpler, it can be seen from the Equation (6) that it is just f3 coefficient. This
means that the parameter f3 in the model may be interpreted directly as the
natural logarithm of the odds ratio.
If there are p predictor variables xl'x2'x3' .....xp , the logistic
regression model takes the form
If one of the predictor for example Xl is a dichotomous exposure variable, the
argument leading to Equation (6) does not change since the contribution to the
odds from the other variables still cancels out (Lunn and McNeil, 1991).
The model for computing odds ratio above showed that each of the x
variables contributes multiplicatively to the odds ratio. Thus the logistic model
presented above is a multiplicative model of disease (Kleinbaum, 1991).
A confidence interval (Cl) of the odds ratio can also be computed from
the logistic regression. This Cl is obtained by exponentiating the confidence
limits obtained from the parameter. Suppose that we compute the Cl of xl a,
dichotomous exposure variable in a model with p predictor variables
xl'x2'x3'·····xp
Thus the odds ratio has the very simple formula
(6)OR =exp(a+ f3) =exp(f3)
exp(a)
1
p
1+ exp(-a - Lf3jXj)
j=l
Prob[D] =
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Thus, to compute the Cl (one sided) we need to know the value of ~,
(x, and the standard error of ~ (Kleinbaum, 1991).
2.10.4. Polytomolls regression.
Suppose that the number of categories in the outcome variable is more
than two (not only binomial), polytomous logistic regression can be employed
to analyze the models instead of logistic regression (Hosmer and Lemeshow,
1989). Polytomous logistic regression model is a generalization of logistic
regression. In logistic regression we have the model for probability {Y= 11 x}
as follows;
1
Prob{Y=llxil = _
1 + exp -(a+L~ixi)
Suppose that we have Y = O,1,2, .... ,k categories, than the model above can
be generalized as (Hosmer and Lemeshow, 1989).
exp (ak+~~ikxi)
Prob{Y=klxi} = _
1 + LkeXP (ak+~~ikxi)
If in logistic regression we have one logit function, i.e. logit of y=O and logit
of y= 1, then in po1ytomous regression with k categories of outcome variable
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we have (k-1) logit functions in which the group coded as 0 serves as the
reference outcome value (Hosmer and Lemeshow, 1989). With regard to
model development strategies, multivariate modelling with polytomous
outcome follows those for the binary outcome variable as discussed above
(Hosmer and Lemeshow, 1989).
Since the outcome categories in polytomous regression model is not
necessarily measured on an ordinal scale, thus polytomous regression is
applicable in this study. Polytomous regression applicable in this study since
according to the case or control groups there were 4 groups in this study, i.e.
community control group (n=181), hospital control group (n=331), in-situ
case group (n=114) and invasive case group (n=75). Thus by recoding these
data, the outcome variable (Le. case or control status) could be expanded as
y=(O,1,2,3). It was decided to put all the independence variables of these data
sets of which significantly identified in each of the final models of each data
sets in logistic regression to develop a polytomous regression model.
The purpose of the analysis of polytomous regression is twofold; first
to investigate whether there is a different in the measurement of association of
disease outcome using two different control groups, namely community
controls and hospital controls, as such it may be decided which of the control
group was better for this type of study ; second to test a hypothesis that
smoking status risk is the same across four data groups. The first purpose may
be achieved by comparing the group coefficients from the outcome of
polytomous regression. The second purpose may be achieved by testing a
hypothesis as follows;
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This hypothesis testing will be done in two ways; first by using a combination
of community and hospital controls; second by using both the control groups
separately.
The hypothesis testing itself may be achieved by calculating the X2 statistic of
the differences between -2 log likelihood of normal polytomous model of the
smoking with othe covariates with a polytomous model in which the
coefficients ({3) of smoking variable is forced· to be the same across the
groups. This can be done in SPIDA by employing option: equal in the usual
polytomous command (plreg). The computation of
2.10.5. Treatment of continous variable.
Even though the logistic regression model can' handle continous
variables as well as categorical variables, in the analysis of this study it was
decided to categorize the continous variables (such as age). The reasons for
treating continous variables in this way were;
1. it enabled the computation and interpretation of the odds ratios and
confidence intervals in a more straight forward way (Kleinbaum, 1991).
2. regression analysis using continous variables often entails stringent
assumptions such as log-linearity of the dose-response relationship. By
categorizing, the necessity of specifying the form of the relationship
between disease and exposure was avoided.
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2.11. Conclusion.
The general purpose of this study is to investigate the association
between cigarette smoking and cervical cancer, either in-situ or invasive
cervical cancer, with respect to other identified risk factors in the particular
study population.
The chosen study design was a community-based and two hospital-
based case-control studies. The data originated from the WHO Collaborative
studies on Neoplasia and Contraception (1985) and a study by Brock and
others (1989) on dietary factors and the risks of cervical cancer. These studies
were conducted in Sydney, Australia in the year 1980 - 1983.
Cases and controls were identified from the data that were collected in
1980 - 1983. The smoking data for the identified cases and controls were
collected in 1991 from the Medical Record Departments of Royal Prince
Alfred hospital and Westmead hospital, Sydney, Australia.
The criteria of cases and controls, the study power and the statistical
analytical technique were also discussed.
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CHAPTER 3.
EXPLORATORY DATA ANALYSIS
ON NON-SMOKING RISK FACTORS
FOR CERVICAL CANCER.
3.1. Introduction.
Results regarding the first research question are presented in this
chapter. This research question is concerned with the known risk factors for
cerviCal cancer. These risk factors were investigated in their own right and
also as a potential confounder for smoking variable.
In this chapter descriptive demographic and socio-economic indicators
are also presented. The effect of reproductive factors, history of contraceptive
methods, gynaecological factors, hystory of sexually transmitted disease and
medical history in general are examined.
3.2. Potential non-smoking risk factors for in-situ cervical cancer with
community controls.
3.2.1. Introduction.
Well established risk factors for cervical cancer such as number of
sexual partners and age at first intercourse were found to be associated with
the risk of in-situ cervical cancer in the study population. Induced abortion and
"safe" period method of contraception were also found to be potentially
associated with the risk of developing in-situ cervical cancer in the study
population.
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Even though use of oral contraceptives (OC) did not show any
significant difference at the 5% level, duration of use of oral contraceptive
showed a significant difference at the 5% level.
3.2.2. Demographic and socio-economic data.
The effect of certain demographic variables including age and marital
status and socio-economic indicators including area of living, education level
(self and spouse), occupation (self and spouse) and drinking habits are shown
in Table 3.l.
There were no significant differences at the 5% level in the distribution
of the variables mentioned above between the case and control groups. One
hundred percent of cases and 98 % of controls lived in the city. This
distribution resulted from the matching of general practitioners attended by
cases in the recruitment of controls. Since the original community data set was
also matched on age, there was similarity in the age distribution of cases and
controls.
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DEMOGRAPIDC AND SOCIO- CASES % CONTROLS % TOTAL %
ECONOMIC VARIABLES n=114 n=181 n=295
Age distribution
< = 30 years old 41.2 40.3 40.7
31 - 40 years old 43.0 44.7 44.1
41 - 50 years old 11.4 11.1 11.2
> 50 years old 4.4 3.9 4.1
Area of living
City 100 98.2 99.3
Town 0 1.7 0.7
Rural 0 0 0
Self education
< 10 years 34.2 31.5 32.5
10-12 years 32.5 36.5 35.0
> 12 years 33.3 32.0 32.5
Husbands education
< 10 years 50.0 44.2 46.4
10-12 years 24.6 26.0 25.4
> 12 years 25.4 29.8 28.1
Self occupation
Housewife or unemployed 23.7 24.9 24.4
Non-professional 14.9 14.9 14.9
Professional 61.4 60.2 60.7
Husband occupation
Unmarried or Unemployed 28.1 21.0 23.7
Non-professional 16.7 12.7 14.2
Professional 55.3 66.3 62.0
Marital status
Never married 25.4 21.5 23.0
Married 60.5 66.3 64.1
Divorced 10.5 11.6 11.2
Widowed 3.5 0.5 1.7
Age at 1st married
Never married 25.4 21.5 23.5
> 24 years 22.8 23.4 23.1
20 - 24 years 35.9 42.0 39.0
< 20 years 15.8 16.0 15.9
Drink beer 29.0 37.6 34.2
Drink wine 79.8 85.6 83.4
Drink spirit 64.9 56.3 59.7
Frequency of drink /week
Never drink 7.9 6.6 7.1
1 - 10 drink 52.6 56.3 54.9
11 - 20 drink 11.4 8.8 9.8
21 - 30 drink 3.5 3.3 3.4
> 30 drink 24.6 24.9 24.7
Table 3.1. Demographic and Socio-economic data of
in-situ cervical cancer cases with community coIitrols.
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3.2.3. Sexual risk factor?
Since cervical cancer is perceived as a sexually transmitted disease
(Doll, 1988) history of sexual relationships could be used as an indicator of
potential exposure of the cervix to certain carcinogenic agents. A measure of
number of sexual partners and age at fIrst intercourse was then recorded.
Forty six per cent of controls had 0 - 1 sexual partner, while this
number was only 18% among cases. Meanwhile 26% of cases had mOle than
6 sexual partners compared to 13 % in the control group. Seventy four per cent
of cases had their fIrst intercourse at the age of less than 20 years old, while
for control group this number was only 57%. Thus, in accordance with most
studies of the risk factors for cervical cancer (Brinton, et.al. , 1990;
Greenberg, et.al. ,1985; Harris, et.al. , 1980), a signifIcant difference at the
5% level between cases and controls was found on these variables.
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Table 3.2. Sexual factors of in-situ cervical cancer cases
with community controls
p < 0.05
SEXUAL FACTOR CASES % CONTROLS % TOTAL %
n=114 n=181 n=295
Nwnbers of sexual partner
0-1 partner 18.4 45.9 35.2
2-3 partners 29.0 23.8 25.8
4-6 partners 26.3 17.1 20.7
> 6 partners 26.3 13.3 18.3
Age at 1st intercourse ......
< 16 10.5 5.0 7.1
16-19 63.2 51.9 56.3
20-24 22.8 34.8 20.2
> 24 or never 3.5 8.3 6.4
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3.2.4. Reproductive risk factor.
The effect of reproductive risk factors including age at menarche,
parity, age at first pregnancy, age at first live birth, spontaneous abortions,
induced abortions, number of breastfed babies and the length of breast-
feeding are presented in Table 3.3.
Only one variable, induced abortion, has a significant difference at the
5% level between the case and control groups.
Even though there was no significant trend, 28 % of cases had there
first pregnancy at age less than 16 years as compared to only 20% of
controls. As in the age at first breastfeeding, 36% of cases first breastfed at
the age less than 16 years, whilst there were only 23% of the control group.
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Table 3.3. Reproductive history of in-situ cervical cancer cases
with community controls.
p < 0.05
REPRODUCTIVE CASES % CONTROLS % TOTAL %
n=114 n=181 n=295
Age at menarche
< 12 years 24.6 13.8 18.0
12 years 18.4 22.1 20.7
13 years 23.7 33.7 29.8
> 13 years 33.3 30.4 31.5
Age at 1st pregnancy
Nulliparous 23.7 27.1 25.8
< 16 years 28.1 19.9 23.0
16-19 years 28.1 26.5 27.1
20-24 years 17.5 22.1 20.3
> 24 years 2.6 4.4 3.7
Age at 1St live birth
No live birth 6.1 5.5 5.8
< 20 years 19.3 22.6 21.4
20-24 years 24.6 26.5 25.8
25-29 years 14.0 12.2 U.9
> 29 years 36.0 33.1 34.2
Age at 1St breast feed
No breast feed 6.1 5.5 5.8
< 20 years 13.2 22.1 18.6
20-24 years 18.4 20.4 19.7
25-29 years 36.0 22.6 27.8
> 29 years 26.3 29.3 28.2
Induce abortion ......
Never 71.9 85.1 80.0
Ever 28.1 14.9 20.0
Spontaneous abortion
Never 83.3 82.3 82.7
Ever 82.3 17.7 17.3
Total pregnancy
Nulliparous 24.7 27.8 26.0
1-2 40.4 34.3 35.9
>2 35.0 37.9 38.0
Number of pregnancy-breastfed
Nulliparous/did not
breastfeed 55.3 45.9 49.5
1-2 23.7 22.6 23.0
3 11.4 15.5 13.9
>3 9.6 16.0 13.6
Length of breast feeding
Nulliparous or
No breastfeed 54.4 46.4 49.5
1-6 months 26.3 22.6 24.1
> 6 months 19.3 30.9 26.4
......
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3.2.5. Medical history.
As well as sexual factors, history of venereal disease and history of
vaginal discharge could be used as a proxy to measure the potential exposure
of the cervix to certain carcinogenic agents.
The computation of X2 statistics of venereal disease and vaginal
discharge variables revealed no significant differences at the 5% level between
cases and controls.
As mentioned before the cases in this data set were recruited from \
~.
hospitals or colposcopy clinics whilst the controls were recruited from the fIles
general practitioners I fIles whom the cases attended. Thus there was a
possibility of selection bias in terms of Pap smear frequency. However it was
interesting to notice the similarity in the pattern of Pap smears between cases
and controls.
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mSTORY OF DISEASES CASES % CONTROLS % TOTAL %
AND OPERATIONS n=114 n=181 n=295
Venereal diseases 6.1 2.2 3.7
Dischal"2e 52.6 48.6 50.2
Frequency of discharge
Never 45.6 50.8 48.8
Once 12.3 13.8 13.2
Twice 11.4 13.8 12.9
> 2x 30.7 21.5 25.1
Nwnber of Pap smear
>3x 36.8 43.6 41.0
2-3 x 43.9 37.6 40.0
0-1 x 19.3 18.8 19.0
Frequencies of Pap smear
< liS yrs or never 11.4 11.0 11.2
1/1-5 yrs 75.4 84.5 81.0
> lIyr 13.2 4.4 7.8
Dilatage and Curetage 40.3 43.4 41.7
Caesarian section 8.8 8.3 8.5
Familv with cancer (Ca) 50.0 44.2 46.4
Mother's mother with Ca 5.3 2.8 3.7
Mother's father with Ca 14.0 11.6 12.5
Father's mother with Ca 10.5 6.6 8.1
Father's father with Ca 7.9 9.4 8.8
Mother with Ca 14.0 9.4 11.2
Father with Ca 15.8 12.2 13.6
Table 3.4. Medical history of in-situ cervical cancer cases
with community controls.
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3.2.6. History of contraceptive practices.
The data on the history of contraceptive practices are presented in
Table 3.5. These data reveal that cases (96%) used more oral contraceptive
than controls (93%). On the other hand the control group used more barrier
contraceptives such as condoms and diaphragms than cases. However, at the
5% significance level, there was no difference with regard to this pattern of
contraceptive use between cases and controls.
At the 5% level of significance, the only contraceptive method which
showed a significant difference was use of "safe period". Thus the "safe
period" variable is examined further in the analysis even though there was no
a priori reason to believe that this method of contraception would protect
against cervical cancer.
In this study population 94 % of women have been exposed to oral
contraceptive at some stage of their life. As mentioned before, there was no
significance difference at the 5% level between cases and controls for this
variable. However, when the length of period of use of oral contraceptive was
compared, there was a significant difference at the 5% level between cases and
controls. Forty five percent of cases took oral contraceptives for more than 72
months compared to 25 % of controls.
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Table 3.5. Contraceptive history of in-situ cervical cancer cases
with community controls
p < 0.05
CONTRACEPTIVE CASES % CONTROLS % TOTAL %
mSTORY n=114 n=181 n=295
Oral contraceptive 95.61 92.82 93.90
Duration of use of oral
contraceptive**
Never use 4.4 7.2 6.1
< 25 months 24.5 32.0 29.1
25-72 months 26.3 35.3 31.9
> 72 months 44.7 25.4 32.9
Injection 0.9 0.8 0.8
lUD 26.2 24.9 25.3
Dia 12.8 14.5 13.7
Condom 37.7 39.2 38.5
Spennicide 22.8 21.5 22.2
Withdrawal 26.3 26.1 26.2
Safe period 13.2 18.8 16.0
Tubectomv 13.2 12.5 12.8
Vasectomy 7.0 6.5 6.8
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3.2.7. Conclusion.
In this particular data set of in-situ cervical cancer cases with
community controls, some of variables showed significant differences at the
5% level. These variables were number of sexual partners, age at first
intercourse, induced abortion, ever use of "safe period" contraceptive method
and duration of use of oral contraceptive. Thus, these variables are examined
further in the logistic regression analysis.
3.3. Potential non-smoking risk factors for in-situ cervical cancer with
hospital controls.
3.3.1. Introduction.
In the study population new variables in addition to number of sexual
partners, age at first intercourse, ever had induced abortion and ever used
"safe period" contraceptive as mentioned in chapter 3.2, were found to be
potential risk factors. These variables were educational level, drinking habit,
history of sexually transmitted disease and ever had vaginal discharge,
frequency of Pap smears, reproductive variables and family history of cancer.
Compared to the community control group, these particular hospital
controls showed a significant difference at the 5 % level for use of oral
contraceptives as well as duration of its use. Also use condoms, IUD and
withdrawal method were potential risk factors.
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3.3.2. Demographic and socio-economic data.
As shown earlier in Table 3.1, demographic variables considered
include age, marital status, socio-economic indicators including area of living,
educational level, occupation and drinking habits are presented in Table 3.6.
In this study population, cases were younger than the controls. Eighty
four percent of cases were aged less than 40 years compared to 47% of
controls, however there was no significant difference at the 5% level.
With regard to the educational level, cases had higher educational
levels than the controls. Thirty three per cent of cases and 25 % of the cases I
spouses finished their high school compared to 14.5% and 8% respectively
among the controls.
There was also a significant different at the 5% level between cases and
controls with regard to their drinking habits. More cases drank wine and
spirits compared to controls. The numbers for these were 80% and 65 %
respectively compared to 59% and 36% respectively.
Marital status and age at first marriage did not come up as significant
factors at the 5% level in this study population.
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Table 3.6. Demographic and sodo-economic data of
in-situ cervical cancer cases with hospital controls.
p < 0.05
DEMOGRAPffiC AND CASES % CONTROLS % TOTAL %
SOCIO-ECONOMIC n=114 n=331 n=445
VARIABLES
Age distribution
< =30 years old 41.2 19.6 25.2
31 - 40 years old 43.0 26.9 31.0
41 - 50 years old 11.4 23.9 20.7
> 50 years old 4.4 29.6 23.1
Area of living
City 100.0 83.7 87.4
Town 0.0 12.4 9.7
Rural 0.0 3.9 2.9
Self education
< 10 years 34.2 60.4 53.7
10-12 years 32.5 25.1 27.0
> 12 years 33.3 14.5 19.3
Husbands education......
< 10 years 50.0 58.3 56.2
10-12 years 24.6 33.5 31.2
> 12 years 25.4 8.2 12.6
Self occupation
Housewife or unemployed 23.7 32.6 30.3
Non-professional 14.9 25.4 22.7
Professional 61.4 42.0 47.0
Husband occupation
Unmarried or unemployed 28.1 23.9 24.9
Non-professional 16.7 26.9 24.3
Professional 55.3 49.2. 50.8
Marital status
Never married 25.4 20.8 22.0
Married 60.5 61.9 61.6
Divorced 10.5 11.2 11.0
Widowed 3.5 6.0 5.4
Age at 1Sl married
Never married 25.4 21.1 22.2
> 24 years 22.8 27.2 26.1
20 - 24 years 36.0 39.6 38.6
< 20 years 15.8 12.1 13.0
Drink beer 29.8 26:0 27.0
Drink wine...... 79.8 58.6 64.0
Drink spirit...... 64.9 35.9 43.4
Frequency of drink Iweek
Never drink 7.9 23.6 19.5
1 - 10 drink 52.6 34.1 38.9
11 - 20 drink 11.4 5.1 6.7
21 - 30 drink 3.5 1.2 1.8
> 30 drink 24.6 35.9 33.0
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3.3.3. Sexual risk factors.
As it was found for in-situ cervical cancer with community controls,
number of sexual partners and age at first intercourse were found to be
significantly different at the 5% level between cases and controls.
Fifty two per cent of cases had had more than 4 sexual partners
compared to only 17% of controls. Sixty eight per cent of controls had only
had 0-1 sexual partner compared to only 18% among cases.
Cases had first intercourse at an earlier age than controls. Seventy four
per cent of cases had their fIrst intercourse at age less than 20 compared to
44% of controls.
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Table 3.7. Sexual factors for in-situ cervical cancer cases
with hospital controls
p < 0.05
SEXUAL FACTOR CASES % CONTROLS % TOTAL %
n=114 n=331 n=445
Numbers of sexual partner ......
0-1 partner 18.4 67.7 55.1
2-3 partners 28.9 15.1 18.6
4-6 partners 26.3 10.0 14.2
> 6 partners 26.3 7.2 12.1
Age at 1st intercourse ....
< 16 10.5 6.6 7.6
16-19 63.2 37.2 43.8
> = 20 26.3 56.2 48.5
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3.3.4. Reproductive risk factor.
Reproductive variables including age at menarche, parity, history of
miscarriages and history of breastfeeding measured in this study are presented
in Table 3.8.
Age at fIrst pregnancy was signifIcantly different at the 5% level
between cases and controls. Twenty seven per cent of cases had their fIrst
pregnancy before the age of 20 years old compared to 17% in the controls.
As it was found in the community control data, induced abortion
showed a signifIcant difference at the 5 % level. More cases had induced
abortions compared to controls. The numbers were 28 % and 20%
respectively.
Even though age at menarche did not reveal any signifIcant difference
at the 5 % level, 25 % of cases reached their menarche at age less than 12
years compared to 15% in the control group.
Two breastfeeding variables, number of babies breastfed and total
duration of breastfeeding, revealed a signifIcant difference at the 5% level
between cases and controls. Cases breastfed less and for shorter periods
compared to controls. Twenty one per cent of cases breastfed more than 2
children compared to 38 % of controls. Nineteen per cent of cases breastfed for
more than 6 months compared to 29 % of controls.
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Table 3.8. Reproductive factors of in-situ cervical cancer cases
with hospital controls
p < 0.05
REPRODUCTIVE CASES % CONTROLS % TOTAL %
n=114 n=331 n=445
Age at menarche
< 12 years 24.6 15.1 17.5
12 years 18.4 20.2 19.8
13 years 23.7 27.5 26.5
> 13 years 33.3 37.2 36.2
Age at 1SI: pregnancy··
Nulliparous 23.7 23.6 23.6
> = 20 years 56.2 59.8 58.0
< 20 years 20.1 16.6 18.3
Age at 1SI live birth
No live birth 36.0 27.5 29.7
> = 20 years 25.4 23.9 24.3
< 20 years 38.6 48.6 46.1
Age at ISI breast feed
Didnot breastfeed 54.4 47.7 49.4
< 16 years 6.1 4.2 4.7
16-19 yea 13.2 11.5 11.9
20-24 years 18.4 26.6 24.5
> 24 years 7.9 10.0 9.4
Induce abortion ••
Ever 28.1 19.9 24.0
Never 71.9 80.1 76.0
Spontaneous abortion
Never 83.3 85.1 84.2
Ever 16.7 14.9 15.8
Total pregnancy
Nulliparous 24.7 18.7 21.7
1-2 40.4 35.3 37.9
>2 35.0 45.9 40.4
Number of pregnancy-breastfed"""
Nulliparous/did not breastfeed 55.3 48.3 50.1
1-2 23.7 13.3 16.0
3 11.4 19.6 17.5
>3 9.6 18.7 16.4
Length of breastfeeding"''''
Nulliparous or
No breastfeed 54.4 40.8 47.6
1-6 months 26.3 30.2 28.3
> 6 months 19.3 29.0 24.2
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3.3.5. Medical history.
Data on medical history, including sexually transmitted disease (STD),
vaginal discharge, frequency of Pap smears and history of cancer within
family members is presented in Table 3.9.
There were significant differences at the 5% level between cases and
controls with regard to their past exposure to STD. In addition, 53 % of cases
had vaginal discharge compared to 26% of controls. Cases also had vaginal
discharge more frequently than controls. Thirty one per cent of cases had
vaginal discharge more than twice compared to 12% of controls.
Among hospital controls, there was a different pattern of Pap smear
exposure compared to community controls. In this study population, cases had
Pap smears more frequently than controls. Eighty per cent of cases had Pap
smears more than twice compared to 54% of controls. There was a significant
difference at the 5% level between cases and controls with regard to their
history of Pap smears.
The history of family members with cancer revealed a significant
difference at the 5 % level for some of the variables. These variables were
mother's mother with cancer, mother's father with cancer, father's mother
with cancer, and mother with cancer.
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Table 3.9. Medical history of in-situ cervical cancer cases
with hospital controls
p < 0.05
mSTORY OF DISEASES CASES % CONTROLS % TOTAL %
AND OPERATIONS n=114 n=331 n=445
Venereal diseases 6.1 1.2 2.5
Discharne 52.6 25.7 32.6
Frequency of discharge......
Never 45.6 73.7 66.5
Once 12.3 10.0 10.6
Twice 11.4' 3.9 5.8
> 2x 30.7 12.4 17.1
Numbers of Pap smear
>3x 36.8 45.9 43.6
2-3 x 43.9 9.7 18.4
0-1 x 19.3 44.4 38.0
Frequencies of Pap smear......
< 1/5 yrs or never 11.4 41.4 26.4
1/1-5 yrs 75.4 46.5 61.0
> 1/vr 13.2 13.2 13.2
Dilatal!e and Curetal!e 40.3 51.1 48.3
Caesarian section 8.8 8.8 8.8
Familv with cancer (Ca) 50.0 41.7 43.8
Mother's mother Ca + 5.3 13.6 9.4
Mother's father Ca + 14.0 5.7 9.9
Father's mother Ca +..... 10.5 9.4 9.9
Father's father Ca + 7.9 3.9 5.9
Mother with Ca ...... 14.0 17.2 15.6
Father with Ca 15.8 10.6 13.2
......
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3.3.6. Practices of contraceptive.
Data on the history of contraceptive practices is presented in Table
3.10. In this study population, only 69% ever had used oral contraceptives.
This number is smaller compared to the study population with community
controls which had 94 %. In the hospital control study, there was a significant
difference at the 5% level between cases and controls with regard to their past
exposure to oral contraceptives. Ninety five per cent of cases had used oral
contraceptives (OC) compared to only 60% on the controls. Cases also had a
longer total duration of use of OC than controls. Forty five per cent of cases
had used OC for more than 72 months compared to 24 % of controls.
Other contraceptive practice variables which showed significant
difference at the 5% level between cases and controls were IUD use, condom
use and use of the withdrawal method. Fifteen per cent of controls had used
!UD compared to 13 % of cases. Thirty eight per cent of cases had used
condoms compared to only 18 % of controls. Twenty six per cent of cases had
used the withdrawal method compared to only 17% of controls.
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Table 3.10. Contraceptive factors of in-situ cervical cancer cases
with hospital controls
p < 0.05
CONTRACEPfIVE HISTORY CASES % CONTROL % TOTAL %
n=114 n=181 n=295
Oral contraceptive 95.6 60.4 69.4
Duration of use of oral contraceptive••
Never use 4.4 39.6 22.0
< 25 months 24.5 21.7 23.1
25-72 months 26.3 15.1 18.0
> 72 months 44.7 23.6 29.0
Injection 0.9 0.3 0.4
IUD 13.2 15.4 14.3
D' • 12.3 12.1 12.1la
Condom 37.7 18.4 23.4
Spennicide 22.8 15.7 17.5
Withdrawal 26.3 17.2 19.5
Safe period 13.2 11.8 12.1
Tubectomy 13.2 19.6 18.0
Vasectomy 7.0 4.8 5.4
••
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
3.3.7. Conclusion.
As a result of the exploratory data analysis for this study population
some variables were retained to be analyzed further using logistic regression.
These variables were number of sexual partners, age at first intercourse,
educational levels (self and spouse), wine and spirit drinking habit, history of
sexually transmitted disease and vaginal discharge, frequency of Pap smears
and reproductive variables including age at first pregnancy, number of
pregnancies breastfed, total duration of breastfeeding and induced abortions.
History of family members with cancer also showed significant difference at
the 5% level. These variables were mother's mother, mother's father, father's
mother and mother with cancer. Since there is no a priori belief that cervical
cancer was a hereditary disease, these variables on family history of cancer
were not be retained for further analysis.
Use of oral contraceptive, duration of use, use of IUD and condoms,
and practice of withdrawal method were also retained for further analysis.
3.4. Potential non-smoking risk factors for invasive cervical cancer
(hospital controls).
3.4.1. Introduction.
In contrast to in-situ cervical cancer, potential risk factors for invasive
cervical cancer are mainly dominated by reproductive variables such as age at
first pregnancy, age at first live birth, age at first breastfeed, number of total
pregnancies and duration of breastfeeding. However number of sexual factors,
marital status, occupation and drinking habit also showed up as potential risk
factors.
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3.4.2. Demographic and sodo-economic data.
The effect of certain demographic variables including age and marital
status and socio economic indicators including area of residence, educational
level (self and spouse), occupation (self and spouse) and drinking habit are
shown in Table 3.11.
There was a significant difference at the 5% level between cases and
controls with regard to area of residence. Eighty four per cent of controls
lived in the city compared to 57% of cases. Meanwhile 36% of cases lived in
towns compared to 12% of controls.
Seventy one per cent of cases were employed in skilled or unskilled
jobs compared to 66 % of controls. For spouses, these numbers were 92 % and
77% respectively. These occupational variables are significantly different at
the 5% level.
Marital status and age at first marriage were also significantly different
at the 5% level between cases and controls. One major difference was with
regard to marital status with 20 % of controls unmarried, but only 4% among
cases.
Beer drinking habit was also significantly different at the 5% level.
Forty three per cent of cases drank beercompared to 26 % of controls.
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Table 3.11. Demographic and sodo-economic data of
invasive cervical cancer cases with hospital controls.
p < 0.05
DEMOGRAPffiC AND CASES % CONTROLS % TOTAL %
SOCIO-ECONOMIC n=75 n=331 n=406
VARIABLES
Age distribution
< =30 years old 10.7 19.6 18.0
31 - 40 years old 25.3 26.9 26.6
41 - 50 years old 25.3 23.9 24.1
> 50 years old 38.7 29.6 31.3
Area of living~~
City 57.3 83.7 78.8
Town 36.0 12.4 16.7
Rural 6.7 3.9 4.4
Self education
< 10 years 73.3 60.4 62.8
10-12 years 16.0 25.1 23.4
> 12 years 10.7 14.5 13.8
Husbands education
< 10 years 48.0 45.3 45.8
10-12 years 37.3 31.4 32.5
> 12 years 14.7 23.3 21.7
Self occupation~~
Housewife or unemployed 29.3 32.6 32.0
Unskilled 42.7 25.7 28.8
Skilled 28.0 41.7 39.2
Husband occupation
Unmarried or unemployed 8.0 23.9 20.9
Unskilled 37.3 26.9 28.0
Skilled 54.7 49.2 50.2
Marital status .
Never married 4.0 20.8 17.7
Married 64.0 61.9 62.3
Divorced 21.3 11.2 13.0
Widowed 10.7 6.0 6.9
Age at 1st married...•
Never married 4.0 20.8 17.7
> 24 years 44.0 27.5 30.5
20 - 24 years 41.3 39.6 39.9
< 20 years 10.7 12.1 11.8
Drink beer 42.7 26.0 29.1
Drink wine 49.3 58.6 56.9
Drink spirit 26.7 35.9 34.2
Frequency of drink Iweek
Never drink 25.3 23.3 23.6
1 - 10 drink 34.7 34.1 34.2
11 - 20 drink 6.7 5.1 5.4
21 - 30 drink 2.7 1.2 1.5
> 30 drink 30.7 36.2 35.2
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3.4.3. Sexual risk factors.
As expected, there were significant differences at the 5 % level between
cases and controls with regard to their number of sexual partners and age at
first intercourse.
Seventeen per cent of cases had more than 4 sexual partners during
their life compared to 12% among the control group. Cases also had their first
intercourse at earlier than the controls. Fifty six per cent of cases had their
first intercourse at age less than 20 compared to 41 % among the control group
(Table 3.12).
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ONTROL % TOTAL %
n=331 n=406
58.67 66.01
29.33 17.73
6.67 9.36
5.33 6.90
6.67 17.00
34.67 36.45
50.67 39.66
8.00 6.90
ervical cancer cases
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Table 3.12. Sexual factors of invasive c
with hospital controls
SEXUAL FACTOR CASES % C
n=75
Numbers of sexual partner
0-1 partner 67.67
2-3 partners 15.11
4-6 partners 9.97
> 6 artners 7.25
Age at IS intercourse
< 16 19.33
16-19 36.86
20-24 37.16
> 24 or never 6.65
p < 0.05
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3.4.4. Reproductive risk factor.
In Table 3.13, the effects of reproductive factor variables including age
at menarche, parity, miscarriages and breastfeeding habits are presented.
"Parity" variables including pregnancy status, age at first pregnancy,
age at first livebirth, age at first breastfeeding, number of total pregnancies,
number of pregnancy breastfed and total months of breastfeeding, showed
significant differences at the 5% level between the case and control groups.
Even though there was no significant difference at the 5% level, 24 %
of cases reached their menarche at age less than 12 compared to 15 % of the
control group. There was no significant difference at the 5 % level, 20% of
controls ever had any induced abortion compared to 11 % of cases.
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Table 3.13. Reproductive factors of invasive cervical cancer cases
with hospital controls
p < 0.05
REPRODUCTIVE CASES % CONTROLS % TOTAL %
n=75 n=331 n=406
Age at menarche
< 12 years 24.0 15.1 16.7
12 years 18.7 20.2 20.0
13 years 22.7 27.5 26.6
> 13 years 34.7 37.2 36.7
Age at 1S[ pregnancy....
Nulliparous 4.0 23.6 20.0
> 24 years 37.3 16.6 20.4
20-24 years 46.7 35.3 37.4
< 20 years 12.0 24.5 22.2
Age at l S[ live birth....
No live birth 9.3 27.5 24.1
> 24 years 34.7 14.5 18.2
20-24 years 44.0 34.1 36.0
< 20 years 12.0 23.9 21.7
Ageat1S[breastf~d""
No breast feed 30.7 47.7 44.6
> 24 years 16.0 10.0 11.1
20-24 years 40.0 26.6 29.1
< 20 years 13.33 15.7 15.3
Induced abortion
Never 89.3 80.1 81.8
Ever 10.7 19.9 18.2
Spontaneous abortion
Never 66.7 61.9 62.8
Ever 33.3 38.1 37.2
Total pregnancy....
Nulliparous 4.0 18.7 16.0
1-2 24.0 35.3 33.2
3 28.0 16.0 18.2
>3 44.0 29.9 32.5
Number of babies
breastfed**
Nulliparous 32.0 48.3 45.3
1-2 36.0 32.9 33.5
3 17.3 10.0 11.3
>3 14.7 8.8 9.8
Length of breastf~ding....
0-6 months 53.3 71.0 67.7
7-12 months 25.3 12.1 14.5
> 12 months 21.3 16.9 17.7
....
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3.4.5. Medical history.
Medical history data, including history of sexually transmitted disease,
vaginal discharge and frequency of Pap smear exposure, is presented on Table
3.14.
There was no significant difference at the 5% level between cases and
controls' with regard to their history of exposure to sexually transmitted
diseases and vaginal discharge.
Compared to the in-situ data, there was a significant difference at the
5% level between cases and controls with regard to their frequency of Pap
smears. Cases had Pap smears more often than controls. Sixty per cent of
cases had Pap smears more than once a year compared to 41 % in the control
group. This difference may be due to selection bias since there was no effort
to ensure that controls had had Pap smears as frequently as cases in the initial
study design (WHO Collaborative Study on Oral Contraceptive and
Neoplasia).
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Table 3.14. Medical history of invasive cervical cancer cases
with hospital controls
p < 0.05
mSTORY OF DISEASES CASES % CONTROL % TOTAL %
AND OPERATIONS n=75 n=331 n=406
Venereal diseases 1.3 1.2 1.2
DischaI1!e 20.0 26.0 24.9
Frequency of discharge
Never 80.0 73.7 74.9
Once 9.3 10.0 9.8
Twice 5.3 3.9 4.2
> 2x 5.3 12.4 11.1
Nwnber of Pap smear
0-1 36.0 34.7 35.0
2-3 5.3 19.3 16.7
>3 58.7 45.9 48.3
Frequencies of Pap smear··
< l!5yrs or never 9.3 12.1 11.6
l!1-5yrs 30.7 46.5 43.6
>l!yr 60.0 41.4 44.8
Dilatage and Curetage 50.7 51.1 51.0
Caesarian section 4.0 8.8 7.9
Familv with cancer (Ca) 37.3 41.7 40.9
Mother's mother Ca + 5.3 13.6 U.1
Mother's father Ca + 8.0 5.7 6.2
Father's mother Ca + 2.7 9.4 8.1
Father's father Ca + 2.7 3.9 3.7
Mother with Ca 16.0 17.2 17.0
Father with Ca 9.3 10.6 10.3
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3.4.6. History of contraceptive practices.
History of contraceptive practice is presented in Table 3.15. There
were no significant differences at the 5 % level between cases and controls
with regard to their contraceptive practices.
Fifty per cent of cases and 60% of controls were exposed to oral
contraceptives at some stage of their life. There was no significant difference
at the 5 % level between cases and controls but 29 % of cases used oral
contraceptive for more than 24 months compared to 32% of controls.
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CONTRACEPrIVE CASES % CONTROL % TOTAL %
mSTORY n=75 n=331 n=406
Oral contraceptive 57.3 60.4 59.8
Duration of use of oral
contraceptive
Never use 42.7 39.6 41.1
< 25 months 28.0 28.0 28.0
25-72 months 16.7 18.7 17.7
> 72 months 12.7 13.6 13.1
IUD 8.0 15.4 14.0
RiIll! 1.3 0.9 1.0
D' • 9.3 12.1 11.6la
Condom 24.0 18.4 19.5
Spennicide 14.7 15.7 15.5
Withdrawal 16.0 17.2 17.0
Safe period 13.3 11.8 12.1
Tubectomy 14.7 19.6 18.7
Vasectomy 5.3 4.8 4.9
Table 3.15. Contraceptive history of invasive cervical cancer cases
with hospital controls
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3.4.7. Conclusion.
There was a little difference between cases and controls in the pattern
of the potential risk factors for in-situ cervical cancer and invasive cervical
cancer in this study population. For invasive cervical cancer, the number of
sexual partners, age at frrst intercourse, occupational variables, reproductive
variables, Pap smears exposure, marital status and beer drinking habit were
found to be significantly different at the 5% level between cases and controls.
Thus these variables are investigated further in the multiple logistic regression
analysis.
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CHAPTER 4.
MULTIPLE LOGISTIC REGRESSION ANALYSIS
ON NON-SMOKING RISK FACTORS
FOR CERVICAL CANCER.
4.1. Introduction.
Variables which have been found to be significantly different at the 5%
level using the standard chi-squared (X2) test (chapter 3) were further
analysed by the multivariate modelling technique, Le. by employing logistic
regression with a dichotomous response variable.
Odds ratio may be computed from the beta (13) coefficient for each
independent variable. By employing the SPIDA statistical package, this odds
ratio is provided in the standard output of the logistic regression procedure as
well as its 95% confidence intervals (Lunn and MacNeil, 1991). A likelihood
ratio test was used to asses fitted variable in the models.
The odds ratio in each situation may be adjusted by the addition of
other independent variables to the model. If there was a biologically plausible
reason that two variables were not independent of each other, Le. there was
interaction, the model was tested with additional interaction terms.
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4.2. Multiple logistic regression on in-situ cervical cancer with community
controls.
The logistic regression analysis of the identified potential risk factors
for in-situ cervical cancer including number of sexual partners, age at first
intercourse, the use of the "safe period" and total duration of oral
contraceptive use is presented in this chapter. The odds ratio (OR), either
crude or adjusted, and 95 % confidence intervals for these estimates are
presented at Table 4.1 to Table 4.5.
4.2.1. Number of sexual partners.
Women who had more than 6 sexual partners in their life time had 5
times more chance of developing in-situ cervical cancer than women with 0-1
sexual partner. Table 4.1 shows that the crude risk of having in-situ cervical
cancer increases steadily with the number of sexual partners.
The effect of number of sexual partners remains stable after adjustment
for various variables, including age at first intercourse, induce abortion
experience, use of "safe period" and total duration of oral contraceptive use
(Table 4.1).
Thus it may be concluded that the effect of number of sexual partners
is a strong risk factor since the measure of association using the odds ratio is
high, the result is significant at the 5% level and the confidence intervals are
not too wide.
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CONTROL VARIABLE NUMBER OF SEXUAL PARTNERS
(OR and 95% en
0-1 2-3 4-6 >6
Crude 1.00 3.05 4.06 5.23
(1.57.5.92) (2.01 8.23) (2.52 10.88)
Age at first intercourse 1.00 2.62 3.48 4.50
(1.31.5.20) (1.68.7.20) (2.09.9.68)
Ever had induced abortion 1.00 2.95 3.53 5.03
(1.51,5.77) (1.72,7.26) (2.41,10.51)
Never use "Safe" period 1.00 3.13 4.37 5.58
1.606.13) (2.148.94) (2.66.11.72)
Total duration of oral contraceptive 1.00 2.74 4.03 4.56
(1.39. 5.39) (1.97. 8.25) (2.16. 9.63)
reference group
Table 4.1. Odds ratio of variable number of sexual partners of in-situ
cervical cancer with community controls.
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4.2.2. Age at iIrSt intercourse.
Women who had their first intercourse at age less than 16 years had
six times the chance of developing in-situ cervical cancer compared to women
who had their first intercourse aged more than 24 years. Table 4.2 presents
this association.
There was also a trend over the four age groups specified; > 24 years,
20-24 years, 16-19 years and < 16 years.
After adjustment for number of sexual partners, the risk became non
significant. This demonstrates that the effect of age at first intercourse is
confounded with the number of sexual partners.
Adjustment using the variables induced abortion experience, use of
"safe period" and total duration of oral contraceptive use also showed a
reduced effect of age at first intercourse. But the effect of age at first
intercourse still remained for the group aged less than 16 years after
adjustment for these variables.
Thus, it may be concluded that even though early age at first
intercourse has some independent effect as a potential risk factor, this effect is
also accounted for by the number of sexual partners. When considered
independently the odds ratio is high and there is a linear trend.
Since the measure of association still persists and there is an a priori
reason for its effect, age at first intercourse is retained together with number
of sexual partners when sexual factors are considered as potential confounders
in the subsequent analysis.
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cervical cancer with community controls.
Table 4.2. Odds ratio of variable age at first intercourse of in-situ
reference group
CONTROL VARIABLE AGE AT FIRST lNTERCOURSE
(OR and 95% Cl)
> 24 years 20 - 24 years 16 - 19 years < 16 years
Crude 1.00 1.65 3.56 6.05
(0.505.52) (1.08.11.78) (1.44.25.47)
Number of sexual partners 1.00 1.12 2.04 2.33
(0.32,3.94) (0.58,7.24) (0.51,10.76)
Ever had induced abortion 1.00 1.61 3.13 . 5.49
(0.48,5.41) (0.94,10.44) (1.30,23.28)
Never use "Safe" period 1.00 1.92 4.12 6.18
(0.57,6.51) (1.22.13.84) (1.45.26.31)
Total duration of QC 1.00 1.50 2.88 5.05
(0.44,5.11) (0.85,9.75) (1.17 21.83)
.
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
.1
I
I
I
I
...---------------------------------
I
I
I
I
I
I
I
I
I
I
':1
I
-I
I
I
I
I
I
I
I
I
4.2.3. Use of "safe period".
Women who had never use "safe" period as their contraceptive practice
had a twice the chance of developing in-situ cervical cancer. This effect
persists after adjustment for number of sexual partners (Table 4.3).
Adjustment to another variables including age at fIrst intercourse,
induced abortion experience and total duration of oral contraceptive use
showed no difference in the effect of never use of "safe period" variable. Thus
the effect of never use of "safe" period as a contraceptive was not confounded
by these variables.
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CONTROL VARIABLE NEVER USE OF "SAFE" PERIOD
Odds Ratio 95% Cl
Crude 2.23 1.17.4.27
Number of sexual partners 2.55 1.31. 4.98
A~e at first intercourse 2.26 1.17.4.38
Ever had induced abortion 2.71 1.38.5.32
Total duration of QC 2.05 1.06.3.99
Table 4.3. Odds ratio of variable never use of "safe period ll of
in-situ cervical cancer with community controls.
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4.2.4. Induced abortion experience.
Women with induced abortion experience showed an increased risk of
developing in-situ cervical cancer. The crude odds ratio, as presented in Table
4.4, showed a doubling the risk of developing in-situ cervical cancer.
The effect of induced abortion experience remains after adjustment for
other variables including number of sexual partners, age at first intercourse,
never use "safe" period and total duration of oral contraceptive use.
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CONTROL VARIABLE EVER HAD INDUCED
ABORTION
Odds Ratio 95% Cl
Crude 2.28 1.27.4.09
Number of sexual partners 1.94 1.05.3.59
Age at first intercourse 1.98 1.09.3.61
Never use "safe" period 2.71 1.47.5.00
Total duration of QC 2.25 1.23.4.13
Table 4.4. Odds ratio of variable ever had induced abortion of
in-situ cervical cancer with community controls.
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4.2.5. Total duration of oral contraceptive use.
There was no significant difference at the 5% level between cases and
controls in use of oral contraceptives. Ninety four per cent of the study
population used oral contraceptives at some stage of their life. When these
data were analysed by total duration of oral contraceptive use, it was found
that 45 % of cases had used oral contraceptives for more than 72 months
compared to 5% of controls (Table 3.5). Further analysis by logistic
regression yields an odds ratio of 2.5 (p < 0.05) for women who used oral
contraceptives for more than 72 months compared to women who used oral
contraceptive for 0-24 months.
After adjustment for other variables including number of sexual
partners, age at first intercourse, induced abortion experience and never use of
"safe period", the effect remains stable (Table 4.5). Thus it maybe concluded
that the effect of total duration of oral contraceptive use for more than 72
months was independent from other variables including number of sexual
partners, age at first intercourse, induced abortion experience and never use
of "safe period" .
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in-situ cervical cancer with community controls.
reference group
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Table 4.5. Odds ratio of variable total duration of oral contraceptive use of
CONTROL VARIABLE TOTAL DURATION OF USE OF OC
OR and 95% Cl)
0-24 months· 25-72 months > 72 months
Crude 1.00 1.05 2.52
(0.56, 1.94) (1.40. 4.57)
Number of sexual partners 1.00 0.96 2.13
(0.50, 1.83) (1.14.3.98)
Age at first intercourse 1.00 1.00 2.21
(0.54, 1.88) (1.20. 4.06)
Never use "Safe" period 1.00 0.94 2.27
(0.50, 1.76) (1.24, 4.15)
Ever had induced abortion 1.00 1.18 2.62
(0.63, 2.23) (1.43. 4.79)
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4.2.6. Conclusion.
The logistic regression analysis of potential risk factor variables
(chapter 4.2) reveiled that certain variables including number of sexual
partners, age at first intercourse, induced abortion experience, never use of
"safe period", and total duration of oral contraceptive use increase the risk of
developing in-situ cervical cancer in this study population. The crude and
adjusted odds ratios for these variables are presented in Tables 4.1 to 4.5.
Thus the variables mentioned above were considered as independent
risk factors for in-situ cervical cancer in this study.population and as such may
be considered as confounders in the analysis of the smoking variables (chapter
5).
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4.3. Multiple logistic regression for in-situ cervical cancer with hospital
controls.
The logistic regression analysis of the identified potential risk factors
for in-situ cervical cancer with hospital controls, including number of sexual
partners, age at first intercourse, education levels (self and spouse), drinking
habit (wine and spirits), medical history of sexually transmitted disease and
vaginal discharge, reproductive variables including age at first pregnancy,
number of pregnancies breastfed, induced abortion experience, Pap smear
history (number and frequency of Pap smears) and history of contraceptive
practice including use of oral contraceptive, total duration of oral
contraceptive use, use of IUDs, use of condoms and use of the withdrawal
method are presented in this chapter. The odds ratios (OR), either crude or
adjusted, and 95% confidence intervals of these variables are presented in
Tables 4.6 to Table 4.23.
4.3.1. Number of sexual partners.
In this study population, women who had more than 6 sexual partners
in their life had 8 times more chance of developing in-situ cervical cancer than
women with 0-1 sexual partner. The crude and adjusted odds ratios for
number of sexual partners is presented in Table 4.6.
Even though the linear trend is not smooth the risk of developing in-
situ cervical cancer increases with the number of sexual partners. The effect of
number of sexual partners is stable after adjustment for other variables
including age at first intercourse, education level (self and spouse), drinking
habit (wine and spirits), medical history of sexually transmitted disease and
vaginal discharge, reproductive variables including age at first pregnancy,
number of babies breastfed, induced abortion experience, Pap smear history
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(number and frequency of Pap smears) and history of contraceptive practices
including use of oral contraceptives, total duration of oral contraceptive use,
use of IUDs, use of condoms and use of the withdrawal method. Thus this
result indicated that the effect of number of sexual partners was relatively
independent of the effect of age at first intercourse, education level (self and
spouse), drinking habit (wine and spirits), medical history of sexually
transmitted disease and vaginal discharge, reproductive variables including
age at first pregnancy, number of babies breastfed, induced abortion
experience, Pap smear history (number and frequency of Pap smears) and
history of contraceptive practice including use of oral contraceptives, total
duration of oral contraceptive use, use of IUDs, use of condoms and use of
withdrawal method.
Thus it may be concluded that the effect of number of sexual partners
is a strong risk factor since the measure of association using the odds ratio is
high, the result is significant at the 5% level and the confidence intervals are
not too wide.
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Table 4.6. Odds ratios for number of sexual partners for in-situ cervical
cancer cases with hospital controls.
CONTROL VARIABLE NUMBER OF SEXUAL PARTNERS
(OR and 95% Cl)
0-1 2-3 4-6 >6
Crude 1.00 7.20 6.25 8.78
(3.72. 13.94) (3.12, 12.50) (4.25, 18.15)
Ever had STD 1.00 7.12 5.93 8.44
(3.68. 13.80) (2.94, 11.97) (4.07, 17.50)
Ever had discharge 1.00 7.02 5.50 7.28
(3.60, 13.66) (2.72. 11.14) (3.47 15.29)
Self education 1.00 7.20 5.74 7.94
(3.69 14.05) (2.85. 11.54) (3.81. 16.56)
Spouse education 1.00 7.81 5.63 8.43
(3.98. 15.33) (2.77 11.45) (3.99, 17.81)
Drank wine 1.00 7.50 5.72 8.16
(3.83, 14.68) (2.83. 11.56) (3.89, 17.01)
Drank spirits 1.00 6.87 5.38 7.63
(3.52. 13.41) (2.66, 10.88) (3.65, 15.94)
Induced abortion experience 1.00 6.35 4.89 7.65
(3.21, 12.53) (2.36, 10.15) (3.60 16.27)
Age at first pregnancy 1.00 7.07 6.13 9.31
(3.62. 13.78) (3.04. 12.37) (4.45 19.47)
Number of babies breastfed 1.00 7.11 6.57 8.61
(3.63. 13.95) (3.23, 13.32) (4.13, 17.96)
Number of Pap smears 1.00 5.90 6.15 7.68
(2.84, 12.29) (2.83 13.35) (3.42. 17.25)
Frequency of Pap smears 1.00 5.57 6.46 7.18
(2.83. 10.96) (3.14, 13.29) (3.39, 15.21)
Ever used OCs 1.00 6.26 4.96 8.24
(3.19. 12.27) (2.46. 10.00) (3.91. 17.38)
Ever used rUDs 1.00 7.26 6.51 9.06
(3.74. 14.08) (3.22. 13.20) (4.36, 18.83)
Ever used condoms 1.00 7.15 5.72 7.55
(3.67, 13.95) (2.84, 11.52) (3.61, 15.82)
Ever practised withdrawal method 1.00 7.07 6.00 8.35
(3.65. 13.70) (2.99. 12.05) (4.02 17.37)
Age at first intercourse 1.00 6.50 5.98 9.00
(3.26. 12.97) (2.91. 12.28) (4.05 20.02)
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4.3.2. Age at first intercourse.
Women who had their first intercourse at age less than 20 twice the
risk of developing in-situ cervical cancer compared to women who had their
first intercourse at age more than 20. For the age group of less than 16 years,
the odds ratio was only marginally non-significant (Odds ratio 2.27 with 95 %
confidence intervals 0.98, 5.26).
After adjustment for number of sexual partners the risk became non
significant. Again, this demonstrates that the effect of age at first intercourse
is confounded with the number of sexual partners. The effect of age at first
intercourse persists, particularly for the category of 16-19 years, after
adjustment for other variables including education levels (self and spouse),
drinking habit (wine and spirits), medical history of sexually transmitted
disease and vaginal discharge, reproductive variables including age at first
. pregnancy, number of babies breastfed, induced abortion experience, Pap
smear history (number and frequency of Pap smears) and history of
contraceptive practices including use of oral contraceptives, total duration of
oral contraceptive use, use of IUDs, use of condoms and practice of
withdrawal method (Table 4.7).
Thus, it may be concluded that even though early age at first
intercourse has some independent effect as a potential risk factor most of this
effect is also accounted for by the number of sexual partners. Since the
measure of association still persists and there is an a priori reason for its
effect, variable age at first intercourse is retained together with number of
sexual partners when sexual factors are considered as potential confounders in
subsequent analysis.
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Table 4.7. Odds ratios of age at first intercourse for in-situ cervical cancer
cases with hospital controls.
CONTROL VARIABLE AGE AT FIRST INTERCOURSE
OR and 95% Cl)
> =20 years 16-19 years < 16 years
Crude 1.00 2.55 2.27
(1.53. 4.27) (0.98, 5.26)
Ever had STD 1.00 2.47 2.18
(1.47 4.14) (0.94, 5.07)
Ever had discharge 1.00 2.33 2.03
(1.38 3.94) (0.86,4.78)
Self education 1.00 2.80 3.16
(1.65. 4.75) (1.32. 7.5S)
Spouse education 1.00 2.58 2.20
(1.52. 4.37) (0.94,5.16)
Drank wine 1.00 2.66 2.65
(l.58. 4.50) (1.12. 6.28)
Drank spirits 1.00 2.49 2.40
(1.47 4.22) (1.01 5.70)
Never had induce abortion 1.00 2.13 2.40
(1.24. 3.66) (1.01. 5.74)
Age at first pregnancy 1.00 2.45 2.18
(1.40. 4.29) (0.92, 5.20)
Number of pregnancy breastfed 1.00 2.71 2.38
(1.59. 4.60) (1.01. 5.57)
Number of Pap smears 1.00 2.27 2.37
(1.28. 4.02) (0.95, 5.95)
Frequency ofPap smears 1.00 2.43 2.33
(1.42 4.16) (0.96, 5.67)
Ever used QC 1.00 2.24 2.17
(1.30 3.74) (0.91, 5.18)
Ever used 100 1.00 2.55 2.27
(1.52. 4.26) (0.98, 5.26)
Ever used condom 1.00 2.39 2.09
(1.42. 4.03) (0.87,4.94)
Ever practise withdrawal method 1.00 2.37 2.14
(1.41. 4.00) (0.92, 5.00)
Number of sexual partners 1.00 1.31 0.80
(0.73,2.35) (0.30, 9.30)
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4.3.3. Educational levels.
Educational levels, either self or spouse, as one of the indicator for
socio-economic levels showed increase in the risk of having in-situ cervical
cancer. The risk increase steadily over the level of education as it was
categorized as < 10 years, 10-12 years and > 12 years (Table 4.8 and Table
4.9). The computation of odds ratio showed significant increase at the 5%
level particularly for category of more than 12 years. Women with education
of more than 12 years had the chance of developing in-situ cervical cancer 2 to
3 times more than women with education less than 10 years. Similarly for
women with spouse education for more than 12 years had increase the chance
of developing in-situ cervical cancer 2 to 4 times more than women with
spouse education < 10 years. The increase risk on the category of more than
12 years remains after adjusting for different potential risk factors including
number of sexual partners, age at first intercourse, drinking habit (wine and
spirits), medical history of sexually transmitted disease and vaginal discharge,
reproductive variables including age at first pregnancy, number of babies
breastfed, induced abortion experience, Pap smear history (number and
frequency of Pap smears) and history of contraceptive practices including use
of oral contraceptives, total duration of oral contraceptive use, use of IUDs,
use of condoms and practice of withdrawal method.
Assuming that the higher the level of education shows a higher socio-
economic status then the outcome of this study is not in accordance with the
belief that cervical cancer is the disease of the poor. This study shows that "::,'.
cervical cancer could happen on any stratum of society. N{O'l"
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CONTROL VARIABLE EDUCATION OF SELF
(OR and 95% Cl)
< 10 years 10-12 years > 12 years
Crude 1.00 1.77 2.73
(1.02 3.06) (1.52. 4.91)
Spouse education 1.00 1.62 1.91
(0.93, 2.84) (0.99, 3.65)
Ever had STD 1.00 1.83 2.91
(LOS. 3.18) (1.60, 5.26)
Ever had vaginal discharge 1.00 1.74 2.58
(1.00, 3.05) (1.42, 4.69)
Drank wine 1.00 1.62 2.43
(0.93,2.84) (1.34. 4.41)
Drank spirits 1.00 1.73 2.74
(0.99, 3.04) (1.51 4.99)
Never had induce abortion 1.00 1.84 2.46
(1.04.3.25) (1.31 4.62)
Age at first pregnancy 1.00 1.87 3.11
(1.07,3.26) (1.71, 5.69)
Number of babies breastfed 1.00 1.72 2.74
(0.98, 3.00) (1.51. 4.96)
Number of Pap smears 1.00 2.01 3.22
(1.08.3.76) (1.64. 6.30)
Frequency of Pap smears 1.00 1.48 2.83
(0.84, 2.60) (1.53, 5.23)
Ever used OCs 1.00 1.56 2.50
(0.89,2.72) (1.37. 4.58)
Ever used IUDs 1.00 1.77 2.72
(1.02, 3.07) (1.51, 4.90)
Ever used condoms 1.00 1.77 2.32
(1.02. 3.08) (1.27. 4.24)
Practise of withdrawal method 1.00 1.80 2.57
(1.03, 3.12) (1.42, 4.65)
Numberofsexualpartn~s 1.00 1.58 2.29
(0.88, 2.86) (1.21, 4.35)
Age at first intercourse 1.00 1.90 3.26
(1.08.3.35) (1.76. 6.02)
reference group
Table 4.8. Odds ratios of variable education of self for in-situ cervical cancer
cases with hospital controls.
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CONTROL VARIABLE EDUCATION OF SPOUSE
(OR and 95% Cl)
< 10 years 10-12 years > 12 years
Crude 1.00 0.91 3.30
(0.53, 1.57) (1.73. 6.310
Self education 1.00 0.88 2.51
(0.51, 1.50 n.24 5.10)
Ever had STD 1.00 0.90 3.30
(0.52, 1.55) n.72. 6.33)
Ever had vaginal discharge 1.00 0.87 2.87
(0.50, 1.50 n.48. 5.57)
Drank wine 1.00 0.87 2.81
(0.50, 1.50) (1.45. 5.44)
Drank spirits 1.00 0.93 3.58
(0.53, 1.63) (1.85. 6.92)
Induced abortion experience 1.00 1.18 4.04
(0.66 2.12) (2.02 8.06)
Age at first pregnancy 1.00 0.92 3.11
(0.53, 1.60 (1.59. 6.10)
Number of babies breastfed 1.00 1.07 3.77
(0.53, 2.14) (1.43. 9.91)
Number of Pap smears 1.00 1.26 5.18
(0.66, 2.39) (2.34. 11.43)
Frequency of Pap smears 1.00 0.61 2.44
(0.34, 1.08) (1.24. 4.83)
Ever used OCs 1.00 0.77 2.95
(0.44, 1.34) (1.50. 5.77)
Ever used IUDs 1.00 0.91 3.32
(0.53, 1.57) n.73. 6.40)
Ever used condoms 1.00 0.86 2.74
(0.50, 1.49) (1.40 5.37)
Practise of withdrawal method 1.00 0.86 3.28
(0.50, 1.48) (1.71. 6.32)
Number of sexual partners 1.00 0.94 3.36
(0.52, 1.70) (1.63. 6.95)
Age at first intercourse 1.00 0.87 3.25
(0.50, 1.50) (1.67.6.29)
reference group
Table 4.9. Odds ratios of variable education of spouse for
in-situ cervical cancer cases with hospital control.
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4.3.4. Drinking habit.
Even though there is no a priori belief that drinking wine or spirits
could increase the risk of cervical cancer, but this study finds that women who
drank wine or spirits had 2.5 times the chance of developing in-situ cervical
cancer compared to women who did not drink wine or spirits (Table 4.10 and
Table 4.11).
The increase in the risk persists even after adjustment for number of
sexual partners, age at first intercourse, years of education (self and spouse),
medical history of sexually transmitted disease and vaginal discharge,
reproductive variables including age at first pregnancy, number of babies
breastfed, induced abortion experience, Pap smear history (number and
frequency of Pap smears) and history of contraceptive practices including use
of oral contraceptives, total duration of oral contraceptive use, use of IUDs,
use of condoms and practice of withdrawal method.
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CONTROL VARIABLE DRANK WINE
OR 95% Cl
Crude 2.67 1.57.4.56
Drank spirits 2.25 1.30.3.90
Self education 2.43 1.41. 4.18
Spouse education 2.39 1.39.4.11
Ever had STD 2.63 1.54.4.51
Ever had vaginal discharge 2.60 1.51. 4.47
Never had induce abortion 2.50 1.43.4.37
Age at first pregnancv 2.93 1.69.5.07
Number of babies breastfed 2.79 1.61. 4.83
Number of Pap smears 2.89 1.61. 5.20
Frequency of Pap smears 2.56 1.47.4.47
Ever used OCs 2.41 1.40.4.18
Ever used IUDs 2.66 1.56.4.55
Ever used condoms 2.59 1.50.4.45
Ever practised of withdrawal method 2.67 1.56.4.58
Number of sexual nartners 2.50 1.41. 4.46
Age at first intercourse 2.83 1.64.4.89
Table 4.10. Odds ratios of variable drank wine for in-situ
cervical cancer cases with hospital controls.
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CONTROL VARIABLE DRANK SPIRITS
OR 95% Cl
Crude 2.70 1.68 4.34
Drank wine 2.36 1.45,3.83
Self education 2.71 1.67,4.38
Spouse education 2.87 1.76,4.68
Ever had STD 2.62 1.63.4.22
Ever had va~inal dischar~e 2.33 1.43,3.79
Induced abortion experience 2.57 1.56,4.25
Age at first pregnancy 2.83 1.75 4.58
Number of babies breastfed 2.93 1.80.4.78
NumberofPapsm~rs 2.50 1.47,4.27
FrequencyofPapsm~rs 2.49 1.53.4.06
Ever used DCs 2.54 1.56.4.13
Ever used rUDs 2.70 1.68.4.33
Ever used condoms 3.14 1.91,5.16
Ever practised of withdrawal method 2.81 1.74,4.54
Number of sexual partners 2.14 1.28,3.59
A~e at first intercourse 2.67 1.65.4.33
Table 4.11. Odds ratios of variable drank spirits of in-situ
cervical cancer cases with hospital controls.
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4.3.5. History of sexually transmitted disease.
Sexually transmitted disease as one of the measure of possible source
of exposure to certain carcinogenic agent showed a significant increase in the
risk of having in-situ cervical cancer. Women who have ever had any sexually
transmitted diseases, c.q. gonorrhoeae or syphilis, had four times the chance
of developing in-situ cervical cancer compared to women who have never had
any sexually trasnmitted disease (STD) (Table 4.12).
After adjustment using the variable number of sexual partners the
effect of STD became non significant (p > 0.05). The non significant effect
was also showed after adjustment using other variables including age at first
intercourse, reproductive variables and drinking habits. Thus even though the
history of STD has some independent effect as a potential risk factor most of
this effect is also accounted for by the number of sexual partners.
During the 50's and 60's STD was belief as the major cause of cervical
cancer, but this theory was changed after the discovery of human papilloma
virus (this virus was not investigated in the original WHO study). Thus STD is
not considered as an independent risk factor in the subsequent analysis.
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CONTROL VARIABLE EVER HAD ANY STD
OR 95% Cl
Crude 3.90 1.00.15.26
Ever had any dischanze 2.49 0.63,9.89"
Self education 4.89 1.20.19.82
Spouse education 4.00 0.98, 16.25
Drank wine 3.67 0.90,14.94
Drank soirits 3.17 0.79,12.77
Never had induced abortion 3.50 0.80, 15.23
Age at first pregnancy 3.46 0.87, 13.77
Number of babies breastfed 3.27 0.83, 12.87
NumberofPaosmears 4.33 1.01. 18.65
Freauencv ofPao smears 4.32 1.08.17.34
Ever used OCs 3.52 0.88, 14.17
Ever used IUDs 3.90 0.99, 15.26
Ever used condoms 3.65 0.93, 14.32
Ever oractised of withdrawal method 3.66 0.91, 14.75
Number of sexual partners 2.23 0.53,9.32
Age at first intercourse 3.24 0.81, 13.02
Table 4.12. Odds ratios of STD variable for in-situ cervical cancer
cases with hospital control.
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4.3.6. Ever had any vaginal discharge.
Women who have ever had any vaginal discharge had 2.5 times the
chance of developing in-situ cervical cancer compared to women who have
never had any vaginal discharge (Table 4.13). After adjustment for variables
including number of sexual partners, age at fIrst intercourse, education levels,
drinking habit, history of STD, reproductive factors including age at fIrst
pregnancy, number of babies breastfed and induced abortion experience, pap
smears and contraceptives history the effect persists. It seems that the effect of
variable ever had any vaginal discharge is modifIed by ever used of oral
contraceptives variable. There was a large increase from the crude odds ratio
of 2.53 to 7.17 after allowing for ever used of oral contraceptives variable.
Thus ever had any vaginal discharge is an independent risk factor for
in-situ cervical cancer in this study population.
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CONTROL VARIABLE EVER HAD ANY
DISCHARGE
OR 95% Cl
Crude 2.53 1.58.4.04
Ever had any STD 2.39 1.48.3.85
Self education 2.44 1.51.3.92
Spouse education 2.87 1.48.5.57
Drank wine 2.60 1.51. 4.47
Drank spirits 2.33 1.43.3.79
Induced abortion experience 2.55 1.55.4.19
Age at first pregnancy 2.49 1.55 4.00
Number of babies breastfed 2.62 1.62.4.23
NumberofPaosmears 2.66 1.54.4.59
Fr~uencyofPapsmears 1.93 1.18.3.16
Ever used OCs 7.17 2.67.19.24
Ever used lOOs 2.52 1.57.4.03
Ever used condoms 2.23 1.38.3.60
Ever practised of withdrawal method 2.41 1.50.3.87
Number of sexual partners 1.91 1.14.3.21
Age at first intercourse 2.32 1.44.3.74
Table 4.13. Odds ratios of variable ever had any vaginal discharge,
for in-situ cervical cancer cases with hospital controls.
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4.3.7. Age at in-st pregnancy.
Women who had their fIrst pregnancy at less than 20 years had twice
the chance of developing in-situ cervical cancer compared to nulliparous
women. Even though there was a trend over the three categories specifIed in "
this variable, the effect of age at fIrst pregnancy became non sognifIcant after
allowing for number of sexual partners. This effect also became non
signifIcant after allowing for age at fIrst intercourse, STD history, ever had
any vaginal discharge, induced abortion experience and ever used of oral
contraceptives (Table 4.14).
Thus even though early age at fIrst pregnancy has some independent
effect as a potential risk factor for in-situ cervical cancer most of this effect is
accounted for by the sexual factors.
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Table 4.14. Odds ratios of variable age at first pregnancy for in-situ cervical
cancer cases with hospital controls.
CONTROL VARIABLE AGE AT FIRST PREGNANCY
(OR and 95% Cl)
Nulliparous :> = 20 years < 20 years
Crude 1.00 1.44 2.03
(0.80, 2.62) (1.05.3.93)
Self education 1.00 1.58 2.51
(0.85, 2.91) (1.26. 4.99)
Spouse education 1.00 1.39 2.06
(0.75, 2.59) (1.04. 4.08)
Ever had STD 1.00 1.44 1.91
(0.79,2.63) (0.98,3.74)
Ever had vaginal discharge 1.00 1.48 1.95
(0.80,2.73) (0.99, 3.85)
Drank wine 1.00 1.51 2.44
(0.82,2.78) (1.23. 4.85)
Drank spirits 1.00 1.56 2.28
(0.84, 2.90) (1.15. 4.54)
Induced abortion exp~rience 1.00 1.05 1.02
(0.57, 1.95) (0.48, 2.13)
Number of babies breastfed 1.00 1.40 2.06
(0.72,2.71) (0.98, 4.32)
Number of Pap smears 1.00 1.82 2.56
(0.93, 3.59) (1.21. 5.41)
Frequency of Pap smears 1.00 1.13 1.61
(0.60, 2.13) (0.79,3.25)
Ever used OCs 1.00 1.23 1.61
(0.66, 2.28) (0.82,3.17)
Ever used lOOs 1.00 1.45 2.03
(0.79,2.66) (1.03. 4.00)
Ever used condoms 1.00 1.36 1.98
(0.74,2.51) (1.01. 3.89)
Ever practised of withdrawal method 1.00 1.40 1.99
(0.77,2.57) (1.02 3.88)
Number of sexual partners 1.00 1.73 1.75
(0.89, 3.35) (0.85, 3.62)
Age at first intercourse 1.00 1.33 1.27
(0.72, 2.44) (0.62, 2.61)
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4.3.8. Number of babies breastfed.
The effect of number of babies breastfed did not show a linear trend
across the specified categories (Table 4.15). The only significant effect was
found when women had one baby breastfed. It shows that women with one
baby breastfed had six times the chance of developing in-situ cervical cancer
compared to women who had four or more babies breastfed.
Even though the effect of number of babies breastfed at the category of .
one pregnancy still persists after allowing for most of the variables, this effect
became non significant after allowing for the number of sexual partners and
ever used of oral contraceptives.
Thus even though the effect of number of babies breastfed has some
independent effect as a potential risk factor most of this effect is also
accounted for by the number of sexual partners.
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CONTROL VARIABLE NUMBER OF BABIES BREASTFED
(OR and 95% Cl)
>=4'" 3 preg 2 preg 1 preg Nopreg/nob
preg reastfed
Crude 1.00 3.39 2.16 6.13 2.74
0.64, 18.0 0.43, 10.70 1.28.29.30 0.60, 12.57
Self education 1.00 3.09 1.92 5.68 2.47
0.56, 16.89 0.38,9.85 1.15.27.98 0.52, 11.65
Spouse education 1.00 2.67 1.73 4.96 2.57
0.50,14.27 0.34,6.68 1.03.23.88 0.56, 11.83
Ever had STD 1.00 3.39 2.17 5.82 2.70
0.64, 18.02 0.44,10.75 1.21,27.88 0.59, 12.37
Ever had vaginal discharge 1.00 3.19 2.03 6.33 2.65
0.59, 17.35 0.40, 10.32 1.29,31.06 0.57, 12.38
Drank wine 1.00 3.14 1.95 6.10 2.59
0.57,17.20 0.38,9.94 1.24,29.90 0.55, 12.15
Drank spirits 1.00 3.95 2.27 7.12 2.77
0.72,21.65 0.45, 11.57 1.44.35.11 0.59, 13.05
Age at first pregnancy 1.00 3.79 2.31 6.46 3.65
0.70,20.35 0.46, 11.58 1.33,31.32 0.77, 17.28
Induced abortion experience 1.00 2.98 2.13 5.66 2.98
0.50, 18.01 0.38, 11.82 1.05,30.52 0.58, 15.23
Number of Pap smears 1.00 6.64 3.16 8.55 3.85
1.08.40.68 0.57, 17.49 1.59 45.98 0.76, 19.56
Frequency of Pap smears 1.00 2.83 1.76 5.56 3.04
0.52, 15.52 0.34,9.00 1.12.27.50 0.64, 14.39
Ever used OCs 1.00 2.64 1.75 4.58 2.42
0.48, 14.63 0.34,8.98 0.92,22.71 0.51, 11.45
Ever used IUDs 1.00 3.38 2.15 6.10 2.75
0.64, 17.95 0.43, 10.67 1.27,29.21 0.60, 12.60
Ever used condoms 1.00 3.06 1.91 5.75 2.48
0.57, 16.48 0.38,9.59 1.19,27.90 0.53, 11.50
Ever practised withdrawal method 1.00 3.25 1.94 5.93 2.63
0.61, 17.41 0.39,9.70 1.23,28.48 0.57, 12.08
Number of sexual partners 1.00 2.72 1.73 5.16 2.15
0.46, 16.01 0.31,9.47 0.98,27.10 0.43, 10.75
Age at first intercourse 1.00 4.62 2.56 7.61 3.87
0.84,25.28 0.51, 12.96 1.56.37.19 0.82, 18.16
reference group
Table 4.15. Odds ratios for variable number of babies breastfed for in-situ
cervical cancer cases with hospital controls.
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4.3.9. Induced abortion experience.
Women who had ever had induced abortion had nine times the chance
of developing in-situ cervical cancer compared to women who had never had
any induce abortion (Table 4.16). This effect persists after allowing for all of
the variables considered in the analysis including number of sexual partners,
age at first intercourse, education levels (self and spouse), ever had any STD,
ever had any vaginal discharge, age at first pregnancy, number of babies
breastfed, pap smear variables (number of pap smears and frequency of pap
smears) and contraceptive practices including ever used of oral contraceptives,
use of ruDs, use of condoms or ever practiced of withdrawal method.
Thus induced abortion experience variable has an independent effect as
a risk factor for in-situ cervical cancer in this study population.
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CONTROL VARIABLE INDUCED ABORTION
EXPERIENCE
OR 95% Cl
Crude 9.08 4.28.19.25
Self education 8.62 4.04,18.40
Spouse education 10.19 4.66,22.30
Ever had STD 8.96 4.20.19.09
Ever had vaginal discharge 9.10 4.24.19.53
Drank wine 8.67 4.03.18.62
Drank spirits 8.59 4.00,18.44
Age at first pregnancy 9.05 4.U.19.88
Number of babies breastfed 8.66 4.03.18.62
Number of Pap smears 11.63 4.57,29.57
Frequency of Pap smears 8.82 4.04.19.24
Ever used OCs 7.63 3.59.16.24
Ever used rUDs 9.36 4.37 20.01
Ever used condoms 8.14 3.83, 17.31
Ever practised of withdrawal method 9.07 4.25.19.38
Number of sexual partners 6.44 2.94.14.11
Age at first intercourse 8.28 3.85.17.82
Table 4.16. Odds ratios for variable induced abortion experience
of in-situ cervical cancer cases with hospital controls.
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4.3.10. Pap smears.
The analysis of Pap smears variables in this study is subject to selection
1
bias since the cases were recruited from colposcopy clinics or hospitals whilst nO .
this method of recruitment was not applied for the controls. Thus it is more
likely that cases have ever been exposed to Pap smears more often compared
to controls.
Even though the logistic regression analysis of number of Pap smears
and frequency of Pap smears variables are presented in Table 4.17 and Table
7
4.18, these variables are not considered in the subsequent analysis. {;t>h.';j •
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reference group
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Table 3.32. Odds ratios for variable number of Pap smears for in-situ cervical
cancer cases with hospital controls.
CONTROL VARIABLE NUMrnERSOFPAPSMEARS
(OR and 95% Cl)
> = 4 times 3 times 2 times 0-1 time
Crude 1.00 42.73 77.64 17.15
9.18, 198.89 17.51. 344.24 4.00,73.59
Self education 1.00 44.63 85.67 18.21
9.51. 209.37 19.06.384.99 4.21 78.82
Spouse education 1.00 47.25 101.84 22.61
9.80.227.86 22.15 468.19 5.06 101.08
Ever had STD 1.00 4.33 77.24 16.77
1.01.18.65 17.40.342.91 3.90,72.09
Ever had vaginal discharge 1.00 49.96 80.41 21.12
9.94, 221.96 17.93,360.55 4.84 92.10
Drank wine 1.00 42.18 82.99 18.66
9.01, 197.48 18.56, 371.11 4.33,80.48
Drank spirits 1.00 39.82 75.43 17.79
8.47, 187.20 18.86, 187.19 4.11.77.03
Age at first pregnancy 1.00 43.01 86.73 19.46
9.20, 201.05 19.41,387.47 4.50.84.17
Induced abortion experience 1.00 62.60 29.78 1.38
7.63. 513.67 5.36. 165.78 36.25
Number of babies breastfed 1.00 46.53 84.34 18.59
9.88,219.21 18.76, 379.30 4.29 80.60
Frequency of Pap smears 1.00 42.88 77.44 98.66
9.22, 199.46 17.42,344.19 20.68. 470.59
Ever used OCs 1.00 44.49 76.29 23.85
9.49. 208.66 17.17.339.09 5.50. 103.44
Ever used IUDs 1.00 44.97 80.90 18.10
9.61, 210.50 18.18,360.02 4.20,78.07
Ever used condoms 1.00 49.24 91.79 21.16
10.36. 234.17 20.27 415.70 4.85.92.42
Ever practised withdrawal method 1.00 45.82 77.65 17.61
9.79,214.54 17.43,345.96 4.08 75.89
Number of sexual partners 1.00 44.54 61.27 19.12
9.18, 216.07 13.52,277.62 4.36 83.84
Age at first intercourse 1.00 40.53 75.05 17.50
8.65 189.88 16.84, 334.40 4.06,75.37
...
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Table 4.18. Odds ratios for variable frequency of Pap smears of in-situ
cervical cancer cases with hospital controls.
CONTROL VARIABLE FREQUENCY OF PAP SMEARS
(OR and 95% Cl)
< 1 x /5years 1 x /1-5 years > 1 x/year
*or never
Crude 1.00 5.58 3.39
(2.89 10.78) (1.43, 8.02)
Self education 1.00 5.79 3.55
(2.94, 11.42) (1.47, 8.56)
Spouse education 1.00 5.85 3.54
(2.96. 11.55) (1.46, 8.56)
Ever had STD 1.00 5.74 3.40
(2.95, 11.19) (1.42, 8.15)
Ever had vaginal discharge 1.00 4.70 2.81
(2.41, 9.17) (1.16,6.75)
Drank wine 1.00 5.43 3.16
(2.79 10.59) (1.32, 7.56)
Drank spirits 1.00 5.30 3.38
(2.71. 10.37) (1.40. 8.14)
Age at first pregnancy 1.00 5.35 3.04
(2.75, 10.40) (1.26, 7.33)
Induced abortion experience 1.00 5.69 2.68
(2.48. 13.08) (0.88, 8.13)
Number of babies breastfed 1.00 5.67 3.34
(2.90, 11.06) (1.37, 8.11)
Frequency of Pap smears 1.00 16.82 12.99
(6.92. 40.89) (4.21. 40.04)
Ever used DCs 1.00 4.11 2.53
(2.08, 8.11) (1.05 6.09)
Ever used rUDs 1.00 5.65 3.49
(2.91 10.97) (1.45. 8.41)
Ever used condoms 1.00 5.00 2.74
(2.57.9.72) (1.13. 6.63)
Ever practised withdrawal method 1.00 5.57 3.11
(2.88, 10.70) (1.30, 7.45)
Number of sexual partners 1.00 4.39 2.63
(2.16 8.90) (1.05. 6.60)
Age at first interc·ourse 1.00 5.33 2.90
(2.75, 10.33) (1.21, 6.94)
...
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4.3.11. History of contraceptive practices.
Four variables of contraceptive practices including ever used of oral
contraceptives, ever used of IUDs, ever used of condoms and ever practiced
of withdrawal method were considered in this analysis (Table 4.19, Table
4.21, Table 4.22, Table 4.23 respectively). From these four variables ever
used of oral contraceptives, ever used of condoms and ever practiced of
withdrawal method showed a significant increas~ in the chance of developing
in-situ cervical cancer.
Women who had ever used of oral contraceptives (QC) had seven times
the chance of developing in-situ cervical cancer compared to women who had
never used of oral contraceptives. The effect of oral contraceptive persists
after controlling for another variables including number of sexual partners, age.
at first intercourse, years of education (self and spouse), drinking habit
including wine and spirits, medical history of sexually transmitted disease and
vaginal discharge, reproductive variables including age at first pregnancy,
number of babies breastfed, induced abortion experience and Pap smear
history (number and frequency of Pap smears).
Investigation on the total duration of used of QC revealed that the
effect increased with the duration og used of QC. Women who had ever used
of QC for more than 72 months had a four times the chance of developing in-
situ cervical cancer compared to women who had never used of QC. The
analysis of total duration of QC used also showed a linear trend in the effect.
The effect of total duration of QC use still persists after allowing for the
number of sexual partners. Thus, it may be concluded that total duration of
QC use has an independent effect as a risk factor for in-situ cervical cancer in
this study population.
Women who had ever used of condoms had a two times chance of
developing in-situ cervical cancer compared to women who had never used of
122
')f volue .
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
condoms (Table 4.22). This effect still persists after allowing for all of the
variables including number of sexual partners, age at first intercourse, years of
education (self and spouse), medical history of sexually transmitted disease
and vaginal discharge, reproductive variables including age at first pregnancy,
number of babies breastfed, induced abortion experience, Pap smear history
(number and frequency of Pap smears), ever used of QC and ever practiced
of withdrawal method.
Thus as well as QC use, ever use of condom shows to be an
independent riak factor for in-situ cervical cancer in this study population.
Women who had ever practiced of withdrawal method had a two times
the chance of developing in-situ cervical cancer compared to women who had
never practiced of withdrawal method (Table 3.38). But this effect became
non significant after allowing for the sexual factors including number of sexual
partners and age at first intercourse. Thus even though ever practice of
withdrawal method has some independent effect as a potential risk factor for
in-situ cervical cancer most of this effect is also accounted for by the sexual
factors.
Thus as a conclusion ever used of QCs and ever used of condoms are
considered as independent risk factors for in-situ cervical cancer and thus are
retained in the subsequent analysis.
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CONTROL VARIABLE EVER USED OF ORAL
CONTRACEPTIVES
OR 95% Cl
Crode 7.68 2.91.20.28
Self education 7.20 2.70.19.20
Spouse education 7.57 2.85,20.12
Ever had STD 7.55 2.85,20.00
Ever had vaginal discharge 7.17 2.67.19.24
Drank wine 6.90 2.6.18.28
Drank spirits 7.27 2.71,19.51
Age at first pregnancy 7.21 2.71.19.51
Number of babies breastfed 6.99 2.63 18.60
Number of Pap smears 7.83 2.85,21.49
Frequency of Pap smears 4.87 1.76,13.47
Induced abortion experience 6.44 2.30,17.37
Ever used IUD 7.70 2.91,20.37
Ever used condom 7.51 2.82.20.03
Ever practise withdrawal method 7.89 2.97.20.97
Number of sexual partners 5.69 2.05,15.82
Age at first intercourse 6.78 2.54,18.10
Table 4.19. Odds ratios for variable ever used of OC for in-situ
cervical cancer cases with hospital controls.
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cervical cancer cases with hospital controls.
reference group
Table 4.20. Odds ratios for variable total duration of OC use for in-situ
CONTROL VARIABLE TOTAL MONTHS OF OC USE
(OR and 95% Cl)
Never used· < = 24 25 -72 > 72 months
months months
Crude 1.00 1.59 3.02 3.89
(0.70, 3.63) (1.35 6.75) (1.86 8.15)
Self education 1.00 1.42 2.90 3.62
(0.61, 3.29) (1.28. 6.57) (1.70 7.68)
Spouse education 1.00 1.45 2.96 4.00
(0.62. 3.36) (1.30.6.74) (1.87 8.54)
Ever had STD 1.00 1.68 2.88 3.93
(0.73. 3.86) (1.27. 6.49) (1.87, 8.27)
Ever had vaginal discharge 1.00 1.60 2.61 3.43
(0.69,3.70) (1.14, 5.98) (1.61,7.31)
Drank: wine 1.00 1.60 2.81 3.41
(0.70. 3.66) (1.25. 6.34) (l.61 7.22)
Drank spirits 1.00 1.58 2.83 3.55
(0.68. 3.67) (1.24, 6.43) (1.66. 7.58)
Age at first pregnancy 1.00 1.47 2.77 3.62 .
(0.64. 3.41) (1.22, 6.25) (1.71, 7.65)
Induced abortion experience 1.00 1.38 2.83 3.30
(0.57,3.29) (1.22. 6.54) (1.52.7.15)
Numbers of pregnancy breastfed 1.00 1.45 2.62 3.65
(0.62. 3.36) (1.16. 5.95) (1.73.7.71)
NumberofPapsmea~ 1.00 1.75 2.89 4.07
(0.72. 4.21) (1.18. 7.06) (1.81 9.17)
Frequency of Pap smea~ 1.00 1.18 1.83 2.36
(0.49.2.81) (0.77,4.31) (1.07 5.23)
Ever used 100 1.00 1.55 2.95 3.87
(0.67,3.58) (1.31, 6.65) (1.85 8.11)
Ever used condom 1.00 1.61 2.88 3.83
(0.69.3.71) (1.27. 6.54) (1.81. 8.10)
Ever practise withdrawal method 1.00 1.57 3.00 4.15
(0.68 3.62) (1.33. 6.76) (1.96,8.76)
Number of sexual partners 1.00 1.44 1.76 2.98
(0.59, 3.52) (0.73,4.24) (1.34. 6.63)
Age at first intercourse 1.00 1.51 2.52 3.43
(0.65. 3.94) (1.11. 5.74) (1.62.7.25)
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CONTROL VARIABLE EVER USED OF ANY IUDs
OR 95% Cl
Crude 1.12 0.65, 1.92
Self education 1.10 0.63, 1.90
Spouse education 0.96 0.55, 1.69
Ever had STD 1.11 0.65, 1.93
Ever had vaginal discharge 1.03 0.59, 1.80
Drank wine 1.04 0.60, 1.82
Drank spirits , 1.08 0.62, 1.88
Age at first pregnancy 0.99 0.57, 1.74
Number of babies breastfed 1.04 0.59, 1.82
NumberofPapsmea~ 1.42 0.75,2.69
Frequency ofPap smears 0.91 0.52, 1.62
Induced abortion experience 0.85 0.47, 1.54
Ever used of OCs 0.98 0.56, 1.69
Ever used of condoms 1.08 0.62, 1.88
Ever practised withdrawal method 1.09 0.63, 1.89
Number of sexual partners 0.81 0.45, 1.49
Age at first intercourse 1.09 0.63, 1.91
Table 4.21. Odds ratios for variable ever used of IUDs for
in-situ cervical cancer cases with hospital controls.
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CONTROL VARIABLE EVER USED OF CONDOMS
OR 95% Cl
Crode 2.61 1.57,4.33
Self education 2.35 1.40,3.96
Spouse education 2.28 1.35.3.86
Ever had STD 2.58 1.55,4.29
Ever had vaginal discharge 2.26 1.34.3.80
Drank wine 2.53 1.51. 4.23
Drank spirits 3.U 1.83.5.31
Age at first pregnancy 2.58 1.55 4.30
Number of babies breastfed 2.64 1.57.4.43
NumberofPapsm~rs 2.35 1.82,6.15
Fr~uencyofPapsm~rs 2.21 1.30,3.75
Induced abortion experience 2.29 1.34,3.91
Ever used of OCs 2.53 1.50.4.27
Ever used of IUDs 2.60 1.57.4.32
Ever practised withdrawal method 2.35 1.37.4.04
Number of sexual partners 2.12 1.22.3.70
Ageatfirstmte~ourse 2.43 1.45.4.08
Table 4.22. Odds ratios for variable ever used of condoms for
in-situ cervical cancer cases with hospital controls.
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CONTROL VARIABLE EVER PRACTISED OF
WITHDRAWAL :METHOD
OR 95% Cl
Crude 1.93 1.11.3.36
Self education 1.81 1.03.3.19
Spouse education 2.00 1.13.3.55
Ever had STD 1.88 1.08.3.29
Ever had vaginal discharge 1.75 0.99,3.08
Drank wine 1.93 1.10.3.37
Drank sPirits 2.09 1.18.3.68
Age at first pregnancy 1.90 1.09.3.31
Number of babies breastfed 1.99 1.13.3.50
Number of Pap smears 2.00 1.06.3.79
Frequency of Pap smears 1.95 1.10.3.79
Induced abortion experience 1.90 1.06.3.43
Ever used of OCs 2.02 1.14 3.59
Ever used of IUDs 1.93 1.11.3.35
Ever used of condoms 1.40 0.77,2.56
Number of sexual partners 1.58 0.86, 2.89
Age at first intercourse 1.65 0.93,2.95
Table 4.23. Odds ratios for variable ever practiced of
withdrawal method for in-situ cervical cancer
cases with hospital controls.
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4.3.12. Conclusion.
The logistic regression analysis for the potential risk factors for in-situ
cervical cancer with hospital controls is presented in this chapter. The crude
and adjusted odds ratios as well as 95 % confidence intervals are listed in Table
4.6 to Table 4.23.
As the result of the analysis variables including number of sexual
partners, age at first intercourse, education levels (self and spouse), drinking
habit (wine and spirits), ever had any vaginal discharge, induced abortion
experience, ever used of oral contraceptives, total duration of oral
contraceptive use and ever used of condoms are identified as the independent
risk factors for in-situ cervical cancer in this study population. Thus all these
variables are included in the analysis of smoking variables (chapter 5).
4.4. Multiple logistic regression on invasive cervical cancer.
The logistic regression analysis of the identified potential risk factors
for invasive cervical cancer (chapter 3.4) is presented in this chapter. These
variables are number of sexual partners, age at first intercourse, occupation
(self and spouse), marital status, age at first marriage, beer drinking habit,
reproductive variables including pregnancy status, age at first pregnancy, age
at first livebirth, age at first breastfeeding, number of total pregnancies,
number of babies breastfed, and total months of breastfeeding, and Pap smear
history (number of Pap smears and frequency of Pap smears).
The crude and adjusted odds ratio as well as 95 % confidence intervals
for these variables are presented in Table 4.24 to Table 4.39
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4.4.1. Number of sexual partners.
Number of sexual partners did not seem to be a major risk factor for
invasive cervical cancer in this study population (Table 4.24). Across the four
categories of number of sexual partners only category of 2-3 sexual partners
showed a significant increase of the chance of developing invasive cervical
cancer. Women who had ever had 2-3 sexual partners had twice (p < 0.05)
the chance of developing invasive cervical cancer compared to women with 0-
1 sexual partner. This effect became non significant afteradjustment for the
age at first intercourse, age at first pregnancy and age at first livebirth. Thus
even though the effect of number of sexual partners has some independent
effect as a potential risk factor most of this effect is also accounted for by the
age at first intercourse.
Since the measure of association still persists and also there is an a
priori reason for its effect, number of sexual partners is retained together with
age at first intercourse when sexual factors are considered as potential
confounders in the subsequent analysis.
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reference group
Table 4.24. Odds ratios of variable number of sexual partners for invasive
cervical cancer cases with hospital controls.
CONTROL VARIABLE NUMBER OF SEXUAL PARTNERS
OR AND 95% Cl
0-1 partner· 2-3 partners 4-6 partners > =7 partners
Crude 1.00 2.26 0.96 1.00
(1.24, 4.13) (0.35, 2.68) (0.33, 3.09)
Marital status 1.00 1.94 0.86 0.93
(1.04 3.61) (0.30, 2.45) (0.29, 3.05)
Age at first marriage 1.00 1.95 1.03 1.09
(1.05. 3.62) (0.36, 2.90) (0.35, 3.42)
Self occupation 1.00 2.39 1.15 1.00
(1.29. 4.41) (0.41, 3.25) (0.32,3.15)
Spouse occupation 1.00 2.09 0.95 1.09
(1.14, 3.85) (0.34, 2.65) (0.35, 3.41)
Beer drinking habit 1.00 2.07 0.90 0.87
(1.13 3.82) (0.32, 2.51) (0.28,2.73)
Ever pregnant 1.00 2.00 0.87 0'.99
(1.08. 3.68) (0.31, 2.47) (0.32,3.11)
Age at first pregnancy 1.00 1.59 0.86 0.94
(0.84, 3.01) (0.30, 2.47) (0.29, 3.03)
Age at first livebirth 1.00 1.76 0.99 0.98
(0.93, 3.32) (0.34, 2.83) (0.30,3.12)
Age at fisrt breastfeeding 1.00 2.11 1.00 0.99
(1.13.3.92) (0.37, 2.82) (0.32,3.11)
Number of total pregnancies 1.00 1.91 1.04 1.09
(1.03, 3.54) (0.36, 2.97) (0.35, 3.47)
Number of babies breastfed 1.00 2.17 0.98 1.06
(1.18. 4.00) (0.35, 2.75) (0.34, 3.30)
Total months of breastfeeding 1.00 2.22 0.86 1.01
(1.21. 4.09) (0.30, 2.44) (0.32,3.16)
Number of Pap smears 1.00 2.62 1.00 1.06
(1.40, 4.90) (0.35, 2.80) (0.34, 3.32)
Frequency of Pap smears 1.00 2.78 1.09 1.08
(1.48. 5.22) (0.39, 3.09) (0.34, 3.37)
Age at first intercourse 1.00 1.7 0.79 0.66
(0.90, 3.21) (0.28, 2.25) (0.20, 2.22)
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4.4.2. Age at flrst intercourse.
Women who had their first intercourse at age less than 16 years had
four times the chance of developing invasive cervical cancer compared to
women who had their first intercourse at the age more than 24 years. The four
times increase in the chance of developing invasive cervical cancer was also
found significant in the category of 16-19 years. This effect of age at first
intercourse still persists after adjustment for the number of sexual partners
(Table 4.25). Thus the effect of age at first intercourse is independent from the
effect of number of sexual partners.
The effect of age at first intercourse became non significant after
allowing for reproductive variables, namely pregnancy status, age at first
pregnancy, age at first livebirth and number of total pregnancies. Thus even
though the effect of early age at first intercourse has some independent effect
as a potential risk factor for inavsive cervical cancer most of this effect is also
accounted for by the reproductive variables. Since the masure of association
still persists and there is an a priori reason for its effect, age at first
intercourse is retained together with number of sexual partners when sexual
factors are considered as potential confounders in subsequent analysis.
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CONTROL VARIABLE AGE AT FIRST INTERCOURSE
OR AND 95% Cl
>24 years· 20-24 years 16-19 years < 16 years
Crode 1.00 2.56 4.33 3.99
(0.93, 7.07) (1.61. 11.68) (1.09. 14.61)
Marital status 1.00 1.73 2.70 2.70
(0.60, 5.05) (0.94,7.74) (0.70, 10.41)
Age at first marriage 1.00 2.05 3.53 3.47
(0.55, 7.71) (0.92, 13.61) (0.74, 16.24)
Self occupation 1.00 2.47 4.05 3.65
(0.89, 6.88) (1.49, 11.02) (0.98, 13.58)
Spouse occupation 1.00 1.96 3.26 3.13
(0.68, 5.61) (1.16. 9.17) (0.83, 11.85)
Beer drinking habit 1.00 2.47 4.02 3.69
(0.89, 6.85) (1.48, 10.89) (1.00, 13.64)
Ever pregnant 1.00 1.47 2.45 2.31
(0.50, 4.28) (0.85, 7.02) (0.60, 8.90)
Age at first pregnancy 1.00 0.91 0.86 0.83
(0.27,3.05) (0.24, 3.12) (0.17,3.91)
Age at first livebirth 1.00 1.46 1.37 1.25
(0.47, 4.56) (0.41, 4.56) (0.28, 5.52)
Age at fisrt breastfeeding 1.00 2.08 3.40 3.21
(0.73,5.98) (1.18,9.76) (0.83, 12.42)
Number of total pregnancies 1.00 1.52 2.34 2.30
(0.52, 4.49) (0.80, 6.87) (0.59, 8.97)
Number of babies breastfed 1.00 2.12 3.64 3.33
(0.75, 6.05) (1.31, 10.01) (0.88, 12.58)
Total months of breastfeeding 1.00 2.23 3.67 3.27
(0.79,6.24) (1.33, 10.11) (0.87, 12.27)
Number of Pap smears 1.00 2.68 4.65 3.79
(0.95, 7.51) (1.71. 12.67) (1.03. 14.03)
Frequency of Pap smears 1.00 2.78 1.09 1.08
(1.48, 5.22) (0.39, 3.09) (0.34, 3.37)
Number of sexual partners 1.00 2.40 3.72 4.52
(0.86, 6.69) (1.34 10.37) (1.14 17.85)
reference group
Table 4.25. Odds ratios of variable age at first intercourse for invasive
cervical cancer cases with hospital controls.
133
I
I
I
I'
t
I
:1
I
I
I
I
I,
I1
I
I
I
I
I
I
I
,:
4.4.3. Occupations.
Occupational variables including self occupation and spouse
occupation, as one of the indicator for socio-economic status are presented in
Table 4.26 and Table 4.27 respectively.
Women who were employed in unskilled occupation had two times the
chance of developing invasive cervical cancer compared to unmarried or
housewife. The effect still persists after allowing for number of sexual
partners, age at first intercourse and reproductive variables (Table 4.26). For
women who were employed in skilled occupation, there was no significant
effect of occupation towards the chance of developing invasive cervical
cancer. Thus unskilled self occupation has some independent effect as a
potential risk factor for invasive cervical cancer. As such this variable is
retained as a potential confounder in subsequent analysis.
Women with spouse who were employed in unskilled occupation as
well as skilled occupation had three times the chance of developing invasive
cervical cancer compared to unmarried or unemployed women (Table 4.27).
The effect of spouse occupation became non significant afetr allowing for
pregnancy status and age at first pregnancy. Thus the effect of spouse
occupation is confounded with the effect of pregnancy status and age at first
pregnancy.
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CONTROL VARIABLE OCCUPATION OF SELF
OR AND 95% Cl
Housewife/ Unskilled Skilled
* occupation occupationunemployed
Crude 1.00 1.93 0.85
(1.04, 3.59) (0.44, 1.66)
Spouse occupation 1.00 2.06 0.98
(1.10, 3.84) (0.50, 1.93)
Marital status 1.00 2.06 1.00
(1.10, 3.86) (0.51, 1.96)
Age at first marriage 1.00 2.02 1.05
(1.08, 3.79) (0.53, 2.07)
Beer drinking habits 1.00 1.97 0.88
(1.05, 3.68) _(0.45, 1.73)
Ever pregnant 1.00 2.17 1.10
(1.16, 4.06) (0.56, 2.16)
Age at first pregnancy 1.00 2.11 1.30
(1.11, 4.01) (0.65, 2.60)
Age at first livebirth 1.00 2.05 1.27
(1.08, 3.90) (0.63, 2.57)
Age at fisrt breastfeeding 1.00 1.86 0.94
(0.99, 3.49) (0.48, 1.86)
Number of total pregnancies 1.00 2.13 1.04
(1.13, 4.01) (0.53, 2.05)
Number of babies breastfed 1.00 1.99 0.91
(1.06, 3.73) (0.46, 1.79)
Total months of breastfeeding 1.00 2.09 0.95
(1.11, 3.94) (0.48, 1.87)
Number of Pap smears 1.00 1.86 0.79
(0.99, 3.48) (0.40, 1.56)
Frequency ofPap smears 1.00 1.81 0.85
(0.97,3.38) (0.43, 1.66)
Number of sexual partners 1.00 2.08 0.91
(1.10 3.94) (046, 1.78)
Age at first intercourse 1.00 1.94 0.96
(1.04 3.63) (0.49, 1.88)
reference group
Table 4.26. Odds ratios of variable self occupation for invasive cervical cancer
cases with hospital controls.
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CONTROL VARIABLE OCCUPATION OF SPOUSE
OR AND 95% Cl
Unmarriedl Unskilled Skilled
* occupation occupationunemployed
Crude 1.00 3.17 2.89
(1.39. 9.67) (1.13. 7.40)
Self occupation 1.00 3.37 3.04
(1.25. 9.01) (1.19,8.04)
Marital status 1.00 0.88 0.79
(0.22, 3.53) (0.21, 3.03)
Age at first marriage 1.00 1.37 1.16
(0.27,6.88) (0.24, 5.64)
Beer drinking habits 1.00 3.58 2.94
(1.35. 9.49) (1.14. 7.57)
Ever pregnant 1.00 1.72 1.38
(0.60, 4.98) (0.49, 3.87)
Age at first pregnancy 1.00 1.30 1.24
(0.43, 3.91) (0.43, 3.62)
Age at first livebirth 1.00 1.78 1.75
(0.60, 5.31) (0.61~ 5.00)
Age at first breastfeeding 1.00 2.95 2.47
(1.08. 8.11) (0.93, 6.56)
Number of total pregnancies 1.00 1.85 1.55
(0.64, 5.37) (0.55, 4.34)
Number of babies breastfed 1.00 3.20 2.48
(1.17.8.72) (0.94, 6.56)
Total months of breastfeeding 1.00 3.22 2.60
(1.20. 8.62) (1.00, 6.72)
Number of Pap smears 1.00 3.94 3.43
(1.45 10.70) (1.29. 9.11)
Frequency of Pap smears 1.00 4.38 4.07
(1.61. 11.96) (1.52, 10.89)
Number of sexual partners 1.00 3.36 2.62
(1.26. 8.92) (1.10. 6.78)
Age at first intercourse 1.00 2.60 2.19
(0.94,7.16) (0.82,5.83)
reference group
Table 4.27. Odds ratioof variable spouse occupation for invasive cervical
cancer cases with hospital controls.
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4.4.4. Marital status and age at first marriage.
Married women had five times the chance of developing invasive
cervical cancer compared to never married women. While women who
divorced or widowed the chance was nine times and eight times respectively of
developing invasive cervical cancer compared to never married women (Table
4.28). The effect of marital status still persists after allowing for number of ,
sexual partners and age at first intercourse. After adjustment for reproductive
variables including pregnancy status and age at first pregnancy, the effect of
marital status became non significant.
Thus even though marital status has some independent effect as a
potential risk factor most of this effect is also accounted for by reproductive
variables. Since the measure of association still persists marital status is
retained as a potential confounder in subsequent analysis.
Women who had their first marriage at age less than 20 years had five
times the chance of developing invasive cervical cancer compared to women
who never married. Women who first married at age 20-24 years old the
chance was three times compared to never married women (Table 4.29).
Most of the effect of age at first marriage became non significant after
adjusting for reproductive variables and age at first intercourse. Thus even
though the effect of early age at first marriage has some independent effect as
a potential risk factor most of this effect is also accounted for by reproductive
variables.
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cases with hospital controls.
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Table 4.28. Odds ratios of variable marital status for invasive cervical cancer
CONTROL VARIABLE MARITAL STATUS
OR AND 95% Cl
Never married" Married Divorced Widowed
Crude 1.00 5.02 9.25 8.04
(1.44 17.51) (2.42. 35.43) (1.74.37.14)
Self occupation 1.00 5.10 9.06 8.33
(1.44 18.15) (2.33.35.24) (1.76. 39.41)
Spouse occupation 1.00 6.08 10.94 9.57
(1.02.36.07) (1.62. 73.84) (1.27. 72.00)
Age at first marriage 1.00 overfit
Beer drinking habit 1.00 5.12 9.59 8.31
(1.46. 17.93) (2.49. 36.98) (1.78, 38.88)
Ever pregnant 1.00 2.01 3.77 3.71
(0.48, 8.34) (0.84, 17.01) (0.70, 19.53)
Age at first pregnancy 1.00 1.94 3.09 2.93
(0.45, 8.40) (0.65, 14.63) (0.53, 16.27)
Age at first livebirth 1.00 3.00 4.60 4.08
(0.74, 12.19) (1.04.20.31) (0.77, 21.47)
Age at first breastfeeding 1.00 4.34 7.31 6.92
(1.19. 15.84) (1.82. 29.34) (1.45,33.07)
Number of total pregnancies 1.00 2.48 4.44 4.55
(0.62, 9.98) (1.01, 19.61) (0.89, 23.37)
Number of babies breastfed 1.00 4.31 8.01 7.29
(1.18. 15.02) (2.00. 31.99) (1.53.34.70)
Total months of breastfeeding 1.00 4.21 7.66 7.54
(1.18. 15.02) (1.96 29.98) (1.60, 35.46)
Number of Pap smears 1.00 6.38 11.69 8.75·
(1.76, 23.09) (2.96 46.16) (1.83 41.81)
Frequency ofPap smears 1.00 7.81 13.91 11.67
(2.14.28.47) (3.45. 55.97) (2.41. 56.49)
Number of sexual partners 1.00 4.71 8.00 7.74
(1.34. 16.53) (2.05.31.26) (1.66.36.12)
Age at first intercourse 1.00 3.77 5.97 5.81
(1.02. 13.96) (1.46. 24.28) (1.19. 28.31)
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CONTROL VARIABLE AGE AT FIRST MARRIAGE
OR AND 95% Cl
Never married'" > 24 years 20-24 years < 20 years
Crude 1.00 2.82 3.63 5.46
(0.74, 10.75) (1.16. 11.31) (1.76. 16.99)
Marital status 1.00 overfit
Self occupation 1.00 3.05 3.75 5.29
(0.79, 11.82) (1.18. 11.92) (1.66. 16.84)
Spouse occupation 1.00 2.36 2.95 4.38
(0.31, 17.79) (0.43,20.18) (0.64, 30.11)
Beer drinking habit 1.00 2.94 3.73 5.43
(0.77, 11.27) (1.19. 11.67) (1.73, 17.00)
Ever pregnant 1.00 1.29 1.40 2.14
(0.30, 5.65) (0.37,5.24) (0.58, 7.96)
Age at first pregnancy 1.00 3.16 1.41 0.96
(0.67, 15.05) (0.35, 5.67) (0.23, 3.97)
Age at first livebirth 1.00 3.88 2.33 1.44
(0.89, 16.85) (0.61, 8.90) (0.36,5.80)
Age at first breastfeeding 1.00 2.96 3.01 4.39
(0.74, 11.84) (0.89, 10.13) (1.31. 14.69)
Number of total pregnancies 1.00 1.76 1.77 2.38
(0.42, 7.46) (0.48, 6.44) (0.65, 8.81)
Number of babies breastfed 1.00 2.68 3.02 4.65
(0.68, 10.52) (0.90, 10.05) (1.42. 15.24)
Total months of breastfeeding 1.00 2.65 2.99 4.65
(0.69, 10.21) (0.93, 9.59) (1.45, 14.86)
Number of Pap smears 1.00 3.78 4.52 6.42
(0.95, 14.94) (1.39,14.72) (2.01, 20.55)
Frequency of Pap smears 1.00 4.42 5.45 7.34
(1.11, 17.59) (1.66, 17.89) (2.28, 23.70)
Number of sexual partners 1.00 3.00 3.40 4.82
(0.78, 11.53) (1.08, 10.67) (1.53, 15.20)
Age at first intercourse 1.00 3.40 2.87 2.82
(0.85, 13.67) (0.81, 10.21) (0.78, 10.18)
reference group
Table 4.29. Odds ratios of variable age at first marriage for invasive cervical
cancer cases with hospital controls.
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4.4.5. Drinking habits.
Women who drank beer had twice the chance of developing invasive
cervical cancer compared to women who did not drink beer (Table 4.30). The
effect of this variable still persists after adjustment for marital status, age at
fIrst marriage, occupation (self and spouse), reproductive variables namely
pregnancy status, age at fIrst pregnancy, age at fIrst livebirth, age at fIrst
breastfeeding and total month of breastfeeding, number of total pregnancies,
number of babies breastfed, pap smear (number of Pap smears and frequency
of Pap smears), number of sexual partners and age at fIrst intercourse.
Thus even though there is no a priori reason, beer drinking habit shows
to have an independent effect in developing invasive cervical cancer in this
study population. Thus this variable is retained as a potential confounder in the
subsequent analysis.
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Table 4.30. Odds ratios of beer drinking habit for invasive cervical
cancer cases with hospital controls.
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CONTROL VARIABLE BEER DRINKING HABIT
OR 95% Cl
2.03 1.20 3.43
2.09 1.22 3.57
2.00 1.17 3.41
2.02 1.19 3.44
2.01 1.18 3.42
2.09 1.22 3.58
2.00 1.15 3.47
1.96 1.13 3.38
2.00 1.18 3.39
1.99 1.16 3.41
2.03 1.20 3.46
1.96 1.15 3.33
2.14 1.25 3.64
2.09 1.23 3.56
1.93 1.13 3.29
1.88 1.10 3.20
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4.4.6. Pregnancy status.
Women who had ever pregnant had six times the chance of developing
invasive cervical cancer compared to women who had never pregnant (Table
4.31). The effect varies from fout times to seven times and still persists after
allowing for marital status, age at first marriage, occupation (self and spouse),
beer drinking habit, reproductive variables namely age at first livebirth, age at
first breastfeeding and total month of breastfeeding, number of babies
breastfed, number of sexual partners and age at first intercourse.
Thus it may be concluded that ever pregnant has an independent effect
as a risk factor for invasive cervical cancer in this study population.
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CONTROL VARIABLE EVER PREGNANT
OR 95% Cl
Crude 6.81 2.04.22.72
Marital status 4.67 1.21, 18.05
A~e at first marria~e 5.07 1.29.19.96
Self occupation 6.89 2.04.23.26
Spouse occupation 5.46 1.48,20.18
Beer drinkin~ habit 7.05 2.10.23.69
A~e at first prelmancy overfit
Age at first livebirth 7.73 1.53.39.00
A~e at first breastfeedin~ 6.31 1.79.22.28
Number of total prelmancies overfit
Number of babies breastfed 6.46 1.83.22.74
Total months of breastfeedin~ 5.83 1.71.19.86
Number of Pap smears 8.66 2.54.29.50
Frequency of Pap smears 9.04 2.65.30.86
Number of sexual partners 6.30 1.88.21.15
Age at first intercourse 5.10 1.45. 18.02
Table 4.31. Odds ratios of variable ever pregnant for invasive cervical
cancer with hospital controls.
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4.4.7. Age at first pregnancy.
As well as pregnancy status, age at first pregnancy shows to be a
strong risk factor for invasive cervical cancer in this study population. Women
who had their first pregnancy at age less than 20 years had 12 times the chance
of developing invasive cervical cancer compared to nulliparous women. The
effect of age at first pregnancy persists and remains significant after allowing
for marital status, age at first marriage, self occupation, reproductive variables
namely age at first breastfeeding and total months of breastfeeding, number of
total pregnancies, number of babies breastfed, pap smear (number of Pap
smears and frequency of Pap smears), number of sexual partners and age at
first intercourse (Table 4.32). Significant trend over the four categories
specified; nulliparous, > 24 years old, 20-24 years old and < 20 years old
was also observed.
Thus age at first pregnancy shows to be a strong independent risk
factor for invasive cervical cancer in this study population.
144
cancer cases with hospital controls.
reference group
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Table 4.32. Odds ratios of variable age at fIrst pregnancy for invasive cervical
CONTROL VARIABLE AGE AT FIRST PREGNANCY
OR AND 95% Cl
Nulliparous• > 24 years 20-24 years < 20 years
Crude 1.00 2.40 6.98 12.13
(0.61, 9.40) (2.03. 24.01) (3.47.42.39)
Marital status 1.00 1.79 4.85 8.26
(0.40, 8.05) (1.20. 19.53) (2.03,33.64)
Age at first marriage 1.00 1.62 7.40 16.61
(0.36, 7.22) (1.76. 31.14) (3.66. 75.35)
Self occupation 1.00 3.05 3.75 5.29
(0.79, 11.82) (1.18. 11.92) (1.66. 16.84)
Spouse occupation 1.00 2.36 2.95 4.38
(0.31, 17.79) (0.43,20.19) (0.64,30.11)
Beer drinking habit 1.00 2.52 7.16 12.30
(0.64, 9.99) (2.07, 24.78) (3.49. 43.30)
Ever pregnant 1.00 overfit
Age at first livebirth 1.00 overfit
Age at first breastfeeding 1.00 1.95 5.95 16.61
(0.44, 8.57) (1.50, 23.63) (4.35, 63.33)
Number of total pregnancies 1.00 3.38 9.25 15.95
(0.21, 53.90) (0.61, 140.0) (1.07 238.1)
Number of babies breastfed 1.00 2.51 7.30 12.55
(0.62, 10.14) (1.95.27.29) (3.41. 46.18)
Total months of breastfeeding 1.00 2.35 6.23 11.36
(0.60, 9.24) (1.74. 22.25) (3.19. 40.50)
Number of Pap smears 1.00 2.98 8.94 14.58
(0.75, 11.89) (2.53, 31.55) (4.11, 51.78)
Frequency of Pap smears 1.00 3.12 9.37 15.53
(0.78, 12.50) (2.65. 33.09) (4.35. 55.45)
Number of sexual partners 1.00 2.38 6.76 10.73
(0.60, 9.37) (1.96, 23.33) (3.03 38.08)
Age at first intercourse 1.00 2.45 7.44 13.40
(0.60, 10.03) (1.81. 30.50) (3.03. 59.30)
...
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4.4.8. Age at fIrSt livebirth.
Women who had their frrst livebirth at age less than 20 years had six
times the chance of developing invasive cervical cancer compared to
nulliparous women. Meanwhile women who had their first livebirth at age 20-
24 years the chance was three times compared to nulliparous women (Table
4.33). The effect of age at frrst livebirth still persists especially at the age
group of less than 20 years after allowing for marital status, ag~ at first
marriage, occupation (self and spouse), beer drinking habit, reproductive
variables namely, age at first breastfeeding and total month of breastfeeding,
number of babies breastfed, number of sexual partners and age at first
intercourse.
Thus age at first livebirth has some independent effect as a potential
risk factor for invasive cervical cancer in this study population. The variable
age at first livebirth variable .is considered as a potential confounder in
subsequent analysis.
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CONTROL VARIABLE AGE AT FIRST LIVE BffiTH
OR AND 95% Cl
Nu live birth" > 24 years 20-24 years < 20 years
Crude 1.00 1.21 3.35 6.38
(0.42, 3.50) (1.37. 8.16) (2.54. 15.99)
Marital status 1.00 0.86 2.12 4.03
(0.27, 2.69) (0.79,5.67) (1.47. 11.06)
Age at first marriage 1.00 0.75 2.87 7.47
(0.24, 2.38) (0.99, 8.33) (2.26, 24.70)
Self occupation 1.00 1.31 3.32 6.60
(0.45, 3.82) (1.33, 8.28) (2.55, 17.09)
Spouse occupation 1.00 0.97 2.61 4.94
(0.32,2.99) (0.98,6.96) (1.79,13.62)
Beer drinking habit 1.00 1.19 3.36 6.13
(0.41, 3.47) (1.37, 8.24) (2.43, 15.48)
Ever preJ:mant 1.00 overfit
Age at first pregnancy 1.00 overfit
Age at first breastfeeding 1.00 0.68 2.18 9.81
(0.17,2.77) (0.66, 7.25) (3.34, 28.29)
Number of total pregnancies 1.00 0.58 1.46 2.77
(0.16,2.12) (0.45, 4.74) (0.83, 9.27)
Number of babies breastfed 1.00 1.19 3.18 6.12
(0.28, 3.69) (1.14, 8.92) (2.23, 16.76)
Total months of breastfeeding 1.00 1.14 2.88 5.74
(0.39, 3.33) (1.12,7.43) (2.22, 14.85)
Number of Pap smears 1.00 1.35 3.81 7.00
(0.46, 3.96) (1.53, 9.47) (2.76, 17.74)
Frequency of Pap smears 1.00 1.39 3.93 7.18
(0.47, 4.10) (1.58 9.76) (2.81. 18.30)
Number of sexual partners 1.00 1.24 3.33 5.72
(0.43, 3.60) (1.36. 8.14) (2.26. 14.46)
Age at first intercourse 1.00 1.12 2.88 5.73
(0.38, 3.34) (1.07,7.78) (1.93, 17.00)
reference group
Table 4.33. Odds ratios of variable age at first livebirth for invasive cervical
cancer cases with hospital controls.
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4.4.9. Age at first breastfeeding.
Women who first breastfed at age less than 20 years had twice the
chance of developing invasive cervical cancer. The two times effect also found
in the age group of 20-24 years (Table 4.34). The effect of age at first
breastfeeding became non significant after adjusting for another reproductive
variables namely pregnancy status, age at first pregnancy, age at first
livebirth, number of total pregnancies, number of babies breastfed and total
months of breastfeeding. The effect also became non significant after adjusting
for number of sexual partners and age at first intercourse.
Thus even though age at first breastfeeding has some independent
effect as a potential risk factor for invasive cervical cancer most of this effect
is also accounted for by another reproductive variables.
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CONTROL VARIABLE AGE AT FIRST BREASTFEEDING
OR AND 95% cr
No breastfeed'" > 24 years 20-24 years < 20 years
Crude 1.00 1.12 2.10 2.28
(0.49, 2.58) (1.11, 3.95) (1.01, 5.12)
Marital status 1.00 0.96 1.56 1.59
(0.39,2.13) (0.81, 3.00) (0.69, 3.65)
Age at first marriage 1.00 0.99 1.62 1.40
(0.41, 2.41) (0.82, 3.23) (0.57,3.47)
Self occupation 1.00 1.23 1.96 2.05
(0.53, 2.88) (1.03. 3.73) (0.90, 4.69)
Spouse occupation 1.00 0.95 1.70 1.80
(0.41, 2.21) (0.89, 3.26) (0.79,4.13)
Beer drinking habit 1.00 1.07 2.04 2.19
(0.46, 2.49) (1.08,3.88) (0.97, 4.98)
Ever pregnant 1.00 0.69 1.30 1.40
(0.29, 1.63) (0.67, 2.52) (0.61, 3.22)
Age at first pregnancy 1.00 1.40 1.18 0.50
(0.52, 3.78) (0.51,2.73) (0.19, 1.33)
Age at first livebirth 1.00 2.23 1.61 0.42
(0.66, 7.56) (0.60, 4.32) (0.15, 1.18)
Number of total pregnancies 1.00 0.76 1.25 1.33
(0.32, 1.81) (0.62, 2.48) (0.56,3.17)
Number of babies breastfed 1.00 1.52 2.68 2.80
(0.11,20.81) (0.21, 33.53) (0.23, 33.32)
Total months of breastfeeding 1.00 0.91 1.58 1.80
(0.37, 2.24) (0.72, 3.47) (0.72, 4.54)
NumberofPapsmea~ 1.00 1.31 2.30 2.52
(0.55, 3.09) (1.20, 4.42) (1.10,5.74)
Frequency of Pap smears 1.00 1.43 2.45 2.63
(0.60, 3.39) (1.27. 4.73) (1.14. 6.06)
Number of sexual partners 1.00 1.10 2.03 1.90
(0.47, 2.56) (1.07,3.85) (0.83, 4.37)
Ageatfi~tinte~ou~e 1.00 1.19 1.67 1.46
(0.50,2.81) (0.86, 3.25) (0.61, 3.49)
reference group
Table 4.34. Odds ratios of variable age at first breastfeeding for invasive
cervical cancer cases with hospital controls.
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4.4.10. Number of total pregnancies.
Number ot total pregnancies showed to be one of strong risk factor for
invasive cervical cancer in this study population. Women who had three
pregnancies had seven times the chance of developing invasive cervical cancer
compared to nulliparous women. Women who had more than three
pregnancies the chance was six times compared to nulliparous women (Table
4.35). The effect of number of total pregnancies remains stable across its
categories after allowing for marital status, age at first marriage, occupation
(self and spouse), beer drinking habit, another reproductive variables namely
age at first breastfeeding and total month of breastfeeding, number of babies
breastfed, number of sexual partners and age at first intercourse.
Thus number of total pregnancies has some independent effect as a
potential risk factor for invasive cervical cancer in this study population. This
variable is retained as a potential confounder in subsequent analysis.
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CONTROL VARIABLE NUMBER OF TOTAL PREGNANClES
OR AND 95% Cl
Nulliparous'" 1-2 preg 3 preg > 3 preg
Crude 1.00 3.19 7.75 6.61
(0.91, 11.27) (2.15.27.94) (1.89 23.14)
Self occupation 1.00 3.35 7.98 6.77
(0.94, 11.96) (2.19, 29.11) (1.90, 24.12)
Spouse occupation 1.00 2.57 5.80 5.00
(0.68,9.70) (1.46. 23.03) (1.30. 19.29)
Marital status 1.00 2.15 4.71 4.17
(0.55, 8.37) (1.15 19.30) (1.15 19.30)
Age at first marriage 1.00 2.45 5.17 4.32
(0.63, 9.54) (1.24 21.55) (1.06. 17.61)
Beer drinking habit 1.00 3.06 7.62 6.36
(0.86, 10.85) (2.10.27.58) (1.81, 22.36)
Ever prelmant 1.00 overfit
Age at first prelmancy 1.00 overfit
Age at first livebirth 1.00 2.94 5.21 3.87
(0.62, 13.93) (1.00.27.04) (0.75,20.00)
Age at first breastfeeding 1.00 3.18 7.09 5.91
(0.87, 11.63) (1.85, 27.16) (1.56, 22.43)
Number of babies breastfed 1.00 3.21 7.54 5.83
(0.88, 11.73) (1.97, 28.83) (1.52. 22.29)
Total months of breastfeeding 1.00 2.90 7.11 5.54
. (0.81, 10.31) (1.94. 26.06) (1.50, 20.49)
NumberofPapsmearn 1.00 3.71 9.14 7.67
(1.04, 13.20) (2.50. 33.41) (2.16.27.16)
Frequency of Pap smears 1.00 3.97 9.70 8.19
(1.11. 14.19) (2.65.35.54) (2.30.29.18)
Number of sexual partners 1.00 2.99 7.03 5.71
(0.84, 10.63) (1.94, 25.48) (1.61 20.22)
Age at first intercourse 1.00 2.51 5.57 4.54
(0.67,9.34) (1.44 21.55) (1.17 16.98)
reference group
Table 4.35. Odds ratios of variable number of total pregnancies for invasive
cervical cancer cases with hospital controls.
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4.4.11. Number of babies breastfed.
Even though for women who had 3 babies breastfed had twice the
chance of developing invasive cervical cancer, it seems that number of babies
breastfed did not contribute much as a potential risk factor for invasive
cervical cancer. The significant effect of number of total pregnancies breastfed
became non significant after allowing for another reproductive variables
including pregnancy status, age at first pregnancy, age at first livebirth, age at
first breastfeeding and number of total pregnancies (Table 4.36).
Thus even though the effect of number of total pregnancies breastfed
has some independent effect as a potential risk factor most of this effect is also
accounted for by another reproductive variables as mentioned above. Thus
variable number of total pregnancies breastfed is not considered in subsequent
analysis.
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CONTROL VARIABLE NUMBER OF BABIES BREASTFED
OR AND 95% Cl
Nulliparous! no 1-2 preg 3 preg > 3 preg
breastfeeding*
Crude 1.00 1.48 2.34 2.26
(0.79,2.76) (1.06. 5.18) (0.97,5.27)
Self occupation 1.00 1.40 2.31 2.23
(0.74,2.64) (1.03. 5.16) (0.94, 5.29)
Spouse occupation 1.00 1.20 1.97 1.79
(0.63, 2.28) (0.87.4.44) (0.76, 4.24)
Marital status 1.00 1.10 1.72 1.78
(0.58, 2.11) (0.76. 3.90) (0.75,4.23)
Age at first marriage 1.00 1.14 1.83 1.55
(0.59, 2.20) (0.80. 4.19) (0.64, 3.74)
Beer drinking habit 1.00 1.41 2.40 2.18
(0.75, 2.65) (1.08, 5.37) (0.92,5.14)
Ever pregnant 1.00 0.92 1.47 1.43
(0.48, 1.76) (0.65, 3.31) (0.60, 3.39)
Age at first pregnancy 1.00 0.84 1.22 0.97
(0.42, 1.67) (0.52, 2.89) (0.39,2.40)
Age at first Iivebirth 1.00 0.95 1.39 1.08
(0.46, 1.97) (0.57,3.36) (0.43, 2.38)
Age at first breastfeeding 1.00 0.67 1.01 0.90
(0.06, 8.09) (0.08, 12.62) (0.07, 11.17)
Number of total pregnancies 1.00 0.96 1.33 1.35
(0.49, 1.86) (0.57,3.14) (0.52, 3.51)
Total months of breastfeeding 1.00 1.19 1.88 1.87
(0.58, 2.44) (0.72,4.92) (0.61, 5.76)
Number of Pap smears 1.00 1.67 2.67 2.41
(0.88,3.17) (1.17. 6.06) (1.02. 5.68)
Frequency of Pap smears 1.00 1.75 3.02 2.45
(0.92, 3.36) (1.31. 6.93) (1.03, 5.83)
Number of sexual partners 1.00 1.40 2.19 2.17
(0.74, 2.63) (0.98, 4.88) (0.92, 5.09)
Age at first intercourse 1.00 1.24 1.95 1.70
(0.65, 2.36) (0.85,4.42) (0.71,4.06)
reference group
Table 4.36. Odds ratios of variable number of babies breastfed for
invasive cervical cancer cases with hospital controls.
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4.4.12. Total months of breastfeeding.
As well as variable number of babies breastfed, total months of
breastfeeding did not show to be an independent risk factor for invasive
cervical cancer in this study population (Table 4.37).
Women who breastfed for 7-12 months had twice the chance of
developing invasive cervical cancer compared to 0-6 months. Meanwhile for
women who breastfed for more than 12 months had 1.5 times chance (p >
0.05) of developing invasive cervical cancer (Table 4.37).
The significant effect of total months of breastfeeding became non
significant after allowing for another reproductive variables including age at
first pregnancy, age at first livebirth, age at first breastfeeding and number of
total pregnancies. The effect became non significant after allowing for
number of sexual partners and age at first intercourse.
Thus even though the effect of total months of breastfeeding has some
independent effect as a potential risk factor most of this effect is also
accounted for by another reproductive variables as mentioned above. As such
variable total months of breastfeeding is not considered in subsequent
analysis.
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CONTROL VARIABLE TOTAL MONTHS OF BREASTFEEDING
OR AND 95% Cl
0-6 momths· 7-12 months > 12 months
Crode 1.00 2.60 1.49
(1.35, 5.02) (0.76, 2.90)
Self occupation 1.00 2.69 1.46
(1.37 5.27) (0.75,2.87)
Spouse occupation 1.00 2.32 1.30
(1.20. 4.51) (0.67, 2.55)
Marital status 1.00 2.21 1.27
(1.13. 4.32) (0.65, 2.49)
Age at first marriage 1.00 2.16 1.19
(1.10, 4.25) (0.60, 2.36)
Beer drinking habit 1.00 2.49 1.45
(1.28. 4.84) (0.74,2.83)
Ever pregnant 1.00 1.99 1.16
(1.02. 3.87) (0.59, 2.27)
Age at first pregnancy 1.00 1.62 0.93
(0.80, 3.28) (0.46, 1.88)
Age at first livebirth 1.00 1.78 1.00
(0.87,3.61) (0.49, 2.03)
Age at first breastfeeding 1.00 2.02 1.14
(0.93, 4.42) (0.52, 2.48)
Number of total pregnancies 1.00 1.92 1.00
(0.95, 3.87) (0.48, 2.05)
Number of babies breastfed 1.00 2.03 1.01
(0.92, 4.47) (0.42, 2.46)
Number of Pap smears 1.00 3.13 1.54
(1.57, 6.22) (0.78, 3.02)
Frequency of Pap smears 1.00 3.04 1.53
(1.54, 6.01) (0.78,3.02)
Number of sexual partners 1.00 2.59 1.50
(1.33, 5.05) (0.77, 2.94)
Age at first intercourse 1.00 2.23 3.27
(0.79,6.22) (0.87, 12.27)
reference group
Table 4.37. Odds ratios of variable total months of breastfeeding for
invasive cervical cancer cases with hospital controls.
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4.4.13. Number of Pap smears and frequency of Pap smears.
As well as the analysis of Pap smears variables in the in-situ study, the
analysis of Pap smears variables in this study is also subject to selection bias
since the cases were recruited from colposcopy clinics or hospitals whilst this
method of recruitment was not applied for the controls. Thus it is more likely
that with regard to history of Pap smears cases were overpresented.
Even though the logistic regression analysis of number of Pap smears
and frequency of Pap smears variables are presented in Table 4.38 and Table
4.39, these variables are not considered in the subsequent analysis.
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reference group
Table 4.38. Odds ratios of variable number of Pap smears for invasive
cervical cancer cases with hospital controls.
CONTROL VARIABLE NUMBER OF PAP SMEARS
OR AND 95% Cl
> 3 x'" 2-3 x 0-1 x
Crude 1.00 0.27 1.23
(0.09, 0.83) (0.71,2.15)
Self occupation 1.00 0.26 1.14
(0.08. 0.78) (0.65, 2.00)
Spouse occupation 1.00 0.30 1.45
(0.10. 0.91) (0.81, 2.58)
Marital status 1.00 0.29 1.55
(0.10 0.90) (0.87, 2.77)
Age at first marriage 1.00 0.30 1.48
(0.10. 0.90) (0.83, 2.63)
Beer drinking habit 1.00 0.26 1.24
(0.08, 0.79) (0.71, 2.18)
Ever pregnant 1.00 0.26 1.52
(0.09. 0.81) (0.86, 2.68)
Age at first pregnancy 1.00 0.27 1.51
(0.09. 0.84) (0.84, 2.73)
Age at first livebirth 1.00 0.26 1.32
(0.08. 0.81) (0.74,2.37)
Age at first breastfeeding 1.00 0.28 1.36
(0.09 0.84) (0.76, 2.41)
Number of total pregnancies 1.00 0.29 1.47
(0.09. 0.88) (0.83, 2.62)
Number of babies breastfed 1.00 0.27 1.36
(0.09, 0.83) (0.77, 2.43)
Total months of breastfeeding 1.00 0.25 1.37
(0.08. 0.78) (0.77, 2.43)
Frequency of Pap smears 1.00 overfit
Number of sexual partners 1.00 0.27 1.38
(0.09. 0.81) (0.78, 2.45)
Age at first intercourse 1.00 0.28 1.33
(0.09, 0.85) (0.75,2.36)
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invasive cervical cancer cases with hospital controls.
reference group
Table 4.39. Odds ratios of variable frequency of Pap smears for
CONTROL VARIABLE FREQUENCY OF PAP SMEARS
OR AND 95% Cl
> l/year 1/1-5years < 1/5years/
never
Crude 1.00 0.83 1.82
(0.33, 2.09) (0.76, 4.36)
Self occupation 1.00 0.92 1.86
(0.36, 2.34) (0.77,4.51)
Spouse occupation 1.00 0.85 2.19
(0.34, 2.16) (0.90, 5.37)
Marital status 1.00 0.85 2.38
(0.33,2.14) (0.97,5.89)
Age at first marriage 1.00 0.88 2.30
(0.35, 2.24) (0.94, 5.65)
Beer drinking habit 1.00 0.87 1.94
(0.34, 2.20) (0.80, 4.71)
Ever pregnant 1.00 0.82 1.68
(0.24, 1.40) (0.78,3.89)
Age at first pregnancy 1.00 0.94 2.49
(0.36, 2.40) (0.99, 6.22)
Age at first livebirth 1.00 0.87 2.09
(0.34, 2.24) (0.84, 5.21)
Age at first breastfeeding 1.00 0.85 2.06
(0.33,2.15) (0.84, 5.05)
Number of total pregnancies 1.00 0.87 2.20
(0.34, 2.21) (0.89,5.41)
Number of babies breastfed 1.00 0.85 2.06
(0.33,2.15) (0.84,5.05)
Total months of breastfeeding 1.00 0.81 1.98
(0.32, 2.06) (0.81, 4.86)
Number of Pap smears 1.00 overfit
Number of sexual partners 1.00 0.87 2.20
(0.34, 2.22) (0.89, 5.43)
Age at first intercourse 1.00 0.89 2.08
(0.35, 2.25) (0.85,5.08)
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4.4.14. Conclusion.
The logistic regression analysis of the potential risk factors for invasive
cervical cancer with hospital controls are presented in this chapter. The crude
and adjusted odds ratio as well as 95% confidence intervals are listed in Table
4.24 to Table 4.39.
As the result of the analysis, variables including number of sexual
partners, age at first intercourse, self occupation, beer drinking habit, marital
status, pregnancy status, age at first pregnancy, age at first livebirth and
number of total pregnancies are identified as the independent risk factors for
invasive cervical cancer in this study population. Thus all these variables are
included in the analysis of smoking variables (chapter 5).
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4.5. Identified risk factors.
4.5.1. Identified risk factors for in-situ cervical cancer.
In this section variables that have already been identified as
independent risk factors for either in-situ or invasive cervical cancer with
either hospital or community controls are revised. These variables are then be
considered further as potential confounders in the analysis of smoking
variables (chapter 5).
4.5.1.1. In-situ cervical cancer with community controls.
As it was presented in section 4.2. some variables including number of
sexual partners, age at first intercourse, induced abortion experience, never
use "safe period" and total duration of oral contraceptive use are identified as
independent risk factors for in-situ cervical cancer with community control.
Thus these variables are considered as potential confounders in the analysis of
smoking variables for in-situ cervical cancer with community controls.
4.5.1.2. In-situ cervical cancer with hospital controls.
From the outcome of the logistic regression analysis presented in
section 4.3. variables including number of sexual partners, age at first
intercourse, years of education (self and spouse), wine and spirits drinking
habit, ever had vaginal discharge, induced abortion experience, ever used of
oral contracpetives, total duration of oral contraceptive use and ever used of
condoms are identified as independent risk factors for in-situ cervical cancer
with hospital controls. Thus these variables are considered further as potential
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confounders in the analysis of smoking variables for in-situ cervical cancer
with hospital controls (chapter 5).
4.5.2. Identified risk factors for invasive cervical cancer (hospital
controls).
Number of sexual partners, age at fIrst intercourse, self occupation,
marital status, beer drinking habit, pregnancy status, age at fIrst pregnancy,
age at fIrst livebirth and number of total pregnancies are identifIed as
independent risk factors for invasive cervical cancer (section 4.3). Thus these
variables are considered further as potential confounders on the analysis of
smoking variables for invasive cervical cancer (chapter 4)..
4.5.3. Conclusion.
The independent risk factors for each of in-situ cervical cancer with
community controls, in-situ cervical cancer with hospital controls and invasive
cervical cancer with hospital controls have been revised.
The identifIed independent risk factors are then be considered as
potential confounders on the analysis of smoking variables and for building the
best models to describe cervical cancer on each data sets.
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CHAPTERS.
SMOKING AS A RISK FACTOR FOR
CERVICAL CANCER
5.1. Introduction.
In this chapter the answer to the third research question is presented.
The third research question is concerned with the association between cigarette
smoking and in-situ or invasive cervical cancer in the study population after
adjusting for other identified risk factors.
Smoking variables are investigated in their own right and after
adjusting for the already identified independent risk factors for cer.vical cancer
as presented in chapter 3. The effect of smoking and other identified
independent risk factors on disease status is examined. The odds ratio is used
as a measure of association and 95 % confidence intervals (95 % Cl) are also
presented.
5.2. Smoking as a risk factor for in-situ cervical cancer.
5.2.1. In-situ cervical cancer with community control.
In this section the association between smoking variables and in-situ
cervical cancer using community controls are presented. The smoking
variables comprised smoking status (ever or never smoked) and number of
cigarettes smoked per day. These are examined in their own right and also
controlled for using other variables including number of sexual partners, age
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at first intercourse, use of "safe period", induced abortion experience and
total duration of use of oral contraceptives.
5.2.1.1. Descriptive statistics of smoking variables.
There was a significant difference at the 5% level between cases and
controls with regard to smoking status. There were more smokers among cases
than controls and also cases smoked more cigarettes per day than controls
(Table 5.1).
Fifty one per cent of this study population had ever smoked in their
life. This comprised 67% of cases and 41 % of controls. With regard to the
number of cigarettes smoked per day, 36% of cases smoked more than 20
cigarettes per day compared to 14% of controls.
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SMOKlNG CASES % CONTROL% TOTAL%
I n=114 n=181 n=295Ever smoked---- 67.5 41.4 51.5
Number of cigarettes smoked/day··
I Did not smoke 32.5 59.1 48.81-10 cigarettes/day 13.2 10.0 11.211-20 cigarettes/day 18.4 16.6 17.3
I 21-30 cigarettes/day
27.2 12.7 18.3
> 30 cil!arettes/dav 8.8 1.7 4.4
...
P < 0.05
I Table 5.1. Smoking variables for in-situ cervical cancer cases
I with community controls.
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5.2.1.2. Smoking as a risk factor for in-situ cervical cancer (community
controls).
Women who had ever smoked had three times the chance of developing
in-situ cervical cancer compared to women who had never smoked (Table
5.2). This measure of association still persists after controlling for variables
including number of sexual partners, age at fIrst intercourse,- induced abortion
experience, never use "safe" period and total duration of oral contraceptive
use (Table 5.2). This risk remains stable at a two-fold increase in the chance
of developing in-situ cervical cancer.
Thus in this particular study population, cigarette smoking is an
independent risk factor for in-situ cervical cancer.
With regard to the amount of cigarettes smoked per day, women who
smoked up to 30 cigarettes per day had four times the chance of developing in-
situ cervical cancer as compared to women who had never smoked. The
relative risk increases considerably to ten for women who smoked more than
30 cigarettes per day (Table 5.3). There was also a linear trend with regard to
the number of cigarettes smoked. After allowing for other variables including
number of sexual partners, age at fIrst intercourse, ll'iduced abortion
experience, never use "safe" period and total duration of oral contraceptive
use, the risk still persists especially for categories of more than 20 cigarettes
smoked per day (Table 5.3).
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CONTROL VARIABLE EVER SMOKED
Odds ratio 95% Cl
Crude 2.98 1.82.4.89
Number of sexual partners 2.44 1.45.4.10
Age at first intercourse 2.74 1.64 4.56
Induced abortion experience 2.86 1.73,4.71
Never use of "safe period" 2.96 1.80 4.88
Total months of QC use 2.75 1.66,4.55
Table 5.2. Odds ratio for variable smoking status for in-situ
cervical cancer cases with community controls.
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CONTROL VARIABLE NUMBER OF CIGARETTES SMOKEDIDAY
(Odds ratio and 95% Cl)
0 1-10 11-20 21-30 > 30
Crude 1.00 2.37 1.01 3.98 10.31
1.08.5.19 1.02.3.97 1.06.7.69 2.66.40.01
Number of sexual partners 1.00 2.12 1.49 3.27 8.33
0.93,4.84 0.73,3.03 1.64.6.52 2.04. 33.95
Age at first intercourse 1.00 2.48 1.90 3.29 9.75
1.11.5.53 0.95,3.79 1.66.6.51 2.48.38.32
Induced abortion experience 1.00 2.47 1.83 3.80 9.76
1.12.5.45 0.91,3.65 1.95.7.40 2.48 38.31
Never use of "safe period" 1.00 2.28 2.07 3.81 11.05
1.03.5.03 1.04.4.14 1.96.7.41 2.79.43.76
Total months of QC use 1.00 2.07 2.04 3.50 9.25
0.92,4.62 1.02. 4.07 1.78.6.88 2.34,36.55
reference group
Table 5.3. Odds ratio for the number of cigarettes smoked per day for
in-situ cervical cancer cases with community controls.
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5.2.1.3. Conclusion.
In this chapter the association of cigarette smoking and in-situ cervical
cancer with community controls, as measured by odds ratio, is presented.
There is a significant increase at the 5 % level of the risk of developing in-situ
cervical cancer for women who had ever smoked. This risk increased with the
number of cigarettes smoked per day.
Thus smoking is an independent risk factor for in-situ cervical cancer
in this study population.
5.2.2. In-situ cervical cancer with hospital contr~ls.
The association between smoking variables and in-situ cervical cancer
with hospital controls is presented in this section. The smoking variables
comprised smoking status (ever or never smoked) and number of cigarettes
smoked per day. These are examined in their own right and also after
controlling for covariates including nUI~ber of sexual partners, age at first
intercourse, education level (self and spouse), wine and spirits drinking habit,
history of vaginal discharge, induced abortion experience, history of
contraceptive practice including oral contraceptive and condom use and also
total duration of use of oral contraceptives.
5.2.2.1. Descriptive statistics of smoking variable.
In this study population, as well as for the study involving in-situ cases
and community controls, there were more cases than controls who had ever
smoked. Cases smoked more cigarettes per day than controls (Table 5.4).
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Sixty seven per cent of cases as compared to 36 per cent of controls
had ever smoked in their life. Twenty five per cent of cases smoked more than
20 cigarettes per day compared to 9% of controls.
Comparing the two different control groups with regard to their
smoking status, namely community and hospital controls, a different pattern
was found. Community controls were more frequently smokers than hospital
controls. The numbers are 41 % and 36% respectively. As shown later, this
difference is statistically significant. ~. 1
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p < 0.05
Table 5.4. Smoking variables for in-situ cervical cancer cases
with hospital controls.
SMOKlNG VARIABLES CASES % CONTROL% TOTAL%
0=114 0=331 0=445
Ever smoked 67.54 35.95 44.05
Number of cigarettes smoked/day
Did not smoke 32.46 64.05 48.25
1-10 cigarettes/day 13.16 9.97 11.,57
11-20 cigarettes/day 18.42 17.22 18.32
21-30 cigarettes/day 27.19 7.55 17.75
> 30 cilzarettes/dav 8.77 1.21 4.22
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5.2.2.2. Smoking as a risk factor for in-situ cervical cancer (hospital
controls).
Women who had ever smoked had three times the chance of developing
in-situ cervical cancer compared to women who had never smoked. This
relative risk remain persists after controlling for variables including number of fIl 0 .f
sexual partners, age at first intercourse, education levels (self and spouse),
wine and spirits drinking habit, history of vaginal discharge, induced abortion
experience and contraceptive practice variables namely use of oral
contraceptive, use of condoms and total duration of oral contraceptives use
(Table 5.5).
There was also a trend over the five categories in the number of
cigarettes smoked per day; never smoked, 1-10 cigarettes per day, 11-20
cigarettes per day, 21-30 cigarettes per day and more than 30 cigarettes per
day (Table 5.6). This measure of effect still persists, especially in the
categories 11-20 cigarettes smoked per day and 21-30 cigarettes smoked per
day, after allowing for variables including number of sexual partners, age at
first intercourse, education levels (self and spouse), wine and spirits drinking
habit, history of vaginal discharge, induced abortion experience and
contraceptive practice variables, namely use of oral contraceptive, use of
condoms and total duration of oral contraceptives use.
Thus, in this particular study population smoking is established as an
independent risk factor for in-situ cervical cancer.
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95% Cl
2.02 5.25
1.25 3.47
1.58 4.13
1.79 4.71
1.65 4.32
1.78 4.66
1.54 4.03
1.61 4.22
1.56 4.23
1.58 4.15
1.64 4.30
1.66 4.33
tus for in-situ
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I CONTROL VARIABLE EVERSMOdds ratioCrode 3.26
I Number of sexual partners 2.08Age at first intercourse 2.55Self education 2.90
Spouse education 2.67
I Wine drinking habit 2.88Spirits drinking habit 2.49
Ever had any va,cinal dischar.ge 2.61
I Induced abortion experience 2.57Ever use QC 2.56
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Table 5.6. Odds ratios for variable amount of cigarettes smoked per day for
in-situ cervical cancer cases with hospital controls.
CONTROL VARIABLE NUMBER OF CIGARETTES SMOKEDIDAY
(Odds ratio and 95% Cl)
0 1-10 11-20 21-30 > 30
Crude 1.00 2.13 3.14 4.89 4.80
1.02. 4.47 1.74.5.65 2.39.10.00 1.14.20.25
Number of sexual partners 1.00 0.96 2.58 2.82 2.42
0.43,2.17 1.37.4.87 1.32.6.06 0.50, 11.59
Age at first intercourse 1.00 1.38 2.77 3.75 3.70
0.65,2.97 1.53,5.02 1.81,7.78 0.85, 16.11
Self education 1.00 1.43 3.25 4.30 4.08
0.66,3.10 1.78 5.93 2.09.8.85 0.93, 17.88
Spouse education 1.00 1.08 3.14 4.23 3.95
0.49,2.41 1.72.5.73 1.05.8.75 0.90, 17.34
Wine drinking habit 1.00 1.41 3.18 4.41 4.25
0.65,3.05 1.75,5.76 2.12,9.15 0.98, 18.39
Spirits drinking habit 1.00 1.27 2.84 3.34 ' 4.30
0.59,2.74 1.57,5.16 1.61,6.92 1.01. 16.24
Ever had vaginal discharge 1.00 1.23 2.90 4.09 3.71
0.57,2.68 1.59.5.28 1.97.8.45 0.85, 16.28
Induced abortion experience 1.00 1.33 3.09 3.50 2.95
0.60,2.93 1.67 5.71 1.64,7.48 0.60, 14.42
Ever used QCs 1.00 1.40 2.86 3.28 4.71
0.65,3.02 1.58,5.20 1.60,6.71 1.02,21.77
Total months of QC use 1.00 1.44 2.92 3.47 5.34
0.67,3.10 1.61.5.31 1.68.7.17 1.18.24.13
Ever used condoms 1.00 1.11 2.90 4.85 4.06
0.50,2.44 1.60,5.27 2.33. 10.09 0.92, 17.95
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5.2.2.3. Conclusion.
The computation of odds ratio and 95 % confidence intervals for the
effect of smoking status, and the number of cigarettes smoked per day for in-
situ cervical cancer is presented in this section. It was found that cigarette
smoking increased the chance of having in-situ cervical cancer in this study
population. The relative risk also increases with the number of cigarettes
smoked per day.
Thus in this study population smoking is established as one of
independent risk factors for in-situ cervical cancer.
5.3. Smoking as a risk factor for invasive cervical cancer (hospital
control).
In this section the association between smoking and invasive cervical
cancer is investigated. Odds ratios, either crude or adjusted, and 95 %
confidence intervals for smoking variables including smoking status and
number of cigarettes smoked per day are presented as a measure of the
association.
5.3.1. Descriptive statistics of smoking variable.
In this study population 40% of cases and controls had ever smoked in
their life. Cases smoked more frequently compared to controls. Fifty three
per cent of cases had ever smoked compared to 36% of controls. Cases
smoked more cigarettes per day than controls. Seventeen per cent of cases
smoked more than 20 cigarettes per day compared to 9% of controls. These
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differences between cases and controls were statistically significant at the 5%
level (Table 5.7).
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p < 0.05
Table 5.7. Smoking variables for invasive cervical cancer cases
with hospital controls.
SMOKING VARIABLES CASES % CONTROL% TOTAL%
0=75 0=331 0=406
Ever smoked 53.33 35.95 39.16
Number of ~iarettes
64.05smoked/day 46.67 60.84
Did not smoke 12.00 9.97 10.34
1-10 cigarettes/day 24.00 17.22 18.47
11-20 cigarettes/day 8.00 7.55 7.64
21-30 cigarettes/day 9.33 1.21 2.71
> 30 cil!:arettes/dav
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5.3.2. Smoking as a risk factor for invasive cervical cancer (hospital
controls).
Women who had ever smoked had twice the chance of developing
invasive cervical cancer compared to women who had never smoked. The
relative risk remains significant at the 5% level after allowing for variables
including number of sexual partners, age at first intercourse, self occupation,
marital status, beer drinking habit, pregnancy status and reproductive variables
namely age at first pregnancy, age at first livebirth and number of total
pregnancies (Table 5.8).
With regard to the number of cigarettes smoked per day, women who
smoked more than 30 cigarettes per day had 11 times the chance of developing
invasive cervical cancer. This significant effect became non significant after
controlling for variables including number of sexual partners, age at first
intercourse, self occupation, marital status, beer drinking habit, pregnancy
status and reproductive variables namely age at first pregnancy, age at first
livebirth and number of total pregnancies (Table 5.9).
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CONTROL VARIABLE EVER SMOKED
Odds ratio 95% Cl
Crude 2.02 1.21.3.37
Number of sexual partners 1.68 1.00.2.82
Age at first intercourse 1.80 1.07.3.04
Self occupation 1.78 1.06 3.00
Marital status 1.95 1.15.3.30
Beer drinking habit 1.72 1.03.2.88
Ever pregnant 1.86 1.10.3.13
Age at first pregnancy 1.76 1.03.3.00
Age at first livebirth 1.74 1.02.2.97
Number of total pregnancies 1.90 1.12.3.22
Table 5.8. Odds ratios for variable smoking status for
invasive cervical cancer cases with hospital controls.
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invasive cervical cancer cases with hospital controls.
reference group
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Table 5.9. Odds ratios for variable amount of cigarettes smoked per day for
CONTROL VARIABLE NUMBER OF CIGARETTES SMOKEDIDAY
(Odds ratio and 95% Cl)
0 1-10 11-20 21-30 > 30
Crude 1.00 1.66 1.91 1.35 11.18
0.72,3.78 1.00,3.66 0.51,3.54 3.04,41.20
Number of sexual partners 1.00 1.44 1.58 2.17 2.03
0.62,3.33 0.81,3.08 0.90,5.21 0.49,8.40
Age at first intercourse 1.00 1.59 1.71 2.30 1.92
0.68,3.69 0.87,3.35 0.96,5.55 0.47,7.75
Self occupation 1.00 1.57 1.69 2.22 2.04
0.68,3.61 0.86,3.31 0.92,5.37 0.50,8.32
Marital status 1.00 1.71 1.73 2.99 2.03
0.74,3.97 0.88,3.42 1.21,7.40 0.50,8.25
Beer drinking habit 1.00 1.57 1.60 2.05 2.10
0.69,3.60 0.82,3.13 0.86,4.88 0.52,8.48
Ever pregnant 1.00 1.80 1.63 2.72 1.68
0.77,4.18 0.83,3.19 1.10.6.71 0.42,6.67
Age at first pregnancy 1.00 1.66 1.67 2.19 1.60
0.70,3.92 0.84,3.34 0.86,5.56 0.39,6.62
Age at first livebirth 1.00 1.70 1.66 2.04 1.66
0.72,3.99 0.84,3.31 0.81,5.13 0.40,6.87
Number of total pregnancies 1.00 1.73 1.68 3.03 1.68
0.74,4.05 0.85,3.33 1.20.7.62 0.41,6.77
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5.3.3. Conclusion.
Smoking status is established as one of independent risk factors for
invasive cervical cancer in this study population. The number of cigarettes
smoked per day does not show to increase the risk of having invasive cervical
cancer.
5.4. Mathematical modelling for cervical cancer.
5.4.1. Introduction.
In this section risk factors for both cervical cancer, in-situ and
invasive, are investigated using mathematical models. These risk factors
include smoking status and the other risk factors that have already been
, identified.
Test of overall goodness of fit can not be performed in these analyses
since the analyses are conducted on a case by case base (McCullagh and
Nelder, 1983). Likelihood ratio tests are conducted to test the significance of
covariates in the model. The general basis for the mathematical models has
been discussed in chapter 2.
5.4.2. Mathematical modelling of in-situ cervical cancer.
5.4.2.1. In-situ cases with community controls.
In this study population number of sexual partners, age at first
intercourse, smoking status (ever smoked), induced abortion experience, non-
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use of 11 safe period11 for contraception and total duration of oral contraceptive
use are established as independent risk factors for in-situ cervical cancer.
Thus with regard to these variables, the following model (model 1) is
used as an initial mathematical model for this study population.
Logistic Regression Analysis
Response: Case
Column Name Coeff StErr p-value Odds 0.95 cr
----------------------------------------------------------------------
0 Constant -3.116 0.857 0.000
3 2-3sp 1.380 0.577 0.017 3.974 1.281 12.322
4 4-6sp 2.019 0.601 0.000 7.527 2.318 24.448
5 >=7sp 1.150 0.689 0.095 3.160 0.819 12.187
7 16-19fi 0.067 0.474 0.888 1. 069 0.422 2.707
8 <16fi 0.028 0.823 0.973 1. 028 0.205 5.158
9 Smoker 1.314 1.022 0.198 3.721 0.502 27.559
14 induce+ 0.776 0.355 0.029 2.172 1.083 4.357
15 Safe- 0.976 0.379 0.010 2.653 1.263 5.572
17 <=72Mo -0.391 0.745 0.600 0.677 0.157 2.914
18 >72Mo 0.724 0.783 0.355 2.064 0.445 9.570
20 smknsp2-3 -1.184 0.748 0.114 0.306 0.071 1.327
21 smknsp4-6 -1. 764 0.807 0.029 0.171 0.035 0.833
22 smknsp>7 0.120 0.876 0.891 1.127 0.203 6.271
24 smkafi16-19 0.595 0.623 0.340 1.813 0.535 6.151
25 smkafi<16 1.039 1.144 0.363 2.827 0.301 26.594
27 smk<72mo 0.028 0.970 0.977 1. 029 0.154 6.886
28 smk>72mo -0.705 1. 007 0.484 0.494 0.069 3.558
30 30-39 agrp 0.089 0.312 0.776 1. 093 0.593 2.017
31 40-49 agrp 0.387 0.501 0.440 1. 473 0.552 3.935
32 >=50 agrp 1.265 0.798 0.113 3.544 0.741 16.943
----------------------------------------------------------------------
df:274 Dev:325.515 %(0): 61.356 #iter:8 RSq: 0.173
Model 1. Full mathematical model of in-situ cervical cancer cases with
community controls.
As it can be seen from this model women who had 2-3 sexual partners
had 4 times the chance of developing in-situ cervical cancer as those with 0-1
sexual partners; this agrees with the crude estimate. For women who had 4-6
sexual partners the the corresponding relative risk was 7 times compared to the
crude estimate of five. Age at first intercourse does not show a significant.
Induced abortion experience and non-use of the 11 safe period 11 for contraceptive
is significant. The adjusted odds ratios for these two variables are 2.17 (95 %
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Cl = 1.08, 4.36) and 2.65 (95% Cl = 1.26, 5.57) respectively. After
allowing for other covariates, total duration of oral contraceptive use did not
show a significant effect in developing in-situ cervical cancer. The only
significant interaction variable is that between smoking and having had 4-6
sexual partners. The estimated coefficient for this variable is -1.76. Even
though one of the interaction variables showed to be significant, the "chunk
test" for these interaction variables did not show to be significant (Table 5.10).
Table 5.10. below presents the likelihood ratio test, odds ratio and
confidence intervals for the smoking status variable in the model. As it can be
seen from Table 5.10 the likelihood ratio test of all the variables tested did not
show any significant difference at the 5 % level. The last model which did not
have interaction variables, total duration of oral contraceptives use and age at
first intercourse variables had the narrowest confidence intervals. Thus
elimination of these variables did not change the odds ratio of smoking as well
as widening the confidence interval.
Thus the most parsimonious mathematical model to describe the chance
of developing in-situ cervical cancer with community controls in this study
population is as follows;
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Model 2. Final mathematical model of in-situ cervical cancer cases
with community controls.
In this final model, three categories in number of sexual partners; 2-3,
4-6 and seven or more sexual partners are significant. The adjusted odds ratios
and 95% confidence intervals for these categories are 2.4 (1.2, 4.9), 3.1 (1.5,
6.7)· and 4.5 (2.1, 9.7) respectively. Smoking has a significant effect in
Dev:342.062 %(0):61.356 #iter:8 RSq: 0.131df:285
Logistic Regression Analysis
Response: Case
Column Name Coeff StErr p-value Odds 0.95 cr
---------------------------------------------------------------------
0 Constant -2.814 0.475 0.000
3 2-3sp 0.893 0.356 0.012 2.441 1.215 4.906
4 4-6sp 1.144 0.384 0.003 3.140 1. 480 6.664
5 >=7sp 1.508 0.389 0.000 4.519 2.107 9.692
9 Smoker 0.831 0.271 0.002 2.296 1.350 3.905
14 induce+ 0.768 0.336 0.022 2.154 1.116 4.160
15 Safe- 1.032 0.357 0.004 2.808 1.395 5.651
30 30-39 agrp 0.057 0.288 0.843 1. 059 0.602 1. 861
31 40-49 agrp 0.352 0.445 0.430 1.421 0.594 3.401
32 >=50 agrp 1. 038 0.714 0.146 2.823 0.696 11. 446
---------------------------------------------------------------------
developing in-situ cervical cancer. The adjusted odds ratio for this variable is
2.3 (1.3, 3.9). Induced abortion experience and non-use of the "safe period"
as a contraceptive still significant at the 5 % level. The adjusted odds ratios and
95% confidence intervals for these variables are 2.1 (1.1, 4.2) and 2.8 (1.4,
5.6) respectively.
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liminated variables Likelihood ratio test Smokinl! status
Xi. statistics p-value OR 95% Cl
e
- -
2.98 1.82,4.89
ction variables 9.751 with 7 df 0.203 2.15 1.25,3.71
duration of Des use 5.086 with 1 df 0.079 2.21 1.29,3.79
t first intercourse 1.710 with 2 df 0.425 2.30 1.35,3.91
e 5.10. Elimination of variables in the mathematical modelling of in-situ
cervical cancer with community controls.
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5.4.2.2. In-situ cases with hospital controls.
In the in-situ cervical cancer with hospital controls, number of sexual
partners, age at first intercourse, smoking status (ever smoked), self education
level, spouse education level, induced abortion experience, ever had vaginal
discharge, ever drank wine, ever drank spirits, ever used of oral
contraceptives, and ever used of condoms are established as independent risk
factors.
Thus with regard to these variables, model 3 is used as an initial
mathematical model on this study population.
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Logistic Regression Analysis
Response: Case
Column Name Coeff StErr p-value Odds 0.95 CI
-----------------------------------------------------------------------
0 Constant -6.598 1.253 0.000
3 2-3sp 1. 746 0.603 0.004 5.731 1. 756 18.698
4 4-6sp 0.991 0.615 0.107 2.694 0.808 8.984
5 >=7sp 1.030 0.779 0.186 2.801 0.608 12.899
6 <20fi -0.003 0.494 0.995 0.997 0.379 2.624
7 Ever smoke 1.516 1. 445 0.294 4.552 0.268 77.230
12 10-12self 0.347 0.537 0.518 1.415 0.494 4.053
13 self>=13 -0.412 0.658 0.531 0.662 0.182 2.406
15 10-12husb 0.015 0.496 0.975 1.016 0.384 2.686
16 Husb>12 1.336 0.758 0.078 3.803 0.862 16.786
17 Induce+ 1.837 0.467 0.000 6.276 2.514 15.666
18 Discharge 0.447 0.320 0.163 1.563 0.835 2.926
19 Wine+ -0.033 0.539 0.951 0.967 0.336 2.782
20 Spirit+ 1.326 0.497 0.008 3.768 1. 423 9.974
21 OC+ 2.454 1. 092 0.025 11.631 1.368 98.856
22 Condom+ 0.653 0.540 0.227 1.922 0.667 5.541
27 smk2-3 -0.208 0.806 0.797 0.813 0.167 3.944
28 smk4-6 -0.148 0.856 0.863 0.862 0.161 4.619
29 smk>7 0.459 0.992 0.644 1.582 0.226 11.062
30 smk<20fi 0.378 0.673 0.575 1. 459 0.390 5.453
32 smks10-12 -0.377 0.703 ·0.592 0.686 0.173 2.720
33 smks>12 1.197 0.853 0.161 3.311 0.622 17.638
35 smkh10-12 0.247 0.679 0.716 1.280 0.338 4.846
36 smkh>12 -0.242 0.984 0.806 0.785 0.114 5.405
37 smkwine 1.061 0.691 0.124 2.890 0.747 11.186
38 smkspi -0.996 0.653 0.127 0.369 0.103 1.328
39 smkoc -1. 629 1.265 0.198 0.196 0.016 2.341
40 smkcond -0.148 0.705 0.834 0.863 0.217 3.433
42 40-49 agrp 0.267 0.688 0.698 1.306 0.339 5.035
43 30-39 1.166 0.614 0.058 3.208 0.964 10.681
44 <=29 agrp 1.208 0.649 0.063 3.348 0.938 11.951
-----------------------------------------------------------------------
df: 414 Dev:304.703 %(0):74.382 iliter:lO RSq: 0.398
Model 3. Full mathematical model for in-situ cervical cancer cases
with hospital controls.
The computer program of this model is attached (appendix 7).
In this model only variables ever had 2-3 sexual partners, ever drank
spirits and ever used oral contraceptives have a significant effect on in-situ
cervical cancer. Women who had 2-3 sexual partners has five times the chance
of developing in-situ cervical cancer compared to women who had 0-1 sexual
partner. The crude odds ratio for this category is 7.2 (3.7, 13.9). Women who
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drank spirits has almost four times the chance of developing in-situ cervical
cancer (the crude odds ratio was 2.7 with 95% cr = 1.7, 4.3). Women who
had ever use of oral contraceptives has 11 times chance of developing in-situ
cervical cancer (the crude odds ratio was 7.7 with 95% cr = 2.9, 20.2), but
95% confidence interval for this variable is quite large (1.4, 98.9). Again
smoking does not show to have a significant effect.
Table 5.11. below presents the likelihood ratio test, odds ratios and
confidence intervals of variable smoking in the model. As it can be seen from
Table 5.11 the likelihood ratio test of all the variables tested does not show
any significant difference at the 5% level but elimination of variables ever
drank wine, ever used of condoms and age at first intercourse changed the
odds ratio of smoking variable to be marginally non significant. Thus these
variables are retained. The deletion of variable ever had any discharge gives a
wider confidence intervals, thus this variable is retained as well as the three
variables mentioned before.
Thus the most parsimonious mathematical model to describe the chance
of developing in-situ cervical cancer in this study population is as follows;
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Logistic Regression Analysis
Response: Case
Column Name Coeff StErr p-value Odds 0.95 Cl
---------------------------------------------------------------------
0 Constant -5.803 0.705 0.000
3 2-3sp 1.665 0.389 0.000 5.285 2.468 11. 318
4 4-6sp 0.873 0.417 0.036 2.394 1. 058 5.416
5 >=7sp 1.360 0.458 0.003 3.895 1.587 9.559
6 <20fi 0.138 0.331 0.676 1.148 0.600 2.197
7 Ever smoke 0.566 0.291 0.051 1. 762 0.997 3.113
15 10-12husb 0.107 0.334 0.747 1.113 0.579 2.141
16 Husb>12 1.246 0.431 0.004 3.476 1. 493 8.096
17 lnduce+ 1.771 0.446 0.000 5.874 2.452 14.072
18 Discharge 0.424 0.301 0.159 1.528 0.847 2.757
19 Wine+ 0.571 0.328 0.081 1. 770 0.931 3.365
20 Spirit+ 0.762 0.310 0.014 2.143 1.167 3.936
21 OC+ 1. 408 0.557 0.011 4.088 1.372 12.178
22 Condom+ 0.576 0.339 0.089 1. 779 0.916 3.455
42 40-49 agrp 0.152 0.660 0.818 1.165 0.319 4.248
43 30-39 1.134 0.592 0.055 3.109 0.974 9.917
44 <=29 agrp 1.252 0.622 0.044 3.497 1. 034 11.826
---------------------------------------------------------------------
df: 428 Dev:315.618 %(0) :74.382 #iter:9 RSq: 0.377
Model 4. Final mathematical model for in-situ cervical cancer cases with
hospital controls.
Even though there is no linear trend, number of sexual partners is
significantly associated with in-situ cervical cancer. The adjusted odds ratios
and 95% confidence intervals for number of sexual partners are 5.3 (1.5,
11.3) for 2-3 sexual partners, 2.4 (1.1, 5.4) for 4-6 sexual partners and 3.9
for seven or more sexual partners. Ever smoked shows to be marginally
significant. The adjusted odds ratio for ever smoked is 1.8 (95 % Cl = 1.0,
3.1). Women with spouse who had more than 12 years of education has 3.5
the chance of developing in-situ cervical cancer compared to women with
spouse who had less than 10 years of education. In this model women who
drank spirits and women who had ever used of oral contraceptives has 2 times
and 4 times the chance of developing in-situ cervical cancer respectively.
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Eliminated variables Likelihood ratio test Smoking status
X"" statistics p-value OR 95% Cl
Crude
- -
3.26 2.02,5.25
Interaction variables 10.383 with 8 df 0.238 1.78 1.00,3.16
self education 0.532 with 2 df 0.766 1.76 1.00.3.11
Historv of discharge 1.965 with 1 df 0.161 1.77 1.00,3.12
Drank wine 2.852 with 1 df 0.091 1.70 0.96,2.97
Ever used of condoms 3.525 with 1 df 0.06 1.68 0.96,2.95
Age at first intercourse 0.084 with 1 df 0.772 1.70 0.97,2.96
Table 5.11. Elimination of variables in the mathematical modelling of in-situ
cervical cancer with hospital controls.
189
190
factors for invasive cervical cancer.
Thus with regard to these variables, model 5 is used as an initial
Model 5. Mathematical model for invasive cervical cancer cases with hospital
controls.
crStErr p-value Odds 0.95
5.4.2. Mathematical modelling of invasive cervical cancer cases with
hospital controls.
In this study population number of sexual partners, age at fIrst
intercourse, smoking status (ever smoked), marital status, pregnancy status,
age at fIrst pregnancy, age at fIrst livebirth, number of total pregnancies, self
occupation and beer drinking habit are established as the independent risk
mathematical model for this study population.
Logistic Regression Analysis
Response: Case
Column Name Coeff
0 Constant -4.902 0.910 0.000
2 >=2sp 0.135 0.444 0.761 1.145 0.479 2.732
3 <20afi 0.404 0.465 0.384 1. 498 0.603 3.724
4 Ever smoke 0.625 0.678 0.357 1.869 0.494 7.064
9 Marit 0.890 0.765 0.244 2.435 0.544 10.898
10 Divorce 1.506 0.818 0.066 4.510 0.908 22.400
11 Widow 1.353 0.899 0.132 3.870 0.665 22.518
12 Ever preg 1.146 0.747 0.125 3.147 0.728 13.601
13 <20age1prg 0.171 0.912 0.852 1.186 0.198 7.091
14 <20 livbirt 0.584 0.912 0.522 1.793 0.300 10.707
16 3 preg 0.722 0.405 0.075 2.058 0.931 4.549
17 >=4preg 0.571 0.380 0.133 1.771 0.841 3.730
19 Unskilled 0.347 0.442 0.433 1.415 0.594 3.367
20 Skilled -0.480 0.527 0.362 0.619 0.220 1.737
21 beer+ 1.012 0.403 0.012 2.751 1.250 6.056
22 smk>=2sp 0.121 0.630 0.848 1.129 0.328 3.882
23 smk<20fi -1.168 0.610 0.056 0.311 0.094 1. 028
25 smkunski 1.173 0.717 0.102 3.232 0.793 13.171
26 smkski 1.371 0.749 0.067 3.940 0.908 17.087
27 smkbeer -0.606 0.611 0.322 0.545 0.165 1. 808
29 40-49agrp -0.191 0.387 0.621 0.826 0.386 1.765
30 30-39agrp -0.040 0.398 0.921 0.961 0.441 2.097
31 <=29agrp 0.118 0.557 0.832 1.126 0.378 3.356
----------------------------------------------------------------------
df:383 Dev:322.982 %(0) :81.527 #iter:9 RSq: 0.169
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Model 6. Final mathematical model of invasive cervical cancer with hospital
controls.
0 Constant -4.004 0.726 0.000
2 >=2sp 0.196 0.302 0.516 1.217 0.673 2.199
3 <20afi 0.388 0.295 0.188 1. 474 0.827 2.627
4 Ever smoke 0.606 0.276 0.028 1. 834 1. 068 3.148
12 Ever preg 1. 887 0.634 0.003 6.601 1.905 22.867
19 Unskilled 0.790 0.329 0.016 2.204 1.155 4.204
20 Skilled 0.099 0.351 0.779 1.104 0.554 2.197
21 beer+ 0.679 0.286 0.018 1.973 1.126 3.455
29 40-49agrp -0.269 0.351 0.444 0.764 0.384 1.522
30 30-39agrp -0.281 0.355 0.428 0.755 0.377 1.513
31 <=29agrp -0.515 0.487 0.290 0.597 0.230 1.552
show any significant difference at the 5% level. The model which does not
have interaction variables, marital status, age at first pregnancy, age at first
livebirth and number of total pregnancies variables has the narrowest
confidence intervals. Elimination of these variables do not change the odds
ratio of smoking as well as broadening the confidence interval.
Thus the most parsimonious mathematical model to describe the chance
of developing invasive cervical cancer in this study population is as follows;
crStErr p-value Odds 0.95
Dev:345.496 %(O}:81.527 #iter:9 RSq: 0.111df:395
For the computer programs see appendix 8.
Compare to both in-situ cervical cancer data sets, invasive cervical
cancer has different pattern with regard to the risk factors. As it is shown in
Model 5 sexual factors does not show to be significant risk factors for
invasive cervical cancer. In this full model only variable ever drank beer
shows to be significantly associated with invasive cervical cancers. The odds
ratio and 95% confidence interval for this variable is 2.7 (1.2, 6.1).
In Table 5.12. the likelihood ratio test, odds ratios and confidence
intervals of variable ever smoked in the models are presented. As it can be
seen from Table 5.12 the likelihood ratio test of all the variables tested do not
Logistic Regression Analysis
Response: Case
Column Name Coeff
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As it is in the full model, sexual factors do not show to be significantly
associated with invasive cervical cancer. Meanwhile ever smoked has a
significant effect on invasive cervical cancer. The adjusted odds ratio for this
variable is 1.8 (95 % Cl = 1.1, 3.1) compared to the crude odds ratio of two
(95 % Cl = 1.2, 3.4). In accordance with the study on risk factors for invasive
cervical cancer conducted in Latin America (Brinton, et.al. , 1985), in this
study women who had ever pregnant has an adjusted odds ratio of 4.7 (95%
Cl = 1.3, 17.2). The crude odds ratio and 95% confidence interval for this
variable is 6.8 (2.0, 22.7). Women who were employed in unskilled
occupation have 2 times the chance of developing invasive cervical cancer.
Beer drinking habit also shows to be significantly associated with the risk of
developing invasive cervical cancer. Women who drank beer has almost twice
the chance of developing invasive cervical cancer.
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Eliminated variables Likelihood ratio test Smokinl! status
X" statistics p-value OR 95% Cl
Crude - - 2.02 1.21,3.37
Interaction variables 9.766 with 5 df 0.082 1.91 1.09,3.34
Marital status 4.441 with 3 df 0.218 1.83 1.05,3.18
Age at first pregnancy 0.041 with 1 df 0.84 1.84 1.06,3.19
Age at first livebirth 3.775 with 1 df 0.052 1.90 1.10, 3.28
Number of total pregnancies 4.491 with 2 df 0.106 1.83 1.07,3.15
Number of sexual partners 0.421 with 1 df 0.516 1.87 1.09,3.19
Age at first intercourse 2.463 with 1 df 0.117 1.90 1.11,3.25
Table 5.12. Elimination of variables in the mathematical modelling of invasive
cervical cancer with hospital controls.
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5.4.3. Conclusion.
Smoking is established as one of the independent risk factors for
cervical cancer. The odds ratios and 95% confidence intervals of such
computations are presented. The most parsimonious mathematical models
representing each study population are discussed.
5.5. Polytomous regression analysis on cervical cancer.
5.5.1. Introduction.
As discussed in chapter 2, polytomous regression analysis in this study
is possible by coding the response variable into four groups; community
controls (coded as 0), hospital controls (coded as 1), invasive cases (coded as
2) and in-situ cases (coded as 3).
The number of cigarettes smoked per day, number of sexual partners,
vaginal discharge history, pregnancy history, us~ of oral contraceptives, non-
use of the "safe period" contraceptive and age group were chosen to be
analyzed using polytomous regression since these variables were found to be
associated with cervical cancer across the study populations. -
The purpose of the analysis using polytomous regression is twofold;
fIrst to investigate whether there are differences in the association \yith the
outcome variable with regard to the different control groups, namely
community controls and hospital controls, from which it may be decided
which control group is better for this type of study; second to test a
hypothesis that the relative risk of smoking status is the same across the four
data groups. The first purpose may be achieved by comparing the group
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coefficients from the po1ytomous regression. The second purpose may be
achieved by testing a hypothesis as follows;
This hypothesis testing may be achieved by calculating the "I} statistic of the
differences between the - 2 log likelihood of the unconstrained po1ytomous
model with a po1ytomous model in which the coefficients (f3s) of the smoking
status variable are forced to be the same in the two case groups. This can be
done in SPIDA by using a qualifier "equal" in the usual po1ytomous command
(plreg). Since this hypothesis testing assumes that f3controlsmk (either
community, hospital or both control groups) is equal to 0 thus this hypthesis
testing will be done in two ways; firstly by combining both control groups and
secondly by analysing separately using different control groups, namely
community and hospital controls.
5.5.2. Polytomous regression analysis.
Coefficients of the variables analyzed in polytomous regression are
presented in Table 5.13 and Table 5.14 below.
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Reference l!roup = Hospital controls
Exposure variables Estimated ~ coefficients ± standard errors
Conununitv controls Invasive cases In-situ cases
Number of sexual partners
* * *2-3 sexual partners 0.70 ±0.27 0.73 ± 0.32 1.75 ± 0.34
4-6 sexual partners 0.15 ± 0.31 -0.23 ±0.53 *1.42 ± 0.37
~ 7 sexual partners
-0.00 ± 0.59 *0.29 ±0.36 1.88 ± 0.39
Ever had vaginal discharge 0.60 ±0.22'" -0.28 ± 0.33 0.60 ± 0.26'"
Ever pregnant -0.18 ±0.25 1.97 ± 0.61· 0.15 ±0.30
Ever used OCs 1.52 ±0.34· -0.16 ± 0.30 1.84 ± 0.50'"
Ever used "safe period" ' .... 0.08 ±0.39 0.33 ± 0.371.10 ± 0.28
Smoked> 10 cigarettes/day
-0.04 ±0.24 0.71 ± 0.28'" 1.03 ± 0.26'"
Age ~ 40 years -1.36 ± 0.26'" 0.13 ± 0.31 -0.96 ± 0.32·
p < 0.05
Table 5.13. Coefficients and standard errors for the exposure variables in
polytomous regression with hospital controls as reference group.
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Reference i!roup = Community controls
Exposure variables Estimated ~ coefficients ± standard errors
Hospital controls Invasive cases In-situ cases
Number of sexual partners
* *2-3 sexual partners -0.70 ± 0.27 0.02±0.36 1.05 ± 0.34
4-6 sexual partners
-0.15 ± 0.31 -0.37 ± 0.56 *1.27 ± 0.37
~ 7 sexual partners *-0.29 ± 0.36 -0.30 ± 0.62 1.59 ± 0.39
Ever had vaginal discharge -0.60 ± 0.22~ -0.88 ± 0.35~ -0.00 ±0.26
Ever pregnant 0.18 ± 0.25 2.14 ± 0.63'" 0.33 ±0.30
Ever used OCs -1.52 ± 0.34'" -1.68 ±OAl'" 0.31 ±0.57
Ever used "safe period" -1.10 ± 0.28~ -1.03 ±OA2~ -0.77 ± 0.34~
Smoked> 10 cigarettes/day 0.04 ± 0.24 0.75 ± 0.32~ 1.07 ± 0.26~
Age ~ 40 years 1.36 ± 0.26'" 1.49 ± 0.36~ 0040 ±0.37
p < 0.05
Table 5.14. Coefficients and standard errors for the exposure variables in
polytomous regression with community controls as reference group.
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Table 5.13 reveals some similarity between invasive cervical cancer
cases and community controls with regard to variable 2-3 sexual partners.
Whilst between in-situ cases and community controls history of vaginal
discharge and history of pregnancy are similar. Table 5.14 shows that invasive .
cases and hospital controls are similar with regard to the variables seven or
more sexual partners, ever used oral contraceptives, practise of "safe period"
contraceptive and aged more than forty years.
Even though the estimated coefficients of the four data groups, namely
community controls, hospital controls, invasive cases and in-situ cases
revealed some similarities in certain variables, these similarities are too small
to conclude that either one of the two control groups is better for this type of
study. Both tables show that the risk of smoking in community or hospital
control groups is the same.
Table 5.15 - 5.17 present the estimated coefficients and standard errors
for invasive and in-situ cases with both control groups combined, hospital
controls and community controls respectively as the reference group.
The major risk factors variables for in-situ cervical cancer, including
number of sexual partners, use of "safe period" for contraceptive and smoking
appear to be significant across either control groups (Table 5.15 - 5.17). Thus
it may be concluded that either type of control group can be employed to
investigate the risk factors for in-situ cervical cancer in this study population.
Pregnancy and smoking status as risk factors for invasive cervical
cancer are also significant across the three different types of control groups
(Table 5.15 - 5.17). Thus either using community controls, hospital controls
or the combined control group some major risk factors for invasive cervical
cancer may be detected.
Thus, from Table 5.15 - 5.17 it may be concluded that to investigate
risk factors for cervical cancer either community, hospital or combined control
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groups may be employed. This conclusion does not really apply for smoking
variables, as it is shown later there is some difference in the risk of smoking
with regard to the type of control groups employed.
Table 5.18 presents the computation of -2 log likelihood for the
polytomous regression models using combined controls, hospital controls and
community controls. The value of the likelihood ratio tests for the difference
between normal polytomous regression models and constrained polytomous
regression on smoking variable are presented as well.
From this table it can be seen that the risk of smoking between in-situ
and invasive cervical cancer is the same when the combined control group and
the hospital control group are employed (the p values are 0.299 and 0.191
respectively). But this risk is different between in-situ and invasive cervical
cancer when community controls are employed (p value = 0.042). Thus it
may be concluded that more precise estimation is gained when all data
available is used. When hospital control groups was ignored, thus 331
subjects were not included, there was not enough data to detect the difference
that may occur.
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Reference 2roup = Community + hospital controls
Exposure variables Estimated 13 coefficients ± standard errors
Invasive cases In-situ cases
Number of sexual partners
*2-3 sexual partners 0.53 ±0.30 1.43 ± 0.31
*4-6 sexual partners
-0.27 ± 0.52 1.36 ± 0.34
*~ 7 sexual partners
-0.09 ±0.57 1.76 ± 0.35
Ever had vaginal discharge -0.49 ± 0.32 0.29 ±0.24
Ever pregnant 2.03 ±0.61'" 0.25 ± 0.27
Ever used OCs -0.42 ± 0.30 1.48 ± 0.50'"
Ever used "safe period" -0.26 ± 0.37 -0.30 ± 0.33
Smoked> 10 cigarettes/daY 0.71 ± 0.27'" 1.05 ± 0.23'"
Age ~ 40 years 0.52 ±0.30 -0.48 ± 0.32
p < 0.05
Table 5.15. Coefficients and standard errors for the exposure
variables in polytomous regression with both controls
combined as reference group.
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Table 5.16. Coefficients and standard errors for the exposure variables in
polytomous regression with hospital controls as reference group.
Reference 2roup = hospital controls
Exposure variables Estimated ~ coefficients ± standard errors
Invasive cases In-situ cases
Numberofsexualpartne~
0.74 ± 0.32* 1.92 ± 0.35*2-3 sexual partners
4-6 sexual partners
-0.17 ± 0.53 1.42 ± 0.37*
~ 7 sexual partners 0.02 ± 0.59 1.99 ± 0.40*
Ever had vaginal discharge
-0.26 ± 0.33 0.67 ±0.28+
Ever pregnant 1.89 ± 0.62· 0.21 ±0.32
Ever used OCs -0.13 ± 0.30 1.91 ± 0.51'"
Ever used "safe period" 0.09 ±0.39 0.47 ± 0.41
Smoked> 10 cigarettes/day 0.73 ±0.28'" 1.17 ± 0.27+
Age ~ 40 years 0.14 ± 0.31 -0.92 ± 0.34'"
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polytomous regression with community controls
as reference group.
p < 0.05
Table 5.17. Coefficients and standard errors for the exposure variables in
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0.02 ±0.27
0.35 ±0.30
*1.03 ± 0.35
*1.29 ± 0.38
*1.62 ± 0.40
0.55 ±0.60
0.48 ± 0.38
1.04 ± 0.27
-0.81 ± 0.35
0.27 ± 0.37
1.65 ± 0.38
2.61 ± 0.71
-0.02 ± 0.40
-0.50 ± 0.60
-0.10 ± 0.67
-0.90 ± 0.38
-1.26 ± 0.48
-1.64 ± 0.48
Numberofsexualpartne~
2-3 sexual partners
4-6 sexual partners
~ 7 sexual partne~
Exposure variables
Reference
Ever used of OCs
Ever had va inal dischar e
A e~40 ears
Ever re ant
Ever used of "safe
Smoked> 10 cigarettes/da
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TYPE OF CONTROLS POLYTOMOUS REGRESSION p-value
MODELS
(-2Iol! Likelihood. elf)
Nonnal Forced
Combined controls 897.994 899.071 0.299
df = 681 df = 682
Hospital controls 735.559 737.272 0.191
df = 500 df = 501
Community controls 591.213 595.342 0.042
df = 350 df = 351
Table 5.18. Comparison of -2 log likelihood values of polytomous regression
models for different type of controls with regard to
smoking variable.
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5.6. Bias.
4 CU/\.R'
Case-control studies are prone to biases. Some biases that can occur in
,/
a case-control study are incidence-prevalence bias (Neyman bias), selection
bias including Berkson I s bias, and information bias including recall bias, and
misclassification bias. To overcome these biases some authors (Cole, 1979;
Kleinbaum, Kupper and Morgenstem, 1981) suggested the use of more than
one control group, in particular to use hospital and community controls
simultaneously to analyse one data set. When the outcomes of these two
different type of controls are in accordance with each other the conclusion is
strengthened.
The discussion on the possibility of bias in this study is presented in
three sections. The first section discusses biases in the initial studies. The
second section discusses biases in this study. In the third section both control
groups are compared with respect to variables analyzed using polytomous
regression. The purpose of this comparison is to find out whether there are
some systematic differences between the two control groups.
In both initial studies the authors stated that all possible sources of bias
in their studies were already considered (WHO, 1985; Brock, et.al. , 1989).
These studies were incidence case based case control studies, so there is no
possibility for Neyman bias. With regard to information bias, attempts to
validate the questionnaires used in both studies were made. This was done by
comparing the data obtained from questionnaires with their medical records
and comparing answers within certain questions. Also the interviewers were
all carried out by women who had been trained in an unbiased manner of
collecting informations. The interviewers were not aware of the cases Qr
control status of subjects. With regard to the diagnoses, there was no
misclassification bias since all the pathological slides examined in Sydney
were sent to the WHO centre in Geneva to be confirmed by pathologists
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employed by WHO. In the WHO study exclusion was also made to reduce the
possibility of selection bias. Subjects with chronic illnesses that might
influence their use of steroid contraceptives were excluded. Even though the
criteria for exclusion of subjects were the same, Brock and' others employed
community controls in their study. This type of control reduced the possibility
of selection bias with regard to their dietary habit. In both studies the non-
response rates were quite low. In the study by Brock and others using
community controls the response rates were 69 % for cases and 70% for
controls. The two studies also proved that the inclusion of non-response
subjects in the separate analysis did not alter the initial results. Thus there was
insignificant selection bias in the initial studies.
Most of the data provided in this study originated from the WHO study
(1985) and Brock, et.al. study (1989) and these initial studies were not
designed specifically to investigate the association between smoking and Ilo! /; (.. ~,
cervical cancer. Thus 'there is a concern with regard to selection bias in this
study with respect to smoking. Since there were no criteria for exclusion of
subjects with smoking related diseases, and there was no information on
?
subjects I medical history with might alter their smoking habit, it is possible ~ I
that controls were over represented with subjects who had smoking related
diseases. As formulated by Berkson (1946) a person with two or more diseases
has a larger chance of being hospitalized than a person with at most one
disease, thus there is a possibility of Berkson I s bias in this study using hospital
subjects.
At the beginning of this study some subjects were identified as having
had a hysterectomy and these subjects were excluded from further analysis.
There were three in-situ cases, forty four hospital controls and fifteen
community controls who already had had a hysterectomy and thus were
excluded from subsequent analyses. The inclusion of these subjects in separate
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with regard to the diagnoses of cases since these data are taken from as studies
The odds ratio estimated from the comparison with the hospital controls may
be formulated as;
analyses does not alter the results presented earlier. Thus there is no selection
bias with regard to the exclusion of the initial subjects.
As for the initial studies, this study is not prone to Neyman bias since
the data collected were incidence data. Also there was no misclassification bias
conducted by WHO and Brock, et.al.
Coughlin (1990) suggested that self reported events tend to be distorted
in a socially desirable direction and behaviours which are associated with a
social stigma or are perceived to be personally threatening are often under-
reported. For example cigarette smoking especially among adolescents or
announced quitters may be denied or minimized. Thus there is a possibility of
recall bias with regard to smoking variables in this study.
The studies on in-situ cases can be formulated as follows;
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between hospital controls and community controls may be formulated as;
From Equation (1) and (2) the odds ratio estimated from the comparison
ORhOSPilal
ORhosPVlcomm =OR .
commumty
(2)
(3)
ad'
ORcommunity =bel
cd'
ORhosPVlComm = del
Meanwhile the odds ratio estimated from the comparison with community
controls is as follows;
or
Equation (3) means that if ORhosp vs comm = 0.5, ORcomm is half the value
of ORh and if ORh is 2, OR is twice the value of ORh .osp osp vs comm comm osp
Thus a value of ORhosp vs comm above unity indicates that the hospital controls
more often reported that they have been exposed compared to community
controls and vice versa.
Using Equation (3) hospital and community controls variables analyzed
in polytomous regression are presented in Table 5.19.
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
,I
I
I
I
I
I
,I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
VARIABLE TYPE OF CONTROL GROUPS ORhosp vs comm
Hosnital Community
Smoking status
Never smoked 212 106
Ever smoked 119 75 0.8
Number of cigarettes smoked/day
ocigarette/day 212 106
1-10 cigarettes/day 33 18 0.9
11-20 cigarettes/day 57 30 0.9
21-30 cigarettes/day 25 23 0.5
> 30 cigarettes/day 4 4 0.5
Number of sexual partners
0-1 sexual partner 224 83
2-3 sexual partners 50 43 0.4
4-6 sexual partners 33 31 0.4
~ 7 sexual partners 24 24 0.4
Pregnancy status
Nulliparous 78 52
Parous 253 129 1.3
History of vaginal discharge
Never had vaginal discharge 246 93
Ever had vaginal discharge 85 88 0.4
History of use of DCs
Never used DCs 131 13
Ever used DCs 200 168 0.1
History of use of "safe period"
Never used "safe period" 292 147
Ever used "safe period" 39 34 0.6
Table 5.19. The odds ratios of comparison between hospital and community
control groups.
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From the hospital vs community odds ratios presented in Table 5.19, it
may be concluded that there are some differences in the odds ratios for in-situ
cervical cancer cases caused by the application of different control groups,
namely hospital and community control groups. These differences are
observed in smoking status, number of cigarettes smoked per day, number of
sexual partners, pregnancy status, vaginal discharge experience, oral
contraceptive use and "safe period" practise. From this result it is still difficult
to make a conclusion whether these differences are a refl~~n of true
differences in exposure between hospital population and community population
or due to information bias or selection bias, for instance Berkson I s bias.
5.7. Conclusion.
In this chapter smoking is established as an independent risk factor for
in-situ cervical cancer with community controls and invasive cervical cancer
with hospital controls.
Based on the mathematical modelling of cervical cancer it may be
concluded that there are some differences with regard to the independent risk
factors for in-situ and invasive cervical cancer. These differences were also
observed in the analysis of in-situ cervical cancer using different control
groups namely hospital controls and community controls. These differences
are also confmned by the outcome of the polytomous regression analysis
conducted for some variables.
The possibility of bias in the inital studies and particularly in this study
have been discussed. From the computation. of the hospital vs community odds
ratios it may be concluded that there are some differences with regard to
certain exposure variable between hospital and community populations. It still
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cannot be concluded whether the differences observed is a true differences or
is the result of information or selection biases.
Even though smoking is established as one of independent risk factors
for in-situ and invasive cervical cancer in this study, this outcome is still
inconclusive since this study failed to control for a strong risk factor for
cervical cancer which has recently been identified, i.e. the history of the
infection of Human Papilloma Virus type 16 or 18 (Herrero, et.al. , 1989;
Munoz, Bosch and Kaldor, 1988; Franscheschi, et.al., 1983)
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CHAPTER 6.
DISCUSSION AND CONCLUSION
6.1. Introduction.
In this section risk factors for cervical cancer that have been identified
in this study are presented in relation to the research questions. These research
questions are as follows;
1. What were the other risk factors associated with in-situ or invasive cervical
cancer in this particular study population ?
2. Were risk factors the same for in-situ and invasive cervical cancer in this
particular study population ?
3. How large was the association between cigarette smoking and in-situ and
invasive cervical cancer in this study population after allowing for other
independent risk factors ?
In the next section the answers to these research question are discussed.
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6.2. Summary of risk factors for cervical cancer identified in this study.
6.2.1. Risk factors for in-situ cervical cancer (community and hospital
controls).
A final analysis of all the main variables found to be associated with
in-situ cervical cancer compared to community controls is given in Model 2
(chapter 5). Some variables including number of sexual partners, smoking
status, induced abortion experience and practised of the "safe period"
contraceptive were identified to be related with an increased the chance of
developing in-situ cervical cancer. Table 6.1 summarises the answer to the
first and the third research questions posed above.
Women who had 2-3 sexual partners have twice the chance of
developing in-situ cervical cancer, while for women who had had 4-6 sexual
partners and seven or more sexual partners the chances are 3 times and 4.5
times respectively compared to women who had 0-1 sexual partner. Women
who have ever smoked have twice the chance of developing in-situ cervical
cancer compared to women who never smoked. The number of cigarettes
smoked per day shows a trend. Women who smoke more than 20 cigarttes per
day are at the higher risk; the chance of developing in-situ cervical cancer for
these women is eight times compared to women who have never smoked.
Women who had ever had induced abortion have twice the chance of
developing in-situ cervical cancer compared to women who never had any
induced abortion. Practise of "safe period" contraceptive gives protection
against in-situ cervical cancer. Women who have never practised "safe period"
contraception have almost three times the chance of developing in-situ cervical
cancer compared to women who practise "safe period" contraception. As
there is no a priori reason why practise of "safe period" contraception reduces
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the risk, this attitude may relate to certain behaviour which is not investigated
in this study.
The final analysis for in-situ cervical cancer with hospital controls was
presented in model 4 (chapter 5). In this model the number of sexual partners,
smoking status, years of education of spouse, induced abortion experience,
spirit drinking habit and use of oral contraceptives were found to be
significantly associated with an increased risk of developing in-situ cervical
cancer.
Women who have had 2-3 sexual partners have 5 times the chance of
developing in-situ cervical cancer compared to women who had 0-1 sexual
partner. Meanwhile for women with 4-6 sexual partners and seven or more
sexual partners the chances are twice and three times respectively compared to
women with 0-1 sexual partner.
In contrast with the community controls, In the study with hospital
controls the association between in-situ cervical cancer with smoking status
showed to be only marginally significant (p = 0.05). Women who ever
smoked had 1.7 times the chance of developing in-situ cervical cancer. There
was no linear trend observed in the analysis of number of cigarettes smoked
per day. The only category of number of cigarettes smoked per day
significantly associated with an increased risk of developing in-situ cervical
cancer was women who smoked 11-20 cigarettes per day. The risk for this
category was two compared to women who never smoked.
Induced abortion experience is strongly associated with in-situ cervical
cancer. Women who have had an induced abortion have five times the chance
of developing in-situ cervical cancer compared to women who have never had
an induced abortion.
Women who drink spirit have twice the chance of devloping in-situ
cervical cancer.
213
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
In contrast to the study with community controls, the study with
hospital controls showed that use of oral contraceptives increases the chance of
developing in-situ cervical cancer. Women who have ever used oral
contraceptives have four times the chance of developing in-situ cervical cancer
compared to women who have never used oral contraceptives. However the
total duration of oral contraceptive use is not associated with an increased risk
of developing in-situ cervical cancer in the study with hospital controls. Table
6.2 summarises these answers to the first and the third research questions.
As can be seen from Table 6.1 and 6.2. there are some differences in
the pattern of risk factors for in-situ cervical cancer. Community controls
identified number of sexual partners, smoking status, induced abortion
experience and practise of "safe period ll contraception as risk factors. In
contrast hospital controls did not identify practise of "safe period"
contraceptive as a risk factor for in-situ cervical cancer. In addition to the risk
factors identified in the community controls, hospital controls identified
duration of spouseeducation, spirit drinking habit and use of oral
contraceptives as risk factors for in-situ cervical cancer.
Thus from the findings in the study of in-situ cervical cancer with
hospital and community controls it may be concluded that the identification of
"minor" risk factors for in-situ cervical cancer depends on the type of control
group. These differences may reflect the different pattern of exposures
between a hospital population and a community population or be the result of
bias, such as selection bias, Berkson I s bias or recall bias.
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Variable Adjusted odds ratio 95% confidence intervals
(reciprocal)
Number of sexual partners
0-1 sexual partners 1.00
2-3 sexual partners 2.44 1.21,4.91
4-6 sexual partners 3.14 1.48,6.66
> 7 sexual partners 4.52 2.11,9.69
Ever smoked 2.30 1.35, 3.90
Number of cigarettes smoked/day
Never smoked 1.00
1-10 cigarettes/day 1.62 0.87,3.03
11-20 cigarettes/day 2.94 1.45,3.94
> 20 cigarettes/day 8.51 2.03,35.58
Induced abortion experience 2.15 1.12,4.16
Never practised of "safe period" 2.81 1.39,5.65
Table 6.1. Adjusted odds ratios of risk factors for in-situ cervical cancer cases
with community controls.
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Variable Adjusted odds ratio 95% confidence intervals
(recinrocal)
Number of sexual partners
0-1 sexual partners 1.00
2-3 sexual partners 5.28 2.47, 11.32
4-6 sexual partners 2.39 1.06,5.42
~ 7 sexual partners 3.89 1.59, 9.56
Age at first intercourse less than
20 years 1.15 0.60,2.20
Ever smoked 1.76 1.00, 3.11
Number of cigarettes smoked/day
Never smoked 1.00
1-10 cigarettes/day 0.49 0.18, 1.31
11-20 cigarettes/day 2.43 1.23, 4.81
21-30 cigarettes/day 2.18 0.92,5.17
> 30 cigarettes/day 2.08 0.34, 12.59
Spouse education of more than 12
years 3.48 1.49, 8.10
Induced abortion experience 5.87 2.45, 14.07
Ever had vaginal discharge 1.53 0.85,2.76
Wine drinking habit 1.77 0.93,3.36
Spirits drinking habit 2.14 1.17,3.94
Ever used of oral contraceptives 4.09 1.37,12.18
Ever used of condoms 1.78 0.92,3.45
Table 6.2. Adjusted odds ratios of risk factors for in-situ cervical cancer
cases with hospital controls.
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6.2.2. Risk factors for invasive cervical cancer (hospital controls).
The analysis for invasive c.ervical cancer with hospital controls gives a
different pattern with regard to the risk factors for cervical cancer (see Model
6 in chapter 5). Sexual factors do not show up as significant risk factors for
invasive cervical cancer in this study population. On the other hand pregnancy
status is a major risk factor for invasive cervical cancer in this study
population. Parous women have almost five times the chance of developing
invasive cervical cancer compared to nulliparous women.
Smoking status is still significantly associated with increased risk of
developing invasive cervical cancer. Women who have ever smoked have
almost twice the chance of developing invasive cervical cancer. However the
analysis involving number of cigarettes smoked per day does not reveal any
significant association with invasive cervical cancer.
In the in-situ cervical cancer study the risk of developing cervical
cancer was higher in a higher socio-economic level as it was reflected by a
higher spouse education. In contrast with this, the risk of developing invasive
cervical cancer was higher in the lower socio-economic level as it was
reflected by type of employment. Women who were engaged in an unskilled
occupation had twice the chance of developing invasive cervical cancer. These
differences may reflect the difference with regard to medical care access since
in-situ is the pre-cursor form of invasive cervical cancer, so women with more
access to medical careare treated earlier than women with less access to
medical care. These differences may reflect a difference in the level of
medical knowledge between these populations.
Women who drink beer have almost twice the chance of developing
invasive cervical cancer. Table 6.3 presents this summary of risk factors for
invasive cervical cancer.
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Variable Adjusted odds ratio 95% confidence intervals
(reciprocal)
More than two sexual partners 1.22 0.67,2.20
Age at first intercourse less than 20
years 1.47 0.83,2.63
Ever smoked 1.83 1.07,3.15
Number of cigarettes smoked/day
Never smoked 1.00
1-20 cigarettes/day 1.71 0.94,3.11
> 20 cigarettes/daY 2.17 0.96,4.92
Ever pregnant (parous women) 6.60 1.91,22.87
Self engaged in unskillediob 2.20 1.15,4.20
Beer drinking habit 1.97 1.13,3.45
Table 6.3. Adjusted odds ratios of risk factors for invasive cervical cancer
with hospital controls.
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6.3. Risk factors for cervical cancer. Discussion.
Risk factors for cervical cancer have been extensively reviewed (Doll,
1988; Brinton and Fraumeni, 1~86; Hakama, 1983). Epidemiological studies
have shown that cervical cancer behaves like a sexually transmitted disease
(Doll, 1988). Thus cervical cancer is more common among women who have
had multiple sexual partners (Tokuhata, 1967; Brinton, et.al., 1990) or whose
spouses are promiscuous (Buckley et.al, 1981; Tokuhata, 1967) and cervical
cancer is not observed in virgin (Gagnon, 1950 in Doll, 1988).
Additional evidence suggests that cervical cancer is caused by sexually
transmitted infection (Doll, 1988). Even though for more than 20 years
attention has been focused on Herpes Simplex virus type 2, its possible role in
cervical cancer is still unclear. The current evidence shows that certain types
of Human Papilloma virus especially type 16 and 18 play a key etiological role
(Francheshi, et.al., 1983).
In addition to sexually transmitted infectious agents other factors
including cigarette smoking (Brinton, et.al., 1990; Greenberg, et.al., 1985),
method of contraception (WHO, 1985; Harris, et.al. , 1980) reproductive
factors (Brinton, et.al. , 1989) and certain dietary factors (Brock, et.al. , 1989;
Marshall, et.al. , 1983) are found to be associated with increased risk of
cervical cancer. In the next section the fmdings in this study are discussed in
relation to other studies.
6.3.1. Sexual factors.
Various indicators of sexual activity have long been associated with
cervical cancer (Hulka, 1982). The major indicators of sexual activity
associated with cervical cancer are number of sexual partners and age at first
intercourse (Hakama, 1983). These two risk factors are highly correlated with
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each other and very few studies have attempted to separate their effects
(Hulka, 1982). Harris, et.al. (1980) found that the effect of age at first
intercourse is confounded with the effect of number of sexual partners. In
contrast Reeves, et.al. (1985) found that the effect of age at first intercourse
particularly for in-situ cervical cancer is independent of the effect of number
of sexual partners.
In this study number of sexual partners was found to be strongly
associated with increased risk of developing cervical cancer, particularly in-
situ cervical cancer. Women who had had seven or more sexual partners have
four times the chance of developing in-situ cervical cancer. However this
finding was not observed in the invasive cervical cancer study. The null effect
associated with number of sexual partners in the invasive cervical cancer study
may be due to information bias since women in this study did not accurately
give their actual number of sexual partners.
In this study early age at first intercourse is confounded with number
of sexual partners. Based on the crude odds ratio, age at first intercourse is
significantly associated with increased risk of developing in-situ cervkal
cancer. After adjustment for the number of sexual partners this effect is
diminished (chapter 3).
Thus the finding of this study with regard to sexual factors is in
accordance withthose of other studies of the risk factors for cervical cancer.
6.3.2. Cigarette smoking.
The association between cigarette smoking and cervical cancer was first
proposed by Winkelstein (1977). Subsequently a number of case-control and
cohort studies have reported an excess risk of cervical cancer among smokers.
The summary of these findings is presented in Tables 1.1 and 1.2.
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Based on these Tables, most studies where adjustment was made for
the two major risk factors for cervical cancer, namely number of sexual
partners and early age at first intercourse show a significant increase in the
risk of developing cervical cancer. A study by Herrero, et.al. (1989) in which
adjustment was made for history of infection of Human Papilloma virus type
16 and 18 showed a significant increase in the risk of developing invasive
cervical cancer among smokers.
Section 4 and 6 of chapter 1 of this paper summarise the biological
plausibility of cigarette smoking as a risk factor for cervical cancer.
In this study cigarette smoking is found to be associated with increased
risk of developing in-situ and invasive cervical cancer. The relative risk
varies from 2.3, 1.7 and 1.8 for in-situ cervical cancer with community
controls, in-situ cervical cancer with hospital controls and invasive cervical
cancer respectively. In the study of in-situ cervical cancer with community
controls a dose-response relationship between number of cigarettes smoked per
day and the increase risk in developing in-situ cervical cancer was also
observed. Women who smoke more than 30 cigarettes per day have 8.~ times
the chance of developing cervical cancer compared to women who never
smoke.
Thus in this study, cigarettes smoking has been established as one of
risk factors for cervical cancer.
6.3.3. Contraceptive practices.
The relationship between oral contraceptive use and cervical cancer has
been investigated in various epidemiological studies with conflicting results
(Brinton, et.al., 1990; Clarke, et.al., 1985; Greenberg, et.al. , 1985; WHO,
1985; Reeves, et.al, 1985; Harris, et.al., 1980). These results may be due to
bias since the use of oral contraceptives is highly correlated with the major
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risk factors for cervical cancer, namely number of sexual partners and age at
first intercourse (Swan and Pettiti, 1982). Two recent well controlled case-
control studies have shown an increased risk of in-situ cervical cancer for long
term pill users (Brinton, eLal., 1990; WHO, 1985). The WHO Collaborative
study of Neoplasia and Steroid contraceptives (1985) gave evidence that use
of oral contraceptives is related to invasive cervical cancer (OR = 1.2-1.5).
J
In this study oral contraceptives are significantly associated with the
increase risk in in-situ cervical cancer (hospital controls). Women who had
ever used oral contraceptives have four times the chance of developing in-situ
cervical cancer.
The barrier method of contraception including condoms and
diaphragms (Celentano, et.al. , 1987; Fasal, et.al, 1981); "safe period"
contraceptive method and tubal ligation (Brock, et,al. , 1989) appear to give
protection.
In this study practise of "safe period" contraceptive appears to give
protection against in-situ cervical cancer (community controls). Women who
never practise "safe period" contraception have almost three times the chance
of developing in-situ cervical cancer.
6.3.4. Sodo-economic factors.
In his review of cervical cancer Hakama (1983) found that the risk of
developing cervical cancer was three times higher in the poorest area of
Copenhagen compared to that in the richest area, and in Finland the risk of
cervical cancer was also highest among women with low sodo-economic status
and low level of education.
In the analysis of in-situ cervical cancer with hospital controls, it was
found that the risk is higher among women whose spouse had more than 12
years of education (OR = 3.5). In contrast the risk of invasive cervical cancer
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is highest for women who engaged in unskilled jobs (OR = 2.2). With regard
to the natural development of cervical cancer, this disparity may be explained
by a bias due to access to medical care. Women with higher socio-economic
level had greater access to medical care compared to women of lower socio-
economic level.
6.3.5. Other risk factors.
This study found that induced abortion experience and spirit and beer
drinking habit are associated with inreased risk of developing cervical cancer.
These findings is not supported by other studies.
Women who have ever had an induced abortion have twice (in-situ
community controls) and five times (in-situ hospital controls) the chance of
developing in-situ cervical cancer. This fmding exists across· two different
control groups. Thus it is not likely that this association is a product of bias.
Thus the association between induced abortion experience and in-situ cervical
cancer needs to be investigated further.
Women who drink spirits have twice the chance of developing in-situ
cervical cancer (hospital controls) and women who drink beer have almost
twice the chance of developing invasive cervical cancer. The association
between drinking habit and cervical cancer is found in the study using the
hospital control group. Drinking habit may be used to measure the socio-
economic level of subjects. Since hospital group was not match on socio-
economic status, the association between drinking habit and cervical cancer .
may be due to bias on sodo-economic status. .( .)
'<;)~).l(
223
'I
,I
I
I
I
I
I
I
I
,I
I
I
I
I
I
I
I
I
I
I
I
6.4. Conclusion.
In this chapter the risk factors identified to be associated with in-situ
cervical cancer and invasive cervical cancer are summarised (Table 6.1 - 6.3).
Major risk factors including smoking status and sexual factors are found to be
associated with increased risk of developing cervical cancer..
The study on in-situ cervical cancer with different control groups
namely hospital and community controls revealed a different pattern with
regard to the risk factors. It is still uncertain whether this difference is a true
difference with regard to different exposure toward the hospital and
community populations or as the result of biases including selection bias,
admission bias, information bias and recall bias.
With regard to the smoking variables, the finding in this study is still
inconclusive since this study was not specifically designed to investigate the
association between cigarette smoking and cervical cancer and also this study
fails to control for another major risk factor for cervical cancer namely history
of infection of Human Papilloma Virus (Herrero. 1990). Thus in order to
establish cigarette smoking as a risk factor for cervical cancer it is still
necessary to further investigate the history of Human Papilloma Virus
infection in this study populations.
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PROJECT 78912 : CoLLABORAIIVE STUDY OF NEOPLAS'IA AND
STEROID CONTRACEPTIVES
FACE SHEET OF FORM 1I
AP?ENDIX 1. 01HGT:-1AL IV'HO nllr:;;Sn():-';NAI~E.
f.i_~~. rJ~
WORLD HEALTH ORGANIZATION
ORGANISATION MDNDIALE DE LA SAHTE INTERVIEW
(others)
Hosp-Centre ital Subject Nb.Form code Project No.
.............................................................................................................
. ..
.... • .o .o.o.o .. .o.o.o.o .. .o.o .o .o.o.o .o
Identification Nos. Q I U 718 19 1 2
--I-..I..-JL...J-.J--I,.-lI...:-V...l;-:-(..:l--I.~~~
Name of subject .••.•.•.•..••••.•..••.••.. (family)/........••••••••••••••••
Address of subject
July 1979
2.
1.
3.
I
I
I \
I
I
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10.2 Referral source: •••.•.••••••••••••••••••.••..••••••••••.•••.•.••••••.•••••
(see instructions for code)
12
12.1
05 V
o 6.V
0 8 ~.
CIIII]74/
9V~~~~O
10
aD vll
LU·lO.l
JI
.0 10. ~
\J l '(0 10•3
.............................................................................
(specify)
Subject's medical record number ••••••••••••••••••
Provisional diagnosis at admission:
6. This subject is a: case(O), control(l), ineligible. case(2),
ineligible control(3)
7. (For matched controls in Chile only) Subject number of corresponding
~
9.
4.
5. Pay status of.subject (local code, see instructions)
8. Type of case or control: breast(l), cervix,(2), corpus uteri(3),
ovary(4), liver(5), gallbladder(6), multiple tumour types(7),
unmatched control(8), control matched to a specific case(9)
11. Place of interview: hospital(l), clinic(2), home(3),
13. Date of therapeutic surgery (000000 = no therapeutic surgery)
12. Date inte~iew completed
'of
13.2 Second,. pathology form co:!:pleted f~r this case (same code.as in 13.1, 8 = no
second 'p,athology form),
12.1 Interviewer ...•..................... e·e •••••••• # ••••••••••• (local
,\' . ....13.1 Type of pathology form completed for this case (0 = nota case,
/ 1 = Form 2.1, 2 = Form 2.2, 3 = Form 2~3, 4 = Form 2.4, 5 = Form 2.5)
10.1 Age at diagnosis or admission (99 = u?known age)
10. Date of diagnosis or admission
.10.3 Presenting symptoms of women with cancers of the ovary, cervix and corpus
, uteri:
Dnone (detected by routine cytology only(O), 0 vaginal bleeding(l)
,00ther(2) ••••••••.•••--:•••••.••••••••••••••• , 0 ~nkI;Qwn (9)
. specify·
c=Jnot a woman with cancer of the ovary, cervix or corpus uteri(8)
.,
>
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I
I
I
1
1
I
.1
!
I
1
1
'I
J/--.----.
1,.\'
- 2 -
I INTERVIEW
I (Read the statement that explains the study and ask permission to beginthe interview. After obtaining the patient's consent, begin).
I GENERAL INFORMATION
\) 1.3' 0 15.:
(local code)
name of country or locality
. .Where ~ere you born?
That means you were how old at your last birthday?
15.1 (Record accuracy of estimate of date of birth.
o = exact date of birth known, 1 = year of birth determined,
2-8 = year of birth believed by interviewer to have been
estimated to within ± 2, 3 ••• 8 years of actual year, .
9 = year of birth believed to have been estimated to no
closer than ± 9 years of actual year)
16.
14. When were you born? (PROBE)
I would like to start by asking you a few general questions about you and
your background.
I
I
I
I
(If not in Israel, code 97)
16.2 (In Israel, for those born outside Israel ask) In what
year did you immigrate to Israel? (96 = born in Israel,
98 = unknown year of immigration)
I
I
I
16.1 (In Israel ask) Where was your mother born?
Where was your father born?
.................
.................
I
I
I
I
I
-_.-.-.. - -------
--------
- 3 -
I
I
I
MEDICAL HISTORY
Now I am going to ask you some questions about illnesses that you may have had
in the past, and the kinds of treatments that you may have received.
17. First, I am going to read a list of diseases to you. Please tell
me whether you have ever had any of them Lbefore you developed the
problem that brought you into the hospital no37. (For healthy
controls, omit the portion of the last sentence in square brackets):
17.3 Where and when were you treated for this condition? ••••••••••
(If answer to G is No, code Os and if DK, code 9s in Ql7.l, 17.2 and
"i:t'O l7K V
l{l-D 17L V
51 0 171
'1.0 0 l7J
~3 D17C
'?If 017D
::t.r 017E
)(;:·tJ l7F ~
~:rD l7G V
fff 017R
17.5, andgotoQ18)
.~LLU 17.1
v~~
EO 17.2
D
o
o
o
year
.............
o
o
o
o
..................................
D
o
site or type
No(O) Yes(l) DK(9)
0 0 D
0 0 0
0 0 0
0 c=J 0
0 0 0
D 0 0
.0 0 c=J
0 0 0
L) ovarian cyst:
K) tuberculosis
D) stomach ulcer
E) stroke
F) diabetes
G) cancer
H) gallbladder disease or gallstones
I) yellow jaundice during pregnancy D
J) jaundice at any other time c=J
17.2 When did you first learn that you had that cancer?
(98 = unknown year)
17.1 What kind of cancer did you have?
(use WHO ICn-9 code)
? ;t A) high blood pressure
" " B) heart trouble or heart diseaseq )::'"
~ ,('j, C) blood clots in your legs(thromboembolism)
( ~lj
~ tI"
9 ~~..
( ;(
~
- (
e
"~
I
I
I
I
I
I
I
I
I
I
I
I ......................................................................
17 .. 4 Validation .
...........................................................................
Source of information coded in Ql7.l and Q17.2
(code 1 = interview only, 2 = validated from medical records)
v~
_. 0 17 •5
------_. , ..__.~..--
.._----~. -.~.~---_ .. _..
17.5
I'
I
I
I!
I
~------
- 4 -
~ow I would like co ask you abouc any operacions chac you may have had ~prior co
chis hospiCalizacio.!i7 PROBE
When Validacion (dia~nosiS.
Answer ('1r) Where ",as chis done opeIadon, yeBr & ath. No)
18. Have you ever had an Ono
operation to prevent you 19••••
from becoming pregnant, Dyes
such as a tubal ligation ODK
or your cubes tied?
19. Have you ever had an Ono 19••••
operation to remove your Oyes
"'omb or uterus? (If No ODK
or DK go co Q20)
19.1 Reason •••••••••••••••••
19.2 Did they take out either Ono
of your ovaries at that
Cime? (If No or DK go Dyes
to Q20) DDK
19.3 How many? ·.............
20. Have y'ou ever had any Ono~the17 operation to Oyes 19••••
remove either of your
ovaries? (If No or DDK
DK go to Q21)
20.1 How many ovaries ",ere
removed then? ..........
20.2 Reason •••••••••••••••••
21. Have you ever had an Ono first
operation to scrape out Oyes
and examine the lining ·.....
of your womb? This is ODK
year
-
sometimes called a "D&C"
or dilatation and last -
curettage. (If No or ·.....
DK go to Q22) year
21.1 How many? ·.............
21.2 Reason(s) ·.............
~._ 22. Have you ever had an [no 19••••
operation on your tubes yes
because you were unable ODT
to have a baby (Tubal
surgery for infertility)?
23. Have you ever had a baby Ono first
delivered by Caesarian Dyes
section (include ODK ·......
hysterotomy for third year
trimester abortion)?
last
(If no or DK, go to Q24)
·......
23.1 How many times? ........ year
'24. Have you had any other Ono
operations on your Dyes 19 •••
female organs? (If No OKor DK go co Q25)
24.1 Reason(s) ..............
25. Have you had any other Ono 19 •••
operations on your Oyes
abdomen or stomach? (If
No or DK go co Q26) o DK
25.1 Reason(s) ..............
I
I
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I
I
I
I
I
I
I
I
I
I
I
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I
I
I
1lIl!!!l~....!::='l__..,.,...- -----.- - -. - ---------------_. -.- -- ---_..-.--------
.--------~------
I \ \
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(Code the following)
A) Tubal ligation: 1) 0 ~ No, 1 ~ Yes, 9 ~ Unknown
/DAl \ltrb
ETIA2 VYf
--7 0 A4\SL~ E
V On \J.YfI
,r-
ffiB2 \l r-o
3) reason (0 ~ no hysterectomy, 1 ~ benign condition, 2 ~ cancer,
8 = unknown reason, 9 = unknown if had hysterectomy)
2) year of hysterectomy (00 = no hysterectomy, 98 = unknown year,
99 = unknown if had hysterectomy)
2) year of tubal ligation (00 ~ no tubal ligation, 98 = unknown
year, 99 = ur~nown if had tubal ligation)
4) source of information (1 ~ interview only, 2 ~ validated,
9 = no information)
Hysterectomy: 1) 0 = No, 1 - Yes, 9 = UnknownB)
f
~
r
I
I
I
I
I
I
4) source of information (1 = interview only, 2 ~ validated,
9 = no information) o B4 Vf7-
2) year of most recent oophorectomy (00 = no oophorectomy,
98 = unknown year, 99 = unknown if had oophorectomy)
3) reason for oophorectomies (0 = no oophorectomy, 1 = benign
ovarian condition, 2 = ovarian cancer, 3 = both, 4 = above
uterine condition, 5 = other, 8 = unknown reason, 9 = unknown
if had oophorectomy)
o C3 \l~J
ffiC2 vry
validated,
one, 2 = two,
unknown if ovaries
interview only, 2
number of ovaries removed (0 = none, 1
8 ~ one or two but number unknown, 9 =
removed)
1)
4) source of information (1
9 = no information)
.C) Oophorectomy:
1I
I
I
,I
I
I
I
I
D) Dilatation and curettage
1) number of D and Cs (0 = none, 1 = one, 2" two,
6 = siX, 7 = seven or more, 8 = unknown number,
9 ~ unknown if had D and C)
2) reasons (0 = no D and C, 1 = for induced or after spontaneous
abortion, 2 = diagnosis of previous uterine cancer, 3 = both,
4 = benign uterine condition such as hyperplasia or polyp,
5 = 1 and 4, 6 2 and 4, 7 = 1 and 2 and 4, 8 = unknown
reason only, 9 = unknown if had D and C
4) source of information (1 ~ interview only, 2 = validated,
9 ~ no information)
I
I
I
I
:..I!I'l:IIl~ ._ -- ...
. ..._.._._---_._---------_..._......,...- .-. -- ..-- ..., _._-----------
I - 6 -
I
,{
5
E) Tubal surgerv for infert:ility: 1) 0" No, 1,. Yes, 9 '" Unknown
V year of operat:ion (00" no surgery for infert:ility, 98 - unknown
year, 99 - unknown if had surgery for infertility.
4) source of information (1 ,. int:erview only, 2 - validat:ed,
9 - no informacion)
tJOEl J_~O/
.rnE2 \ibl
Caesarian seccions (including hvscerocomies):
4) source of informacion (1 • incerview only, 2 2 validated,
9 • no information)
LBefore this hospitalizatioBl have you ever had any operations
or biopsies for benign lumps fn either of your breascs?
DF4 Vb\(
OGl ~..br
DRl ~_.~l.
o DK(9)DYes(l) ;o No(O) ;
OthernkKeracions on female organs (from item 24:1) 0 2 no, 1 2 yes,
9"'u own
Other abdominal operations: 1) 0 2 No, 1,. Yes, 9 '" Unknown
1) code number of caesarian seccions (0 2 none, 1 2 one, ••••
7 2 seven or mo~e; 8 • unknown number, 9 '" unknown if
ever had caesarian seccion)
F)
H)
26.(
I
I
I
I
I
I
I
I
l.8
(If No code Os and if DK code 9s in Q2 6.1 to 26.5B and go to Q27)
26.1 How many differenc times? •••••••• (0'" none, 12 one,
2'" two, •.• ~ .•• 6'" six, 7 = seven or more, 8 • unknown
number, 9 '" unknown if ever had breast biopsy)
26.2 When was che first time? LWhen was chiil (PROBE)
(98 = unknown date, 99 = unknown if ever had breast biopsy)
2,6.3 Where was the first j;here w~s chiil biopsy performed?
I
....................................................................................................................
26.4 Validation (include pathology number) .••.•••••••.••••••••
I
I
I
I
......................................................................................................................
26.5 H~stologic diagnoses of first benign breasc lesion (from
validation) (Mark an "x" in each box that is applicable)
c:J no validation (0)
c:J inflammatory or infectious condition only (1)
c:J fibroadenoma (3)
c:J nipple adenoma (4)
c:J fibrocyscic disease without mention of epithelial
hyperplasia or papillomatosis <s)
I
I
r-1 fibrocystic disease with epithelial hyperplasia
LJ or papillomatosis (6)
c:J intraductal papilloma (7)
c:J other •••••••••••••••••••••••••••••••••••••••• (2)
specify
I
I
From 26.5 code:
A) Primary diagnosis (code highest code number)
B) Secondary diagnosis, if any (code second highest code number.
If there is only one diagnosis, code 8; if no validacion,
code 0).
o 'V (-0
26.5A:
o J~I26.SB
__H. ..,..-_
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REPRODUCTIVE HISTORY
~ • How old were you when you first began to menstruate? (PROBE)
DDK(9)O· yes(l)
Let' s begin with your first pregnancy (PROBE and complete the
following table)
o no(O) 0 yes(l) 0 DK(9)
(If no, code Os and if DK code 9s in items A-R following the table, and in
Q30 and Q30.1, and go to Q31).
29. Now I would like to ask you about any previous pregnancies that yo.u
may have had. I would like to know about any time that you were
pregnant, even if the pregnancy did not end with the birth of a
live baby. Have you ever had any type of pregnancy? (PROBE)
28. Are you pregnant now? 0 no(O)
1
I
I
I
I
I
I
I
I
I
I
I
I
I
(1) (2) .(~)
(4) (5) (6)
How old Did this pregnancy Were you given
were you end with the birth of pills or For how many
Were you gi
Pregnancy when this a live
baby? (If injections to help months did you any pills
c
No. pregnancy not as
k) How did it you to keep from breast feed in
jections
ended? end?).
*
loosing your the child?
dry up yOUl
(years) (PROBE) baby?
breast mill
1
-
2 -
TOTAL
Record outcome of each pregnancy as follows:
pregnancy)
I
I·
I
*
live birth
stillbirth
miscarriage (spontaneous abortion)
induced abortion
abortion, unknown type
ectopic pregnancy· (tubal
hydatidiform mole
unknown (unknown outcome)
.- -- .. ------
---_._--_._---
------
J,;J81 rn Z9Q
....
V8oED2~
'- \) (J I CD2$G
~zJrn9H
. ,y.\H LD29I
:v{)(1\{ ,crn29J
/. "M"'~\l8roZ9K~.ab"D29L
V\J;~'fm29M
,/IJ&D9N
J ~:.81' [I}90
V ~Cfc{II19P v
Age at first live birth (g7 = previously pregnant but no live
birth, 98 = unknown age)
Age at end of first pregnancy (98 = unknown age)
Age at last (most recent) pregnancy (98 = unknown age)
Age at first breast feeding (97 = previously pregnant but
never breast fed, 98 = unknown age)
Number of known stillbirths
Outcome of first pregnancy (1 = 1ivebirth, 2 = stillborn,
3 = miscarriage, 4 = induced abortion, 5 = abortion, unknown type,
5 = ectopic pregnancy, 7 = hydatidiform mole, 8 = unknown outcome
Number of known- live births
Number of known miscarriages (spontaneous abortions)
Number of known induced abortions
Number of known abortions of any kind
Number of known ectopic pregnancies
Number of known hydatidiform moles
Total number of known pregnancies
Number of pregnancies after which child was known to have been
breast fed
Number of pregnancies during which pills or injections were
known to have been given for maintenance of pregnancy
Total known months of breast feeding
G)
I)
D)
J)
0)
P)
- 8 -
(Code the following:)
Q1 Number of years since woman last breast fed (66 = less than
1 year, 01 = from 1 up to but not including 2 years, OZ = from
2 up to but not including 3 years, etc., 77 = never breast fed.
88 = unknown number of years since last breast fed. 99 = unknown
whether ever breast fed).
~1r C)
iI ~ 1S- A)
!~ [G B)
I
I
I
I
I
I
I
I
I
I~
I
I
I'
I
~ ....\0 .:::; -
R) Number of pregnancies after which pills or injections were known
to have been given to suppress lactation (0 = none, 1 = one, ••••••
8 = eight or more)
I
- 9 -
(If yes, code 66 in Q.29Q and go to Q.32)
(Code 888888 if first pregnancy did not end with a live birth)
DDK (9)Dno (0)
30.1 Was it a boy or a girl? (1 = boy, 2 = girl, 3 = twins
of opposite sex, 7 = first pregnancy d~d not end in a
live birth, 8 = unknown sex
Are you curre~tlY nursing Lbreast feedini! a child?
(If the first pregnancy ended in a live birth ask) What
was the date of birth of your first child?
30.
31.I
I
I
I
I q J 32. Have you ever tried for over a year to become pregnant but wereunable to become pregnant?
32.3 How many years _was it before you finally got pregnant?
--..
'/ I. ~'~:~\DV 'v",-l'-"'~>' 33
am
- \i (O( LU32.3
DDK(9)Ono(O) D yes(l)
Ono(o)
(If no code Os and if DK code 9s in Q32.l to 32.3 and go to Q33)
32.1 How old were you when you first had this problem?
(98 = unknown age)
32.2 Did you ever consult a doctor about this problem?
D no(O) D operation(l) Dx-rays(2) D DK(9)
(Code: 97 = the woman never did get pregnant after
trying, 98 = unknown number of years)
33. Have you ever had an operation or X-ray treatment that stopped
you from having any more menstrual periods?
I
I
I
I
I
I
I
(If answer is operation, check to see if details are recorded in
Q19-20.2. If answer is no or operation, code Os, and if DK,
code 9s in Q33.l, 33.2, 33.5, and 33.6 and go to Q34)
33.3 Where did you receive these treatments? •.•.••••••••••••••••
............................. ,. .
........... .. . ......... . .. . ..................................
VIOY ffi3.2
specify
year
(If cancer, check to see that this is recorded in Q17-17.5).
When did you have these treatments?
(98 = unknown year)
33.2
'33~1 Why did you receive the X-ray treatments?
o cancer(l) 0 other reason(2)
Dunknown reason(8)
t
(
I
I
I
I
1
I
..._--_._--------_....- --
34. LBefore~ou developed the problem that brought you to the hospital/ ~~~
clini.E/ have you ever had any /;thei/ X-ray or radiation treatments? J ~f~1JD34
\J lOb 033.6
- la -
..............................
(g~itre) (4)
'J \0'1' 110
you had a menstrual period? •.•••••• ~ ?
•..•.•.••.....•.. '" ~ .........•...... v ~ffj3:~1r
ODK(9)
.........................................
Dyes(l)
D Thyroid enlargement
D Previous cancer (5)
(If a previous cancer, check to see that the details ~re recorded
in Q17-17.5).
How old were you then?
(99 = unknown)
Ono(o)
33.4 Validation:
33.5 Source of information coded in Q33
(Code 1 = interview only, 2 = validated from medical records)
33.6 Source of information coded in Q33.1 and 33.2
(Code 1 = interview only, 2 = validated from medical records)
......................................................
......................................................
DOther (6)
... (~;~~a;,) .
D Unknown reason (8)
34.1 What was the reason for these treatments? (PROBE)
D Tinea (1)
D Acne (2)
D Enlarged tonsils (3)
(If no, code 0 and if DK code 9 in Q34.1 and go to Q35)
35.1
!.:
f3S.. When was the last time that
(99 = unknown month or year)
Iq
t
If
I
I
I
I
I i~
I
I
I
I
I
I
,
I
r
I i; ,~
I ~I
I 1,,
I
I
I
I
I
Ir
I
I
I
I
I
I
I
I
!,
I
I
I iI
I III
I
I II!
I
!
I IiI
I I
I
I
I
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Calendar (for recording times of use of contraceptives and other events)
Year Jan Feb Mar Apr May Jun Jul Aug Sept Oct Nov Dec
-
I
- 11 -
oD
No(O) Yes (I) DK(9)
0 0 0 .,V!~.I'Z;; D36A \
",
D. 0 0 .I~l:s I D36B
• .,>'
D 0 0 (1.>_'1. D36C
0 D 0 UC 036D
0 0 0 Ilb. 036&.
0 0 0 '~:f--D 36F .
0 0 0 "',:L~'. D 36G (
0 0 0 j,l:1';.D36H.,;;»' '
0 .0. 0 /:U7·036I,
-0 0 D ~j D36Jr
0 0 0 l.fZ1-iD3 6K i
0 0 0 ~t;z:.>t D36L .
0 0 '0 k'l.:'Y 0 36M J
ospecify......................
Implantation$ under the skin
Oral contraceptives or the "pill"
Vaginal ring
The safe period or rhythm method
A diaphragm
Injections regularly every few months
Any other method
Condom by your partner
IOO or loop
Withdrawal
Jelly or foam
Douching after intercourse
Your partner having a vasectomy or
sterilization procedure
If answer to: is: then:
36A yes(l) complete Q37.1-Q37.8
36A no(O) draw a line through table on page 13 & code Os in Q37.7-37.8
36A DK(9) draw a line through table on page 13 & code 9s in 037.7-37.8
36B yes(l) complete Q38.1-Q38.l0
36B no(O) draw a line through table on page 15 & code Os in Q38.8-38.10
36B DK(9) draw a line through table on page 15 & code 9s in 038.8-38.10
36C yes(l) complete Q39.1-39.8
36C no(O) draw a line through table on page 17 & code Os in Q39.7-39.8
36C DK(9) draw a line through table on page 17 & code 9s in Q39.7-39.8
I vlf M) Having your tubes cut or tied or
other sterilization procedure
(Dees answ.er correspond to response
in QI8?)
l-z,r N)
36.1 Have you ever taken oral contraceptives for any reason other than for
birth control? Ono, 0 yes, DDK (if Yes, code 1 in Q36A)
36. Many different methods of birth control are used by women or their male
partners to keep the woman from getting pregnant. I am going to name some
of these methods, and I want you to. please tell me whether you have ever
used any of them.
CONTRACEPTIVE HISTORY
9 \l z... A)
q \\~ B)
od\ C)
! It jD)
J ll~ &)
( ntF)
4 II ~ G)
( Ilq H)
~ I~V I)
( I 7.-., J)
~ i't,1.. K)
~ /1.--> L)
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I !
~-" . - .'_ ....
37.1 37.2 37.• 3 37.4 37.5 37·6
Periods When was the What kind Where did For how That means Valida-of use Is t [2nd, et;; of pills you get long did you stopped tion(begin time that were they? these pills? you take taking them
with you began (Record (record them? about when? (O=no
first taking birth . brand exact (months) l=yes)
period) control pills? name) source)
1 ITIfJ ern m fIfE 0'
IUo \'2.;1- 1Z8 }~1 { £>0 Us /J2-
.J
37.1.1 37.2.1 37.4.1 37.5.1 37.6.1
ffiTI [IT] CD ITITI 02
5 i"!>r /111 11.7 -r>I i ~ '1 ns- ~ n~
37.1.2 37.2.2 37.4.2 37.5.2 37.6.2
EIID []I] m Efjjj D
IV,! { 11('1 ''IF /'1(,·,.3 I~~ 14 -z...l'Ie
37.1.3 37.1.3 37.4.3 37.5.3 37 •.6.3
CIJj3 []I] DJ~ ITflj 0
-4
'. 1jC9 JffIPJ-
'>$'. ,l{r- I'Ve I tl'f
37.1.4 37.2.4 37.4.4 37.5.4 37.6.4
DTIJ CID ,my tI!fJ 0.5
"'rTr' 1%8 It"f ,~~J~ 4!:"'r 3~;537.1.5 37.4.5 37.5.5 37.6.5
I
I
I
I
I
I
I
I
I
I
I
1
I
I
I
I
I
I'
I
~
-I
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37. (Ask only of women who ever used oral contraceptives)
I would like to ask you more about your use of oral contraceptives. Very
often, a woman will use them for a while then stop to get pregnant or for
other reasons, and then use them again. I want to know about each different
period of time when you used them. I also need to know the kind of pills that
you took. To help you remember this, I have some samples of different kinds
of pills. (Show the samples and ask Q37.l to 37.5 for each period of pill
use. PROBE. Use calendar. See instructions for codes)
- 14 -
37.7 [Before you developed the problem that brought you to the V 9 0hospi tallclinic this timi! did a doctor ever advise you to l.b 37. 7
stop taking oral contraceptives?
37.1 37.2 37.3 37.4 37.5 37·6
Periods When was the What kind Where did For how That means
of use Is t [2nd, eti/ of pills you get long did you stopped Valida-
time that: were they? these pills? you take taking them tion
you began (Record (record them? about when? (O=no
taking birth brand exact (months) l=yes)
control pills? name) source)
EIIEJ6 QfIj !ID DJ D
v:>"r tt-z- tbl . Iby Ibi>- Ibh J~t
37.1.6 37. 2.6 37.4.l 37.5.6 37.6.6
7 ITIB [I]] IT] om 0
Ib8 I&:( ffo . rr{ « I?z.. 1('5 . J1V'
37.1. 7 37.2.7 37.4.7 37.5.7 37.6.7
8 tIff] CIJJ [[] EIm 0
ift ~ rrr . q.g ~ '1'{ /80 i81
37.1.8 37.2.8 37.4.8 37.5.8 37.6.8
-
9 CIftJ [IT] [[] rtfjj 0/~1.. Ifl!> if}1;f i6>~ r~6 f6l I(]$
37.1.9 37.2.9 37.4.9 37.5.9 37.6.9
10
fIB:] ITIJ [[] fiIfJ 0
J61 IfJo t'1( J?1,.R 1<t5 19Y J1}."-
37.1.10 37.2.10 37.4.10 37.5.10 37.6.10
I )
fl(
I
I
I
I
I
I
I ~"
I
'I
I
I
I
I
I
I
I
I
I
~
37.8
o no(~) 0 yes(l) DDK(~)
(Code whether women used oral contraceptives within one month ~prior to the date in Item 10. Code 0 = no, 1 = yes, 9 = DK) \J;~ 037.8
... _. -- - --_._- -----~
I
r I'·/, ..:
\
,
)
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38.1 38.2 38.3 38.4 38.5 38. 6 ;8.7
Period When was the What was Where did What dose How many About when Valida-
of l.~t [ind,eti! the name you get did you injections did you tion?
use time of the these receive? did you stop (O=no,(begin that you injectial? injections How often receive? getting
with began (record (record did you these l=yes)
first receiving brand) source) receive an injection;
period) injections? injection?
EIED 0 ~ rn ITITJ 01 \'r8 IC(" 2Q) '2,O} 20~ 'Mlr UJGD'~ ;-
38.1.1 38.2.1 38.4.1 38. 5 •1 38.6.1 3R 7.L-
1,,-10 E1IBITEfj 0 CED rn 0
2 101- 2-0& ~ every ~2- 2.-11 'J,/ l.f 2.(~"",D's \'~/,
38.1. 2 38 •.2. 2 38.f!-·2 38.5.2 38.6.2 38.7.2
1!J--.J6;
om I mg'S , om0 I I I rn 0-
~3 1,..lb Zlt 2-l l B every ~'2f~ 12.--2 2-23 k-?-l(D;~
38.1.3 38.2.3 38.4.3 _ 38.5.3 38 •.6.3 38.7.3
1~.-.-.." lIfE~ I mgs DJ· 00 I 1 1
rzzt""1-Zb
'1,,2:-1
every 2"JO ~j 2-;32- Z?J;·4
ohiZV «
38.1.4 38. 2.4 38. 4.4 38. 5 •4 38. 6.4 38.7.4
~ ?"< ..oL.0 I IDQ's"'K IT] [[Bg 0r I I I
5 Z,J8 ~)~- 136 ~~ 2,Jr It '2Jfo 1ft '2..,(1-,2f838.1. 5 38.2.5 38.4. 38.5.5 38.6.5 38.7.5
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
~.
38. (Ask only of women who have ever received injections for birth control)
I would like to ask you more about the injections that you received to
keep from getting pregnant. Sometimes women take injections for a while,
then stop to get pregnant or for other reasons, and then take. them again.
We want to know about each period of time that you had injections. (Ask
Q.38.l to 38.6 for each period of time injections were received. PROBE.
Use calendar. See instructions for codes)
38.8 A) When you. were receJ.vJ.ng these injections were you
ever given pills to bring on a menstrual period?
38.10 (Code whether the woman had an injection within the three
months prior to the date in Item 10. Code 0 = no, 1 = yes,
9 = DK)
ounknown(§)
o yes(l)
.......................................
Ono(2)
Validation
D no(2)
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C) Source of information in A)
(1 = validation, 2 = interview only)
B)
LBefore you developed the ~rob1em that brought you into the
hospital/clinic this tim~ did a doctor ever advise you to
stop getting injections for birth control?
38.9
I
,
./
./
.. Ir-' /"
I
I A
I
I
I
I
I
I
I
I
I
I
I
I
I
.1
I
I
I~, _.
\
<
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
~~-:.
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39. (Ask only of women who ever had an intrauterine device)
I would like to ask you more about your use of lUDs. Sometimes a woman may
use one for a while, then it may accidentally come out or the woman may have it
removed for some reason, and later she may use one again. I want to know
about each time that you had an lUD. (Ask Q39.1 to 39.5 for each period of
lUD use. PROBE. Use calendar. See instructions for co~es)
39. 1 39.2 39.3 :3.9.4 39.5 39.6
Period When was the What kind Where did For how About when, Valida-
of use 1st Ond, et;} of lUD you get the long did then, did tion?
(begin time that you was it? lUD? you.wear you stop (O=no,
with had an IUD put (record it (mths)? wearing it?
firstd) in? source) l=yes)per:x.o
fIETI [I] IT] DIE D1 2\j 6' v ~g~~r Z,lj7 2fO; ~)I 2{""z..
39.1.1 39.2.1 39.4.1 39.5.1 39.6.1
ETID CD CD rrrn D2 ~tr '1,cr ~ ~f11 ~Zf9 V:XP
39.1.2 39.2.2 39.4.2 39.5.2 39.6.2
ITEJ IT] CD DIB 0
:3
'26'1 (1&/ Zb'2- %3 ~-2-6b 2.6r-
39.1.3 39.2.3 39.4.3 39.5.3 39.6.3
4 ITEE IT] DJ ' DIB .0
U(j t.-br ~fo Zrf ~ 2fl ?f-? -q:t.r
39.1.4 39.2.4 39.4.4 39.5.4 39.6.4
5 tItE CD DJ" ffm 0
'l:f17-""f6 27-,.. t1-(j '. 2fiZ40 UJi
39.1.5 39.2.5 39.4.5 39.5.5 39.6.5
40. Have you ever been advised by a doctor to not begin using:
No(O) Yes(l) DK(9)
40.1 oral contraceptives? 0 0 0 ?:il'-{ 4Q
40.2 injectable contraceptives? D 0 0 ~rD40.2
40.3 an IUD? D 0 0 11& 0
40.3
OTHER HORMONES AND MEDICATION
A) (If any given for abortion ask) How many times did you receive them
to end a pregnancy early? (Code 0 if none given for abortion)
~~
0-
41.1.A
'- z.(0
41.IB
0 2-
41.1«::
~) 0
39.8
v,~l
l.d:T
..J'Z.J2. 0
39.7
Dyes(l)
opregnancy test
-18-
Ono(2)
o abortion
LBefore you developed the ~roblem that brought you to the
hospital/clinic this tim~ did a doctor ever advise you
to stop using an IUD?
(Codes for A, Band C: 0 = none, 1 = one, ••••••• 7 = seven
or more, 8 = unknown number of times, 9 ='unknown whether
woman ever received hormones for either of these purposes)
c:Junknown which reason
39.7
B) (If any given as pregnancy test ask) How many times
did you have a pregnancy test like this? (Code 0 if none given
for pregnancy test)
C) (If unknown reason ask) About how many times did you
have these hormones? (Code 0 if none given for unknown reason)
39.8 (Code whether women wore an IUD within one month prior to the
date in Item 10. Code 0 = no, 1 = yes, 9 = DK)
41.2 How old were you when you first received these hormones? •••••••••
(98 = unknown age)
Ono(O) Dpills(l) Dinjections(2) Dboth(3) DDK(9)
(If no, code Os and if DK code 9s in Q4l.1 and Q41.2 and go to Q42)
41.1 Were they for a pregnancy test or to end a pregnancy early,
or did you have them for both reasons?
41. Female hormones are sometimes given in the form of pills or injections
to test whether a woman is pregnant, or to cause a pregnancy to end
before a baby develops. Have you ever. had pills or injections for
either of these reasons?
1 \.)
j (\
I
I
I'
I
I
I
I
I
'I
I
I
I l
I \-
I ~
I
I ~
I,
I
~-
......--------------------~----~
(If no code Os and if DK code 9s in Q43.l to 43.4 and go to Q44)
(If no, code Os and if DK code 9s in Q42.l and 42.2 and go to Q43)
Dno Dyes DDK
2,..~
D'
43.1
DDK(9)
..............................................
Dyes(l)
c=JOther (4)
specify
c=J Unknown type (8)
Dno(o)
42.2 How old were you when you first used this method? ••.•••••••
(98 = unknown age)
Have you ever taken female hormone pills for treatment of problems
related to the menopause or the "change of life"?
Have you ever taken pills or received injections after having sexual
relations to prevent you from becoming pregnant?
43.1 What was the name of the pills? (PROBE)
DPremarin or other conjugated estrogens (1)
c=JDiethylstilbesterol (DES) or stilbesterol (2)
42.1 About how many times have you attempted to keep from
becoming pregnant by this method? ••.••.•••••••
(98 = unknown number of times)
(Code: 1 = conjugated estrogens, 2 = DES or stilbesterol, 3 = both,
4 = other types, 5 = other and conjugated, 6 = other and DES or
stilbesterol, 7 = conjugated estrogens, DES or stilbesterol and
other, 8 = unknown type only, 9 = unknown if ever took estrogens,
o = never took estrogens)I
I,
-1('
I . 42.
I
I
I r
I~ 2-ctr 43.
I
I
I
I
I
I
I
I
143.2 When did you first take them?
(98 = unknown year)
43.3 When was the most recent time that you took them?
(98 = unknown year)
43.4 For about how long did you take them? (PROBE to ascertain total
months of use)
(98 = unknown number of months)
(If no, code 0 and if DK code 9 in Q44.l and Q44.2 and go to Q45)
,;44. Have you ever taken female hormone pills for treatment of any
menstrual or ovarian problems?,I
I Dno(o) D yes(l) DDK(9)
,.f
I
I
II
I
·1
I
I
I
I
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44.1 Were these pills oral contraceptives, or other types of pills?
o oral contraceptives (1) Dother pills (2) Dboth (3)
D injections (4) 0 unknown whether oral contraceptives or other pills (8)
(If oral contraceptives were used, details should be recorded
in Q36A and 37.1 to 37.8).
44.2 What kind of problem was it?
Dheavy blood loss (1)
o very light flow (2)
o no menstrual flow (3)
E:]irregular menses (4)
[:]painful menses (5)
c:Jovarian cyst (6)
c:Jother ••.•.....•••.....•...........•.•••. (7)
specify
c=Junknu~~ reason (8)
\J30D
._{] 44.
45. Have you ever used female sex hormones/estrogens
reasons?
I
I Ono(O) c=Jyes(l) DDK(9)
.for any other
I
I
; 46.
I ~ ]o~
I
I
I
I
I
~..
(If No, code 0 and if DK code 9 in Q45.l and go to Q46)
45.1 What was the reason? ••••••••••••••••••••••••••••••••••••••
.....................................................................................................................
(see instructions for code)
Have you ever taken other types of hormones, such as cortisone or
thyroid hormone, continuously for more than six months? PROBE
Ono(o) E:]thyroid(l) c:Jcortisone or other adrenocortical hormones(2)
oother(3) ••••••••••••••••••••••••••••••••••••••• c=J DK(9)
specify
(If No, code 0 and if DK code 9 in Q46.l and go to Q47)
~U45.l
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46.1 Why did you take this hormone? ..••••.••••••••••••••••••••••
............................................................
V}Oj
046.1
I o thyroid insuffiency (1)Dobesity (to lose weight) (2)
47. Have you ever been treated for high blood pressure?
£:]adrenocortical insufficiency (3)
Dchronic inflammatory condition or collagen disease (4)
DDK(9)Ono(O)
Dother (5) •.•••••.•••.•••••.•.•••..•••••••••••.••••••
specify
E:]unknown reason (8)I
I
I
I
I
I
J
I
I
I
(If no code Os and if DK code 9s in Q47.l-47.4 and go to Q48)
47.1 Did you ever take Reserpine?
Ono(O)
(If no code Os and if DK code 9s in Q47.2-47.4 and go to Q48)
47.2 When did you first take it?
(98 = unknown year)
47.3 When was the most recent time that you took it?
(98 = unknown year)
47.4 For about how long did you take it? (00 = none,
01 = from less than one month up to but not including
2 months, 02 = from 2 up to but not including 3 months,
•.••.•. etc., 98 x unknown number of months)
48. Have you ever had a chest X::ray?
~
r--,..--., -7. 4
I Ono Dyes DDK(If no code 0 and if DK code 9 in Q48.l and go to Q49) o 311
I
,I
I
I
I
~.
48.1 About how many chest X-rays do you think that you have had?
Would you say that it was:
o only one (1)
Omore than 1 but less than 10 (2)
010 or more but not as many as 20 (3)
0 20 or more (4)
Ounable to estimate number (8)
~12.
De.l
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49.1 Which of the following kinds of alcoholic beverages do
you usually drink?
50. I would like to ask you a few questions about illness that your
-parents or grandparents may have had. Have any of these members
of your family ever had any of the following diseases?
~1l,v \ ~ M~
k:l1~
FAMILY HISTORY
No(O) Yes(l) mill)
A) Beer 0 0 0 '. #5:ttl}9.1A
B) Wine 0 0 0 ·}}~~;El~m
C) Distilled spirits (use local terms) 0 0 0 !!~.lC~....
D) Other local alcoholic drinks 0 0 0 J~rLk.1D(specify) ........................
About how many drinks do you have per week (PROBE) •••••••••••••• ,~
(66 ~ less than one, 98 = unknown number of drinks) ~ ~9.2
"""")/7- ..'
49. Do you ever drink alcoholic beverages? c=Jno(O) c=Jyes(l) c=J DK (9)
(If no, code Os and if DK code 9s in Q49.l and Q49.2 and go to QSO)
( }13
f )1'1
X)If"
;.,. j &(;,
'> t r 49.2~
No(O) Yes(l) DK(9)
A) Heart disease 0 0 0 gt5J D50A
B) Tuberculosis 0 0 0 3lq o SOB
C) Stroke D 0 0 1'2..0 Dsoc
\ "3 2-1 'D) Cancer 0 D 0
~'l[~'DsoD
E) Diabetes D 0 0 ) '2-'2. 0 50E
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
.-I---L----..
,..---------
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What kind of cancer wall it? (PROBE)
50.1 (If answer to D is No, Code 011 and if DK code 9s in the folloving table and
go to QS1)
I
I
Unknown
I
Who b.ad cancer? None Breast Ovary COrpUII Cervix Liver Gallbladder Otb.er(specify) type Unk11OVl1
(PROBE) (0) (1) (2) (3) (4) (S) (6) (7) (8) (9)
P> 2-J A 0 Hotb.er' smother 0 IT 0 IT IT 0 0 D 0 ~>;Dso.1 iI ~ J z.~ • D..mor" , ..... 0 0 0 0 0 0 >..~P'O.,
I ~'1X"c DFa~er'smotb.er 0 0 ODD D 0 D D~~50.1f sit D 0 Fatb.er' s fatb.er 0 0 ODD Di"",1C Dso.1I 9 1'f( X "0 Mother D 0 ODD D D 0 D~~D50.1
(/ 1,1#0 o Fatb.er 0 0 0 0 0 0 1~D50.1
I
I
I
I
I
I
I
I
I
I
I
I
I
~ 'Il!#i#.t],;.'
.-----------------------------
I
/
If
I
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RESIDENTIAL AND SOCIOECONOMIC FACTORS
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
51. Now I am going to ask you about the places that you have lived in the past 15
years (starting with the current place of residence and working backward
in time, PROBE and complete the following table)
-1- -2- -3- -4- -5-
Name of foreign country, No. of Type of area (check 1)
part of city, town or years of Foreign Major Rt
Residence rural area Dates (years) residence country city Town aI
Current from:
residence to: present
Most recent from:
prior residence to:
Second most from:
recent to:
~tJQlII!1 wc;;; %l••,.'.
I
"
It
I
I
= major city, 2 = town,Type of area of current residence (1
3 = rural area, 9 = unknown)
Number of different known areas of residence in the past
15 years
Number of the past 15 years in a foreign country
Number of the past 15 years in a major city
Number of the past 15 years in a town
Number of the past 15 years in a rural area
(In Israel ask) Would you consid1!-10urself religious,
traditional, or non-religious? L-J reli~us(l),
c=Jtraditional(2),E:]non-religiOus(3), L-Junknown(9)
A)
C)
D)
E)
F)
G)
(Code the following:)
51. ~
J ~l1)C
3Jo
B) Number of the past 15 years in area of current· residence(99 = lJIl1fJoo;m ~ars) CD
m
~J2_ rn
JJ3[O
3:>'( 0Js
13rffis
'1' :;!~IT1What is your race or ethnic background? ••..••.•..•.•.••••••.•....•.•••• _
What is your religion? •••.•...•..•.•.••.•.••••.•••••.•••..••.•••••..••• ?, _~fQ
5·3.1
I.
I
I
I
x
){
~
J7,
I ~ 33b 52.
~ 3Jf 53
I
(If not in Israel, code 8)
OyesOno
...................................................................
How old were you when you were first married?
(99 = unknown age)
What was the date of your first marriage?
Have you ever attended school?
(If no, code 00 and if unknown code 99 in Q55.1 and go to Q56).
55.1 For how many years did you go to school? (PROBE; record such
things as matriculation, completion of middle school, degrees
or certificates received) •....••.•.••••••••.••.•.••••.•••.••••••••
54.- Wp.a.j: is your current marital status? (PROBE) OSingle (never married) (0)'1 1.:T'I :05,
l-Jmarried(l), Oseparated or divorced(2), Owidowed(3h c=Junknown(9) -
(If never married code Os and if unknown code 9s in Q54.1-54.2 and go to Q55) .
t 55.
I
I
I
I
I (Code: 00 = none or less than 1 year, 01 = from 1 up to but notincluding 2 years, etc., 98 = unknown years of schooling, 99 = unknownwhether ever attended school)
I
I
I
I \
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J:4t;:-J
rn7 v.................................
GYNAECOLOGIC HISTORY
..................................................................................
.....................................................................................
What kind of work do you usually do?
(If woman has never been married record 00, if she has ask:) What
kind of work does Ldi~ your most recent/present husband usually do?
(Occupation code from instructions)
(Occupation code from instructions)
(Code: 00 = none or less than 1 year, 01 = from 1 up to but not
including 2 years, etc., 77 = woman never married, 98 = unknown years
of schooling, 99 = unknown whether ever attended school)
56. (If woman has never been married, code 77 and go to Q57; otherwise
-
ask:)
~ 3°ii For how many years did your most recent/present husband go toschool? PROBE as in Q55.l ..........
I
57.
I~ 5iG
I } 58.j '1 r
I
I
I
I
59. Women can go to a doctor and have a pap test to find out whether
she may have cancer of the cervix. This is also called a cervical
smear or cancer smear or cervical cytology. Many women who we·
have been talking to have had pap tests. Not counting recent pap
tests, have you ever had a pap test before six months ago?
(Begin this section of the interview with the following statement, or a
similar one, to prepare the woman for the sensitive questions that will be asked).
We are almost finished with the interview, and you have been very patient. We
are goin~ to end with some rather personal questions, and you may find some of
them a l~ttle embarrassing. I hope you will understand that we are asking them
only because they are very important for the success of this project. Please
remember that whatever information you give us will be kept strictly confidential.
./
Q60)
V3..~
hP
oJr~!it:1"f /'D/
59.2
Before 6 months ago, about how frequently did you usually have
a Pap smear? (Code: 7 = more frequently than once a
year, 1 = about once a year, 2 = about once every 2 years,
3 = about once every 3 years, •.•••• etc., 5 = about once
every 5 years or less frequently, 6 = only one Pap smear prior
to 6 months ago, 8 = unknown frequency).
About how many times have you had a pap smear before six
months ago? (Code number as ascertained from the respondent;
98 = unknown number of times)
59.1
(If No, record Os and if DK record 9s in Q59.l, Q59.2 and Q59.4 and go to
~59.2
Ono
I
I
.<1,
I
I
I
I
I
I
I
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59.3 Where was~er~ thisLthes~ pap smear~~ done?
I
I ! 59.4
.................................................................
How old were you when you first had a pap smear?
(Code respondent's answer; 98 = unknown age)
I 59.5 Validation ..•..•••••••.•..•••..•.••••.. ~ ...••..•.•..••....•••..•
.................................................................
I
I
.................................................................
(Code number of pap smears prior to six months ago
that were confirmed from medical records. 0 = none,
records checked, 1 = one, 2 = two, .•..••• 7 = seven,
8 = ei~ht or more, 9 = no validation)
3J-/
o
59.5
(If no Code Os and if DK code 9s in Q60.l to Q60.4 and go to Q6l)
~l...
~ D 6<
:5 t"'J
mo.
r~{60.
3(1
060.
DDK(9)
How many times have you gone to a doctor for this problem?
(Code: 1 = one, 2 = two, etc., 7 = 7 or more,
8 = unknown number of times)
Did you ever have a fever or lower abdominal cramps when
you had ~his problem? PROBE
Ono (2,) Dfever (1) 0 cramps (2) Dboth together (3)
Dboth but at different times (4) DDK (§)
When did you most recently have this problem?
PROBE
(Code 98 for unknown month, estimate year, use calendar)
Ono(o)
60.1 How old wer~ you when you first went to a doctor for this
problem? .•••••..••••
(98 = unknown age)
60.2
60.3
60.4
60. Have you ever had to go to a doctor, or other practitioner
because you had an abnormal vaginal discharge?
:b (J
9
I
I
I
I
I
I
I
I
I
I
-61. How many marriages or other sexual relationships have you had in
your life?
(Code: 0 = none, 1 = one, ..•.••••• 7 = seven or more,
8 = unknown number, 9 = no information obtained) ..v
I
I
I
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(If no code Os and if DK code 9s in the following table. If yes, ask
the following questions and complete the table)
Have you ever gone to see a doctor and were told that you had a veneral
disease?
/
V
_.) be>
'--063
J 3f'Y
lED
LU62
DDK(9)o no(O)
How old were you when you had the first of these relationships
Lfirst had this relationshiE!?
(Code: 00 = never had a relationship, 99 = unknown age)
I
\.
62.
L
;C1
63.
~ ~~O
I
I.-
\l)
I
I
I
(Code: 0 = none, 1 = one, ....•..••. 7 = seven or more, 8 = unknown
number of times, 9 = no answer obtained, or woman uncertain
whether she had the disease.
I
I
I
I
*
Did you have either
of these diseases?
63.1 D Gonorrhea
63.2 o Syphilis
How many different times *
did you have this problem?
.................................................
..................................................
'3 b {
063.]
162--063. J
I
I
I
I
I
I
I
I
/
I
I
I
'.
'-"VJ,..,.,Iu ... ,n•.J1\."",L J. V 1"" ..J!.I..,.lUl, VL' l..,t.lJL·l",J\'~J..:\ ~\J.';lJ
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Leave none blank unless otherwise
Ask all questions as they are written. If the woman being interviewed
,
does not understand the question, the interviewer may provide an
explanation and rephrase the question
(11) Items 11-12.1 and 14-63.2 should be completed by the interviewer.
(lO>" Items 1-10.3 and 13-13.2 should be completed from medical records by the
supervisor. Items 6-9,10.2, 10.3 and 13-13.2' should be completed after.
the interview so that the interviewer will not know who 15 a case and who
is a control.
(9) The term "local cod-e" indicates that the code for the corresponding item
will be different for each center. Local codes are provided in this ~et
of instructions.
(8) tVhenever age is to be recorded, code age at last birthday •
(7) Ask all questions in the order in which they appear on the form. Go
from one ques.tion to the next uriless directions in parenthesis indicate
that a question is to be skipped.
INSTRUCTIONS fOR ADXINISTERING AND CODING QUESTIONNAIRE
(Form 1: Inter~iew)
STEROI.D l..:ml'rI:"\CZl"!.':!:VES
/
(6) The word PROBE inqicates that the interviewer should, if necessary, ask
the question in more than one 'vay, or ask related questions to obtai~ an
answer to the question on the form. Gare must be taken, however, not to
ask leading questions that would imply to the study subject what answers
might be "expected". In questions that are followed by a list of
possible answers, and the word PROBE follows the question (Q34.l, 43.1,
46, 54 and 60.3), or appears in the instructions (Q44.2), the list of
possible answers may be read to the study subject.
(2) Code 9ls~for unknown answers uniess otherwise specified. DK = don't
know. This code is also used if the interviewer is unable to ask the
question or obtain an answer.
(3) Directions to interviewers and codes are 1n parepthesis ( ).
(5)
(1) All boxes must be filled 1n.
specified.
January 1982
A. General Instructions
(12) In the instructions below for specific items on the questionnaire) the
numbers refer,to the corres~onding question numbers on the questionnaire.
(4) Alternative ways of asking questions are 1n brackets [ ];
I • " M'\_.
I
I
I
I
I ~.
I'
I:
I
I
I
I
I
I
.1
I
I
I
I
I
I1
I ~ .~.,,-".i~''M''''''"''i..--.-'-_. ---.• ,
-2-
I
I
I
I
", .
B. Informed consent
Before intervie~ing a woman, she must be read a statement that informs
her of the nature of the study and requests her to participate. Her consent
must be obtained before the intervie\.J can begin. Informed consent does not
imply that the woman is told the exact purpose 0.£ the study. It does mean
that she must be told what \.Ji11 be expected of her if she agrees "'t'C)"""
participate in the study. The statement to be read to each study subject
will, of course, be read in the local language. It should conform to local
customs and medical practice, and be approved by the local human subjects
review group. It is suggested, however, that it contain the elements included
in the following sample statement:
C. Instructions for the Face Sheet of the Questionnaire
llHello. 1'1y name ~s I work ~n the Department of
---In collaboration with (the Ministry of Health/~~IO), we are conducting a study
of factors that may influence the health of women in this country. As part of
this study, we are interviewing many women who have bee~ hospitalized (or have
seen a doctor).for a number of different reasons. We are interviewing both
healthy and ill women. Your name has been selected from the records of this
hospital (clinic, institution), and we want you tb take part in this study.
Your participation \.Jill involve my interviewing you and asking you some
questions. The interview will include questions abo~t your past medical
history, medications and treatments that you have had, your marriages,
pregnancies, an~ contraceptive practices, places that you have lived and
worked and other personal questions. All information that you provide uS'will
be kept strictly confidential, and your na~e will not appear in any report of
the results of this study. Your participation is, of course, voluntary, and
you do not have to anSvler any questions that you do not want to answer. May I
begin the intervie\v?"
I
I
I
I
I
I
I
I
I
1. Identifying numbers
Project number: This number is used to distinguish this project from
others sponsored by ~~O. The project number for this study is 78912.
Centre and Hospital Numbers: Code numbers for participating centres and
hospitals are as follows:
Participating Centre Participating HospitalI
I
Name
Siriraj 'Hospital (Thailand).
Number
0017
Name
Siriraj
Number
01
'. 01
'" ...._-- ... "_'''' 02
03
Ol~
Univ: of Philippines College of 1'1edicine 0019
I
I
Univers1ty of Chile
Philippine General
" :~':: ,: '.,.' :~~ ~ : .. 0103 .. _:~~ ..J .J. Aguirre
Del Salvador
Sotcro Del Rio
San Jose
01
I
I
I
Chulalon~korn Hospital (Thailand)
Chnim Sheba Medical Centre (Israel)
0111 C.hulnlongkorn 01
0180 Tel Hashomer 01
Donolo 02
Tel Aviv Municipal
Hedical Ccntcr 03
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* For controls selected through the cytology screening programmes only.
3. Address of subject:· Record sufficient detail to be able to locate
subject again if necessary. This information need not be included on
the English version of the questionnaire.
4. Medical Record number: Record the record number for the subject from
the records of the hospital or clinic through which the iubject was
identified for study.
01
01
01
01
01
02
01
02
03
04
01
02
03
04
Bcrlinson 04
HClshnron 05
Knplnn 06
Meir 07
Hadnssah,Jerusalem 08
Shanre ~sadek 09
Assaf Harofe la
Har lIazofim 11
Rambam 12
Carmel 13
Suan Dock
Universitario
San Juan De Dios
Cytology' screening
program*
Rengifo
Hospital General de
Mexil;:o
Kenyatta National
University College
Hospital
Prince Albert
Westmead
Textile hospital No. 1
Textile hospital No. 2
Textile hospital No. 3
Cytology Screening
Programme*
0242
0025
0007
0020
0035
0706
0630
University of Ibadan School
of Medicine (Nigeria)
Commonwealth Institute of Health
University of Sydney (Australia)
Hospital General de Mexico
Chiang Mai Medical College (Thailand)
Subject number: Each study subject 'will be assigned a unique study
number, starting from 00001. Numbers will be assigned to subjects ~n
the order in which they are recruited for study. If a subject is not
interviewed, her number will not be used again for another study
subject.
Shanghai Institute of Planned
Parenthood Research (China)
Universidad Del Valle,
Cali,. Colombia
2. Name of sub jec t:. Record sufficient detail to be able to positively
identify the subject. If necessary, include parents' name, clan,
tribe, caste, etc. This information need not be included on the -------.
English version of the questionnaire.
Kenyatta National Hospital
(Kenya)
I
I
I
I
I
I
I
I,
I, 4++
I: +++
I
I: +++
I:
I~
I
11
I',
I,
I,
I:
I'
II ·H"-jo
I
I
I!
I:
I
II iH+
5.
6.
7.
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P~y st.1l.l\S: This refers to tile mcch,wism of payment utilized by the
subject, and will be .:l local code. It is incluJcd ~s a mcasurc of
socio-economic status.
a. In China, Israel, Kenya, Mexico, and Nigeria this 1S not
Cl pp lic"o b 1.e . Codc :: 8. .<
b. In Chile,: code 1 = lISSSfl (lo\..,Ter), 2 :: Sermena (higher), 3 =
Sermcna/private, 4 = Sermina/public, 9:: unkno\vo
c. In Thailand, code 1 = charity, 2 = semi-private, 3 = private,
9 = unknmvo
d. In the Philippines, code 1 = charity, 2 :: medicare, 3 = private,
9 :: unknmm
e. In Australia, code 1 :: public, 2 = private (shared room), 3 =
private (single room), 9 :: unknown
f. In Colombia, code l=ward (8alas), 2=priv~te,. 9=unknown
Type of study subject: If the. subject is a case that is eligible for
inclusion in the study, Code O. If she is a control that is eligible,
Code 1. If the subject has been interviewed and is subsequently found
to be ineligible, Code 2 if she is an ineligible case, and code 3 if
she is an eligible control.
Subject number of corresponding case: In all centres ~xcept Chile,
Colombia and China, this item should be left blank. In these three
countries, if the subject is a control that is matched to a specific
case, record the subject number of the corresponding case; otherwise
leave this item blank.
I·
8. Type of case or control:
has two (or more) of the
code 7 :: multiple tumour
code 0 = thyroid.
If the subject is a case who simultaneously
types of neoplasms that we are studying,
types. In Israel only (on a pilot basis),
I
I
I
I
I
I
I
I
I
I
9.
10.
10.1
Provisional diagnosis at admission: Obtain this information from
medical records. Code the diagnosis of admission even if it differs
from subsequent diagnoses. If the woman is admitted with a "rule out"
diagnosis, code what is suspected. Code according to the Ninth
Revision of the ~ffiO International Classification of Diseases. Use
only the first three digits of the code (see pages 3-34 of Volume 1).
For external causes of injury and poisoning, do not use the
supplementary classification (E code); and do not use the V-code). For
controls without disease, such as women with a normal pap smear, code
650. This is the code for normal deliveries, and such women are
ineligible for inclusion in this study.
Date of diagnosis or admission: For cases diagnosed as out-patients;
record date of histologic diagnosis; for cases diagnosed as
inpatients, record the date of the hospitalization when canger was
first suspected; for hospital controls, record date of admission; for
controls with normal pap smears, record date· of most recent pap smear.
All questions (excep~ Q35) that involve the time since an event should .--
be answered in relation to this date. We are not interested in events
·after this date.
Age at diagnosis o~ ndmission: This item is included here even though
age is ascertained during the interview (Item 15-) so that we will have
datn on age from subjects who are not interv{ewed. Record the age that
is found in the medical record, even if it differs from the age
obtained at interview. Record age at last birthday (i.e. completed
ycar~ since birth).
10.2 Referal source: Record the referal source of the woman. Code as
follm'is:
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Date interview completed: If subject is not interviewed, code date
interview attempted if possible. otherwise code 000000.
Presenting symptoms: Obtain presenting symptoms of women with cancer
of the ovary. uterine corpus. or cervix from medical records. If
necessary, the supervisor may supplement this information by
questionning.the subject, but interviewers should not do so.
.~
'..
For cases 'only, if the woman was originally admitted specifically for
any of the conditions which make a woman ineligible as a control, and
while in the hospital was found to have one of the neoplasms of
interest, then code 6. If she was originally admitted for other
conditions that do not make a woman ineligible as a control, and while
in a hospital is found to have one of the neoplasms of interest, then
code 7. The conditions that render a woman ineligible as a control
are: circulatory or cardiovascular diseases, diabetes, chronic renal
disease or renal transplant, a previously diagnosed cancer, chronic
liver disease, and obstetrical condition, and any (non-neoplastic)
gynaecologic condition. If a woman ~vas admitted for evaluation of a
breast lump, and ~vas found to have breast cancer, codes 6 or 7 should
not be used; but if she was found to have one of the other cancers that
we are studying. then code 6.
Interviewer: Each investigator should assign a different number to
each interviewer. This is a quality c9ntrol procedure to allow us to
compare respons~s elicited by various interviewers.
Date of therapeutic surRery: Record the"dat'e'surgery"was per'formed t~ .....,.-.
treat the condition for which the woman was admitted to the hospital.
This does not include biopsies, D an~ Cs or other procedures which are
diagnostic rather than therapeutic. Consider a cone biopsy of the
cervix and removal of a breast nodule to be diagnostic procedures. If
the woman is not scheduled for surgery by the time study of this
subject is completed, Code 000000. If there was surgery prior to
interview, but the date is unknown. Code 999999. This code should
rarely be usec.
o - family planning clinic, first visit
1 = other type of clinic
2 = private physician
3 = self re feral
4 = other hospital
5 = (cases only) same hospital; woman originally admitted for a
condition other than her neoplasm that would have made her
ineligible as a control
6 = ("Cases only) same hospital; ~voman originally admitted for a
condition other than her neoplasm that would not have made her
ineligible as a control
7 = other
9 = unknm-ln
If the wbman was referred from a family planning clinic, ascertain if
her condition was detected during the woman's first visit to the clinic
(code a), or during a subsequent visit. If it is the latter, the woman
is not eligible for inclusion in the study.
10.3
12.
12.1
13 •
I
I
I
I
I
I
I
I
I
I "• I;. :
I ,I'., .
I :: I
I
I
I
it.
I ,;
;1.
I . .
; ~ .'
I
.~! .
I
I
I~ ;i
14-15 Date of birth and age: Probe to obtain as accurate an estimate as
possible. If necessary, relate date to historical events, local
calandars, etc. Code best estimate of year and age. Code gls if day
or month unknown. If date of birth and age are inconsistent and if the
inconsistency cannot be resolved after careful probing, then accept the
date of birth as correct, and code it and the age that is consistent
with the date of birth.
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Place of birth:
a. Thailand:
or farm. ",', ,,-.. " .... ,_.' .. ' .. " .. ' .':'
.... ~- - ;' _ .. _.._~._,J... ~ _ ._40-.f! .
Tvpe of p:ltholo~'1 form(s): Indicate the type of pathoiogy Form 2 that
~ completed for the case. Code 0 if this is <1 control subject. A
Form 2 should be completed for each case, even if no pathology slides
are obtained. Form 2.1 is for breast cancer, Form 2.2 is Ear nebplasms
of the cerv'ix, Form 2.3 is for cancers of the corpus uteri, Form 2.4 is
for ovari;.m tumours, and Form 2.5 is for tlJm~'urs 'or the liver and
gallbladder •. For thyroid, code 6 (Israel only, pilot basis).
If the subject simultaneously has two tumours of the types that we are
studying, one Form 2 should be completed for each tumour. Use Item
13.2 for rccording the Form 2 for th~ second tumours that ~s
diagnosed. rf the \-lOman has bilatcral breast cancer, one Form 2.1 \-.1ill
be completed for each side, and a 1 will be coded in both items 13.1
and 13.2 However, bilateral ovarian tumours will be assumed to
represent a single primary malignancy, and one Form 2.4 will be
completed, and this item (13.2) will consequently be coded 8. For
thyroid code 6 (Israel only, pilot basis).
Instructions for remainder of questionnaire
2 = To\vu: Second and third class cities
1 = City: Greater Hanlla and other first class cities
1 = City: A densely populated municipal area with predominantly
modern living structures such as Bangkok, Chiang Mai, Haad Yai, and
Ubol-ratch-tani.
2 = Town: the "Ampue-Huang" or ma~n district of each province •
Accuracy of date of birth: The interviewer should make a judgement as
to the accuracy of the date of birth thnt is ascertained. If the
subject kno\-.1S her birthday, Code O. If the interviewer has been able to
determine the year of birth by knowing that the woman was born during a
particular animal year or year according to some other local calendar,
or year of an important historical event, then Code 1. Otherwise the
accuracy with which the date of birth was ascertained should be
estimated as being within 2, 3, 4 •••.•• or 8 years of the actual date
and correspondingly coded a number from 2 to 8 inclusive. Code 9 if it
is believed that the date of birth has been estimated to no closer than
9 years of the actual date.
3 = Rural area:, ,.,,:,illage.
4 .~: b 'c ForJ'lgn' orn
b. Philippines:
lJ .1
13.2
D.
15.1
o .
16.
I
I
I
1
I
I
I:
I
1
I:
I:
.1:
I:
I.
I'
I::
..
I
I·
I
I
I
2 = To,vn: anything not included in a city or rural area
1 = City: the Mexico City D.F. and the capital of each st~te
1 = City: all state capitals (including the surrounding
metropolitan areas)
d. In Israel: 1 = Born 1n Europe
2 = Born 1n Asia
3 = Born in Africa
4 = Born 1n Israel, both parents born 1n Europe
5 = Born 1n Israel, parents born in Asia or Africa
6 = Born 1n Israel, parents born 1n Israel
7 = Born 1n Israel, parents of mixed birth
9 = Unknmyn
e. Mexico:
.....;j ....farms
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1 = City: . capita.! of each state
2 = Town: ..any place not in 1, 3 or 4
3 = Rural area: .-towns less' than 2,000 population,
4 = Foreign born'
3 = Ru~nl nrea: Villages and farms
2 = Town: any place not included in 1, 3 or 4
3 = Rural area: villages and farms
4 = Foreign born
3 = Rural area: villas, rancherios, and ejidos
4 = Foreign born
4 = Foreign born
c. Chile:
'. .,
1 City: The city each district .~= major 1n
2 = Town: Any place not included 1n 1- or 3.
3 = Rural area: Villages and farms.
4 = Foreign born
g. Australia:
f. Nigeria:
I·
I':
I
I
'I·
I·
I,
I
I·
I
I
I
I
I
I
I'
I I ••
I
I
..
I
I
I
·1
I
I l-++
I
I
I
I
I
I
I
I
I
I
I~
h. Nairobi
1 City: N~li robi
2 = Tm.,rn: any place not 1n 1, J or !~
3 = Itu r<1 1 arca: villages and farms
.'. ,
4 = Foreign born ~
1. Colombia;
1 = City: capital of each province
2 = Town; any place not 1n 1) 3 or 4
3 = Rural area: villages and farms
4 = Foreign born
j. China
1 = City
2 = Town
3 = Rural aJ"ea
.,
4 = Foreign born
17.1-17.5 Previous cancer: Record answers to Q.17.1 and 17.2 on the lines
fo1lo,~ing the questions. Determine as accurately as possible the name
and location of the institution where the woman was treated and when
she was there (Q.17.3). If possible, determine from records of that
institution when the diagnosis was made and what kind of cancer it
was. Then code items 17.1 and 17.2, based on the best information
available frqm both the patient and the records. Use the 3-digit HHO
international classification of diseases (9th Revision) to code 17.1.
Code in 17.5 the source of the information used in coding 17.1 and
17.2 Note that all these items refer to previous cancer, not the
condition for which the woman is currently being treated. If the
woman has had more than one previous cancer, code the first one unless
it is skin cancer.
18-25.1 Previous surgical operations: A~k each of the questions in the 'table
in order. If the answer to a question is no) proceed down the table
to the next question. If the answer is DK) PROBE. If the answer is
yes) proceed across the table and ask when and where the operation was
performed. Record as accurately as possible the name and location of
the institution where the operation w~s performed. If possible,
determine from the records of that institution when the operation was
performed, ,~hat was done, and the reason for' it. Record this
. information in the last column 'of the table. . _ ~_.. '" ~_._ .._-_.-
I
I
I
I'·
I.
I
I
I'
I
I,
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Use the h~st inforlllation from both the interv'ieH [lnd the recants to
code item:> A through II [allOt'ling th8 table. \'lhcn c()Gin~ source of
infarmCltion, if any information is obtained from the medical records,
code 2 (vnlidated); if vo.lidation not nttempted, code 1; if no
infonnntion.wns obt.:J.ined from either source, code 9. Code ye(lr of
surgery as accurntcly 3S possible. It ~ay be necessary to check back
and change the dates of tubal ligc.tion, hysterectomy, or oophorectomy
after use of 'the calendar (Q.37, 38, and 39). If the reason for any
oper3tion is cancer, check to sce that this is correctly recorded in
Q.17-17.5. If a D and C Has performed [or an abortion, be sure that
this is sho~m in Q.29. Consider a fractional curettage to be a D&C.
If the reason for a D&C is given as a symptom such as lI!:>leeding ll or
"pain", the interviever should probe and validate to <lscertain the
result of the D&C. If this has not been done, assume the condition to
have been benign and code a 4 in D2. Consider bilateral snlpingectomy
to be a tubal ligation (Q.18). Consider a unila.teral salpingectomy to
be another operation on female organs (Q.24).
From th~ ansvers to Q.19.2-20.l, determine and code the total number of
ovaries that have been removed. If part 6f an ovary was left in
place, consider the ovary not to have been removed. Code date of last
operation to remove an entire ovary.
26-26.5 Previous benign breast disease: In question 26, omit the portion in
brackets if questioning a healthy control outside the hospital. In
questions 26.2 and 26.3, ask the portions in brackets if the women had
just one previous biopsy. In Q.26.3, record name and location of the
institution in which the first biopsy was performed. If possible
determine from records of that institution ,,,hen the first biopsy was
performed and the histologic diagnosis. Record in ~.26.4 the
histologic diagn~sis exactly as written in the records. Then mark an
"XII in the box by all appropriate histologic diagnoses in Q.26.5.
Fibrocystic disease is a complex of conditions and has many synonyms.
These include cystic mastitis, chronic cystic mastitis and cystic
disease. Fibrocystic disease may be further subdivided as being
characterized by apocrine metaplasia, adenosis, sclerosing adenosis,
and calcification. All of these conditions should be included in the
category "fibrocystic disease without mention of epithelial hyperplasia
or papillomatosis ll • Fibrocystic disease with epithelial hyperplasia
or papillomatosis includes those fibrocystic lesions with proliferation
of ductal epithelial cells which mayor may not exhibit some degree of
atypia. If you are unsure hov to classify the histologic diagnoses,
leave Q26.5 blank and it will be completed from Q26.4 at the
coordinating centre.
I:
I.
1-:
I
27.
29.
Age at first menstrual period: Code 99 if age unknovn. 00 = never
menstruated.
Previous pregnancies: Begin by reading the statement in Q.29, and then
'ask whether the vomen has ever had any type of pregnancy. Explain
that we are interested in all pregnancies, including those ending in
induced abortions, miscarriages, stillbirths, etc. Consider
spontaneous termination of pregnancy at or before 28 Heeks of gestation
'to be a miscarriage (spontaneous abortion), and termination of .
pregnancy after 28 weeks with the birth of a dead baby to be a
stillbirth. Explain to the women that we are also interested in
induced nbortions. It may be useful to say:. llHomen can be given
trentments to cause them to lose tlleir pregnancy before a live baby
develops. This can be done by giving the woman injections, by
scraping or sucking out her Homb, by putting some fluid in the womb,
and by other means. He are also interested in any times that you had
such t::l:"C~1tmcl . 11
I -lQ-
I··
I·
I
I
I:
Use onc line or the tnblc to record informati.on on e;lch prq;n,1ncy.
Begin \lit:h the first prcgn:1l1cy and record information on all
prcgn:mcies in the order in \vhich they occurred. Considcr· twins as a
single prcgn<Jncy. Record the pregllnncy number in column 1 .:md the age
of thc ivomen. nt the termination of C.:lch pregnancy in column 2. Record
the outcome of each prcgn.:lncy in column ~hree according to the footnote
under the table. If twins were born .:lnd one was alive nnd the other
stillborn, retord as a live birth. In column 4, record yes if the
women received pills or injections for maintenance of the pregnancy and
no if she did not. In column 5, record the number of months (or
fraction thereof) during which the women nursed her baby. Record zero
(0) if she did not breast feed. In column 6, record "yes" or "no", or
"DK" to indic.:lte iVhether the i.,omen reported receiving pills or
injections. to suppress lactation (DK means the woman didn't know, or
the question was not asked or answered).
Then code items A-R following the table according to the codes given on
the interview form. When codirig items F-P and R, note the word
"knm.;n": If, for example) the woman had tiVO kno\.;n stillbirths, and the
outcome of a third pregnancy is unknoivu, then item G should be coded 02
because she had two known stillbirths.
Date of birth of first child: Estimate year as accurately as
possible. Code 9 I S for unknOiVU days or months.
In item F ,. code the number of pregnancies knm.;n to have been follm... ed
by the birth of 1 or more live births. Count twins only once.
, .In item D, code age at first breastfeeding, regardless of the duration
of breastfeeding •
Code item P to the nearest month; code 000 for no breastfeeding; code
001 for breastfeeding less than one-and-a-half months; if twins are
breastfed, code the duration of breastfeeding for the twin that was
breastfed for the longest time.
than the
this sum
be equal to or greater
It may be greater than
be included in item J.
Note that the number in item J should
sum of the numbe.rs in items H and I.
because abortions of unknoiVn type may
For item Q, calculate the number of years since the woman last
breastfcd as follows: take the age at last pregnancy following which
the woman breastfed, add the number of months the child \vas breastfed
and round-off the woman's age at cessation of breastfeeding to the
nearest year. Then subtract that age from the age in Ql5.
30.
I
I
I
.1
I
I
I
30.1 Sex of first child: ·3 =: twins of .opposite sex.
I
31 Currently breastfeeding:
following this question~
go to Q32).
There is an error in the parenthesis
It should read: (If yes, code 66 in Q29Q·and
. - ~'. . ,..._ ~ .. , ---~.",,_ .
I
I
.33 to
33.6
Artifical menopause: Record the answers to Q33, 33.1 , and 32.2 on the
lines or in the boxes following these questions. Determine as
accurately as possible the name and location of the institution where
the ",oman received X-ray treatments (Q33.3) .. If possible, determine
from the records of that institution the reason for the treatments and
I·
I
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Calendar: This is an aid for determining times of use of oral contraceptives,injectable contraceptives, and IUD's Record on the calendar such
useful events as marriages, divorces, birthdays, pregnancies,gynaecologic operations, and menopause. Then, to/hen obtaining ansto/ersto Q.37-39, PROBE and record on the calendar times of use in relationto these events. Also, you may find that the original estimates oftimes of some of the other e{ents were incorrect. If so, go back andchange them.
I ...·
I
I
I,
I
I
I
I
I
I
I
I
I
I.
I~
I~
34
34.1
35
35.1
36.
37.
37;1
37.2
the ye~r of treatment. Then code Q3J, 33.1, and 33.2, based on thebest infol"l!t;lt:ion :lv.1ilable [rolll both the p,1tient and the rc--::ords. Incoding Q33, use also infonnation oht.1ined from v<llid.:1ting Q17.1-J.7.2
and Q.19-20.2. Code in QJ3.5 the zource of the in[orrn.1tion· used in
coding Q.J3. Code in Q33.6 the source of the in[ormat~on used i~
coding QJJ.l and 33.2 ~
..~' .
Prior radiatipn treatment: Ask the portion of the question in thefirst set of brackets of all women except normal controls (e.g. inChile), and use the t%rd "other", in the second set of brackets, if the
woman had an X-ray induced menopause.
Reason for radiation treatments: If more than one reason, list themfollmo/ing the Il other ll category, and code 6.
Time of last menstrual period: Code 99 for unknown month. Estimateyear if possible; othenlise code 99 for unknmvn year. 0000 = never
menstruated.
Age at last menstrual period: 00 = never menstruated.
Methods of contraception: Include vaginal pills or suppositories thatcontain such spermicidal agents such as jelly ~r foam (36J). Record
other vaginal pills or suppositories in 36N, and distinguish betweenthose that do or do not contain hormones. Consider women \o/ho have hadbilateral salpingectomy to have had a tubal ligation (36M).
Use of oral contraceptives: Use the calendar to record all periods ofuse of oral contraceptives, regardless of the reason for use. To aidin the identification of specific types of oral contraceptives, theinterviewer should show the women samples of the types of oral
contraceptives that have been used in the country. If the women usedoral contraceptives for a period of time, stopped for two or more
months, and then started using them again, consider use after anyinterval of non-use of 2 or more months duration as a separate periodof use. Also, if the women changed from one known brand or type oforal contraceptive to another (or from a known to an unknmvn type, oran unknown type to a known type), consider the times during which eac~type was used as a separate period of use. Consider changes from oneunknown type to another unknown type no~ to distinguish differentperiods of use •. ' Ask Q37 .1-37.5 for each period of use. Record the
answers under the boxed for the codes. Code after validation if
validation done.
Date t%man began using oral contraceptives: Using calendar, estimatedate to the nearest month. Code 99 'for month if unable to estimate
month.
Type of oral contraceptives: Record exact name and dosage or strengthof the preparations used. Code oral contraceptives used according tothe code in appendix 1. If the code is not found in appendix 1, sendthe composition of the preparation (including dosage) to the
coordinating centre, and a cede will be assigned.
,I
I
37.3
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Sour({~ of or.,l cont:rac"pti\'{'~: Record the sourcc in ,:u[Cicir
so th,ll: ~:ol1lc()ne could go to the som"cc to validate the in for
obtained from the recpondant.
I
I
I
I
37.1t
37.5
HOIlths of use: Estimate to nearest month as accurately as
usin~ calendar as an aid. If unable to estimate months of USt,
99 (unkno\.Jn duro.tion of use). Code 01 for less thLln one month of use,
as well as for use of about one month's duration. Code 98 for 98 or
more months of use. \\Then the woman is currently using oral
contr~ceptives (code in Q37.5 is 9797), thcn calculate duration of use
up until the date in QIO.
Date woman stopped using oral contraceptives: Using calendar estimate
date to nearest month. Months between beginning and stopping use
should equal months of use. Code 99 for month if unable to estimate
month. If the woman is currently using oral contraceptives, code 9797
for the date of cessation of use.
I:
37.6
37.7
37.8
Validafion: If possible, go to the place where the woman obtained her
oral contraceptives and ascertain from the records, for each period of
use, the type of preparation used, and the dates of use. Then code
Q.37.l, 37.2, 37.4 and 37.5, using the best information available from
both the interview and the records. If any information is obtained
from records code yes (1) in Q.37.6; otherwise code no (0).
Advised to stop taking oral contraceptives: Ask the portion in
brackets of all women except normal ,controls (e.g. in Chile). Note
that the codes are as follows: no = 2, yes = 1, DK = 8. The reason
for this is that 0 = never used oral contraceptives and 9 = unknown if
ever used oral ~ontraceptives.
Use of oral contraceptives in the past month: Code whether the women
had used oral contraceptives any time during the month prior to the
date in Item 10. If validation performed, code after validation
completed.
Date woman began receiving injections: Using calendar, estimate date
to the nearest month. Code 99 for month if unable to estimate month.
3 =Dihydrogyprogesterone acetofcnide 75 mg + oestradiol ocnanthate
10 mg (Ova Repos)
2 =Dihydroxyprogesterone acetofenide 150 mg + oestradiol oenanthate
10 mg (Agurin, Cicnor, Deladroxate, Deprans, Ginoplan, Luvonal,
Nonestrol, Normensil, Patector, Perlutal~ Topasel)
........" ...-......
Code:
Use of injectable steroid contrace~tives: Use the calendar to record
all periods of use of injectable contraceptives. If the woman received
injections for a period of time, then did not receive an injection for
two or more months after her usual time for an injection, and then
received them again, consider such use after missed ~njections as new
periods of use. Also if the type, dosage, or frequency of injections
was changed, consider each change to be the beginning of a new period
of use. Ask Q38.l-38.6 for each period of use. Record answers under
the boxes for the codes. Code after validation if validation done.
1 =Depot-Medroxyprogesterone 'acetate (DHPA, Depo-Clinovir,
Depot-Progevera, Depo-Provera)
Name of injection: Record exact name if known.
38.1"
38.2
38.
I,
I
I
I
I {+ =Dihydro:<ypt'og~stcrol1c ~lceto[enide 75 mg + oestradi.ol oenanth3te 5mg (An.:t[0.rtin)
5 =Dihydroxypcogcsterollc acctofcnidc 150 mg + oestradiol J benzoate
l7bcta butyrate 10 mg (Unimcns)
I,; 6 =Depo-Medroxyprogcstcronc acetate + estradiol sypion3te(Cycloprovcr~) ~
,7 =Norethisterone oenanthate (Norigest, Noristat) NET-OEN)
8 =Hydroxyprogesterone Caproate (in China)
I
I
I:
I
9 =Unknown type
o =Megestrol Acetate (7300) (in China)
For practical purposes, some injectable contraceptives may be
identified by the frequency of injections and the dates of use. In
some countries, for example:
a) If in-jections ,vere given every 3 months,- the product ,vas probably
DNPA; or if before 1977 it could be NET-OEN.
b) If injections were g~ven every two months, the product was probably
NET-OEN.
.
c) If injections were given every month, the product was probably.
cycloprovera; or if before 1976, it could have been deladroxate"
These are not absolute rules for identifying injectable
contraceptives. Criteria for identifying products from the frequency
of injections and dates of use will vary from one country to another.
Local investigators should develop guidelines for the interviewers to
follow to identify the products that have been available locally.
.. ..~.
Source of injections: Record the source in sufficient detail so that
someone could go to the source to validate the information from the
respondant.
Date woman stopped rece~v~ng injections:' If schedule ,vas changed, then
this is the dat~,when the schedule was changed. Estimate date to
nearest month, using tqe calendar. Dates of beginning and stopping
injections and frequency of injections should provide information in
agreement with total number of injections. Code 99 for month if
unable to estimate month.
Dose and Frequency of injections: Record dose and frequency. If the
injectable is a progestogen-estrogen combination, record dose of
progestogen. If dose or frequency of injections was changed, then
consider the time that the new schedule of injections began to be the
beginning of a new period of use., Code 999 for unknown dose and code
9 for unknown frequency of injec tions·.
Code 99 ifNumber of injections: Record approximate total number.
unable to estimate number of injections.
38.3
38.4
38.6 ,
38.5
I
I-
t
I
I
I
,I
I,
I
'/',
.. '.. " '"n, "po,,, i b I", r,o to t hc Ploco "hcr" th" WOman rcc icvcd her'"J~:;'l'i;;;;;- "od "sc" et., in [ro", t b0 rec ord" for ".'C h pe ,. i od 0 [ uzc, th e
typC, dO'''g", and fr"quoncy of "dmioistration of thc injectable
COn t r.'C "pt i vc as "c l! .'s thc d.ll cs of thc firs t and ,."" in jcc t ion.
Thcn code Q.J8.1, 38.2, 38,1" 38.5 and 38.6, usinr, the best'infor"'''tion
avail"Llc from both rhe intervie" and the records. If any information
is obt.,inod from records, codc ycs (l) '" Q.38. 7; other"ise code no(0). , ~
38.8 Use of estroeens to induce menstruation: Ask the question and record
the anzoer in the appropriatc box a[tor Q3B.8A. Include "Iso use 01
estrogen-progestogen preparations such "s oral contraceptives th"t were
uSed to induce menstruation. If Possible, determine from the records
ohether estrogens were ever given to induce menstruation. Record this
infor",ation in Q3B.8B. Then code Q3B.8A using the best information
available, and indicate in Q3B.8C the source of the information. Note
that in Q38.8A, no :::~, yes::: 1, and unknown::: 8
Type of IUD: Record exact name if known. Code as foll mvs :
..
r-
,
01 ::: Anchor
.13 ::: Gyne-T
+26 ::: Chinese Ring
02 ::: Antig on
14 ::: Koppar-T-R~cip
*27 ::: Shanghai V
03 ::: Beospir
15 :: Lippes Loop
04 ::: Copper-T
16 ::: Omga05
::: COpper-T-Kabi
17 :: Ortho COpper-T
\
06 :: Copper-T 200
18 :: Ota Ring
L
r
07 :: Corolle
19 :: Progestasert
~
•
08 :: Cu-7
20 :: Saf-T-Coil
,-
09 ::: DANA Cuprum
21 ::: SCOY10
:::: DANA Super
22 :: SZontagh knot
.......... '" ~.. ...... .... ~ ..... -- '.' . ~ .
11 :::: DANA Super Fix
23 :: Yusei Ring
12 :: Gravigard
24 == Zipper Ring25 ::: Dalkon Shield
94 ::: other or unknOtvn inert IUn95 ::: other or unkno~....n copper lUD96 ::: othet" or unknolm hormonal IUD97 ::: other run I... i th knot-m name but unknolvo
classification
99 ::: unknm....n type of IUn
38.9 Advised to stop receiving in~ctions: Ask' the portion in braCkets of
all women excep' normal controls (e.g. in Chile). Note that the codes
are as follows: no = 2, yes = 1, DK = 8. The reason for this is that
o = neve': received injections for contraception and 9 = unkno"n if .verreceived such injections.
3B.IO Received an injection within the past 3 months: Code whether the ~men
had received aq injection for contraception any time during the 3
months prior to the date in Item 10. If validation performed, codeafter validation completed.
39. Use of IUDs: Use the calendar to record all periods of use of IODs.
To aid in the identification of specific types of IUDs, the interViewer
should show the women samples of all rUDs that have COmmonly been Used
in the country. If'a device Oas removed or expulsed and not reinser'ed
oithin one month, then consider the period of use to have.nded; and
consider subsequent use to be a separate period of use. Ask Q39.1-39.5
for each period of use. Record the ansoers under the boxes for the
codes. COde after validation if validation is done.
39.1 Date IUD inserted: Using calendar, estimate date to the nearest
month. Code 99 for month if unable to estimate month.I 39.2
I
I
I.,
I:
I· .
I:
I~
I
I
I
I
I
I
I
I ·'.
I'
I
)43-43.4 Pills taken for menopausal symptoms:
41.1A There \vas an error on the original printing of the form. Code 0 if non
g1ven for abortion
39.3 Snurce or TU!): Rcconl .source in suffici.ent detail so that someone could
go to-tTic I;ource tu vall.(.1:lre the infonn.1ti.on from the re:.pond.:lt1t.
had used an rUD'any
If validation
Use of IUD in the past month Code whether the woman
time during the month prior to the date in Item 10.
performed, code after validation completed.
39.4 Duration nf use: Estinwte to the ne.:irest month <1S nccur.::;te1y as
possible, using ca1cndJ.r .:lS <1Il J.id. Code 99 if unJ.bJe to estimate
duration of use. Code 01 Ear less th.:lo onc month of use, J.S \vell J.S for
use of J.bout one month's duration. Code 98.fo'r 93 or moce months of use.
39.5 Date \vomnn stopped usi.ng rUD: Using calendar, estimate date to nearest
montll. Months between date rUD inserted and dJ.te IUD was removed or
expulsed should equal months of use. Code 99 for month if unable to
estimate month. Code 9797 if still using an rUD.
39.7 Validation: rf possible, go to the place where the woman received her
IUD(s) and ascertain from the records, for each period of use, the date~
of insertion and removal or expulsion, the type of rUD, and the duration
of use. Then code Q.39.I, 39.2, 39.4, and 39.5 ~sing the best
information available from both the interview and the records. If any
informat~on is obtained from re~ords, code yes (1) in Q.39.6; other\vise
code no(O).
If ans\.,.er to Q.43 is yes, ask Q.43.l and put an lIX ll in any box that
applies. If the ~"omen does not knmv the name of the pil1(s), probe and
ask such questions as "Was it perhaps Premarin, or DES?lI. If a woman
took more than one type of estrogen, record the year of first use of any
type (including an unknown type) in.Q.43.2, and the year of most recent
use in Q.43.3. In Q.43.4, record total months of use of all types
combined (including any unknown type); code 97 for 97 or more months of
use.
39.7 Advised to stop using rUD: Ask the portion in brackets of all women
'except normal ~ontrois (e.g. in Chile). Note that the codes are as
follows: no = 2, yes = I, DK = 8. The reason for this is that 0 = never
used an IUD, and 9 = unknown if ever used an rUD.
39.8
40. Advised to not begin using contraceptives: This item should not be
confused with advice to stop using contraceptives.
I
'I
t
I
I
I
'I
I
I
I
I'
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I
I·
I·
I
44-44.2 Hormone treatment" for menstrual problems: If injections of hormones
were given for treatment of menstrual or ovarian problems, code as
fo110\vs:
I
Q4l~ = 1 (yes)
Q44.1 = 4 (injections)
In Q44.2, code the major
reason is given. PROBE.
..:,. ,....-... -
- _ .. _ ......... ••••••_~j ..:.-~: _,... - _ ••__ ~ ••• ........ --_••
reason for the treatment if more than one
I
I
I
I
I
I
I i-++
I
I
I
I
I ++
I
++
I
I
I
I
I
I
I
I
I
I
I~ '
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45- /.5.1 Use of sex hormon(~s fot:" other rc~.1sons; The code for QI.S.l ].5 3S
follo~';5 ;
1 = acne or othcr skin problems
2 = frigidity
3 = treatt:lcnt to become pregnant
4 = benign breast disease '. ,
5 follo~ing miscarriage
'~
=
6 = heart disease
7 other to induce weight galn, myasthenia grav1.S, ITP, etc.)
8 = unknown
Other codes will be added as needed. If none of the above reasons apply,
do not code.
46-46.1 Use of other hormones: Record the answer "to Q46.l on the lines
following the question. If you are unable to code 46.1, leave it uncoded
and it will be coded at the coordinating centre. Chronic inflammatory
and colla~en diseases include glomerulonephritis, rheumatoid artheritis,
leupis erythematosis, and others.
47.1 Use of reserpine: Use local names for this drug if applicable.
49.1 Types of alcoholic beverages: In Thailand, consider Nan Khao (rice wine)
as wine, Hae Khong (comn1ercial rice brandy) as distilled spirits, and Lao
Rong (rice brandy) as other local alcoholic drinks.
49.2 Number of drinks per day: A drink is 'defined as a bottle or glass of
beer, a wine glass of wine, or a single mixed drink of distilled spirits.
pS =Z 65 drinks per week
50-50.1 Family History: If any parent or grandparent had cancer, complete
the table in Q.SO.l. Ask first "~.;rho had cancer?", and indicate the
individualCs) by marking an IIX" in the box preceding the appropriate
relative(s). For each relative who had cancer, ask "Hhat kind of cancer
was it?", and mark an "Xll in the appropriate box.
51. Residential history: The main purpose or this question is to determine
changes in residen~e that may reflect changes in the availability of
contraceptives to the study subject. We are therefore not interested in
moves from one dwelling place to another in the same town or village or
in the same area or ~.;rard of a city. We are interes ted' in any moves from
one city, town or village (or farm) to another, or any major moves within
a city from one section to another. . We are also, of course, interesced
in moves to and from foreign countries. Question the women) and record
all areas of residence in column 2 of the table, starting with the
.current one and working backward in time to the place of residence 15
years ago. In column 3, record the dates (years) during which the-Women
lived at each place, and in column 4 record the number of years (or
, fraction thereof) that she lived at each location. In column 5, use an
"X" to indicate whether the residence was a foreign country, a major
urbanized city, a town, or a rural area (village or farm). It may be
helpful to use the calendar as an aid in determining dates.
Code items A-G following the table. Code to the nearest year. Code 01
for less than or equal to 17 months. Code 9's for unknown items. In
item B, code the total number of the past 15 years during ~.;rhich the ~-loman
lived in the area of her current residence. If she lived in the area
during more th30 one time period, include all times in the past 15
years. The numbers in items D, E, F and G should add up to 15.
The following'definitions will be used for maJ~r cities and towns 1n each
country:
1 = City: all state capitals (including the surrounding metropolitan
areas)
1 = City: A densely populated municipal area with predominantly
modern living structures such as Bangkok, Chiang Mai, Haad
Yai, and Ubol-ratch-tani.
"_"_~'·""I_~""".' , •••• "' ••_ p.-I~ ~ -._ _ _.oa._ _ __ _._
.I~......• •• J••••• ..... " . ..... .",' ...'.,-....
2 = Town: any place not included in 1 or 3
3 = Rural area: villages and farms
3 = Rural area: Villages and farms
3 = Rural area: villas, rancherios, and ejidos
2 = Town: anything not included in a city or rural area
1 = City: the Mexico City D.F. and the capital of each state
3 = Rural area: Villages and farms
3 = Rural area: village or farm
2 = Town: Second and third class cities
1 = City: Greater Manila and other first class cities
-17-
2 = Town: the "Ampue-Huang" or main distri,ct of each province.
2 = TO\~: Any ',place not inc luded 1n 1. or 3.
1 = City: Jerusalem, Haifa, Tel Aviv, Beersheba
3 = Rural area: Kibbutz, mushave, farm, agricultural village
1 = City: The major city in each district
2 = To\~: Any place not included in 1. or 3:
f. Nigeria:
e. Hexico:
d. Philippines:
c. Chile:
b.Israe-l:
a. Thailand:
In all countries code 8 1n 5lA if womall 15 a resident of a prLson or
other institution.
I
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53. Religion: 0:= no religion, 1 = Buddhist, 2:= Catholic, 3 = Hindu,
4 = Jewish, 5 = Muslim, 6 = Protestant, 7 = other, 9 = unknown
I ...,
I
I
I,
I
I;
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I'
I':
I,
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g. Australi'l:
1 := City: capital at each state
2 := Town: any place not in 1, 3 or 4
3 := Rural area: town less than 2,000 population, farms
'. .~..
4 := Foreign .born
h. Nairobi:
1 = City: Nairobi
2 := To\vn: any place not ~n 1,
.,
or L~..J
3 = Rural area: villages and farms
4 = Foreign born
i. Colombia:
1 = City: capital of each province
2 := Tm'111: any place not ~n 1, 3 or 4
3 = Rural area: villages and farms
4 = Foreign born
Race or ethnic background: This question need not be asked if the answer
is obvious to the.'interviewer. Otherwise, record what the subject
reports as believing herself to be. Code: 01 = Arab, 02 := Caucasian
(white), 03 = Chinese, 04 = Filipino, 05 := Hill tribe (of Thailand), 06 =
Indian (from Indian subcontinent, including Pak:stan, Bangladesh, Nepal,
Sri Lanka), 07 = Japanese, 08 = ~1alay, 09 := Native American (American
Indian or native of the western hemisphere), la = Negro (black), 11 =
Thai, 12 = Mestizo, 13 = Australian Aborigine, 99 = unknown.
54. Marital status: A marriage is any cohabitation with a male partne~ on a
permanent or semi-permanent basis. This includes common-law
marriages. Record "single" only for' ,·wmen that have never had any type
of marriage.
02 := unskilled laborcr, vendor, regular army
01 = housewife (use only if no other usual occupation)
.. ' ..
...... : ..
.'
Record as accurately as possible. If day or
Estimate year as closely as possible.
occupation. Code as follows:
00' = never married (for code for husband's ~ccupation~
54.2 Date of first marriage:
month unknown, code 9's.
I
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·59.3 Place where previous pap smears were taken: Record with sufficient
detail so that someone could go to the place to ascertain numbers of
previous Pap smears.
I i", ....' .
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03 := [arm l.Joorer
04 = shop clerk, untrained office worker
05 = skilled industrial or office worker
'.
.~
06 = skilled farm worker or small land owner-farmer, member of kibbutz or
cooperativ~ farm
07 = shop O\·mer, m£ln£lgerial-level office \vorkcr, army officer
08 = large land owner
09 = professional, owner of industry or business (other than a single
shop)
10 :::: Prostitute
86 :::: priest, monk, nun, yeshiva student, etc.
·87 :::: student
88 = unemployed (this does not include housewives; for husband's
occupation ~ode unemployed only if he was usually without a job)
99 :::: unknown occupation
Gynaecologic History
Without answers to the following questions, we will not be able to assess
a~equately the relationship between neoplasms and st~roid hormones. Two of
the most important things that we need to know are the numbers of sexual
partners the women has had, and the age at which she first had sexual
intercourse. These are sensitive matters, but information on them must be
obtained. Great skill and sensitivity on the part of the interviewer will be
required. Prior to beginning this section of the interview, it may be useful
to prepare the woman for the sensitive questions that are to come. A
statement for this purpose is included in the questionnaire. It may be
modified by the interviewer as needed.
59. Previous Pap smears: 've are interested in previous Pap smears only. To
avoid getting information on the smear that may have resulted in the
woman being diagnosed as having cervical cancer, and to get comparable
information from controls, we are asking only about Pap smears before ~ix
months ago. Be sure not to include information on more recent smears.
59.2 Frequency of Pap smears: If the woman has ,had two or more Pap smears
before six months ago, estimate the approximate frequency with which she
had Pap smears. Code to the nearest year . ._ ~_ ~_ _ r .. ~ _ ~.:.:. I
I . \" ~ "~'I .. 59.5
./;.'t+
I
I ++1'
V.11 id.1tion·: There H.15 .:tn error i.n the first printing of the
qucsti.olllwire. The illstructi.on~; in pan;nthescs shoulJ re,ld "Code number
of P;lp sr.1Cars prior to si.x 1II0ntlls .:l~~o that \-:ere confirmed [ram rncdic.:J.l
records". This chnnge will make 59.5 consistent Hith 59.1 and 59.2. In
codi.ng this item, cod.:; only those Sl:< or more months prior to the ·cl.:lte in
item 10. 0 = validation performed nod no p;lp srncnr found. 9 = no
valid.:ltion performed. ~ .
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60.
61.
6j2.
I
63.
I
,
I
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I
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Vagin.:tl discharge: The \Yord "doctor" in this question may be interpreted
as also referring to other providers of care, including local indigenous
practitioners.
Number of marriages or other sexual relationships: Until no\Y, the
question of the number of marriages h.:lS llOt been ascertained. The term
"other sexu31 relationships" should be translated into the local language
in terms that imply number of marriages or othe'r sexual relationships
(i.e. the number of men Hith whom the woman has had a sexual
relationship).
Age at first sexual relationship: Translate this question so that it
implies that \Ye want to know the age at first sexual intercourse.
/
Veneral disease: If the woman has ever had a v~nereal disease, ask first
"Did you have either of these diseases?" and put an "X" in the box
preceding either of the diseases that she had. Then, for each disease
she had) ask "HO\o1 many times did you have this problem?", and record the
answers in the table. Code each disease in the table according to the
code given below the table. Code 0 for any disease that she did not have.
I
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(02) 646-6444Fax: (02) 6464853 Telephone
A World Health Organization Collaborating Centre for Rehabilitation
Cumberland College of Health Sciences
/
cc: Dr K Nurtjojo \
,I
Yours faithfully
Dr Kaye Brock '
Senior Lecturer
School of Community Health
Dear Dr Dowsett
,,.
I was involved in this project both in the capacity of co-ordinato! in 1982-3 and as a Ph.D
student. My particular area was in situ cervical cancer and as you can see from the
enclosed publication one of the most striking ri~k factors was smoking. On return to
Australia after my post-doctoral position at National Cancer Institute I have an academic
position at Sydney University (Cumberland Gollege) and am interested tos~ if the same
relationship exists in invasive cervical cancer, cases. Unfortunately the WHO questionnaire
did not include smoking questions - as in 1980 no one believed this association. lt is
therefore I request permission to access medical records of invasive cervical cancer cases
and controls from this WHO study to record smoking data. Either I or my research student
(Dr K Nurtjojo) will ~ccess these files and all due confidentially will be observed.
./
.......
APPE:.:lDIX 3. REQUEST TO THE 'ETHICS COMHITTEE
I am writing to you as sec!etary of the Human Ethics Review Committee to seek permission
to re-access medical records of patients in your hospital who preViously have consented to
be involved in a World Health Organization study of Gynaecological Cancer aIid Steroid
Contraceptive Use conducted between 1980 and 1986 (prof.Hudson was the Principal
T.."oC't;,.."tnr "t ,xToC'tm<>o:>A o:>s Drnf' ~h"''::lT'Tl1~n U'!:I<! !:It ROy!:ll Prinrp AlfrpJ1 Hn~pl·t<>n
...... .I.'Y'-".:J\.J.E:>':41.V.L"'" .. ,....,.,;t.......""""""'" "'" ......." .... .........~ ........_ .... .,._w _.. _... -----..-..-----.----:... -~.J'~
Dr Dowsett
Secretary Human Ethics Review Committee
Westmead Hospital
Westmead 2145
5 June 1991
\
East ,Street, tidcombe, New sOuth Wales, Australia, 2141
" , "" ...:\,
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APPENDIX 4.
SAS PROGRAMS TO GENERATE THE DATA IN TEXT FILE FORMAT
1. General data set.
libname milib •c: \sas\" ;
data temp;
set milib.s ;
file "insgen2.dat" ;
if v4= '1' then delete;
ifv49= 'I' or v49= '9' then delete;
put vI v2 v3 v4 age v27 v29 v313 v314 v315 v316 v317 v321 v329 v330 v336
v337 v339 v340 v344 v345 v346 v347 v348 v349 v358 v359 v360 v361 v362;
run;
2. Contraceptive practices data.
libname milib ·c:\sas\" ;
data temp;
set milib.s ;
file "inscon1.dat";
if v4 = '2' then delete;
ifv49='I' orv49='9' then delete;
put vI v2 v3 v4 age v112 v113 v114 v115 v116 v117 v118 v119 vI20 vI21 vI22
vI23 vI24 vI25;
run;
3. Medical history data.
libname milib ·c:\sas\" ;
data temp;
set milib.s ;
file "inshist1.dat" ;
ifv4= '2' then delete;
if v49 = '1' or v49 = '9' then delete;
put vI v2 v3 v4 age v31 v32 v33 v34 v35 v36 v37 v38 v39 v40 v41 v42
v46 v49 v53 v57 v60 v63 v65 v352 v353 v354;
run;
4. Reproductive history data.
libname milib "c: \sas\" ;
data temp;
set milib.s ;
file "insrepr1.dat" ;
ifv4= '2' then delete;
if v49 = 'I' or v49 = '9' then delete;
put vI v2 v3 v4 age v72 v74 v75 v76 v78 v80 v81 v82 v83 v84 v87 v89 v90 v91 vllI;
run;
5. Family medical history data.
libname milib "c:\sas\· ;
data temp;
set milib.s ;
file "insfam1.dat";
if v4= '2' then delete;
if v49 = 'I' or v49 = '9' then delete;
put vI v2 v3 v4 age v318 v319 v320 v321 v322 v323 v324 v325 v326 v327 v328;
run;
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6. Smoking data (community cases and controls only)
libname milib "c:\sas\" ;
data temp;
set milib.s ;
file "inssmkl.dat" ;
ifv4= '2' then delete;
if v49 = 'I' or v49 = '9' then delete;
put vI v2 v3 v4 age smokeI smoke3 smoke5;
run;
7. Length of QC use data.
libname milib "c:\sas\" ;
data temp;
set milib.s ;
file "inspiI2.dat";
if v4=' I' then delete;
ifv49='I' orv49='9' then delete;
put vI v2 v3 v4 age vI28 vI29 vI35 vI36 vI42 vI43 vI49 vI50 vI56 vI57
vI63 vI64 vI70 vl71 vl77 vI78 vI84 vI85 vI9I v192;
run;
8. Length of injection use data.
libname milib "c:\sas\" ;
data temp;
set milib.s ;
file "insinj l.dat";
if v4= '2' then delete;
ifv49='I' orv49='9' then delete;
put vI v2 v3 v4 age v200 v20I v203 v209 v2I0 v2I2 v2I8 v2I9 v22I
v227 v228 v230 v236 v237 v239;
run;
9. Length ofIUD use data.
libname milib "c:\sas\" ;
data temp;
set milib.s ;
file "insiudl.dat";
ifv4='2' then delete;
if v49 = ' I' or v49 = '9' then delete;
put vI v2 v3 v4 age v250 v257 v264 v271 v278;
run;
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APPENDIX 5.
TABULATION AND CHI-SQUARED COMPUTATION.
(IN THIS EXAMPLE THE PROGRAMS WRITTEN FOR IN-SITU CASES WITH
COMMUNITY CONTROLS ARE SHOWN)
1. CONTRACEPTIVE DATA
%nover
%out contra
$tab4 : = (0;1),(1;0)
$tab8:= (0;1),(1;0)
$tabll := (0;1),(1;0)
$tab12 : = (0;1),(0;1)
$tab13 : = (0;1),(0;1)
$tab17 := (0;1;9),(0;1;0)
$tab18 := (0;1),(0;1)
$tab18 : = (0;1),(0;1)
$tab20 : = (0; 1;2;3),(0;1;2;3)
$case : = rec(inscon1[;4],t=$tab4)
$oc : = inscon1[;6]
$inject : = inscon1[;7]
$iud : = rec(insconl[;8],t=$tab8)
$implant : = insconl[;9]
$ring:= insconl[;10]
$safe := rec(inscon1[;1l],t=$tabll)
$diaph : = rec(insconl[;12],t=$tab12)
$condom : = rec(inscon1[;13],t=$tab13)
$withdraw:= insconl[;14]
$jelly := insconl[;15]
$douch:= insconl[;16]
$vasect:= rec(insconl[;17],t=$tab17)
$tubes := rec(inscon1[; 18],t=$tab18)
$othmeth : = inscon1[;19]
$agrp : = ind(rec(insconl[;20],t=$tab20))
$data : = $case,$oc,$iud,$safe,$diaph
$data := $data,$condom,$withdraw,$jelly,$douch,$vasect,$tubes
$dnam := "Case"; "OC"; "inject"; "100"; "implan"; "ring"; "Safe"; "Diaph"
$dnam := $dnam;"Condom"; "Witdraw";"Jelly"; "Douch"; "Vasect"; "Tubes"
%label $data $dnam
tab ($data,y= 1,x=(2,,1l),p=2,ch=1)
2. AREA OF LIVING DATA
%nover
%out tage.out
$tab4:= (0;1),(1;0)
$gtab15 := (1;15;99),(14;15;99),(1;0;0)
$case:= rec (insgenl[;4],t=$tab4)
$area : = insgen1[;14]
$yeararea := rec(insgen1[;15],g=$gtabl5)
$agrp : = insgen1[;5]
$data : = $case,$area,$agrp
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$dnam:= "Case";"area";"agrp"
%label $data $dnam
tab($Data,y= 1,x= (2,3),p=2,eh= 1)
3.DRINKING HABIT
%nover
%out tdrink.out
$taM : = (0;1),(1;0)
$tab8 : = (0;1;6;9),(1;0;0;1)
$tab9 := (0;1),(1;0)
$tab11 : = (0;1;2;6;9),(0;1;1;1;0)
$gtab12 : = (0;1),(0;98),(0;1)
$ease := ree (insgen1[;4],t=$taM)
$beer := ree(insgen1[;8],t=$tab8)
Swine : = ree(insgen1[;9],t=$tab9)
$spirit : = insgen1[;10]
$othdrink : = ree(insgen1[;11],t=$tab11)
$sumdrink : = ind(ree(insgen1[;12],g=$gtab12))
$data := $ease,$beer,Swine,$spirit,$othdrink,$sumdrink
$dnam : = "Case"; "Beer"; "Wine"; "Spirit"; "Othdrink"; "sumdrink"
%label $data $dnam
tab($data,y= 1,x=(2,,6),p=2,eh= 1)
4.FAMILY HISTORY DATA
%nover
%out tfam.out
$taM : = (0;1),(1;0)
$tab6 := (9,1)
$tab7 := (9,1)
$tab8 := (0;1;9),(0;1;0)
$tab9 := (9,1)
$tablO := (0;1;9),(0;1;0)
$tab11 : = (1;2;9),(0;1;0)
$tab12 := (0;5;7;8;9),(0;1;1;1;1)
$tab13 := (1;2;9),(0;1;1)
$tab14 := (0;7;8;9),(0;1;1;1)
$tab15 := (1;2;9),(0;1;1)
$tab16 : = (0;7;8;9),(0;1;1;1)
$ease : = ree (insfam1[;4],t=$taM)
$hd : = ree(insfam1[;6],t=$tab6)
$kp : = ree(insfam1[;7],t=$tab7)
$stroke : = ree(insfam1[;8],t=$tab8)
$ea : = ree(insfam1[;9],t=$tab9)
$dm:= ree(insfam1[;10],t=$tab10)
$momo := ree(insfaml[;l1],t=$tabll)
$mofa : = ree(insfam1[;12],t=$tab12)
$famo : = ree(insfam1[;13],t=$tab13)
$fafa : = ree(insfam1[;14],t=$tab14)
$mo : = ree(insfam1[;15],t=$tab15)
$fa : = ree(insfam1[;16],t=$tab16)
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$data := $case,$HD,$KP,$Stroke,$CA,$DM,$MoMo,$MoFa,$FaMo,$FaFa,$Mo,$Fa
$dnam :=
"Case"; "HD + "; "KP+ "; "Stroke+ "; "CA+ "; "DM+"; "MoMo + "; "MoFa+"; "FaMo+"
$dnam:= $dnam;"FaFa+";"Mo+";"Fa+"
%label $data $dnam
tab($data,y= 1,x=(2,,12),p=2,ch= 1)
5.LENGTH OF IUD DATA
%nover
%out tiud
$tab4 : = (0;1),(1;0)
$gtab6 := (0;1;13;25),(0;12;24;98),(0;1;2;3)
$tabll : = (0;1;2;3),(0;1;2;3)
$case : = ree(insiud1[;4],t=$tab4)
$length : = sum.row(insiud1[;6,,10])
$length : = ind(ree($length,g=$gtab6»
$agrp := ind(ree(insiud1[;1l],t=$tabll»
$data := $case,$length
$dnam : = "Case"; "Length"
%label $data $dnam
tab($data,y= 1,x=2,p=2,ch= 1)
6.MARITAL DATA
%nover
%out tmarit
$tab4 : = (0;1),(1;0)
$tab18 : = (0;1;2;3),(0;1;2;3)
$gtab19 : = (0;16;20;25;30;88;99),(0;19;24;29;37;88;99),(0;1;2;3;3;0;0)
$case : = ree (insgen1[;4],t=$tab4)
$marit : = (ree(insgen1[;18],t=$tab18»
$agemarit : = insgen1[;19]
desc($agemarit)
$agemarit := (ree(insgen1[;19],g=$gtab19»
$data : = $case,$marit,$agemarit
$dnam := "Case"; "Marital";"Agemarit"
%label $data $dnam
tab($data,y= 1,x=(2,3),p=2,ch= 1)
7.MEDICAL HISTORY DATA
%nover
!%out tmed
$tab4:= (0;1),(1;0)
$gtab21 : = (0;1;2),(0;1;8),(0;1;2)
$gtab23 := (0;1),(0;6),(0;1)
$tab24:= (0;1;6),(0;1;0)
$gtab26 : = (0;25;98),(24;42;98),(0;1;0)
$gtab27 := (0;1;2;3),(0;1;2;8),(0;1;2;3)
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$case := ree(inshist1[;4],t=$tab4)
!$tublig := inshist1[;18]
/ !$dc: = (ree(inshist1[;21],g=$gtab21»
!$sc : = ree(inshist1[;23],g=$gtab23)
!$othop : = ree(inshist1[;24],t=$tab24)
!$discharg : = inshist1[;25]
!$olddisch : = (ree(inshist1[;26],g=$gtab26»
$manydisc : = (ree(inshist1[;27],g=$gtab27»
$data : = $case,$tublig,$dc,$sc,$othop,$discharg,$olddisch,$manydisc
$dnam: = "Case"; "Tlig+ ";"DC";"SC+ ";"OthOp+ ";"Discharge+ "; "Olddisch"; "manydisc"
%label $data $dnam
tab($data,y= 1,x=(2,,8),p=2,ch=1)
8.TOTAL MONTH OF BREASTFEEDING DATA
%nover
$tab4:= (0;1),(1;0)
$tab18 := (1;2;3),(0;1;2)
$case : = ree (insrepr1[;4],t=$tab4)
$MonBf: = (ree(insrepr1[;18],t=$tab18»
$data : = $case,$Monbf
$dnam: = "Case"; "monbf"
%label $data $dnam
tab($data,y=1,x=2,p=2,ch= 1)
9.PAP SMEARS HISTORY DATA
%nover
%out pap
$tab4 : = (0;1),(1;0)
$tab24 : = (1;2;3;98),(0;1;2;2)
$tab25 : = (0;1;2;3;4;5;6;7;8),(0;1;1;1;1;1;0;2;2)
$tab31 : = (0;1;2;3),(0;1;2;3)
$case : = ree (insgen1[;4],t=$tab4)
!$pap : = (ree(insgen1[;24],t=$tab24»
$freqpap : = ind(ree(insgen1[;25],t=$tab25»
$agrp : = ind(ree(insgen1[;31],t=$tab31»
!$data : = $case,$pap,$freqpap
!$dnam:= "Case";"pap";"freqpap"
$data := $case,$freqpap,$agrp
$dnam : = "Case";"1/5yr/never";"1/1-5yrs"; "> l/yr"
$dnam:= $dnam;" < 30 agrp";"30-39 agrp";"40-49 agrp";" > =50 agrp"
%label $data $dnam
tab($data,y= 1,x=(2,3),p=2,ch=1)
10.LENGTH OF OC USE DATA.
%nover
%out pill
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$tab3 := (0; 1),(1;0)
$tab6 : = (98;99),(0;0)
$gtab6 : = (0;1;25;73),(0;24;72;260),(0;1;2;3)
$tab25:= (0;1;2;3),(0;1;2;3)
$case : = ree(inspil1[;3],t=$tab3)
$length : = ree(inspil1[;6,8,10,12,14,16,18,20,22,24],t=$tab6)
$length : = sum.row(inspil1[;6,8,10,12,14,16,18,20,22,24])
$length : = ind(ree($length,g=$gtab6))
$agrp : = ind(ree(inspil1[;25],t=$tab25))
$data : = $case,$length,$agrp
$dnam:= "Case";"lengthpil"
$dnam : = $dnam;" < 30 agrp"; "30-39 agrp"; "40-49 agrp";" > =50 agrp"
%label $data $dnam
tab($data,y= 1,x=2,p=2,ch= 1)
1l.PLACE OF BIRTH DATA.
%nover
%out pob.out
$tab4 := (0;1),(1;0)
$tab7 : = (1;2;3;4;7),(1;1;1;0;0)
$tab31 : = (0;1;2;3),(0;1;2;3)
$case := ree (insgen1[;4],t=$tab4)
$pob : = (ree(insgen1[;7],t=$tab7))
$agrp : = ind(ree(insgen1[;31],t=$tab31))
$data : = $case,$pob,$agrp
!$dnam:= "Case";"POB"
$dnam : = "Case"; "Ozbom"
. $dnam: = $dnam;" < 30 agrp"; "30-39 agrp"; "40-49 agrp";" > =50 agrp"
%label $data $dnam
tab($Data,y= 1,x=2,p=2,ch= 1)
12.REPRODUCTIVE HISTORY DATA.
%nover
%out repro
$tab4 := (0;1),(1;0)
!$gtab6 := (0;12;13;14),(11;12;13;17),(0;1;2;3)
$gtab6 : = (0;12;13;14),(11;12;13;17),(3;2;1;0)
$tab7 := (0;1;2;6),(0;1;1;1)
$gtab8 := (0;6;20;25;30),(0;19;24;29;50),(0;1;2;3;4)
$gtab9 : = (0;6;20;25;30;97),(0;19;24;29;50;97),(0;1;2;3;4;0)
$gtablO : = (0;6;20;25;30;97;98;99),(0;19;24;29;50;97;98;99),(0;1;2;3 ;4;1;1;1)
$tab13 : = (1;2;3),(0;1;1)
$tab14 := (1;2;3),(0;1;1)
$tab15 := (0;1;2;3;4;6;8),(0;1;2;2;2;2;2)
$tab17 := (0;1;2;3;4;5;6),(0;1;2;3;4;4;4)
$tab18 : = (1;2;3),(2;1;0)
$tab21 : = (0;1;2;3),(0;1;2;3)
$case : = ree (insrepr1[;4],t=$tab4)
$Menarche : = ind(rec(insrepr1[;6],g=$gtab6))
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$Pregnan : = (ree(insrepr1[;7],t=$tab7»
$AgeFpreg : = (ree(insrepr1[;8],g=$gtab8»
$Agelivbir := (ree(insrepr1[;9],g=$gtab9»
$AgeBf: = (ree(insrepr1[;1O],g=$gtab10»
$SA : = rec(insrepr1[;13],t=$tab13)
$Induce : = ree(insrepr1[;14],t=$tab14)
$AnyAb : = (rec(insrepr1[;15],t=$tab15»
$PregBf:= (rec(insrepr1[;17],t=$tab17»
$MonBf: = ind(ree(insrepr1[;18],t=$tab18»
$agrp : = ind(ree(insrepr1[;21],t=$tab21))
$data : = $case,$Menarche,$Pregnan,$AgeFpreg,$Agelivbir,$AgeBf,$SA
$data : = $data,$Induce,$AnyAb,$PregBf,$Monbf
$dnam : = "Case"; "agemenar"; "preg";"age1preg"; "agellivbir"; "age1bf'; "SA"
$dnam:= $dnam;"induce";"anyab";"pregbf";"monbf"
%label $data $dnam
tab($data,y= 1,x=(2,,1l),p=2,ch= 1)
13.YEARS OF SCHOOL DATA.
%nover
%out tschool
$tab4 : = (0;1),(1;0)
$tab20 := (1;2;3),(0;1;2)
$tab21 : = (1;2;3;9),(0;1;2;0)
$case : = ree (insgen1[;4],t=$tab4)
$yearsch : = (rec(insgen1[;20],t=$tab20»
$husbsch: = (ree(insgen1[;21],t=$tab21»
$data := $case,$yearsch,$husbsch
$dnam : = "Case";"selfsch"; "husbsch"
%label $data $dnam
tab($data,y= 1,x=(2,3),p=2,ch= 1)
14.SEXUAL FACTORS DATA.
%nover
%out sex
$tab4:= (0;1),(1;0)
$tab26 : = (1;2;3;4),(0;1;2;3)
$tab27 := (1;2;3;4),(0;1;2;3)
$tab31 := (0;1;2;3),(0;1;2;3)
$case : = ree (insgen1[;4],t=$tab4)
$sexpart : = ind(ree(insgen1[;26],t=$tab26»
$agesex : = ind(ree(insgen1[;27],t=$tab27»
$agrp := ind(ree(insgen1[;31],t=$tab31»
$data : = $case,$sexpart,$agesex
$dnam:= "Case";"Nosexpart";"Age1sex"
%label $data $dnam
tab($data,y= 1,x=(2,3),p=2,ch= 1)
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i5.SMOKING DATA.
%nover
%out smk
$tab3 := (0;1),(1;0)
$gtab7 : = (0;1;10;20;30),(0;9;19;29;80),(0;1;2;3;4)
$tab8 : = (0;1;2;3),(0;1;2;3)
$case : = ree (inssmk1[;3],t=$tab3)
$smoke : = inssmk1[;5]
$Nocig : = (ree(inssmk1[;7],g=$gtab7))
$agrp : = (ree(inssmk1[;8],t=$tab8))
$data := $case,$smoke,$nocig
$dnam:= "Case";"Smoker";"Nocig"
%label $data $dnam
tab($data,y= 1,x=(2,3),p=2,ch= 1)
16.TOTAL PREGNANCIES DATA
%nover
%out ttotprg
$tab4 : = (0;1;2;3),(1;0;0;0)
$tab16 := (0;1;2;3;4;5;6;7;8;9;10;12;13;16),(0;1;1;2;3;3;3;3;3;3;3;3;3;3)
$case := ree (insrepr1[;4],t=$tab4)
$totpreg := (ree(insrepr1[;16],t=$tab16))
$data := $case,$totpreg
$dnam:= "Case";"totpreg"
%label $data $dnam
tab($data,y= 1,x=2,p=2,ch= 1)
17.VENEREAL DISEASE HISTORY DATA
%nover
%out tvd
$tab4 : = (0;1),(1;0)
$tab13 := (0;1;9),(0;1;0)
$case : = ree (insgen1[;4],t=$tab4)
$famca := ree(insgen1[;13],t=$tab13)
$vd := (insgen1[;28])
$data : = $case,$famca,$vd
$dnam:= "Case";"FamCA";"VD"
%label $data $dnam
tab($data,y= 1,x=(2,3),p=2,ch= 1)
18.OCCUPATION DATA.
%nover
%out twork
$tab4 : = (0;1),(1;0)
$tab22 : = (1;2;4;5;7;9;87;99),(0;1;1;2;2;2;2;1)
$tab23 : = (0;2;4;5;6;7;9;87;88;99),(0;1;1;2;2;2;2;2;0;1)
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$ease : = ree (insgen1[;4],t=$tab4)
$work : = (ree(insgen1[;22],t=$tab22))
$husbwork: = (ree(insgen1[;23],t=$tab23))
$agrp : = insgen1[;31]
$data : = $ease,$work,$husbwork,$agrp
$dnam := "Case";"SelfWork"; "Husbwork"; "agrp"
%label $data $dnam
tab($data,y= 1,x=(2,,4),p=2,eh= 1)
EXAMPLE OF INDIVIDUAL LOGISTIC PROGRAMS.
THIS EXAMPLE IS FOR IN-SITU CASES WITH COMMUNITY CONTROLS.
%nover
%outLOGCOM
!1. SEX
$tab31 : = (0;1;2;3),(1;0;0;0)
$tab231 : = (0;1;2;3;4;5;6;7;8;9),(0;0;1;2;3;2;2;3;3;3)
$gtab241 := (0;1;2;3;4;10;16;20;25;99),(0;1;2;3;4;15;19;24;59;99),(0;0;0;1;2;2;1;0;0;2)
$tab291 := (0; 1;2;3),(3;2;1;0)
!2.SMK
$tab32 : = (0;1;2),(0;1;1)
!3. VD
!4. SCHOOL
$tab174:= (1;2;3;9),(0;1;2;0)
$gtab184 :=
(0;1;2;3;4;10;13;77;79;98;99),(0;1;2;3;9;12;40;77;79;98;99),(0;0;1;2;0;1;2;0;0;0;0)
!5. REPRO
$gtab65 : = (0;6;13;20;25;60),(0;6;19;24;43;60),(0;0;2;1;1;0)
$tab115 : = (0;1;2;3;4;6;12),(1;0;0;0;0;0;0)
$tab125 : = (0;1;2;3;8),(1;0;0;0;0)
$tab155 := (0;1;2;3;4;5;6;8),(4;3;2;1;0;0;0;0)
$gtab165 : = (0;1;7;13;144;224),(0;6;12;90;144;224),(0;1;2;3;3;3)
18. PAP
$gtab218 : = (0;2;3;4;98;99),(1;2;3;7;98;99),(3;2;1;0;0;3)
$tab228 := (0;1;2;3;4;5;6;7;8;9),(0;1;1;1;1;1;0;2;2;0)
!9.MED
$tab239 := (0;1;8),(0;1;0)
1l0. FAM
$tab910 : = (0;;9),(0;1;1;1;1;1;1;1;1;0)
$tabll10 := (0;;9),(0;1;1;1;1;1;1;1;1;0)
$tab131O : = (0;;9),(0;1;1;1;1;1;1;1;1;0)
lll. DRINK '
$tab611 := (0;1),(0;1)
$tab711 : = (0;1),(0;1)
!12. CONTRA
$tab412:= (0;1;9),(0;1;0)
$tab612 := (0;1),(0;1)
$tab1212 := (0;1),(0;1)
!RECODE
!l.SEX
$ease : = ree (genish[;3],t=$tab31)
$sexpart : = ind(rec(genish[;23],t=$tab231))
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$agesex : = ind(rec(genish[;24],g=$gtab241»
$agrp := ind(rec(genish[;29],t=$tab291»
!2.SMK
$Smkstat := rec(smkish[;3],t=$tab32)
!3.VD
$vd := genish[;25]
!4.SCHOOL
$yearsch:= ind(rec(genish[;17],t=$tabI74»
$husbsch: = ind(rec(genish[;18],g=$gtabI84»
!5.REPRO
$AgeFpreg := ind(rec(reproish[;6],g=$gtab65»
$SA:= rec(reproish[;1l],t=$tab1l5)
$Induce : = rec(reproish[;12],t=$tabI25)
$PregBf: = ind(rec(reproish[;15],t=$tabI55»
$MonBf: = ind(rec(reproish[;16],g=$gtabI65»
!8.PAP
$pap := ind(rec(genish[;21],g=$gtab218»
$freqpap := ind(rec(genish[;22],t=$tab228»
!9.MED
$discharg := rec(histish[;23],t=$tab239)
!lO.FAM
$momo := rec(famish[;9],t=$tab91O)
$famo := rec(famish[; 1l],t=$tablll0)
$mo := rec(famish[;13],t=$tab1310)
!ll.DRINK
Swine := rec(genish[;6],t=$tab611)
$spirit := rec(genish[;7],t=$tab711)
!12.CONTRA
$oc := rec(contrish[;4],t=$tab412)
$iud : = rec(contrish[;6],t=$tab612)
$condom:= contrish[;ll]
$withdraw := rec(contrish[;12],t=$tab1212)
!DATA
$cj.ata := $case,$sexpart,$agesex,$SMKSTAT,$vd
$data := $data,$yearsch,$husbsch,$agefpreg,$sa,$induce,$pregbf,$monbf
$data : = $data,$pap,$freqpap,$discharg,$momo,$famo,$mo
$data := $data,$wine,$spirit,$oc,$iud,$condom,$withdraw,$agrp
!LABEL
$dnam: = "Case"; "O-lsp"; "2-3sp";"4-6sp";" > =7sp";" > =20fi"
$dnam := $dnam;"16-19fi";" <16fi"
$dnam := $dnam; "Ever smoke"; "VD + "
$dnam: = $dnam;" < 10"; "10-12self"; "self> = 13"; "Husb < =10"; "10-12husb"; "Husb> 12"
$dnam:= .$dnam;"Nopreg";" > =20";" < =19"; "SA-";"Induce-"
$dnam := $dnam;" > =4bf"; "3bf"; "2bf";" Ibf"; "NoPregBF"
$dnam := $dnam; "Omonbf"; "1-6monBF"; "7-12monbf"; "> 12 monbf"
$dnam:= $dnam;" > =4";"3";"2";"0-1 ";" < 1/5yr/never";"1/2-5yrs";" > =l/yr"
$dnam := $dnam; "Discharge"; "MoMo + "; "FaMo+ "; "Mo + "
$dnam := $dnam; "Wine+ "; "Spirit+ "
$dnam := $dnam;"OC + "; "IUD + "; "Condom+ "; "Witdraw+ "
$dnam:= $dnam;" > =50 agrp";"40-49 agrp";"30-39";" < =29 agrp"
!$dnam:= $dnam;" < = 29agrp";"30-39agrp";"40-49agrp";" > =50agrp"
%label $data $dnam
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!Computation.
Desc($data)
lSCHOOL to PAP
lreg($data,y= l,x=(12,13,32,,34,49, ,51))
lreg($data,y= l,x=(12,13,36,37,49, ,51))
lreg($data,y= l,x= (15, 16,32,,34,49,,51))
lreg($data,y= l,x=(15,16,36,37,49,,51))
lSCHOOL to MED
lreg($data,y= l,x= (12, 13,38,49,,51))
lreg($data,y= l,x= (15,16,38,49,,51))
lSCHOOL to FAM
lreg($data,y= l,x=(12, 13 ,39,49,,51))
lreg($data,y= l,x= (12, 13,40,49,,51))
lreg($data,y= l,x= (12, 13,41,49,,51))
lreg($data,y= l,x=(15,16,39,49, ,51))
lreg($data,y= l,x= (15, 16,40,49, ,51))
lreg($data,y= l,x= (15,16,41,49 ,,51))
!SCHOOL to DRINK
lreg($data,y= l,x=(12, 13 ,42,49, ,51))
lreg($data,y= l,x=(12,13,43,49,,51))
lreg($data,y= 1,x=(15, 16,42,49,,51))
lreg($data,y= l,x= (15,16,43,49, ,51))
lSCHOOL to CONTRA
lreg($data,y= l,x= (12, 13 ,44,49,,51))
lreg($data,y= l,x=(12, 13,45,49,,51))
lreg($data,y= l,x=(12,13,46,49, ,51))
lreg($data,y= l,x= (12,13,47,49,,51))
lreg($data,y= l,x=(15,16,44,49, ,51))
lreg($data,y= 1,x=(15, 16,45,49,,51))
lreg($data,y= l,x=(15,16,46,49,,51))
lreg($data,y= l,x=(15,16,47,49,,51))
lREPRO to PAP
lreg($data,y= l,x= (18, 19,32, ,34,49,,51))
lreg($data,y= 1,x=(20,32,,34,49, ,51))
lreg($data,y= l,x= (21,32, ,34,49,,51))
lreg($data,y= l,x=(23,,26,32,,34,49,,51))
lreg($data,y= l,x=(28,,30,32,,34,49,,51))
lreg($data,y= l,x=(18,19,36,37,49,,51))
lreg($data,y= l,x=(20,36,37,49, ,51))
lreg($data,y= l,x=(21,36,37,49,,51))
lreg($data,y= l,x= (23, ,26,36,37,49,,51))
lreg($data,y= l,x= (28, ,30,36,37,49,,51))
lREPRO to MED
lreg($data,y= l,x= (18, 19,38,49,,51))
lreg($data,y= l,x=(20,38,49,,51))
lreg($data,y= l,x=(21,38,49,,51))
lreg($data,y= l,x=(23, ,26,38,49,,51))
lreg($data,y= l,x= (28,,30,38,49,,51))
lREPRO to FAM
lreg($data,y= l,x= (18,19,39,49,,51))
lreg($data,y= l,x= (20,39,49,,51))
lreg($data,y= l,x= (21,39,49,,51))
lreg($data,y= l,x= (23 ,,26,39,49,,51))
lreg($data,y= l,x=(28,,30,39,49,,51))
lreg($data,y= l,x=(18,19,40,49,,51))
lreg($data,y= l,x= (20,40,49,,51))
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lreg($data,y= l,x=(21,40,49,,51»
lreg($data,y= l,x=(23,,26,40,49, ,51»
lreg($data,y= l,x=(28,,30,40,49,,51»
lreg($data,y= l,x=(18, 19,41,49,,51»
lreg($data,y= l,x=(20,41,49,,51»
lreg($data,y= l,x=(21,41,49,,51»
lreg($data,y= l,x= (23, ,26,41,49,,51»
lreg($data,y= l,x=(28,,30,41,49,,51»
lREPRO to DRINK
lreg($data,y= 1,x=(18,19,42,49,,51»
lreg($data,y= 1,x=(20,42,49,,51»
lreg($data,y= l,x= (21,42,49,,51»
lreg($data,y= 1,x=(23,,26,42,49,,51»
lreg($data,y= 1,x=(28, ,30,42,49, ,51»
lreg($data,y= 1,x=(18,19,43,49,,51»
lreg($data,y= 1,x=(20,43,49, ,51»
lreg($data,y= 1,x=(21,43,49,,51»)
lreg($data,y= 1,x=(23,,26,43,49,,51»
lreg($data,y= l,x= (28, ,30,43,49,,51»
lREPRO to CONTRA
lreg($data,y= 1,x=(18,19,44,49,,51»
lreg($data,y= 1,x=(20,44,49,,51»
lreg($data,y= l,x=(21,44,49,,51»
lreg($data,y= 1,x=(23,,26,44,49, ,51»
lreg($data,y= l,x=(28,,30,44,49, ,51»
lreg($data,y= 1,x=(18,19,45,49,,51»
lreg($data,y= 1,x=(20,45,49,,51»
lreg($data,y= 1,x=(21,45,49,,51»
lreg($data,y= 1,x=(23 ,,26,45,49,,51»
lreg($data,y= 1,x=(28, ,30,45,49,,51»
lreg($data,y= 1,x=(18,19,46,49,,51»
lreg($data,y= 1,x=(20,46,49,,51»
lreg($data,y= 1,x=(21,46,49,,51»
lreg($data,y= 1,x=(23 ,,26,46,49,,51»
lreg($data,y= 1,x=(28,,30,46,49,,51»
lreg($data,y= 1,x=(18,19,47,49,,51»)
lreg($data,y= 1,x=(20,47,49,,51»
lreg($data,y= 1,x=(21,47,49, ,51»
lreg($data,y= l,x= (23,,26,47,49,,51»
lreg($data,y= 1,x=(28,,30,47,49,,51»
lPAP to PAP
lreg($data,y= l,x= (32,,34,36,37,49,,51)
lPAP to MED
lreg($data,y= 1,x=(32,,34,38,49,,51»
lreg($data,y= 1,x=(36,37,38, ,45,49,,51»
IPAP to FAM
lreg($data,y= l,x= (32,,34,39,49,,51»
lreg($data,y= 1,x=(32,,34,40,49,,51»
lreg($data,y= 1,x=(32,,34,41,49,,51»
lreg($data,y= 1,x=(36,37,39,49,,51»
lreg($data,y= 1,x=(36,37,40,49,,51»
lreg($data,y= 1,x=(36,37,41,49,,51»
!PAP to DRINK
lreg($data,y= 1,x=(32,,34,42,49,,51»
lreg($data,y= 1,x=(32,,34,43,49,,51»
lreg($data,y= l,x=(36,37,42,49,,51»
lreg($data,y= 1,x=(36,37,43,49,,51»
IPAP to CONTRA
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lreg($data,y= l,x=(32,,34,44,49,,51))
lreg($data,y= l,x=(32,,34,45,49,,51))
lreg($data,y = l,x = (32, ,34,46,49, ,51))
lreg($data,y= l,x=(32,,34,47,49,,51))
lreg($data,y= l,x= (36,37,44,49,,51))
lreg($data,y= l,x=(36,37,45,49,,51))
lreg($data,y= l,x= (36,37,46,49,,51))
lreg($data,y= l,x=(36,37,47,49,,51))
!MED toFAM
lreg($data,y= l,x= (38,39,49,,51))
lreg($data,y= l,x=(38,40,49,,51))
lreg($data,y= l,x=(38,41,49,,51))
!MED to DRINK
lreg($data,y= l,x= (38,43,49,,51))
lreg($data,y= l,x=(38,42,49,,51))
!MED to CONTRA
lreg($data,y= l,x=(38,44,49,,51))
lreg($data,y= l,x= (38,45,49,,51))
lreg($data,y= l,x=(38,46,49,,51))
lreg($data,y= l,x=(38,47,49,,51))
!FAMtoFAM
lreg($data,y= l,x= (39,40,49,,51))
lreg($data,y= l,x=(39,41,49,,51))
lreg($data,y= l,x=(40,41,49,,51))
!FAM to DRINK
lreg($data,y= l,x=(39,42,49,,51))
lreg($data,y= l,x=(40,42,49,,51))
lreg($data,y= l,x= (41,42,49,,51))
lreg($data,y= l,x=(39,43,49,,51))
lreg($data,y= l,x=(40,43,49,,51))
lreg($data,y= l,x=(41,43,49,,51))
!DRINK to CONTRA
lreg($data,y= l,x=(42,44,49,,51))
lreg($data,y= l,x=(43,44,49,,51))
lreg($data,y= l,x=(42,45,49,,51))
lreg($data,y= l,x=(43,45,49,,51))
lreg($data,y= l,x=(42,46,49,,51))
lreg($data,y= l,x=(43,46,49,,51))
lreg($data,y= l,x=(42,47,49,,51))
lreg($data,y= l,x=(43,47,49,,51))
!CONTRA to CONTRA
lreg($data,y= l,x=(44,45,49,,51))
lreg($data,y= l,x= (44,46,49,,51))
lreg($data,y= l,x=(44,47,49,,51))
lreg($data,y= l,x=(45,46,49,,51))
lreg($data,y= l,x= (45,47,49,,51))
lreg($data,y= l,x=(46,47,49,,51))
!NSP to AFI
lreg($data,y= l,x=(3,,5,7,8,49,,51))
!SEX to SMK
lreg($data,y= l,x=(3, ,5,9,49,,51))
lreg($data,y= l,x=(7,,9,49,,51))
!SEX to VD
lreg($data,y= l,x=(3, ,5,10,49,,51))
lreg($data,y= l,x= (7,8,10,49,,51))
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!SEX to SCHOOL
lreg($data,y= 1,x=(3,,5,12,13,49,,51))
lreg($data,y= 1,x=(3,,5,15, 16,49,,51))
lreg($data,y= 1,x=(7,8,12,13,49,,51))
lreg($data,y= 1,x=(7,8,15,16,49,,51))
!SEX to REPRO
lreg($data,y= 1,x=(3,,5,18,19,49,,51))
lreg($data,y= 1,x=(3,,5,20,49,,51))
lreg($data,y= 1,x=(3,,5,21,49,,51))
lreg($data,y= 1,x=(3,,5,23, ,26,49,,51))
lreg($data,y= 1,x=(3, ,5,28,,30,49, ,51))
lreg($data,y= 1,x=(7,8,18,19,49,,51))
lreg($data,y= 1,x=(7,8,20,49,,51))
lreg($data,y= 1,x=(7,8,21,19,49,,51))
lreg($data,y= 1,x=(7,8,23,,26,49,,51))
lreg($data,y= 1,x=(7,8,28,,30,49,,51))
!SEX to PAP
lreg($data,y= 1,x=(3,,5,32, ,34,49, ,51))
lreg($data,y= 1,x=(3,,5,36,37,49,,51))
lreg($data,y= 1,x=(7,8,32,,34,49,,51))
lreg($data,y= 1,x=(7,8,36,37,49,,51))
!SEX to MED
lreg($data,y= 1,x=(3,,5,38,49,,51))
lreg($data,y= 1,x=(7,8,38,49,,51))
!SEXtoFAM
lreg($data,y= 1,x=(3,,5,39,49,,51))
lreg($data,y= 1,x=(3,,5,40,49,,51))
lreg($data,y= 1,x=(3, ,5,41,49,,51))
lreg($data,y= 1,x=(7,8,39,49,,51))
lreg($data,y= 1,x=(7,8,40,49,,51))
lreg($data,y= 1,x=(7,8,41,49,,51))
!SEX to DRINK
lreg($data,y= 1,x=(3,,5,42,49,,51))
lreg($data,y= 1,x=(3,,5,43,49, ,51))
lreg($data,y= 1,x=(7,8,42,49,,51))
lreg($data,y= 1,x=(7,8,43,49,,51))
!SEX to CONTRA
lreg($data,y= 1,x=(3,,5,44,49,,51))
lreg($data,y= 1,x=(3,,5,45,49,,51))
lreg($data,y= 1,x=(3,,5,46,49,,51))
lreg($data,y= 1,x=(3,,5,47,49,,51))
lreg($data,y= 1,x=(7,8,44,49,,51))
lreg($data,y= 1,x=(7,8,45,49,,51))
lreg($qata,y= 1,x=(7,8,46,49,,51))
lreg($data,y= 1,x=(7,8,47,49, ,51))
!SMK to VD
lreg($data,y= 1,x=(9,10,49,,51))
!SMK to SCHOOL
lreg($data,y= 1,x=(9,12,13,49,,51))
lreg($data,y= 1,x=(9,15,16,49,,51))
!SMK to REPRO
lreg($data,y= 1,x=(9,18, 19,49,,51))
lreg($data,y= 1,x= (9,20,49,,51))
lreg($data,y= 1,x= (9,21,49,,51))
lreg($data,y= 1,x=(9,23, ,26,49,,51))
lreg($data,y= 1,x=(9,28,,30,49,,51))
!SMK to PAP
lreg($data,y= 1,x=(9,32,,34,49,,51))
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lreg($data,y= l,x=(9,36,37,49,,51))
!SMK to MED
lreg($data,y= l,x=(9,38,49,,51))
!SMKto FAM
lreg($data,y= l,x=(9,39,49,,51))
lreg($data,y= l,x= (9,40,49, ,51))
lreg($data,y= l,x=(9,41,49,,51))
!SMK to DRINK
lreg($data,y= l,x=(9,42,49,,51))
lreg($data,y= l,x=(9,43,49,,51))
!SMK to CONTRA
lreg($data,y= l,x=(9,44,49,,51))
lreg($data,y= l,x= (9,45,49,,51))
lreg($data,y= l,x=(9,46,49,,51))
lreg($data,y= l,x=(9,47,49,,51))
!VD to SCHOOL
lreg($data,y= l,x=(10,12,13,49, ,51))
lreg($data,y= l,x=(10,15,16,49,,51))
!SCHOOL to SCHOOL
lreg($data,y= l,x= (12, 13 ,15,16,49, ,51))
!SCHOOL to REPRO
lreg($data,y= l,x= (12,13,18"19,49,,51))
lreg($data,y= l,x= (12,13,20,49,,51))
lreg($data,y= l,x= (12, 13,21,49,,51))
lreg($data,y= l,x= (12,13,23, ,26,49,,51))
lreg($data,y= l,x=(12,13,28, ,30,49,,51))
lreg($data,y= l,x=(15,16,18,,19,49,,51))
lreg($data,y= l,x= (15,16,20,49, ,51))
lreg($data,y= l,x=(15,16,21,49, ,51))
lreg($data,y= l,x= (15,16,23,,26,49,,51))
lreg($data,y= l,x=(15,16,28,,30,49,,51))
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APPENDIX 6.
MODELLING ON IN-SITU CASES WITH COMMUNITY CONTROLS.
%nover
%out MODCOMM
!1. SEX
$tab41 := (0;1),(1;0)
$tab261 := (1;2;3;4),(0;1;2;3)
$tab271 : = (1;2;3;4),(0;0;1;2)
$tab311 : = (0;1;2;3),(0;1;2;3)
, !2.SMK
$gtab72 := (0;1;20;30),(0;19;29;80),(0;1;2;3)
!3. REPRO
$tab143 : = (1;2;3),(0;1;1)
$tab183 : = (1;2;3),(2;1;0)
!4. CONTRA
$tab114 := (0;1),(1;0)
!5. PILL
$tab65 : = (98;99),(0;0)
$gtab65 := (0;1;73),(0;72;260),(0;1;2)
!RECODE
!1. SEX
$case : = ree (insgen1[;4],t=$tab41)
$sexpart := ind(ree(insgen1[;26],t=$tab261»
$agesex : = ind(ree(insgen1[;27],t=$tab271»
$agrp := ind(ree(insgen1[;31],t=$tab311»
!2.SMK
$smoke := inssmk1[;5]
$Nocig : = ind(ree(inssmk1[;7],g=$gtab72»
!3. REPRO
$Induce : = rec(insrepr1[;14],t=$tab143)
$MonBf: = ind(rec(insrepr1[;18],t=$tab183»
!4. CONTRA
$safe := ree(inscon1[;11],t=$tab114)
!5.PILL
$length : = ree(inspill[;6,8,10,12,14,16,18,20,22,24],t=$tab65)
$length : = sum.row(inspill[;6,8,10,12,14,16,18,20,22,24])
$length : = ind(ree($length,g=$gtab65»
!INTERACTION
$nspsmk : = $sexpart*$smoke
$afismk : = $agesex*$smoke
$pilsmk := $length*$smoke
!DATA
$data := $case,$sexpart,$agesex,$smoke,$nocig,$induce
$data : = $data,$safe,$length,$nspsmk,$afismk,$pilsmk,$agrp
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!LABEL
$dnam : = "Case"; "O-lsp"; "2-3sp"; "4-6sp";" > =7sp"
$dnam : = $dnam;" > =20 afi"; "16-19fi";" < 16fi"
$dnam:= $dnam; "Smoker"; "Nosmk";"1-20";"21-30"; ">30"
$dnam : = $dnam;"induce+"; "Safe-"; "Neverused"; " < = 72Mo"; " > 72Mo"
$dnam : = $dnam;"smknspO-l ";"smknsp2-3"; "smknsp4-6"; "smknsp > 7"
$dnam : = $dnam; "smkafi> 20"; "smkafiI6-19"; "smkafi < 16"
$dnam:= $dnam;"smkOC-";"smk<72mo";"smk>72mo"
$dnam:= $dnam;" < 30 agrp";"30-39 agrp";"40-49 agrp";" > =50 agrp"
%label $data $dnam
lreg($data,y= l,x=(3,,5,7,8,9,11"13,14,15,17,18,20, ,22,24,25,27,28,30,,32))
lreg($data,y= l,x= (3 ,,5,7,8,9,11,;13,14,15,17,18,30, ,32))
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APPENDIX 7. MODELLING ON IN-SITU CASES WITH HOSPITAL CONTROLS.
%nover
%out MODHOSP
!1. SEX
$tab31 := (0;1;2;3),(1;0;0;0)
$tab231 : = (0;1;2;3;4;5;6;7;8;9),(0;0;1;2;3;2;2;3;3;3)
$gtab241 := (0;1;2;3;4;10;16;20;25;99),(0;1;2;3;4;15;19;24;59;99),(0;0;0;1;1;1;1;0;0;1)
$tab291 := (0;1;2;3),(3;2;1;0)
!2. SMK
$tab32:= (0;1;2),(0;1;1)
$tab42 := (0;1;2;3;4;5),(0;1;1;2;2;2)
14. SCHOOL
$tab174:= (1;2;3;9),(0;1;2;0)
$gtab184 :=
(0; 1;2;3;4;10;13;77;79;98;99),(0;1;2;3;9;12;40;77;79;98;99),(0;0;1;2;0; 1;2;0;0;0;0)
!5. REPRO
$tabl25 : = (0;1;2;3;8),(0;0;1;1;1)
!9.MED
$tab239 := (0;1;8),(0;1;0)
!12. CONTRA
$tab412:= (0;1;9),(0;1;0)
113. LENGTH
$tab613 := (98;99),(0;0)
$gtab613 : = (0;1;73),(0;72;495),(0;1;2)
lRECODE
I1.SEX
$ease:= ree (genish[;3],t=$tab31)
$sexpart : = ind(rec(genish[;23],t=$tab231»
$agesex : = (rec(genish[;24],g=$gtab241»
$agrp : = ind(rec(genish[;29],t=$tab291»
!2.SMK
$Smkstat : = rec(smkish[;3],t=$tab32)
$amount : = ind(rec(smkish[;4],t=$tab42»
!4.SCHOOL
$yearseh:= ind(rec(genish[;17],t=$tab174»
$husbseh: = ind(rec(genish[;18],g=$gtab184»
!5.REPRO
$Induee : = rec(reproish[;12],t=$tab125)
!9.MED
$diseharg : = rec(histish[;23],t=$tab239)
!11.DRINK
Swine : = genish[;6]
$spirit : = genish[;7]
!12.CONTRA
$oe : = ree(eontrish[;4],t=$tab412)
$eondom : = eontrish[;11]
!13.LENGTH
$length : = rec(pillish[;5,7,9,11,13,15,17,19,21,23],t=$tab613)
$length:= sum.row(pillish[;5,7,9,11,13,15,17,19,21,23])
$length : = ind(rec($length,g=$gtab613»
!INTERACTION
$nspsmk := $sexpart*$smkstat
$afismk := $agesex*$smkstat
$ssehsmk : = $yearseh*$smkstat
$hsehsmk : = $husbseh*$smkstat
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$winesmk := $wine*$smkstat
$spismk := $spirit*$smkstat
$ocsmk := $oc*$smkstat
$condosmk := $condom*$smkstat
!DATA
$data := $case,$sexpart,$agesex,$SMKSTAT,$amount
$data := $data,$yearsch,$husbsch,$induce
$data := $data,$discharg
$data := $data,$wine,$spirit,$oc,$condom
$data := $data,$length
$data : = $data,$nspsmk,$afismk,$sschsmk,$hschsmk,$winesmk
$data : = $data,$spismk,$ocsmk,$condosmk,$agrp
!LABEL
$dnam : = "C~e"; "0-1sp"; "2-3sp"; "4-6sp";" > =7sp";" <20fi"
$dnam : = $dnam; "Ever smoke"
$dnam:= $dnam;"0";"1-20";" >20"
$dnam:= $dnam;" < 10"; "10-12self"; "self> =13";"Husb < =10";"10-12husb";"Husb> 12"
$dnam : = $dnam; "Induce+"
$dnam : = $dnam; "Discharge"
$dnam : = $dnam; "Wine+"; "Spirit+"
$dnam : = $dnam;"QC+"; "Condom+"
$dnam:= $dnam;"Never";" < =72Mo";">72 Mo"
$dnam:= $dnam;"smkO-1 "; "smk2-3"; "smk4-6"; "smk>7"
$dnam : = $dnam;"smk < 20fi"
$dnam:= $dnam;"smks< 10"; "smks"10-12"; "smks> 12"
$dnam : = $dnam; "smkh< 10";"smkh"10-12"; "smkh> 12"
$dnam : = $dnam; "smkwine"; "smkspi"; "smkoc";"smkcond"
$dnam : = $dnam;" > =50 agrp"; "40-49 agrp"; "30-39";" < =29 agrp"
%label $data $dnam
lreg($data,y= 1,x=(3"7,9,10,12,13,15,16,17,,22,24,25,42, ,44»
lreg($data,y= 1,x=(3,,7,9,10,12,13,15,16,17,,22,24,25,27, ,30,32,33 ,35, ,40,42, ,44»
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APPENDIX 8.
MODELLING ON INVASIVE WITH HOSPITAL CONTROLS.
%nover
%outMODINV
!1. SEX
$tab31 := (0;1;2;3),(1;0;0;0)
$tab231 : = (0;1;2;3;4;5;6;7;8;9),(0;0;1;1;1;1;1;1;1;1)
$gtab241 : = (0;1;2;3 ;4;10;16;20;25;99),(0;1;2;3;4;15;19;24;55;99),(0;0;0;1;1;1;1;0;0;1)
$tab291 := (0;1;2;3),(3;2;1;0)
!2.SMK
$tab32 := (0;1;2),(0;1;1)
$tab42 : = (0;1;2;3;4;5),(0;1;1;2;2;2)
!3. MARIT
!4. REPRO
$tab54 := (0;1;3),(0;1;1)
$gtab64 := (0;13;20;25;60),(0; 19;24;43;60),(0;1;0;0;0)
$gtab74 : = (0;15;20;25;91;97),(0;19;24;37;91;97),(0;1;0;0;0;0)
$tab144 : = (0;1;2;3;4;5;6;7;8;9;10;12;13;16),(0;0;0;1;2;2;2;2;2;2;2;2;2;2)
!5. WORK
$tab195 := (1;2;3;4;5;6;7;9;22;87;88;86),(0;1;1;1;2;2;2;2;1;2;0;2)
!8. DRINK
lRECODE
l1.SEX
$case:= ree (geniv[;3],t=$tab31)
$sexpart := (ree(geniv[;23],t=$tab231))
$agesex : = (ree(geniv[;24],g=$gtab241))
$agrp : = ind(ree(geniv[;29],t=$tab291))
!2.SMK
$Smkstat : = ree(smkiv[;3],t=$tab32)
$amount : = ind(ree(smkiv[;4],t=$tab42))
!3.MARIT
$marit : = ind(geniv[;15])
14.REPRO
$Pregnan : = ree(reproiv[;5],t=$tab54)
$AgeFpreg := (ree(reproiv[;6],g=$gtab64))
$Agelivbir : = (ree(reproiv[;7],g=$gtab74))
$totpreg : = ind(ree(reproiv[;14],t=$tabI44))
!5.WORK
$work : = ind(ree(geniv[;19],t=$tabI95))
!8.DRINK
$beer := geniv[;5]
!INTERACTION
$nspsmk : = $sexpart*$smkstat
$afismk : = $agesex*$smkstat
$worksmk : = $work*$smkstat
$beersmk : = $beer*$smkstat
!DATA
$data := $case,$sexpart,$agesex,$smkstat,$amount,$marit
$data : = $DATA,$pregnan,$agefpreg,$agelivbir
$data : = $data,$totpreg,$work
$data : = $data,$beer,$nspsmk,$afismk,$worksmk,$beersmk,$agrp
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!LABEL
$dnam : = "Case";" > = 2sp"; " < 20afi"
$dnam: = $dnam;"Ever smoke";"O";" < =20";" > =21"
$dnam : = $dnam; "Never married"; "Marit"; "Divorce"; "Widow"
$dnam : = $dnam; "Ever preg";" <20age1prg"
$dnam : = $dnam;" < 20 livbirt"
$dnam : = $dnam; "0-2preg"; "3 preg";" > =4preg"
$dnam : = $dnam; "Housewife/Unjob"; "Unskilled"; "Skilled"
$dnam : = $dnam; "beer+ "
$dnam : = $dnam;"smk> =2sp"; "smk< 20fi"; "smkwife";"smkunski"; "smkski"; "smkbeer"
!$dnam: = $dnam;" < = 29 agrp";"30-39 agrp";"40-49 agrp";" > =50 agrp"
$dnam : = $dnam;" > =50agrp"; "40-49agrp"; "30-39agrp";" < =29agrp"
%label $data $dnam
lreg($data,y= 1,x=(2,,4,9,,11,12,13,14,16,17,19,20,21,29,,31))
lreg($data,y= 1,x=(2,,4,9, ,11,12,13,14,16,17,19,20,21,22,23,25, ,27,29,,31))
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APPENDIX 9.
POLYTOMOUS REGRESSION PROGRAM.
%nover
%out plreg
%com
$tab3 := (0;;9),(0;0;1;2;3;2;2;3;3;3;3)
$gtab4:= (0;1;2;3;4;10;16;20;25;99),(0;1;2;3;4;15;19;24;55;99),(0;0;1;2;3;3;2;1;3)
$tab5 := (8,1)
$tab6 : = (2;3;6),(1; 1;1)
$tab7 := (9,1)
$tab9 : = (2,1)
$gtab10 := (0;1;2;3;4;5;7;11;21;31),(0;1;2;3;4;5;10;20;30;40),(0;1;2;3;4;4;1;2;3;4)
$case := plreg[;2]
$nsp := ind(rec(plreg[;3],t=$tab3»
$afi : = ind(rec(plreg[;4],g=$gtab4»
$disch : = rec(plreg[;5],t=$tab5)
$preg : = rec(plreg[;6],t=$tab6)
$oc : = rec(plreg[;7],t=$tab7)
$safe : = plreg[;8]
$smkstat : = rec(plreg[;9],t=$tab9)
$amount : = ind(rec(plreg[;10],g=$gtablO»
$agrp : = ind(plreg[;11])
$data : = $case,$nsp,$afi,$disch,$preg,$oc,$safe,$smkstat,$amount,$agrp
$dnam : = "Case"; "O-lnsp"; "2-3nsp"; "4-6nsp";" > =7nsp"
$dnam : = $dnam;" > 24afi"; "20-24afi"; "16-19afi"; " < 16afi"
$dnam : = $dnam; "disch+ If; "preg+"; "oc+"; "safe+ "; "smk+"
$dnam := $dnam; "Ocig";"1-10cig";"11-20cig"; "21-30cig";" > 30cig"
$dnam:= $dnam;" <30agrp"; "30-39agrp";"40-49agrp";" > =50agrp"
%label $data $dnam
!desc($data)
!lreg($data,y= 1,suc= 1,fail=3,x=(3, ,5,7"9,10,,13,16, ,19,21,,23»
!lreg($data,y= 1,suc=0,fail=3,x=(3,,5,7"9,10,,13,16, ,19,21,,23»
!lreg($data,y= 1,suc=1,fail=2,x=(3,,5,7,,9,10,,13,16, ,19,21,,23»
$data:= $data[;1,,5,10"13],sum.row($data[;17"19]),sum.row($data[;22,23])
$dnam : = $dnam[1,,5,10"13]; "smok> 10/day"; "age 40+"
%label $data $dnam
!lreg($data,y= 1,suc= 1,fail=3,x=(3,,11»
!lreg($data,y=1,suc=O,fail=3,x=(3" 11»
!lreg($data,y= 1,suc=1,fail=2,x=(3"11»
!plreg($data,y= 1,omit=1,x=(3" 11»
$d:= $data
$g := $d[;l] + 10*(sum.row($d[;2,,11]*(1,2,4,8,16,32,64,128,256,512»)
$data : = $d,$g
$d : = condense($data,y= 12,x=(1,,11),t=2,d= 1)
$d : = $d[2,,(rdim($d)-1)]
plreg($d,y=2,x= (4"12),w= 13)
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